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Abstract 
Human thin filament myopathies are a group of skeletal muscle diseases caused by 
mutations in thin filament protein genes. Over 170 mutations within the human skeletal 
Cl-actin gene, ACTA], cause congenital actin myopathies (CAM). These are dominant, 
often lethal mutations resulting in death at birth or shortly after. Several mutations have 
been identified in the genes encoding for Troponin I and Troponin T proteins, which 
cause arthrogryposis. The aim of this work was to see if the Drosophila Indirect Flight 
Muscles can be used as a genetic model system, with which to study the ACTA] and 
arthrogryposis disorders and understand their aetiology. 
Six different mutations in the Drosophila Act88F gene, GI5R, I136M, DI54N, VI63L, 
VI63M and D292V, homologous to the human CAM actin mutations were 
transgenically expressed in Drosophila Indirect Flight Muscles (lFM) as wild type 
heterozygotes. All the mutants were dominant and with some myofibrillar defects 
similar to those seen in humans. Certain mutations resulted in intranuclear rods, similar 
to those found in humans and split Z-discs. The mutations varied in severity and 
matched that of the human mutations. An extra copy of wild type actin rescued the 
phenotype of all the heterozygote mutants, suggesting that upregulation of expression of 
the wild type actin gene might be a future prospect for therapy. 
Atypically, flies heterozygous for the R372H Act88F mutation complete normal IFM 
myogenesis and young flies can fly, but later become flightless and by day 7 show the 
Drosophila equivalent of the human nemaline phenotype. Electron microscopy revealed 
progressive loss of muscle structure. From the ultrastructure, the phenotypic 
requirement for muscle usage and the known u-actinin binding sites on the actin 
monomer, the R372H mutation is proposed to reduce the strength of F-actin/u-actinin 
binding, leading to muscle damage during use and breakdown of muscle structure. 
Binding studies confirmed a I3-fold reduction in u-actinin binding for R372H actin. 
The GAL4/UAS system was employed for the study of arthrogryposis mutations. The 
wild-type TnT and TnI IFM isoforms were transgenically expressed to rescue the TnT 
and TnI IFM nulls, respectively. Only the TnI null was rescued. The TnI arthrogryposis 
mutants were transgenically expressed and resulted in hypercontracted muscles. 
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1. Introduction 
Chapter 1: Introduction 
1.1 Muscle disease 
Over the past decade, there has been an increase in awareness of the mechanisms of 
cardiac and skeletal muscle diseases. Mutations in a large number of protein 
components of the sarcomere, the functional unit of skeletal and cardiac muscle, have 
been discovered to cause a range of muscle disorders (reviewed in Laing and Nowak, 
2005; Tajsharghi, 2008). Since the early 1990s, mutations in genes coding for skeletal 
muscle thin filament proteins have been identified that are associated with various 
clinical symptoms and result in specific structural changes within the sarcomere (Sung 
et al., 2003; Goebel, 2007; Laing et al., 2009). Many thin filament diseases present 
themselves at birth (congenital myopathies), hence it is not possible to follow the 
development of the disease. Currently our understanding regarding the pathobiology of 
the gene defects remains limited, despite some of these proteins being studied for 
decades. A greater understanding of how the presence of the mutated proteins in the 
patient's muscle is leading to weakness and disease is needed. 
1.1.1 Thin filament myopathies 
1.1.1.1 ACTA1 congenital myopathies 
Actin forms the core of the thin filament of the sarcomere where it interacts with a 
plethora of proteins and produces the force for muscle contraction (Craig and Padron, 
2004). Six actin isoforms exist in humans, which show 90 % similarity at the amino 
acid level (Sheterline et al., 1998). Cardiac a-actin (ACTCl) is the principal actin 
isoform expressed in skeletal muscle during gestation (Ilkovski et al., 2005). By 25-27 
weeks pre-parturition skeletal muscle a-actin (ACTAl) becomes the dominant and 
permanent isoform in human adult muscle (Ilkovski et al., 2005). 
By 2009, more than 170 different mutations in the human ACTAl gene have been 
reported that cause congenital myopathies (reviewed in Laing et al., 2009). These are a 
group of skeletal muscle disorders characterized by generalized muscle weakness 
(Sparrow et al., 2003). They are often clinically severe with most patients dying at birth 
or shortly after (Romero and Fardeau, 1996). Most are dominant de novo mutations 
(Laing et al., 2009). The prevalence of ACTAl congenital myopathies is 1 in 500,000 
live births (Wallgren-Pettersson, 1990; North et 01.,2008). 
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Clinicians have divided the ACTA1 disorders into six subtypes depending on the age of 
the disease onset and severity: adult onset, mild, typical, intermediate, severe and other 
forms (Wallgren-Pettersson, 1999). The severe subtype is presented at birth or even in 
utero, where patients show no spontaneous movement and require mechanical 
ventilation (Lammens et aI., 1997). These patients typically do not survive more than a 
few weeks. Survival to birth may be because the predominant actin isoform of foetal 
skeletal muscle is cardiac actin. 
Five distinct overlapping (Jungbluth et al., 2001; Schroder et al., 2004) pathological 
phenotypes are caused by mutations in the ACTA1 gene in humans (Figure 1.1): (a) 
actin filament aggregate myopathy, (b) intranuclear rod myopathy, (c) nemaline 
myopathy (Nowak et al., 1999; Sparrow et al., 2003), (d) congenital fibre type 
disproportion and (e) myopathy with core-like areas. Appearance of any of these 
features in a muscle biopsy is an indicator of an ACTA1 mutation. Other common 
pathological features are fiber atrophy and/or hypotrophy. 
Of the five histopathologies, nemaline rod myopathy is the most common phenotype 
(Figure 1.1 C). The ~erm nemaline was applied because of the thread-like appearance of 
the rods (nema means thread in Greek) (Shy et al., 1963; Wallgren-Petterson, 1999, 
North et al., 2007). NM is genetically heterogeneous, with disease-causing mutations 
identified in different genes coding the thin filament proteins a-skeletal actin (ACTAl) 
(Jungbluth et al., 2001; Nowak et al., 1999), a-tropomyosin (TM3) (Durling et al., 
2002; Laing et al., 1995; Tan et al., 1999; Wattanasirichaigoon et al., 2002), ~­
tropomyosin (TM2) (Donner et al., 2002). Troponin-T (TNNT1) (Johnston et al., 2000) 
and nebulin (NEB) (Pelin et al., 1999; Sewry et al., 2001). ACTA1 mutations cause 
20 % to 30 % of all known NM cases after mutations in nebulin, which make it the 
second most common cause ofNM (Laing et al., 2009). ACTA1 mutations causing NM 
are mostly severe with early death (Agrawal et al., 2004; Wallgren-Petterson et al., 
2004). 
Clinicians diagnose human nemaline myopathy by muscle biopsies and Gomori 
trichrome staining (Engel and Cunningham 1963; Nienhuis et al., 1967), which 
contrasts the dark blue nemaline rods against the pale blue fibres. The nemaline rods are 
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also visible in electron micrographs as electron dense bodies (Figure 1.1 C). Nemaline 
rods show the same appearance independent of age or severity (Shimomura and 
Nonaka, 1989) and the phenotype is already apparent at birth in most patients. Patients 
diagnosed with NM can present muscle weakness before nemaline rods are visible 
(Tajsharghi et al., 2007; North et aI, 1999). This suggests that the nemaline rods may be 
a secondary symptom of the disease and not be directly responsible for the skeletal 
muscle weakness (Michele and Metzger, 2000). Another symptom is signs of type I 
muscle fibre atrophy. The decrease in size could also suggest an abortive regenerative 
response (Sanoudou et al., 2003). Each cell is unable to produce the same absolute force 
as a wild-type one resulting in an abortive partly muscle weakness in NM. 
The less frequent intranuclear rod myopathy (lR) is characterized by filamentous actin 
rod inclusions in the fibre nuclei (Figure 1.1 D) and is often associated with a severe 
clinical phenotype (Hutchinson et al., 2006; Kaimaktchiev et al., 2006). Mutations that 
cause intranuclear rod myopathy have been identified on 12 amino acid residues, 
leading to 13 ACTAl changes. Eight of these residues cluster between residues 139-165, 
possibly a hot spot for this disorder (Laing et al., 2009). 
The also infrequent actin filament aggregate myopathy (AM) is characterized by large 
accumulations of filamentous actin in the muscle fibres (Figure 1.1 A, B) and is often 
associated with severe disease. Ten different mutations have been identified that cause 
AM. A hot spot for mutations associated with this disorder has been identified between 
residues 144 and 165. All known mutations associated with actin filament aggregate 
myopathy and intranuclear rod myopathy have implicated ACTAl (Nowak et al., 1999; 
Sparrow et al., 2003; Laing and Nowak, 2005; Hutchinson et al., 2006). 
Congenital fibre type disproportion (CFTD) is characterized by an early onset, 
nonprogressive muscle weakness caused where the type 1 muscle fibres are at least 
12 % smaller compared to the type 2 fibres (Figure 1.1 E) (Laing et al., 2004). Eight 
mutations in the ACTA 1 gene have been identified that cause CFTD and cluster on one 
area on the actin monomer, suggesting the involvement with a specific actin interaction 
partner (Laing et aI., 2009). Mutations in TPM3 and selenoprotein NI have been 
identified to also cause CFTD (Clarke et al., 2006). 
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Figure 1.1. Microscopic images of the different histopathologies caused by the 
ACTAl mutations. (A) Actin filament aggregate myopathy (AM), light microscopy of 
transverse muscle section (Gomori trichrome stain), accumulated actin filaments are 
stained darker than the pale blue myofibrils (arrow). (B) Electron microscopy (EM) of 
AM, accumulation of filamentous actin inclusions within areas devoid of sarcomeres 
(arrows, enlarged in inset). (C) EM of nemaline myopathy, accumulations of nemaline 
bodies in the sarcoplasm (arrow). (D) EM of intranuclear rod myopathy, an actin rod 
within the muscle nucleus. (E) Congenital fiber type disproportion, light microscopy 
showing small (pale) type 1 and larger (dark) type 2 muscle fibers, respectively. (F) 
Core myopathy, light microscopy of core-like areas (arrow) (reduced nicotinamide 
adenine dinucleotide staining). Images reproduced from Sparrow et al., 2003 and Laing 
et al., 2009. 
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Two mutations in ACTA] are known to cause myopathy with core-like areas identified 
by myofibril disruption and absence of mitochondria (Figure 1.1 F) (Kaindl et al., 
2004). One patient has presented both nemaline myopathy and myopathy with core-like 
areas (Jungbluth et al., 2001). 
The congenital ACTA] mutations are distributed throughout all six coding exons of the 
gene. The number of mutations reported in each exon correlates to the size of each 
exon, though no particular hotspots have been identified. Most ACTA1 cases are de 
novo, isolated cases caused by dominant missense mutations although 17 recessive 
cases have been reported (Sparrow et al., 2003; Nowak et al., 2007; Laing et al., 2009). 
Recessive ACTA1 mutations are mostly nonsense, frameshift or splice-site mutations 
that are predicted to prematurely tenninate translation, or cause omission of entire exons 
from the mRNA. These result in a lack of skeletal a-actin protein. Patients carrying 
these mutations survive by upregulating their cardiac ACTC] gene (Sparrow et al., 
2003; Agrawal et al., 2004; Nowak. et aI., 2007). Four missense mutations are 
associated with recessive disease (H73D, L94P, E259V, M299K) and have been 
hypothesized to be functional null mutations (Sparrow et al., 2003), two of which (L94P 
and E259V) have been demonstrated in transfected fibroblast cultures to be so (Costa et 
al., 2004). All patients with recessive ACTA1 disease therefore lack functional skeletal 
muscle a-actin. The heterozygous carriers for a nonsense mutation (parents or siblings 
of patients with recessive mutations) do not display any disease symptoms suggesting 
that a single wild type actin copy is sufficient for nonnal muscle development, function 
and subsequent maintenance throughout life (Sparrow et al., 2003). 
As the recessive ACTA] mutations produce null alleles, the dominancy of the non-
recessive mutations must not be due to insufficient wild type actin levels but caused by 
the interference with wild type actin function. That is, the mutant actin monomer 
interacts with the wild-type actin, incorporates into polymerized filamentous actin and 
interferes with the function, assembly, and stability of the thin filaments. As actin has 
numerous interacting partners the dominant ACTA] mutations may disrupt any of the 
skeletal muscle a-actin nonnal functions. Hitherto, the experimental evidence shows 
that different monomer or polymer actin properties are affected by the different 
dominant ACTA] mutations (Hennessey et al., 1992). However, no apparent 
correlations between the functions affected, the location of the mutations within known 
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actin-binding sites to other proteins or actin itself and the five histopathological 
phenotypes have as yet been found (reviewed by Sparrow et al., 2003; Feng and 
Marston 2009). 
1.1.1.2 Arthrogryposis 
Arthrogryposes are a group of complex, rare human congenital disorders characterized 
by permanent non-progressive joint contractures Goint fixation caused by atrophy and 
shortening of muscle fibres or loss of normal elasticity of skin) that affect limb function 
(Figure 1.2) (Bamshad et al. , 1996a;b). The precise course of the distal arthrogryposes 
(DA) malformations is unclear. It has been proposed that decreased fetal movement 
may lead to contractures at birth via the accumulation of additional connective tissue 
around the joints (Hall, 1997). The reduced movement could be due to muscular or 
neuronal disorders, connective tissue abnormalities or problems within the uterus (Hall 
et al., 1982; Hall, 1997; Gordon, 1998). 
Figure 1.2. Typical malformations observed at the distal ends in patients with 
DA2B. (A) Hands showing camptodactyly and ulnar deviation. (B) Feet characterized 
by camptodactyly. Images reproduced from Sung et aI, 2003. 
Two types of arthrogryposis have been identified which are caused by mutations in thin 
filament proteins. These are Distal arthrogryposis type 1 (DA 1) and Distal 
arthrogryposis type 2B (DA2B, also called DA2A) (Bamshad et al. 1996a;b). The first 
is caused by mutations in the tropomyosin gene (TPM2) and the latter by mutations in 
the skeletal troponin I (TNNI2) and troponin T (TNNT3) genes that are specific to fast-
twitch myofibres (Sung et al. 2003). Unlike NM, DA is not accompanied by muscle 
wasting (Bealls, 2005). Consequently, the thin filament protein mutation-induced 
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muscle weakness stems from other phenomena likely associated with altered regulation 
of muscle contraction. 
1.2 Model organisms of human muscle disease 
Currently there are no known therapeutic treatments to alleviate or cure the symptoms 
of ACTA] associated congenital myopathies or arthrogryposis. Several experimental 
model systems for ACTA] associated congenital myopathies exist where the majority of 
22 different congenital myopathy mutant ACTA] genes have been expressed in vitro, or 
examined in cultured fibroblasts, myocytes and myotubes. These showed a variety of 
defects, including the inability of the actin to fold (two mutants), or formation of 
aggregates in vivo (Costa et al., 2004; Domazetovska et al., 2007a;b; Ilkovski et al., 
2004). Although these studies have been able to reproduce the sarcoplasmic and nuclear 
actin aggregations they have not furthered our understanding as to how these 
phenotypes form or how the ACTA] associated congenital myopathies are caused. Four 
arthrogryposis mutants have been studied in ATPase assays or tropomyosin binding 
assays (Wang et al., 2005; Robinson et al., 2006). These studies have not been able to 
offer an explanation for the disease. The use of a solely in vitro or in vivo approach to 
study thin filament mutations does not offer a complete understanding of the 
mechanism for these diseases. However, studying a mutation in the context of the whole 
organism may help to better understand how it leads to disease. 
In the age of genomics, the genetic sequences of entire organisms are now available. 
However, knowing the sequence of genes causing human disease reveals little about 
their normal function. Legal and ethical arguments justify the experimentation on other 
organisms in order to investigate both normal and abnormal functions, and to improve 
the duration and quality of life of people. The human muscle is inaccessible during 
foetal development, which argues the case for experimentation on other organisms. The 
European Union has funded MYORES, a large research network on 'Multi-organismic 
approaches to muscle development and disease' to research human muscle disease. 
Model organisms currently being used to study these diseases include mice, the 
zebrafish Danio rerio the nematode Caenorhabditis elegans and the fruit fly Drosophila 
melanogaster. The literature demonstrates the importance of these model genetic 
organisms in the study of human skeletal myopathies as their use has increased in the 
last 20 years (reviewed in Bedell et aI., 1997; Sparrow et al., 2008). 
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1.2.1 Model genetic organisms - mice, zebrafish, nematodes 
Human skeletal myopathies have been studied in mice, zebrafish and nematode animal 
models. The reasoning for using these model organisms to study human skeletal 
myopathies is because they contain striated muscle groups conserved to humans 
(reviewed in Bedell et al., 1997; Lecroisey et al., 2007, Sparrow et al., 2008). The 
genome sequences of these organisms are known and have been catalogued in the 
Mouse Genome Database (http://informatics.jax.org/), the Zebrafish Information 
Service (http://Zfin.org/) and Wormbase (http://www.wormbase.org/). These databases 
facilitate the search for human disease gene homologues in these organisms and allow 
the comparison of sequences and selection of specific sequence changes for the ready 
creation of transgenic human disease animals. Information on the organisms' biology, 
genetics, transgenic stock collections and bibliography are also available in these 
databases. 
A valuable genetic model organism of a human disease should be able to offer: cheap 
maintenance and grow in large numbers; have fast generation times; an annotated 
genome sequence; a well understood biology and genetics; information shared 
resources; transgenesis tools and contain the genes of interest to a high sequence 
identity to its human counterparts. Ideally a perfect genetic model organism would 
cover all these points but this is not possible. Though each organism has its own 
advantages and limitations as models for human muscle diseases. 
Mice have generally been the animal of choice for studying human disease as they are 
more homologous anatomically and physiologically to humans than zebrafish or 
invertebrates. Most murine genes have functional counterparts in humans. Mutations 
that cause diseases in humans often cause similar diseases in mice. Compared to most 
mammals, mice are easy to maintain and have a short breeding cycle (-2 months). Well 
known genetics and transgenesis systems are available in mice for the creation of 
disease models (reviewed in Bedell et al., 1997a). 
Zebrafish has emerged as human disease model due to its high similarity in the 
developmental gene pathways and regulatory mechanisms to humans. Its organs are 
more homologous to those of humans than invertebrates and myogenesis proceeds in 
waves similar to those in mammals (Barbazuk et al., 2000; Postlethwait et al., 2000; Liu 
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et al., 2002; Lieschke and Currie, 2007). Although the facilities required for culturing 
fish are more costly to maintain than for invertebrate models, sperm can be stored 
frozen which allows many different mutations and transgenic lines to be kept for long 
periods at low cost. Further advantages include good transgenesis tools, external 
fertilisation, which facilitates genetic and cellular manipulation, rapid development, a 3 
month generation time (Kimmel et al., 1989), high fecundity and the embryos are 
transparent, which allows muscle defects to be easily identified using microscopy. 
Although the nematode physiology is very distant from that of humans, sequencing of 
the C. elegans genome (c. elegans Sequencing Consortium, 1998) revealed that more 
than 50 % of human genes have homologues in the nematode. Growing nematodes is 
easy and cheap on Escherichia coli spread Petri plates. As the female worm is a self-
fertilizing hermaphrodite, homozygotes are readily produced without the need to mate. 
Genetic crosses are easily made and different mutant lines can be stored by freezing. 
Worms can be grown in large numbers, which allows the recovery of primary mutations 
and screening for secondary mutations in other genes that either reduce the severity of 
the primary mutation or enhance it. The body wall muscles have been the target of most 
genetic studies (Wood, 1988). These muscles are prominent and as the organism is 
small and translucent they can be readily visualized by microscopy of the whole 
organIsm. 
The ability to manipulate the genetics of these organisms has founded their potential in 
understanding muscle development and human muscle disease mutations. Point 
mutations in these organisms can be introduced by irradiation or feeding with chemical 
mutagens (ENU mutagen) (Russell et al., 1979; Wood, 1988; McArdle et aI., 1998; 
Paton et al., 2001). Transgenesis methods are available for introducing foreign DNA 
with homologues of human disease genes in nematodes (reviewed in Rieckher et al., 
2009) zebrafish (Raz et al., 1998; Weinberg, 1998) and mice (Hogan et al., 1994) by 
embryo microinjection. Retroviral systems can be employed for insertional mutagenesis 
in zebrafish (Gaiano et al., 1996; Amsterdam et al., 1999; GolIing et al., 2002; 
Sivasubbu et al., 2007). Some human skeletal myopathies are caused due to the lack of 
protein synthesis. Gene knockouts in mice are achieved using the Cre/ LoxP site-specific 
recombination system (Chambers, 1994) and in nematodes using RNA interference 
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(RNAi) (http://www.wormbook.org/). In zebrafish, morpholino anti sense RNA 
oligonucleotides are used to block mRNA transcription (Nasevicius and Ekker, 2000). 
1.2.1.1 Model organism studies of human muscular disease 
Use of these animals has allowed the generation of several models of human skeletal 
muscle diseases to be studied. The most extensively studied skeletal myopathy among 
mice, zebrafish and nematodes is Duchenne Muscular Dystrophy (reviewed in Sparrow 
et al., 2008), a disease caused by mutations in the human dystrophin gene resulting in 
progressive muscle degeneration and death. Several dystrophin mutants exist in 
zebrafish that result in lack of the protein (Hoffman et al., 1987 Guyon et al., 2007; 
Kunkel et al., 2006). A zebrafish dystrophy model reveals that that dystrophin is 
required for the formation of stable muscle attachments (Bassett et al., 2003; Guyon et 
al., 2007). 
Mutations inactivating the C. elegans dys-l gene alone cause only mild muscle 
degeneration (Bessou et al., 1998; Gieseler et aI., 1999). However, when the dys-l 
mutation is combined with another mutation, hlh-l (MyoD homologue) (Chen et al., 
1994), it results in a progressive muscular dystrophy (Gieseler et al., 2000). C. elegans 
screens have identified the molecules serotonin and prednisone as possible drugs to 
alleviate the symptoms of dystrophin mutations (Bessou et al., 1998; Gaud et al., 2004; 
Carre-Pierrat et al., 2006). 
In mice the Dmdmdx model that results in loss of dystrophin has been used extensively to 
study the disease but it presents only a mild phenotype possibly due to muscle 
regeneration effects (Collins et al., 2003). 
1.2.1.2 Limitations 
These model genetic organisms are not perfect. The generation of transgenic mice is 
time consuming and expensive compared to nematodes and zebrafish. It is also 
nontrivial to misexpress transgenes in regulated, temporal and tissue specific manners 
(Bedell et al., 1997a; b). As mammals, mice develop in utero, which makes the study of 
muscle diseases that manifest during early stages of development difficult. 
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When working with a model system for human muscle disease one problem is that the 
animal is unlikely to recapitulate the human disease well enough. In contrast to 
mammals and zebrafish, the nematode muscle lacks both an adaptive immune response 
and regenerative capacity in response to dysfunction. This is a disadvantage, as the 
model system cannot fully mimic a muscle disease. However, this can also be an 
advantage as it allows investigation of the molecular mechanisms of the disease without 
complications from immune or repair responses. 
While zebrafish muscle shares closer homologies to humans than nematodes, processing 
and screening large numbers of animals for muscle mutations and for chemicals that 
suppress a disease phenotype is slow and labour intensive. As RNAi approaches are not 
yet possible in zebrafish, the effects of gene knockdowns cannot be examined across the 
whole transcriptome. Furthennore, the zebrafish genome underwent a duplication event 
after the mammalian and fish lineages diverged (Amores et al., 1998; Postlethwait et 
al., 1998). Hence, there is polyploidy for specific genes, making the study of a 
particular gene in zebrafish more complicated compared to invertebrates, where 
occasions nematodes and flies often possess a single gene isofonn of a human disease 
homologue in a tissue or in the whole organism. The single dystrophin genes present in 
nematodes and flies (Roberts and Bobrow, 1998; Greener and Roberts, 2000; Grisoni et 
al., 2002) simplify the study of muscular dystrophy compared to zebrafish, which 
contain 29 orthologues for human dystrophin (Steffen et al., 2007). 
The study of an individual animal model for a human disease may be limited in the 
amount that can be learnt but from mUltiple animal models one can appreciate different 
aspects of the human disease and even screen and test potential therapeutic agents at 
low cost and reduced ethical impact. Drosophila melanogaster has presented itself as an 
additional model organism for the study of human muscle disease. 
11 
1. Introduction 
1.3 Drosophila as a model animal for the study of human 
disease genes 
With the completion of the Drosophila genome sequence (Adams et al., 2000), a cross-
genomic analysis was conducted of all human disease genes known to have at least one 
mutant allele listed in the Online Mendelian Inheritance in Man (OMIM). Using 
Homophila (http://homophila.sdsc.edu) of the current 3714 human disease genes 
(defined by matches with expectation values, E-value :::;10-1°), 657 genes 
(E-value :::;10-10°) are estimated to have sufficiently well conserved homologues that 
could be analyzed in Drosophila. Many of the genetic pathways that are involved in 
basic developmental mechanisms in vertebrates and invertebrates have remained intact 
during evolution. Thus insights gained from studies in Drosophila can be applied in 
vertebrate systems. As most human disease genes have counterparts in the Drosophila 
genome and many of these are involved in cancer, neuromuscular disorders, 
immunological disorders, as well as heart disease (Bier 2005, Vidal and Cagan, 2006) 
the fly is becoming increasingly popular for studying the molecular mechanisms of 
human disease. A rapidly expanding collection of mutations exists in many homologues 
of human disease genes (Rubin et al., 2000). 
For such a small organism, flies are equipped with several attractive features that make 
them a valuable experimental genetic model system. They are inexpensive to maintain, 
with a rapid breeding time (- 12 days) and the capacity to generate a large number of 
individuals from a single cross. The fly genome is well annotated and consists of just 
four chromosomes. A general fly resource, FIybase (http://flybase.bio.indiana.edu),is 
available where a complete breakdown of the biology and genome of Drosophila as 
well as links to other sources can be found. The fly has a well-defined musculature that 
can be readily examined by light and fluorescent microscopy. The organism is 
accessible during all stages of muscle development and many specimens can be rapidly 
screened. In addition there is considerable information known about the details of 
myogenesis in flies (reviewed in Sparrow et al., 2008). 
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1.3.1 Genetic tools 
The strength of Drosophila as a genetic model system relies on its plethora of available 
genetic tools. A very important genetic tool specific to Drosophila, balancer 
chromosomes, are small genomic pieces that during meiosis prevent recombination 
between homologous chromosomes. These allow lethal mutations and deletions to be 
studied and be maintained indefinitely. Mutants have been produced in flies for the 
study of genetics, development, behaviour etc. for nearly a century (reviewed in Bakel 
et al., 2008). Early studies relied on spontaneous mutagenesis. The traditional way for 
obtaining mutants was to feed flies a mutagen most commonly ethyl-methane 
sulphonate, EMS or to subject them to irradiation (Mogami and Hotta, 1981, Deak et 
al., 1982). But in the last half-century Drosophila geneticists have mutagenized flies 
and 'screened' for mutations with specific phenotypes. 
1.3.1.1 Transgenesis methods in Drosophila 
The efficient and reliable transgenesis system for gene manipulation has released 
Drosophila's potential to study human diseases (reviewed in Venken and Bellen, 2007). 
Transgenic constructs can be readily introduced in flies to misexpress genes of interest 
in a spatially and temporally specific manner. The recent generation of nearly 19000 P-
element and piggyBac insertions covering the Drosophila genome allowed the 
screening of the entire genome for loss of function alleles, a feature not yet applicable to 
any other species (Parks et al., 2004; Thibault et al., 2004). If the disease causing 
protein has a dominant effect it is possible to overexpress the associated gene in a wild-
type fly background. 
Transgenic manipulation of Drosophila has enabled the study of specific mutations. 
Transposon-based transgenesis techniques exploit native P-elements called transposons 
that mobilise autonomously within the fly genome (Castro and Carareto, 2004). P-
elements encode for a transposase that recognises a 31-base pair inverse terminal repeat 
at the transposon's 5' end and an ll-basepair subterminal inverted repeat at the 3' end 
(Figure 1.3 A). These repeats are important for transposition to occur by the transposase 
(Beall and Rio, 1997). 
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For P-element mediated transgenesis, a vector containing the transposon' s ends, the 
sequence of interest and a marker (usually red eyes) (Karess and Rubin, 1984) is 
coinjected with a helper plasmid that carries the gene for the transposase or with the 
enzyme itself (Kaufman and Rio, 1991 ; Rubin and Spradl ing, 1982; pradling and 
Rubin, 1982) (Figure 1.3 B). Separation of the transposase from the transposon allows 
the regulated mobilisation of genes into the genome. 
A Transposon 
Key 
" S'repeat ~ 3 ' repeat 
B Binary transformation system 
Helper 
+ ~vector 
transposon 
~ Transposition 
I lnsertion site duplication 
Figure 1.3. T ransposon transformation system. (A) Transposons consist of two 
inverted terminal repeats that flank an open reading frame encoding a transposa e. (B) 
The helper plasmid carrying the transposase and a vector plasmid carrying the 
transposon and a marker are cotransformed. Transposition results in the duplication of 
the insertion site and is recognized by the marker. Image reproduced from Venken and 
Bellen, 2007. 
When P-elements carrying constructs of interest are microinjected into the syncytial 
blastoderm of Drosophila along with a source of transposase, th transgenes become 
integrated only in the genome of the germ line cells (Figure 1.4) (Laski et al. 1986). 
The transgene will be stably inherited to the progeny from thes indi iduals (Rubin and 
Spradling, 1982). Transgene integration is identified by selecting for the marker. This 
way entire genes can be introduced for rescue experiments, in vitro rnutagenized genes 
and promoter-reporter fusions for in vivo gene expression studies (see section 1.4). 
P-elements can also be used to knockout gene expression by transposing into genes and 
disrupting their function. 
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Figure 1.4. Drosophila transgenesis. Less than I-hour-old Drosophila embryos 
(generation zero, GO), obtained from a white eyed (white) parent (P) are injected with 
transgenic DNA carrying a red eye marker (white +). Rapid nuclear divisions create a 
syncytium. Transgenic DNA is integrated into the germ cells (red pole cell) and 
becomes transmitted from GO generation to the next (G 1 progeny). Integration of 
transgenic DNA is identified using the white + marker. When integrated in a white-
strain, this transgene gives transgenic flies a darker eye colour. Image reproduced from 
Venken and BelIen, 2007. 
1.3.1.2 Enhancer and protein trapping 
Enhancer and protein trapping strategies using transposons are widely used in 
Drosophila for identifying and studying the function of new genes on the basis of their 
expression pattern (BelIen et aI. , 1989; Bier et al., 1989; Wilson et al., 1989). For 
enhancer (promoter) trapping a P-element transposon carrying a reporter gene (e.g. 
GAL4, GFP, lacZ) linked to a weak promoter can be mobilised randomly into the 
genome to a large number of chromosomal locations. P-element constructs have a 
preference for inserting into the 5' regulatory region of functional transcription units 
(Spradling et al., 1995). Thus integration near a gene enhancer may activate the 
transcription of the weak promoter and express the reporter under the control of that 
enhancer. If on the other hand the construct integrates into a gene, the trap may disrupt 
gene function. 
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Protein traps differ from enhancer traps in the sense that the reporter sequence lacks a 
promoter, hence, it is expressed only when its mRNA is covalently ligated to an 
endogenous mRNA via splicing or read-through transcription (Lukacsovich et al., 
2001). The reporter gene expression matches that of the trapped gene since its 
transcription starts from the promoter of this gene. A number of GFP traps exist that 
were designed to create intact gene fusions for live cell localisation studies (Morin et 
al., 2001; Clyne et al., 2003). In this case a P-element containing GFP as an exon inserts 
into a genomic intron, which may lead to the appearance of green fluorescent tissues. 
Altogether these strategies have produced very large collections of enhancer traps, 
expression reporters and gene knockouts (Parks et al., 2004). 
1.3.1.3 The GAL4/UAS system 
GAL4 is a yeast regulatory protein that regulates the transcription of genes induced by 
galactose (Laughon et al., 1984; Laughon and Gesteland, 1984). In the presence of 
galactose, GAL4 binds to four specific 17-base pair sites within a DNA sequence termed 
the Upstream Activating Sequence (VAS) and activates transcription of the galactose 
genes located downstream of VAS (Guarente et al., 1982; Bram and Kornberg, 1985; 
Giniger et al., 1985). The activity of GAL4 is not restricted to yeast but it can function 
in a variety of biological systems to activate transcription from the VAS element 
(Kakidani and Ptashne, 1988; Ma et al., 2003; Webster et al., 1988). 
The GAL4/VAS system has been used very successfully and widely in Drosophila to 
express genes and study their roles during development (Brand and Perrimon, 1993; 
Duffy, 2002). The system consists of two elements: a GAL4 'driver' and a GAL4-
responsive VAS line (Figure 1.5). The driver line uses an enhancer or the promoter of a 
gene with known expression pattern (regulatory element) cloned upstream of the GAL4 
coding sequence, which allows GAL4 expression in a spatially and temporally 
controlled manner. The flies expressing GAL4 alone rarely show abnormalities 
associated to this event probably due to the absence of targets for GAL4 in the 
Drosophila genome. A pan-muscle driver, dmefl-GAL4, exists but several tissue-
specific drivers are also available. 
The responder line bears the sequence of the target gene cloned downstream of multiple 
binding sites (VAS). In the absence of GAL4 the target gene remains transcriptionally 
16 
1. Introduction 
silent. Mating of the driver and the responder lines results in progeny bearing both the 
responder and the driver transgenes simultaneously. In these flies, the GAL4 protein 
binds to the UAS sequence and activates transcription of the responder gene only in the 
cells/tissues expressing GAL4. The pattern of expression of the reporter gene is 
therefore the same as that of the GAL4 driver. Maintaining the responder and driver as 
separate parental lines allows 1) the propagation of flies bearing transgenes encoding 
lethal alleles or toxic products that only become active in the offspring of crosses 
between the responder line and the GAL4 driver and 2) the ready 'mix and match' of 
driver and responder produced by different investigators. 
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Figure 1.5. T he GAL4-UAS system in Drosophila. The driver line carrying a tissue 
specific promoter upstream of the GAL4 coding sequence and the responder line 
carrying a gene (GFP in this case) are crossed. In the progeny the fly that carries both 
the GAL4 and the UAS-GFP the GAL4 will bind to the UAS sequences and activate 
transcription of the downstream GFP gene. In the flies carrying the GAL4 insert alone 
there is no GFP gene to be activated. Likewise in flies carrying the UAS-GFP insert 
there is no GAL4 to activate its transcription and therefore there is no GFP expression. 
Image reproduced from Duffy, 2002. 
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An increasingly common approach used to study gene function and development in 
Drosophila is RNAi interference (RNAi). The GAL41UAS system is used to express a 
transgenic RNAi construct that forms a double stranded hairpin RNA (dsRNA) capable 
of degrading or suppressing translation of homologous mRNAs. The dsRNA is cleaved 
into 25 base pair fragments (Fire et al., 1998; Hanunond et al., 2000), which then act as 
a 'degradation template' for the target mRNA (Yang et al. , 2000). In Drosophila the 
method involves expressing the gene fragments in an inverted repeat (IR) separated by 
an intron (Figure 1.6) (Lee and Carthew, 2003). The complementarity of the inverted 
repeats results in the expression of an RNAi hairpin loop, which activates the long 
dsRNA pathway. The dsRNA to target the gene of interest is cloned downstream of the 
UAS sequence. Expression of the dsRNA is achieved by using specific GAL4 drivers 
thus homologous mRNA is degraded in specific spatial or temporal patterns. Two large 
collections of UAS-RNAi lines have been made. One is available from the National 
Institute of Genetics in Japan (http: //www.shigen.nig.ac.jp/fy/nigfly) and another 
through the Vienna Drosophila RNAi Center in Austria (http://www.vdrc.at.) where 
Dickson and colleagues have created a collection of 22,270 transgenic Drosophila lines 
in which 12,088 genes can be silenced; 88 % of the fly's predicted protein-coding genes 
(Dietzl et al., 2007). 
GAL4 driller line 
======8 Precursor hairpin RNA 
SIR As 
UAS Responder line 
Degradation of miRNAs 
Figure 1.6. dsRNA in Drosophila. The responder line bears the GAL4 binding site 
upstream of a gene cloned as an inverted repeat (rR) and when crossed with a tissue 
specific GAL4 driver results in expression of the IR. The IR are separated by a 
functional intron which becomes spliced out leaving a long dsRNA molecule that will 
be processed into small interfering RNAs (siRNAs) which will eventually trigger the 
homologous mRNA degradation. Image modified from the Vienna stock centre website 
(http://www.vdrc.at) . 
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1.3.2 Drosophila Indirect Flight Muscles as a model to study 
mutations in muscle proteins 
Drosophila studies of human skeletal myopathies have concentrated in the larval 
muscles or in the adult Indirect Flight Muscles (IFM) (Calado et al. 2000, Abu-Baker et 
al., 2003; Grumbling and Strelets, 2006, de Haro et al., 2006; Rajendra et al., 2007; 
Garcia-Lopez et al., 2008). The latter are located in the fly's thorax and are responsible 
for powering flight. They are a suitable model for studying human skeletal myopathies 
as they are the only fibrillar type of muscle found in flies (Josephson, 2006) that its 
structure resembles human skeletal muscle. Furthermore, they occupy the majority of 
the thorax hence they can be easily accessed by microdissection for analysis. 
1.3.2.1 IFM development 
Drosophila undergoes myogenesis twice; once during embryonic development to 
generate the larval musculature and again during the pupal development to form the 
muscles of the adult fly (Bate, 1993). The IFM are split into two groups, the dorso-
ventral (DVMs) and the dorsal-longitudinal (DLMs). These muscles originate from a 
subset of myoblasts of the wing imaginal discs, which differentiates during larval and 
pupal stages (Femandes et al., 1991; Bate, 1993, Farrell et aI., 1996). Three larval 
oblique muscles (LOM) survive the second wave of histolysis that takes place in the 
early pupal stages and serve as templates for the DLM. In contrast, the DVM do not use 
larval templates; the myoblast fuse de novo to form the muscle fibres. At 6-8 hours after 
puparium formation (APF) myoblasts migrate from the wing imaginal discs and fuse to 
the three LOM (Figure 1.7 A) (Femandes et al., 1991). The myoblast fusion continues 
until about 30 hours APF. Between 12 and 16 hours APF myoblast fusion causes each 
of the three LOM templates to split longitudinally, giving rise to 6 developing DLM 
(Figure 1.7 B). Around 16-22 hours APF the DLM elongate and attach to the tendon 
cells (Figure 1.3.1 C). By 32-36 hours the DLM shorten to about 113 of their original 
length and the tendon cells elongate (Figure 1.7 D). The DLM start elongating again 
between 42-44 hours APF whereas the tendon cells retract towards the cuticle (Figure 
1.7 E). Between 46-48 hours APF myofibrillogenesis initiates (Figure 1.7 F) and the 
myofibrils continue to grow in length and thickness until they become mature 
myofibrils (Femandes et al., 1991; Reedy and Beall, 1993). 
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Figure 1.7. IFM development. (A) At 6-8 hours APF myoblasts fuse to the remnants 
of the larval oblique muscles (LOM). (B) Myoblast fusion causes the three LOM which 
have escaped histolysis and serve as templates (TEM) for the DLM to split around 12-
16 hours APF. (C) By 16-22 hours APF myoblast fusion causes the IFM to lengthen and 
attach to the tendon cells (TC). (D) Around 32-36 hours APF the DLM shorten at about 
1/3 of their length whereas the tendon cells elongate. (E) By 42 hours APF 
myofibrillogenesis is initiated, the muscles increase in length and size and the region of 
tendon and muscle processes (TCM) retracts. (F) At 46 hours APF functional myofibres 
have formed which continue to grow until they reach their fmal size. Image taken from 
Nongthomba et al. , 2003, not to scale. 
1.3.2.2 IFM of Drosophila meianogaster 
The IFM are so-called because they are not attached directly to the wings; instead they 
induce wing movement by distorting the fly's thorax. The position of the DLMs and 
DVMs is shown in Figure 1.8 A. Jumping of the fly is caused by contraction of the 
tergal depressor of the trochanter (TDT), which is another thoracic muscle. When it 
contracts (shortens) it lengthens and stretches the DLM oriented perpendicular to it 
(Figure 1.8 C). The DLM responds to stretch with a delayed rise in active tension 
(stretch activation response) causing it to contract (Figure 1.8 C). This causes a 
reciprocal delayed stretch activation of contraction in the DVM. As the two sets of 
muscles alternately contract, the thorax oscillates rapidly; causing deformation of the 
wing hinges that make the wings beat at the resonant frequency of the flight system. 
Stretch activation is essential to sustain flight in small insects (Drosophila beats its 
wings for flight at 200 Hz) (MolIoy et al. , 1987). When the wings beat at frequencies 
well above the firing capability of the motorneurons the contractions of the IFM are not 
coincident with motorneuron firing and Ca2+ activation and consequently these muscles 
are called asynchronous. 
20 
1. Introduction 
A B 
DLM DVM 
c 
Figure 1.8. The indirect flight muscles of Drosophila melanogaster. Each hemithorax 
contains a set of (A) dorso-longitudinal (DLMs) and (B) dorso-ventral (DVMs) 
muscles. (C) During flight contraction of opposing muscles deforms the thorax resulting 
in wing movement. Images A and B reproduced from Demerec, 1950 and C from 
Vigoreaux, 2001 . 
1.3.2.3 The IFM as a model to study muscle mutations 
Five important features of the IFM identify them as an excellent model for studying the 
effects of transgenes on muscle development. First they are dispensable for viability 
(Bemstein et al. , 1993). Second, correct assembly and structure maintenance of muscle 
fibres are vital requirements for successful muscle function . So any mutation or 
silencing of an IFM specific gene that has an effect on muscle structure can be easily 
screened by a fl ightless phenotype. Some flightless mutants are also easily identifiable 
from the permanent atypical position of their wings beside their bodies when not flying 
in contrast to wild type flies (Kronert et ai, 1999; Spradling et al., 1999). In mutants 
resulting in hypercontraction of the lFM, the wings are held permanently in a vertical 
position hence allowing easy identification of such mutants (Nongthomba et al., 2003) . 
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Morphological defects in the IFM can rapidly be identified by polarized light 
microscopy of chemically clarified cuticles (Figure 1.9) (Nongthomba and 
Ramachandra, 1999). The third advantage that the IFM have to offer is that they 
develop over 4 days (Reedy and BeaU, 1993) so that one can study the effect of a 
transgene throughout muscle development, from pupal stages to adult flies. Fourth, 
there is little or no evidence in Drosophila for sarcomere protein turnover (Smith et al., 
1970), regeneration or repair. Satellite cells have not been found (Taylor, 2006). Thus 
unlike mouse models of muscle disease the IFM model is not complicated by 
regeneration. Fifth, they have an innate immune response but no adaptive. So without 
the complications of repair or immune responses one can investigate the basic molecular 
mechanisms of the muscle mutation. However this is also a limitation of the Drosophila 
system as it cannot fully reproduce the hunlan disease condition. 
Figure 1.9. Mutagenized flies with defects in the IFM can be visualized using light 
microscopy. Image reproduced from Vigoreaux et al. , 2001. 
Drosophila !FM have a long history of being used successfully to investigate the effects 
of mutations in actin and other sarcomeric proteins on muscle function (0 Donnell and 
Bemstein, 1988; Drummond et al., 1990; Bemstein et al. , 1993; Molloy et al., 1993; 
Nongthomba et al. , 2004). The availability of IFM-specific null mutants for the muscle 
proteins; myosin heavy chain (Mhc\ actin (KM88), tropomyosin (I£m(3)3Tm2), 
Troponin I (upf) and Troponin T (hdp 3) (Bemstein et al., 1993) has allowed the study of 
transgenic mutations for these genes in a wild type null background. Genetic 
deficiencies also permit the study of dosage requirements for IFM function (Bemstein et 
al. , 1993; Kreuz et al., 1996; Vigoreaux et al., 1998). 
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1.3.2.4 Dissection of genetic interactions in the IFM 
The IFM is a very good system for identification of protein interactions using genetic 
approaches. Two fly strains each carrying a mutation in a different gene can be mated to 
generate progeny that are heterozygous for both mutations (Kronert et al., 1999; Prado 
et al., 1995). A genetic interaction is evident if the phenotype of the progeny is different 
from that of either parent (e.g. flightless progeny from two flighted parents) or if the 
progeny exhibits an otherwise recessive phenotype. Such genetic interactions may 
indicate that the mutations affect an interaction between two proteins that are in direct 
contact, function in the same pathway or are components of the same protein complex. 
An example is suppressor mutations, like those that have been identified for the 
hypercontraction phenotype of the IFM troponin mutant hdp2 that autodestructs the 
muscles (Figure 1.10). Suppressor mutations for hdp2 are located in genes encoding 
troponin I (Prado et aI. , 1995), tropomyosin (Naimi et al. , 2001), myosin heavy chain 
(Kronert et al., 1999; Nongthomba et al., 2003) and actin (Sarah Haigh, PhD thesis, 
2003 , University of York) 
suppresso 
Figure 1.10. Genetic approaches to isolate mutations that affect the IFM. Flightless 
mutants exhibit abnormal wing position. The effects of a mutation can be reverted using 
intergenic or intragenic mutations. Image reproduced from Vigoreaux et al. 2001. 
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1.4 Drosophila models of human skeletal myopathies 
Hitherto there have been relatively few studies in Drosophila aimed at understanding 
human muscle diseases (reviewed in Sevdali and Sparrow, in preparation). The 
Drosophila models of the different myopathies, which do exist reproduce the human 
phenotype to different extents and have made some significant contributions towards 
our understanding of the molecular basis of the diseases. The skeletal myopathies have 
been modelled in both the larval muscles and in the IFM ofthe adult. 
1.4.1 Duchenne muscular dystrophy 
Duchenne muscular dystrophy is caused by mutations in genes of the Dystrophin (Dys)-
Dystroglycan (Dg) complex (DGC) expressed in skeletal muscle cells (Hoffman et al., 
1987). Domains known to mediate the interactions between members of the DGC are 
highly conserved between humans and flies, suggesting that the structure of the DGC is 
identical (Greener and Roberts, 2000). Similar to vertebrates, the dystrophin products 
are expressed in a tissue specific manner (Neuman et al., 2001; 2005; Dekkers et al., 
2004; Van der Plas et al., 2006; Shcherbata et al., 2007). Flies are a desirable system for 
the study of this disease because they express a single dystrophin gene (Greener and 
Roberts, 2000) ad thus reduces the genetic complexity found in vertebrate systems 
where multiple copies can exist. The study in Drosophila has revealed two roles for 
dystrophin gene products: maintaining synaptic homeostasis and preserving the 
structural stability of the muscle and its attachment. Drosophila dystrophyn-
dystroglycan mutants develop age-dependant muscle degeneration and mobility defects 
(Shcherbata et ai., 2007). 
1.4.2 Bart~ syndrome 
Barth syndrome (BTHS) IS an X-linked disease where patients present with 
cardiomyopathy and skeletal muscle weakness (Barth et al., 1999). The disease is 
caused by mutations in tafazzin (Bione et al., 1996), a phospholipid acyltransferase 
(Neuwald, 1997). Patients with BTHS display mitochondrial abnormalities (Barth et al., 
1993; Vreken et al., 2000; Schlame et al., 2000; Bissler et. al., 2002; Schlame et al., 
2002; Valianpour et al., 2002). Hitherto yeast, fibroblasts and lymphoblasts have been 
used to study BTHS, but the inability to replicate the tissue pathology of the disease is a 
major limitation of these models (Ou et al., 2004; Vreken et al., 2000; Xu et al., 2003). 
Drosophila expresses several tafazzin isoforms (Grumbling and Strelets, 2006) and as 
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IFM have abundant mitochondria flies have emerged as an attractive experimental 
system for BTHS research. In tafazzin-deficient flies, total cardiolipin levels were 
reduced by 80%, the main cardiolipin species was absent similar to BTHS patients 
(Grumbling and Strelets, 2006) and displayed flight defects with reduced locomotor 
activity. Their IFM showed mitochondrial abnormalities, mostly in the cristae 
membranes which displayed hyperdense aberrant phenotypes such as swirls, curls and 
rings (Grumbling and Strelets, 2006). 
1.4.3 Spinal muscular atrophy 
Spinal muscular atrophy (SMA) is a genetic disorder associated with recessive loss-of 
function mutations in the human survival motor neurons 1 gene (SMN 1) (Lefebvre et 
al., 1995). The most severe form is the most common and patients die within 2 years of 
birth (Ogino and Wilson, 2004; Monani 2005). The disease is characterized by loss of 
motor neurons and progressive muscular atrophy in the limps and trunk (Ogino and 
Wilson, 2004). In a Drosophila model of SMA, hypomorphic SmnE33 mutants reduce 
dSMN levels in adult thorax, are unable to fly or jump and exhibit severe 
neuromuscular defects (Rajendra et al., 2007). The Smn mutant myofibres fail to form 
thin filaments resembling the IFM-specific actin Act88F null mutants. SMA patients 
have also been shown to exhibit myofibrillar and sarcomeric abnormalities (Szliwowski 
and Drochmans, 1975; Braun et al., 1995). The most surprising finding was that in wild 
type flies dSMN colocalized with sarcomeric actin and a-actinin in the IFM myofibrils 
revealing for the first time that SMN is a sarcomeric protein. Although it is not currently 
known whether the phenotype observed in the SmnE33 hypomorphs is due to reduced 
dSMN levels or the motoneurons or a combination of the two, there is a promising 
future for examining myogenesis and motoneuron development during pupal stages. 
1.4.4 Oculopharyngeal muscular dystrophy 
Oculopharyngeal muscular dystrophy (OPMD) IS an adult-onset syndrome 
characterized by progressive muscle degeneration that is caused by short GCG repeat 
expansions of an N-terminal polyalanine tract within the nuclear poly(A)-binding 
protein 1 (P ABPN1) (Brais et al., 1998). A coiled-coil N-terminal domain is responsible 
for stimulation of poly(A) polymerase (Kerwitz et al., 2003), whereas a central RNA-
binding domain and an arginine-rich COOH-terminal domain are involved in binding 
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tail (Kuhn et al., 2003). Mutant PABPN1 aggregates as intranuclear 
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inclusions. A Drosophila model of OPMD exists where mutant PABPNl is expressed 
specifically in the musculature (Chartier et ai, 2006). The wing position of the mutant 
flies was normal at day 1 but by day 2 they displayed abnormal wing phenotypes, were 
flightless and displayed nuclear PABPNl inclusions (Calado et aI., 2000; Abu-Baker et 
al., 2003) demonstrating that the disease is also progressive in Drosophila. Flies where 
the alanine extension is deleted (P ABPNI-M) did not display inclusions. Expression of 
PABPNI-17A with a deletion of the RNA-binding (PABPNI-17A-~RRM) domain did 
not cause muscle defects or in abnormal intranuclear accumulation. This suggests that 
the RNA-binding domain is required for the OPMD phenotype. 
The mode ling of different skeletal muscle diseases in Drosophila is possible and has 
already contributed significantly to the understanding of these skeletal muscle diseases. 
Clearly Drosophila IFM are developing as a useful genetic model for a range of 
muscular diseases. Modelling of thin filament skeletal myopathies (including the 
nemaline ACTA1 myopathies and arthrogryposis) has not as yet been reported. 
1.4.5 Drosophila IFM: a model for thin filament myopathies 
Drosophila expresses a single actin isoform, ACT88F, which encodes all of the 
sarcomeric actin present in the IFM (Fyrberg et al., 1983; Ball et al., 1987) and is 
highly homologous (- 93 % homology) to the human a-skeletal actin (Figure 1.11) 
(Hanauer et al., 1983). Hence it is possible to introduce mutations in the Act88F gene 
that are homologous to the human ACTA1 nemaline myopathy mutations. Initial studies 
(Sarah Haigh, 2003, PhD thesis, University of York) showed that genomic mutations in 
the IFM-specific ACT88F gene at specific residues (A13V, R256C, G268D, R372H) 
associated in humans with NM (A138P, R256H1L, G268RJC, R372H) are dominant 
flightless and cause variable sarcomere lengths and in the zebra body phenotype which 
is also found in human patients and is thought to be the beginning of nemaline rods. 
Three of these ACT88F mutants do not make sarcomeres during early myogenesis and 
the flies cannot fly. However the ACT88~372H mutant has normal myogenesis and the 
pupae show normal myofibrils, but adults develop the nemaline phenotype clearly 
demonstrating two pathways to the 'nemaline' phenotypes. 
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-DDDAGALVIDNGSGMCKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDEAQS 59 
DEDETTALVCDNGSGLVKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDEAQS 60 
:*:: *** *****: ******************************************* 
KRGILTLKYPIEHGIITNWDDMEKIWHHTFYNELRVAPEEHPVLLTEAPLNPKANREKMT 119 
KRGILTLKYPIEHGIITNWDDMEKIWHHTFYNELRVAPEEHPTLLTEAPLNPKANREKMT 120 
******************************************.***************** 
QIMFETFNSPAMYVAIQAVLSLYASGRTTGIVLDSGDGVSHTVPIYEGFALPHAILRLDL 179 
QIMFETFNVPAMYVAIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYEGYALPHAIMRLDL 180 
******** ******************************:*.******:******:**** 
AGRDLTDYLMKILTERGYSFTTTAEREIVRDIKEKLCYVALDFEQEMATAAASTSLEKSY 239 
AGRDLTDYLMKILTERGYSFVTTAEREIVRDIKEKLCYVALDFENEMATAASSSSLEK-- 238 
********************.***********************:******:*:**** 
ELPDGQVITIGNERFRCPEALFQPSFLGMESCGIHETVYNSIMKCDVDIRKDLYANSVLS 299 
----------------------------------------------------------MS 240 
: * 
GGTTMYPGIADRMQKEITALAPSTIKIKIIAPPERKYSVWIGGSlLASLSTFQQMWISKQ 359 
GGTTMYPGIADRMQKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWITKQ 300 
************************:********************************:** 
EYDESGPGIVHRKCF 374 
EYDEAGPSIVHRKCF 315 
****:**.******* 
Figure 1.11. Alignment of human ACTA! and Drosophila ACT88F protein 
sequences. The sequences of the two proteins show 93% homology. The annotation 
symbol for Acta} is X56644.2 (release 27) and for Act88F NP _524367.1. Note: '.' 
indicates that the residues in that column are identical in all sequences in the alignment, 
':' indicates that conserved substitutions have been observed, '.' indicates that semi-
conserved substitutions are observed. 
All four reported TnI mutations responsible for Distal Arthrogryposes cause increased 
contractility (Sung et al., 2003; Robinson et al., 2006) and are hence likely to cause 
muscle hypercontraction in vivo. TnI mutations in Drosophila IFM have also been 
identified that cause muscle hypercontraction (Deak 1977; Deak et al., 1982; Beall and 
Fyrberg 1991; Barbas et al., 1993, Nongthomba et al., 2004). In the IFM TnI and TnT 
nulls exist which can be used to study arthrogryposis mutants using transgenesis. 
Nemaline myopathy and arthrogryposis are both diseases caused by mutations in 
sarcomeric thin filament proteins. The organisation of the thin filament will now be 
discussed. 
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1.5 Organisation of skeletal muscle 
Skeletal muscle is made up of multinucleated cells called muscle fibres (or myofibres) 
that are aligned parallel to each other. Each myofibre contains multiple contractile 
protein assemblies called myofibrils (Figure 1.12). Mitochondria are located between 
the myofibrils and nuclei are found in the periphery of the cytoplasm (Figure 1.12). 
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Figure 1.12. Muscle organisation. Skeletal muscle is composed of muscles fibres, 
which in turn consist of myofibrils, nuclei located in the periphery of the muscle fibre 
shown in blue. Myofibrils consist of repeating units called sarcomeres that power 
muscle contraction. Image reproduced from Lehninger et al. 2000. 
Each myofibril is a long array of by specialized and highly ordered repeating contractile 
units, the sarcomeres (Figure 1.13). The sarcomere is composed of myosin-based thick 
and actin-based thin filaments arranged parallel to each other in a lattice. Longitudinal 
sections of electron micrographs from muscle fibres show an electron dense area called 
the Z-disc, which demarcates each sarcomere and anchors actin thin filaments from 
adjacent sarcomeres. The actin thin filaments extend from the Z-discs across a lighter 
area termed the I-band followed by a darker area termed the A-band. Myosin thick 
filaments project from the M-line, extend through the H-zone and interdigitate with 
actin thin filaments across the A-band. Sarcomere passive stiffness is maintained by a 
third filament system whereby a long modular protein, titin, connects the thick filaments 
to the Z-disc (Granzier and Labeit, 2007). 
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Figure 1.13. Sarcomere structure. EM showing a single sarcomere and schematic 
representation of its major components: myosin thick filaments actin thin filaments and 
Z-discs. Image reproduced from http://themedicalbiochernistrypage.org/muscle.html. 
1.5.1 Thick filament- Myosin 
Myosin, a large multidomain protein (520 kDa) is the major component of the thick 
filaments (reviewed in Geeves and Holmes 2005). Myosin acts as a molecular motor 
that converts the chemical energy of ATP hydrolysis into mechanical force (Ruppel and 
Spudich, 1996). Muscle myosin is composed of two heavy chain (MHC) (- 220 kDa) 
subunits and two pairs of light chain (MLC) (- 20 kDa) subunits. The MHC and two 
light chains from a globular, NH2-terminal head domain, which contains the binding 
sites for actin and nucleotides and exhibit the motor function (Rayment et al. , 1993; 
MiIligan et al., 1996). Myosin heads are excluded in the sarcomere H-zone. The 
COOH-terminal regions of the MHC associate to form an a -helical coiled-coil dimer 
rod which subsequently polymerize to form thick filaments ( quire and Vibert, 1987· 
Ruppel and Spudich, 1996). Contraction of muscle is the result of cyclic interactions 
between the globular heads of the myosin molecules, also known as cross-bridges, and 
the actin filaments . Myosin powers muscle contraction by hydrolysi of ATP an 
interaction with the actin thin filaments and a large conformational change. This 
mechanism undergoes a number of cycles to dri e muscle contraction (Geeves and 
Holmes, 2005). As a result each end of the thick filament' pulls the thin filaments with 
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which it interacts toward the H-zone (Figure 1.13). 
1.5.2 Thin filament 
The major constituent of the thin filament is actin, although numerous others proteins 
have been identified that are important for its length maintenance, stabi lity and function 
(reviewed in Clark et al., 2002). Thin filament stabilizers such as tropomyosin and 
nebulin span the entire length of the thin filanlent (Figure 1.14 A). The thin fi lament is 
capped at the A-band by tropomodulin and at the Z-disc by CapZ. Other thin filament 
proteins such as a -actinin are involved in thin filament attachment at the Z-disc (Figure 
1.14 A). The troponin complex, which binds to the thin filament consists of three 
subunits : troponin C (TnC), troponin I (TnI) and troporun T (TnT). Each thin filament 
strand consists of repeats each containing seven actin monomers one tropomyosin 
coiled coil dimer and one troponin complex (Figure 1.14 B). These represent only a 
handful of actin binding proteins (ABPs), though many more exist but are not relevant 
to this thesis. 
A 
B 
B >-) -----. p p .,------« B 
Troponin complvc: 
TN-I binds to OCIln 
TN-C binds Co·. 
TN-T binds to tropomyosin 
Tropomyosin 
Rope-Ilk~ prot~ln 
Runs along OCIIII fllom~nt 
7 actin binding SIUS 
~bulin 
Figure 1.14. Thin filam ent organisation in striated muscle. (A) Schematic 
representation of sarcomere showing the actin thin filaments (green) titin (grey), 
myosin thick filaments (purple), tropomodulin (red) nebulin (yellow) CapZ (cyan) a -
actinin (blue) are indicated. Z: Z-disc M: M-line, B: barbed end and P: pointed end. 
Image reproduced from Littlefield and Fowler 2008. (B) Actin monomer shown in 
light purple, the troponjn complex of TnI TnT and Tne shown in darker purple. 
tropomyosin dimers in light blue and nebulin in black. Image reproduced from Laing 
and Nowak, 2005. 
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1.5.2.1 Actin 
Actin is the second most abundant sarcomeric protein (20 % in muscle). Actins are a 
highly conserved protein family, at the amino acid level human skeletal muscle a -actin 
shares 100 % homology with mouse skeletal muscle a-actin and 87 % homology with 
rice cytoskeletal actin (Sheterline et al. 1998). Thus most residues in skeletal muscle a -
actin may be classified as highly conserved, and any amino acid change is likely to be 
disease causing. It is a single 375 amino acid polypeptide chain (MW - 42 kDa) that 
binds to both adenosine nucleotide (ATP or ADP) and a divalent cation (usually 
magnesium or calcium) (reviewed in Sheterline et al., 1998). It exists in two forms, 
monomeric G-actin and polymeric filamentous F -actin, which is a linear chain of actin 
monomers (Holmes et al., 1990). The mono mer is divided into two domains (inner and 
outer) by a cleft, which forms the binding site for ATP in G-actin (ADP in F-actin) and 
the divalent ion (Figure 1.15) (Kabsch et ai. , 1990; Otterbein et al., 2001). The domains 
are connected together by two polypeptide chains known as the 'hinge' , which allows 
domain movement (Sparrow et al. , 2003). The small domain of the monomer consists of 
subdomains 1 and 2 that are located on the outer surface of the actin filament, which are 
exposed and available for interactions with other proteins (Kabsch et al., 1990; 
Sheterline et al., 1998). Subdomain 1 contains both the NH2- and COOH- termini of the 
molecule and is involved in interactions with myosin. Subdomains 3 and 4 form the 
large domain of the monomer and are close to the filament axis, which interacts across 
to the sub domains 3 and 4 of actin in the second strand (Sparrow et al., 2003). 
IV 
III 
Figure 1.15. G-actin structure. Cartoon of G-actin bound to ATP and Ca2+, depicting 
the four actin subdomains (I, n, Ill, IV) the nucleotide and divalent ion binding sites 
and the NH2- and COOH-termini. PDB file 2hf4, image was produced in PYMOL. 
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In vitro, actin is monomeric under low ionic strength conditions (0.2 mM Ca2+ or 0.05 
mM Mg2l . Elevating the ionic strength to physiological conditions (2 mM MgCh and 
100 mM KCl), in neutral or slightly acidic pH causes monorneric G-actin to polymerize 
into F-actin filaments (Sheterline et al., 1998). The process is reversible upon lowering 
the ionic strength. F-actin filaments are polarized, right-handed, double-helical 
polymers composed of 370 subunits per pm with one twist of the double helix every 36 
nm (Figure 1.16 A) (Hanson and Lowy, 1964; Sparrow et al., 2003). This polarity was 
first identified in electron micrographs of myosin SI fragment decorated actin 
filaments, which appeared as a thread of arrowheads repeating every 36 nm. One end of 
the filament became known as the barbed end (attached to the Z-disc) and the other as 
the pointed end (at the end of the A-band). In the F-actin helix, each actin contacts four 
other actins, the preceding and following actin on the same filament and two actins 
across on the other filament (Figure 1.16). Residues facilitating the intra-strand contacts 
between subunits and those contributing to the inter-strand contacts are highlighted in 
Figures 1.16 B and C, respectively. 
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Figure 1.16. Intra- and inter-strand contact within F-actin. (A) F-actin helix 
composed of 13 subunits. The two subunits marked by the oval are magnified in b and 
the three subunit marked by the triangle are magnified in c. Residues facilitating the 
intra-strand contacts between subunits (B) and those contributing to the inter-strand 
contacts (C) are highlighted. Black numb rs rep res nt the residu numbers and red 
numbers represent subdomain numbers ' n, n + 1 and n + 2 are subunit numbers. Image 
reproduced from Oda et al., 2009. 
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1.5.2.2. Tropomyosin 
Tropomyosins (MW ~ 37 kDa) are constructed of two a-helices arranged into a coiled-
coil structure. They bind as a dimer along the sides adjacent to the thin filaments in a 
head-to-tail manner (Figure 1.14 A, B), with an overlap of 8-11 amino acids (Wegner, 
1979). Depending on the isofonn, six to seven (in muscle) actin monomers may be 
spanned by a tropomyosin molecule (Perry, 2001). Tropomyosin interacts with 
tropomodulin to stabilize the thin filament by slowing its polymerisation and 
depolymerisation from the pointed ends (Broschat et al., 1989; Broschat, 1990; Sung 
and Lin, 1994; Vera et al., 2000; Greenfield and Fowler, 2002). Tropomyosin binding 
protects the thin filament against severing and depolymerisation from cofilin (Des 
Marais et al., 2005; Nishida et al., 1985; Ono and Ono, 2002), DNasel (Hitchcock et al., 
1976) and gelsolin (Fujime and Ishiwata, 1971; Ishikawa et al., 1989). The Drosophila 
Tm isofonns are encoded by two genes Tml and Tm2. The Tml gene encodes two 
additional Tm IFM specific isofonns, TnH33 and TnH34, which contain a 200 amino 
acid long proline and alanine rich extension (KarliK and Fyrberg, 1986; Bullard et al., 
1988; Barbas et al., 1991; BeaU and Fyrberg, 1991). 
1.5.2.3 Troponin complex 
The actomyosin interaction must be regulated so that contraction occurs only in 
response to appropriate signals from the nervous system. The regulation is mediated by 
the troponin complex and by tropomyosin (Figure 1.14 B) (reviewed in Craig and 
Lehman, 2001). The troponin complex consists of three interacting subunits, the Ca2+ 
binding subunit Troponin C (MW ~ 18 kDa); the inhibitory subunit Troponin I (MW ~ 
20 kDa) that binds actin and inhibits the actomyosin ATPase and Troponin T (MW ~ 30 
kDa), which binds to tropomyosin and anchors the troponin complex to the thin 
filaments (Hitchcock, 1975). 
In relaxed muscle when Ca2+ levels are low, the inhibitory domain of TnI binds actin in 
such a way that tropomyosin sterically blocks the myosin head-binding sites on the 
outer domain of the thin filaments. Upon Ca2+ binding to TnC, the affinity of the 
inhibitory region of Tnl becomes stronger for TnC than for actin (Potter and Gergely, 
1974). This results in confonnational changes in the troponin complex which allows 
tropomyosin to shift its position to expose the weak myosin-binding sites on actin, 
thereby allowing cross-bridges to fonn (Huxley 1972; Parry and Squire, 1973; Lehman 
33 
1. Introduction 
et al. 1994, 1995; Tobacman, 1996; McKillop and Oeeves, 1993; Vibert et al., 1997). 
Myosin binding activates the myosin ATPase and causes further translocation of 
tropomyosin on actin filaments allowing strong, force-generating interactions between 
actin and myosin (Craig and Lehman, 2001). 
1.5.2.4 Nebulin 
Nebulin is a 600-900 kDa actin-binding protein found only in vertebrate sarcomeres 
(Wang and Williamson, 1980). A single nebulin molecule spans the entire length of the 
thin filament (Figure 1.14 A) hence nebulin is thought to be a ruler of thin filament 
lenghts (Littlefield and Fowler, 1998; McElhinny et al., 2003). Its NH2-terminus 
interacts with tropomodulin whereas its COOH-terminus extends into the Z-disc (Nave 
et al. 1990; McElhinny et al., 2001). The closest homologue found in Drosophila is 
Lasp, which is characterized by actin-binding nebulin repeats (Chen et al., 1993, 
Suyama et aI., 2009). 
1.5.2.5 Tropomodulin 
Tropomodulins (Tmods) (MW - 40 kDa) are a conserved family of actin and 
tropomyosin binding proteins that are associated stoichiometrically with thin filament 
pointed ends in all vertebrate, worm and fly striated muscles (Figure 1.14 A) (reviewed 
in Fowler, 1997; Fischer and Fowler, 2003). Unlike actin cytoskeletal structures in 
nonmuscle cells where barbed ends are the predominant assembly ends (Pollard et al., 
2000), muscle cells actin dynamics predominates at the thin filament pointed ends 
(Little field and Fowler, 2008). A substantial body of data demonstrates that thin 
filament lengths are controlled by inhibition of actin assembly at pointed ends by 
Tmods (Oregorio and Fowler, 1995). This is achieved by two distinct regions within the 
Tmod protein sequence; (1) an actin capping NH2-terminal region which binds to two 
tropomyosin molecules (Vera et al., 2000; Kostyukova et al., 2006) and (2) a second 
COOH-terminal actin-binding site, which may cap two actin monomers (Oregorio et al., 
1995; Fowler et al., 2003; Wear et al., 2003). Binding to tropomyosin is required in 
order to achieve high affinity pointed end capping (~< lnM) (Weber, 1994). 
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1.5.3 The Z-disc 
The Z-disc is an electron dense structure that represents the lateral borders of the 
sarcomeres in striated muscle (reviewed in Clark et al., 2002). It stabilizes the filament 
lattices of adjacent sarcomeres thus ensuring that active and passive tensions are 
transmitted along the sarcomeres. It consists of numerous proteins that anchor both the 
thin and thick filaments to the Z-disc (Frank et al., 2006). Thin filaments from adjacent 
sarcomeres overlap and terminate within the Z-disc where they are anchored by the 
capping protein CapZ, a-actinin and nebulin, other proteins are also present (reviewed 
in Clark et al., 2002). A large modular protein, titin, connects the thick filaments to the 
Z-disc (reviewed in Clark et al., 2002). In Drosophila, there is no titin homologue but 
the function of tit in is divided between projectin and sallimus (Burkart et al. 2007). 
1.5.3.1 Capping protein (CapZ) 
Capping protein is a heterodimeric protein consisting of a and ~ subunits. It was named 
capping protein because of its ability to inhibit growth of the actin filament at the 
barbed end (Isenberg et al., 1980). The sarcomeric isoform of capping protein, CapZ, is 
localized at the Z-disc in muscle (Figure 1.14 A) (Casella et al., 1987), probably 
through an interaction with a-actinin and another thin filament protein, nebulin, at the 
Z-disc (Figure 1.17 A) (Papa et al., 1999; Pappas et al., 2008). CapZ binds to the barbed 
end of the thin filament with a high affinity (KcJ ::::: 1 nM) and a 1: 1 stoichiometry 
(Caldwell et al., 1989; Schafer et al., 1993; Wear et al., 2003) thus preventing both the 
addition and loss of actin monomers at the fast growing end (Isenberg et al., 1980). The 
a and ~ subunits have very similar secondary structures despite their complete lack of 
sequence similarity (Wear et al., 2003). Capping protein binding to actin is mediated via 
the COOH-terminal extensions of the a and ~ subunits. In the crystal structure the 
COOH-terminal end of the a subunit forms an amphipathic helix, which is folded down 
on the surface of the protein. The COOH-terminal end of the ~ subunit is also an 
amphipathic helix, but longer than in its CPa counterpart and protrudes from the rest of 
the structure via a long loop (Narita et al., 2006) to caps the thin filaments in a 
'tentacular' mechanism (Figure 1.17 B) (Yamashita et al., 2003). 
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Figure 1.17. Actin-CapZ interaction. (A) Model of the architecture of CapZ, nebulin 
and a -actinin at the Z-disc. The CapZ heterodimer is shown in blue circles the a -actinin 
homodimers in vertical grey bars and nebulin in red. Diagram reproduced from Pappas 
et al., 2003 . (B) Crystal structure of the CapZ heterodimer, the CPa subunit is shown in 
yellow, and the CP~ subunit in red, the first residue (252) of the disordered region is 
indicated. Picture reproduced from Wear et al., 2003 . 
The X-ray crystal structure of CP has inspired a model where the COOH-terminal 30 
amino acids of the a and ~ subunits are mobile extensions (, tentacles ' ) responsible for 
high affinity binding to and capping of the F-actin barbed end (yamashita et al. , 2003). 
The proposed mechanism for the binding of CP to the thin filament barbed end involves 
two steps. First, basic residues on the a -tentacle interact with the acidic residues of the 
end actin protomers on the actin filament. The freely mobile ~-tentacle binds to the 
hydrophobic cleft between subdomain 1 and 3 of the end actin protomer (Figure 1.18). 
The flexibility of the CapZ extensions probably acts to uncap the actin filament for 
incorporation of exogenous actin at the barbed end without disrupting the sarcomeric 
structure (Littlefield et al. , 2001). 
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Figure 1.18. CapZ binding to the barbed end of the thin filament. The monomers of 
the actin filament are shown in grey and the CapZ heterodimer in white. Acidic residues 
(red) of the end actin protomers B and B-1 on the barbed end of the filament attract 
basic residues (blue) on the CP a-tentacle. The hydrophobic surface (yellow) of the 
flexible B tentacle (indicated) binds to the hydrophobic cleft (yellow) on the terminal 
protomer, B thereby stabilizing the binding. Picture reproduced from Narita et al., 2006. 
1.5.3.2 a-Actinin 
a-Actinin (MW ~ 97 kDa) is found in both muscle and non-muscle cells at points where 
F -actin filaments are anchored within a variety of intracellular structures. It belongs to a 
highly conserved family of actin-binding proteins, the spectrin superfamily that contains 
spectrin, utrophin and dystrophin (Blanchard et al., 1989; Pascual et al. , 1997). a-
Actinin cross-links anti-parallel actin filaments (Luther, 2000) found in the Z-disc of 
striated muscle (Figure 1.14 A) (Sorimachi et al., 1997; Young et al., 1998; Young and 
Gautel, 2000), smooth muscle and in stress fibres of non-muscle cells (Blanchard et al. , 
1989). Actin thin filaments of adjacent sarcomeres overlap and terminate within the Z-
disc where they are linked by transversely oriented a-actinin molecules that form 
ladder-like structures with the thin filaments (Figure 1.19 A) (Meyer and Aebi, 1990; 
Vigoreaux 1994). 
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a-Actinin exists as an anti-parallel homodimer in which the four spectrin repeats of the 
anti-parallel partners are aligned and the actin-binding domains are placed at both ends 
of the homodimer (Djinovic-Carugo et al., 1999, Tang et al., 200 I). Its NH2-tenninus 
contains an actin-binding domain (ABD) which itself consists of two-tandem calponin 
homology domains (CHI and CH2). The central region consists of four-tandem spectrin 
3-helix-motifs (RI-R4) that are homologous to similar repeats in spectrin and 
dystrophin (Figure 1.19 B). The COOH-tenninal calmodulin (CaM)-like domain, 
contains four EF hand motifs (Davison and Critchley, 1988; Blanchard et al., 1989; 
Trave et al., 1995). To date there is no atomic structure of the complete protein or any 
of its homologues. However, structures of its domains have been reported (Franzot et 
al., 2005; Borrego-Diaz et al., 2006). Cryo-EM reconstructions of a-actinin decorated 
F-actin (McGough, et al., 1994) and biochemical data (Mimura and Asano, 1987; 
Lebart et al., 1993) place the a-actinin actin-binding site between residues 83-117 and 
350-372 of the actin monomer (Figure 1.19 C). 
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Figure 1.19. Structures of a-actinin and the thin filament. (A) At the Z-discs a -
actinin (aA) homodimers (green) form cross-bridges with actin filaments (other 
proteins that are not shown here are also involved). Image reproduced from Djinovic-
Carugo et aI. , 1999. (B) The domain architecture of a -actinin: actin binding domain 
(ABD) (green), CaM-like domains (pink) and R1- R4 domains (light blue). Image 
reproduced from Janmey and Lindberg, 2004. (C) Two actin monomers along the thin 
filament shown in cyan (actin 1) and pink (actin 2) and a -actinin. On the a -actinin 
structure the actin binding domain is shown in yellow and the calponin homology 
domain (CAL) in magenta. Red circles highlight the a -actinin binding sites on actin. 
Image reproduced from Tang et al., 2001. 
1.5.4 Connecting filaments 
During muscle contraction to prevent the sarcomere from overstretching or shortening 
too much a third filament called the connecting filament, provides an elastic structure 
that is adaptive to the force applied. In vertebrate muscles passive elasticity of a 
stretched muscle fibre is achieved by titin, a giant modular protein (MW - 3.7 MDa) 
(reviewed in Granzier and Labeit 2005). The NH2-terminal ends of titin, from adjacent 
sarcomeres, overlap in the Z-disc, and the molecule reaches across half the sarcomere to 
the M-line thereby forming a third filament system (Figure 1.14 A). The region of titin 
that spans the I-band is composed of immunoglobulin-like (Ig) repeats and PEVK 
sequences that can be extended a variable amount, depending on the isoform present in 
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a particular muscle (Labeit and Kolmerer 1995b; Li et al. 2001). 
In Drosophila, the role of titin is divided between projectin and two or more isofonns 
encoded by the sallimus gene (reviewed in Bullard et al., 2006). Unlike titin none of 
these proteins extend fully across the half sarcomere. In the IFM, the NH2-tenninal part 
of projectin contains Ig domains and extensible PEVK sequences in a pattern that is 
similar to that of I-band titin (Labeit and Kolmerer, 1995). It extends from the Z-disc 
across the I-band and reaches the end of the thick filament (Ayme-Southgate et aI., 
2005; Bullard et al., 2005). In the IFM of adult flies, kettin is the most abundant 
sallimus isofonn, composed of 35 Ig domains separated by linker sequences and binds 
to actin and extends from the Z-disc to the ends of the thick filaments (Burkart et al. 
2007). Kettin and projectin join at the I-band to form the connecting filament of the 
IFM (Bullard et al., 2005). 
1.5.5 Thin filament assembly and roles of actin-capping proteins 
1.5.5.1 Actin polymerization in vitro 
The nucleotide-binding site of G-actin is almost exclusively associated with ATP in 
vivo. Assembly of G-actin to F-actin is accompanied by hydrolysis of ATP to ADP and 
the release of inorganic phosphate. Hydrolysis of the bound ATP of newly added actin 
subunits is carried through three sequential steps: first it is converted to ADP.Pi, 
followed by the release of Pi and a conformation change in the actin filament (earlier 
and Pantaloni, 1986; earlier et al., 1987; Melki et al., 1996; Fujiwara et al., 2007). 
Dissociated ADP-actin subunits exchange their bound ADP for ATP in solution (Neidl 
and Engel, 1979), a process that is accelerated by profilin (discussed in section 1.5.5.2). 
Polymerization of G-actin monomers into F-actin filaments proceeds in three sequential 
phases: an initial nucleation phase, followed by an almost linear elongation phase and a 
steady-state phase (reviewed by Pollard, 1990; earlier, 1991; Estes, 1992). The 
nucleation phase is characterized by the fonnation of a small oligomer called a nucleus. 
Kinetic analysis and structural considerations suggest that nuclei consist of just three 
actin molecules. After a significant number of nuclei have been fonned, rapid subunit 
addition ensues. In vitro the polymerization progresses into the elongation phase during 
which the relationship of total polymer versus time is approximately linear. As F-actin 
filaments grow the concentration of free G-actin decreases until equilibrium between 
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the monomeric and polymeric actin has been reached. This concentration of free 
monomers in equilibrium with a population of actin filaments is referred to as the 
Critical concentration, Cc. Above this value, a solution of G-actin will polymerize; 
below this value a solution ofF-actin will depolymerise. Association and dissociation of 
monomers normally occurs at either end of the filament, but association predominantly 
occurs at the barbed end and dissociation at the pointed end (Carlier et al., 1987 Pollard, 
1986). Under physiological conditions the Cc at the barbed end is about 0.1 )lM and at 
the pointed end Cc is about 0.7 )lM (Rickard and Sheterline, 1986). Solvent conditions 
influence the Cc e.g. in the presence phalloidin, the initial nucleation phase of ATP-G-
actin shortens, and the elongation phase is accelerated by a factor of 2 (Dancker et aI., 
1975). 
The slower rate of addition at the pointed end allows for ATP hydrolysis of the terminal 
monomer (Coue and Korn, 1986). Thus the pointed end has an ADP-bound actin 
terminal monomer and the barbed end an ATP-bound actin monomer. Since the two 
ends share the same monomer pool in order to achieve equilibrium there will be a loss 
of monomers from the pointed ends and gain from the barbed end. Hence, assembled 
ATP monomers move progressively along the filament from the barbed end (the end 
associated with Z-discs) of the sarcomere, toward the free pointed end of the filament 
(located in the middle of the sarcomere) to be released as ADP monomers (Wegner, 
1976). The continual flux of actin subunits « 1 subunit per second) from the pointed to 
the barbed end of the filament results in unidirectional growth of the actin filament 
(Oosawa, 1972; Wegner, 1976). 
The length of actin filaments is not an inherent property, as in in vivo and in vitro 
studies, actin subunits assemble to different polymer lengths (Oosawa, 1970; Pollard 
and Borisy, 2003). Since the -1 )lm lengths of the mature striated muscle thin filaments 
are extremely precise, they must be regulated by actin binding proteins (ABPs). Within 
cells thin filament dynamics are modulated by over 70 classes of ABPs (reviewed in 
Pollard et al., 2000; Dos Remedios et al., 2001). Some ABPs bind to G-actin and 
maintain the monomer pool (profilin, cofilin). Others sever filaments thus creating ends 
for addition of actin subunits (gelsolin). Some associate with the barbed or pointed end 
and inhibit the assembly/disassembly process (CapZ, tropomodulin). Alternatively some 
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nucleate new filaments (formin). The role of certain ABPs relevant to this thesis will be 
discussed. 
1.5.5.2 Profllin 
Profilins are a family of small cytoplasmic proteins (14-17 kDa) that sequester 
monomeric actin and function in processes related to F -actin nucleation and 
polymerization (Witke, 2004). Profilin binds to subdomains 1 and 3 of actin in a 1:1 
complex (Mockrin et al., 1980; Schutt et al., 1993). It acts as nucleotide exchange factor 
for actin with a higher affinity for ATP-bound G-actin than for ADP-bound G-actin 
(Stossel et al., 1985; Pollard and Cooper, 1984; Goldschmidt-Clermont et al., 1991). 
When profilin binds to G-actin it forms a less compact structure (Schutt et al., 1993), 
hence facilitating nucleotide exchange, which generates polymerization-competent 
ATP-G-actin (Gieselmann et al., 1995; Perelroizen et al., 1995). Profilin binding to 
actin monomers inhibits nucleation and elongation of pointed ends but not elongation of 
barbed ends (Korenbaum et al., 1998). Hence, profilin has two functions related to 
actin. Alone it inhibits actin polymerization by sequestering free G-actin (Tobacman et 
al., 1982; 1983) and can also promote nucleotide exchange of ADP-bound G-actin to 
ATP-bound G-actin. Binding of profilin to actin monomers prevents spontaneous 
nucleation of actin filaments (Pollard and Cooper, 1984) without affecting elongation of 
existing filaments (Tilney et al., 1983; Pollard and Cooper, 1984). 
1.5.5.3 Capping proteins and their function in thin filament assembly 
There is increasingly strong evidence that actin thin filaments in muscle cells elongate 
from their pointed ends (reviewed in Littlefield and Fowler, 2008). Thin filament 
lengths are controlled by inhibition of actin assembly at pointed ends by tropomodulins 
(Littlefield and Fowler, 2008). In Drosophila thin filaments elongate from their pointed 
ends and are capped by the Drosophila tropomodulin homologue sanpodo (Mardahl-
Dumensil and Fowler, 2001). At their barbed ends actin thin filaments are capped by 
CapZ (Fowler, 1996). Inhibition of thin filament capping by CapZ in chicken skeletal 
myotubes led to impairment in myofibril assembly but had little effect on thin filaments 
of mature myofibrils (Schafer et al., 1995). This suggested that that barbed end 
polymerization does not modulate thin filament lengths (Schafer et al., 1995). Instead, 
the role of CapZ may be to organize actin filaments at the Z-discs during early stages of 
myofibrillogenesis (Fowler, 1996). The degree of thin filament overlap at the Z-disc is 
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most likely to have a physiological significance as Z-disc width is related to the speed 
of muscle shortening. For example, fast and slow twitch fibres have narrow and wide Z-
discs respectively (Rowe, 1973; Vigoreaux, 1994). Z-disc width can vary from - 160 
nm in cardiac muscle (Goldstein et aI., 1979) to - 30 nm in fish skeletal muscle 
(Franzini-Armstrong, 1973). The widths of Z-discs from human biopsies in nemaline 
myopathy cases can however be greater than 1 )lm (Morris et al., 1990). 
The role of barbed/pointed end capping proteins, severmg and sequestering actin 
proteins is pivotal as thin filament reassembly takes place during development of human 
skeletal muscle when the cardiac ACTC1 actin isoform is replaced by the skeletal actin 
isoform ACTA1 pre-parturition (Ilkovski et aI., 2005). Unregulated thin filament 
elongation from the barbed and/or pointed end due to the ACTA1 mutations may be one 
of the causes of nemaline rod formation. Nemaline bodies are penetrated by thin 
filaments and their ultrastructure resembles Z-disc lattice pattern (Luther and Squire, 
2002). They can often be seen to have structural continuity with the Z-discs hence, they 
are considered to derive from lateral expansion of the Z-disc (Engel and Gomez, 1967; 
Yamaguchi et al., 1982; Morris et al., 1990). 
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1.6 General Aims 
More than 170 different mutations within the ACTAl gene in humans are associated 
with nemaline myopathy. intranuclear rod myopathy. actin filament aggregate 
myopathy. myopathy with core-like areas and congenital fibre type disproportion 
(reviewed in Laing et al., 2009; Feng and Marston. 2009). Five mutations in the TnT 
and TnI genes are responsible distal arthrogryposis. Most of the mutations in both 
ACTAl congenital myopathies and arthrogryposis are typically missense mutations 
causing the change of a single amino acid in the thin filament proteins. This raises the 
question of the mechanisms by which such minor changes result in contractile 
dysfunctions. 
The general aim of this project was to investigate if Drosophila IFM can be used as a 
model genetic system that recapitulates the different phenotypes associated with ACTAl 
congenital myopathies and arthrogryposes causing mutations. The approach was to 
create Act88F transgenic flies carrying ACTAl homologous mutations that each results 
in a variety of the human histopathologies. Also, VAS-TnI and VAS-TnT transgenic 
flies were created carrying the different arthrogryposis mutations. If Drosophila IFM 
could successfully reproduce some of the phenotypes observed in human patients the 
next aim was to understand how the mutations in the thin filament proteins result in 
sarcomeric disease. The outcome of this work will not only provide insights into the 
mechanisms of the disease but it should also contribute into the better understanding of 
muscle thin filament assembly and maintenance. 
1.6.1 Objectives 
1) To choose mutations that cause a complete range of ACTAl myopathies and 
introduce these mutations into the Act88F gene. 
2) To express these mutations transgenically to determine whether Drosophila IFM can 
be used as a model system to study nemaline myopathy. 
3) To follow the development of the nemaline phenotype in the Act88p372H mutant by 
examining changes in the structure and function of the IFM. 
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4) To isolate ACT88FR372H actin to determine why this mutation causes the nemaline 
phenotype through biophysical techniques. 
5) To make and express VAS constructs carrying the Drosophila wild type TnI and TnT 
IFM-specific isoforms, with a muscle-specific GAL4 driver line so as to rescue the IFM 
TnT (Upl) and TnI (hdp3) null mutants. 
6) To make and express VAS constructs of the IFM-specific TnI and TnT isoforms 
carrying arthrogryposis mutations, so as to determine whether Drosophila IFM can be 
used as a model to study arthrogryposis. A truncated TnT was also expressed to 
investigate the role of the protein's COOH-terminus. 
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Chapter 2: Materials and Methods 
2.1 Fly experiments 
2.1.1 Fly stocks 
Genotypes and source of origin of the fly stocks used in this project are summarized in 
Table 2.1 
Table 2.1. Fly stocks used in this work 
Line Genotype Source 
Canton-S Wild type Bloomington stock centre 
Texas Wild type Bloomington stock centre 
UH3-GAL4 w[*], P{GawB}-UH3 Dr. Upendra Nongthomba 
dmefl-GAL4 y[l] w[*]; P{w(+mC)=GAL4-Met2.R}3 Dr Frank Schnorrer 
UAS-GFP-Act88F+ w[*]; P{ w(+mC)=UASp-GFP, Act88F } 1-2 Bloomington stock centre 
(9254), R{jper et al., 2005 
UAS-GFP-Act88F+ w[*]; P{w(+mC)=UASp-GFP, Act88F } 15-1 Bloomington stock centre 
y w; su-hdp2 (2B)/ CyO, y+ 
(9253), Rijper et al., 2005 
2BICyo Nongthomba et al., 2003 
uiOl JuplOl Prof. John Sparrow 
hd/ Jhdp2 Prof. John Sparrow 
Multiple balancer y w; CyOllj; MKRSI TM6b, Tb, Hu Dr. Sean Sweeney 
A2-3 y w; CyOISp; A2-3, DrI TM6b, Tb, Hu Prof. John Sparrow 
FM7 FM7, y w BIDf(l)C49 Prof. John Sparrow 
UAS-dsRNAi[ cpb] y w; P{UASp- dsRNAi[cpb]} Vienna Drosophila RNAi 
Center (9299) 
2.1.2 Fly stock maintenance 
Fly stocks were grown in plastic vials containing standard yeast-sugar medium at 25°C 
in a controlled temperature room apart from the dmefl-GAL4 experiments which were 
first grown at an 18°C room and larvae were subsequently moved to the 25 °C room. 
2.1.3 Fly manipulation and setting up crosses 
Flies were anesthetized using di-ethyl ether or CO2 and manipulated under a dissection 
microscope. To set up crosses male and virgin female flies for the correct genotype 
were put in the same vial. 
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2.1.4 P-element mobilisation 
Mobilisation of a P-element containing the Act88f"?372H transgene was achieved by 
crossing the Act88f"?372H mutant line to an active transposase coding line (~2-3) (Figure 
2.1 A). Flies carrying both the Act88f"?372H P-element marked with ry + (red eyes) and 
the ~2-3 active transposase coding line were recovered (Figure 2.1 B). P-element 
transposition occurs in the germ line of these individuals. These flies were then crossed 
to another line (TM3, Ser, ry) maintaining the ry (brown eyes) background to be able to 
recognize the ones carrying the Act88f"?372H P-element, which has a ry + marker 
(Figure 2.1 B). Flies from the offspring were selected for the red eyes (ry +) and the Ser 
marker. These were crossed to the Act88rM88 null line (r/06, eS ) (Figure 2.1 C). Flies 
from the offspring were selected against the third chromosome where the Act88f"?372H 
was originally inserted that still had red eyes (ry +), the Ser marker, KM88 and darker 
cuticle pigmentation due to eS (Figure 2.1 D). 
2.1.5 Pupal aging 
For the pupal aging experiments pre-pupae, identifiable by their white coloured cuticle 
and the appearance of spiracles were collected. The pre-pupal stage is regarded as time 
o hours after puparium formation (APF). If pupae at that stage are kept at 25 °C, 
eclosion takes place between 96 hours and 104 hours APF. When 0 hold pre-pupae 
were identified, the spot of the vial where they were positioned was circled with a 
permanent pen and the vial was placed in a 25 °C incubator until the pupae developed to 
the desired age. 
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Figure 2.1. Mobilisation of the P-element in the Act8Sr371H line. '+' indicates wild 
type alleles, '0' male and '~ ' for female flies. 
2.1.6 Petri plate confinement 
Small round Petri dishes were filled with standard yeast-sugar medium to within 2 mm 
of the bottom of the rim, which allowed enough space for the flies to walk but not jump. 
Flies that had just emerged from their pupal case had their wings clipped with a pair of 
microsurgical scissors and were aged in these petri-plates at 25 QC to be subsequently 
used for immunofluorescence. 
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2.1.7 Flight-testing 
Flight-testing was performed following a standard protocol (Drummond et al., 1991). 
Vials containing 1- and/or 7-day old flies were put into a transparent Perspex box (W-
20, H-40, D-20 cm) (Figure 2.2) with a lamp placed above the flight box to encourage 
the flies to fly upwards. Three areas in the box were defmed as Up (U), Horizontal (H) 
and Down CD) and a 9 cm petri dish placed at the bottom of the box. These zones were 
used to score flies that flew Up, Horizontally, Down, or did not fly (Flightless, N). The 
data were converted to a flight index which is the percentage of the number of flies 
flying Up and Horizontally divided by the total number of flies tested . 
• 
• u 
H 
D 
• N 
Figure 2.2. Flight-testing box. Up (U) Horizontally (H), Down (D), or didn't fly 
(Flightless, N) according to the areas defined by the red lines and the petri dish at the 
bottom of the box. 
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2.2 Microscopy of the IFM 
2.2.1 Transmission Electron Microscopy 
Electron microscopy of IFMs was perfonned as described elsewhere (Kronert et al., 
1995). Briefly, fly thoraces were bisected in dissection buffer [100 mM sucrose, 100 
mM sodium phosphate buffer pH 7.2, 2 mM EGTA (Ethylene glycol tetraacetic acid)], 
followed by overnight fixation in primary fixative (4 % parafonnaldehyde, 2 % 
glutaraldehyde, 100 mM sucrose, 100 mM NaPi buffer pH 7.2, 2 mM EGTA) at 4°C. 
Fixed samples were washed 3 times in 100 mM sodium phosphate buffer pH 7.2, 
followed by secondary fixation in 1 % 100 mM OS04 and then washed again 3 times in 
100 mM NaPi buffer pH 7.2. Samples were dehydrated using an alcohol series (25%, 50 
%, 75 %, 90 %, 100 %) and then washed twice with epoxypropane. The IFMs were 
infiltrated with a mixture of 25 % araldite resin: 75 % epoxypropane, followed by 50% 
araldite resin: 50% epoxypropane, then 75 % araldite resin:25 % epoxypropane, and 
finally 100 % resin for 30 minutes each time. The samples were placed in resin at 37°C 
for 2 hours and then embedded in moulds to polymerize at 60 °C for 48 hours. Thin 
sections were cut by Meg Stark in the Technology Facility. Sections were examined 
using a FEI Tecnai 12 Bio Twin electron microscope at 120 kV. The procedure was 
carried by myself up to before the sectioning for the samples in Chapter 5 and by Meg 
Stark from after the primary fixation up to the sectioning for the samples presented in 
Chapters 3 and 4. 
2.2.2 Immunostaining of single myofihrils 
Immunostaining ofIFMs was perfonned as described elsewhere (Kulke et al., 2001). In 
brief, fly head and abdomen were removed, thoraces were dissected in York modified 
glycerol solution [0.1 M NaCI, 20 mM NaPi pH 7.2, 5 mM, 2 mM MgCh, 2 mM 
ethylene glycol tetraacetic acid (EGTA), 50 % glycerol, 0.5 % Triton X-lOO and 
complete protease inhibitor cocktail-Roche] (Peckbam et al., 1990). Half thoraces were 
left overnight at -20°C in rigor solution. The next day glycerol was washed out (3x) 
using rigor buffer without glycerol, and with rigor buffer without glycerol or Triton X-
100 (3x). The half thoraces were then placed in relaxing solution [O.lM NaCI, 20 mM 
NaPi, 6 mM MgCh, 5 mM ATP (Adenosine-S'-triphosphate), 2 mM EGTA, 90 mM 
KPr and complete protease inhibitor cocktail-Roche] followed by 15 minutes into 
blocking solution (relaxing solution containing 1 % BSA). The thoraces were then 
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incubated with primary antibody (diluted in relaxing solution) for 60 minutes, then 
washed thrice with relaxing solution and incubated with the secondary antibody (diluted 
in relaxing solution) for another 60 minutes. TRITC-phalloidin (I: I 000) was used in 
first and second antibody incubations to stain the actin thin filaments and to also prevent 
them from depolymerising. After the incubation with the secondary antibody thoraces 
were washed thrice with relaxing solution and the IFMs were removed from the cuticle 
and teased on a microscope slide in relaxing solution to fray apart the myofibrils. The 
myofibrils were then fixed in relaxing solution containing 2% paraformaldehyde for 10 
minutes and distilled H20 was used to wash the fixed myofibrils. A drop of Prolong 
Antifade (Invitrogen Molecular Probes) mountant was then added; a coverslip was 
placed over the sample and allowed it to set for a few hours. Imaging was carried out 
using confocal microscopy with a 60x lens objective, in a Zeiss LSM 510 META 
microscope with LSM imaging software. 3D reconstructions of Z-stacks were created 
using Volocity LE 3D imaging software. The antibodies used for this procedure and for 
the procedure in section 2.2.3 during this project are summarized in Table 2.2. 
2.2.3 Dissection of adult and pupal thoraces 
To dissect the IFM, flies were anaesthetized using ether and placed on a card. The head 
and abdomen were removed using forceps and the fly thorax was cut in half along the 
longitudinal axis using a pair of microsurgical scissors (Fine Science Tools) while 
submerged in an appropriate solution. Using a pair of sharp tungsten needles the IFM 
were removed from the cuticle and transferred to the appropriate buffer at -20 QC until 
use (never longer than 5 days). For isolation of IFM for immunostaining thoraces were 
dissected in 4 % paraformaldehyde and left for 30 minutes. 
To isolate the IFM from pupae, a glass slide with double sticky tape was used to hold 
pupae of the desired age in order to remove the pupal cases. Pupae were then transferred 
on a Sylgard plate (Dow Coming silicone elastomere kit) lying on their dorsal side 
where entomology needles were used to pin them through their heads. After submersion 
in 4 % paraformaldehyde, a small incision was made in the posterior end of the pupa 
followed by a second incision along the longitudinal axis, which exposed the IFM. 
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2.2.4 Immunostaining of half thoraces 
Both adult half thoraces and IFM from pupae were washed 3 times with relaxing 
solution and left for 1 hour in rigor solution, followed by 15 minutes into relaxing 
solution. The samples were incubated with primary antibody (diluted in relaxing 
solution) overnight on a shaker at 4°C, then washed thrice with relaxing solution and 
incubated with the secondary antibody (diluted in relaxing solution) for 5 hours on a 
shaker at room temperature. TRITC-phalloidin (1:1000) was used in the first and second 
antibody incubations to prevent thin filaments from depolymerising. When staining for 
nuclei the DAPI (4,6-diamino-2-phenylindole) stain was used at 1 llg/ml, during the last 
15 minutes of the secondary antibody incubation. After the secondary antibody and 
DAPI incubation, thoraces were washed thrice with relaxing solution and the IFMs were 
removed from the cuticle and placed on a microscopy slide in a drop of relaxing 
solution. A drop of Prolong antifade was then added and a coverslip was placed over the 
sample. Confocal imaging was carried out using a Zeiss LSM 510 MET A microscope 
with LSM imaging software. Deconvolution imaging was carried out using an Olympus 
fluorescence microscope and Softworx software (Deltavision, USA). 
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Table 2.2. Antibodies used for immunostaining of single myofibrils and half 
thoraces 
Antibodies Description Source 
Anti-a-actinin Anti-a-actinin monoclonal antibody Prof. Belinda Bullard 
developed in rat 
Anti-GFP Anti-GFP IgG polyclonal antibody (whole abcam ab290 
molecule) developed in rabbit 
Anti-Kettin Monoclonal antibody to KIg 16 (Ig number Prof. Belinda Bullard 
16 in kettin) developed in rat 
Anti-Myosin Anti-Myosin monoclonal antibody Prof. Belinda Bullard 
developed in rat 
Anti-Obscurin Anti-Obscurin polyclonal antibody Prof. Belinda Bullard 
developed in rabbit 
Anti- Anti-Tropomodulin polyclonal antibody Prof. Velia Fowler 
Tropomodulin developed in rat 
Anti- Anti-Tropomyosin mono clonal antibody Prof. Belinda Bullard 
Tropomyosin developed in rat 
Anti-Z210 Anti-Zetalin monoclonal antibody Dr. Judith Saide 
(zetalin) developed in mouse 
Anti-rat-FITC Anti-rat IgG (whole molecule) FITC- Sigma AldrichIF- 6258 
conjugate developed in goat 
Anti-rabbit- Anti-rabbit IgG (whole molecule) FITC- Sigma AldrichIF-9887 
FITC conjugate developed in goat against purified 
rabbit IgG 
Anti-rat-Cy5 Anti-Rat Cy5-conjugate AffiniPure F(ab')2 Jackson Immunoresearch// 
Fragment IgG (H+L) developed in goat 112-176-062 
(minimum crossreaction to Human, Bovine, 
Horse Serum Proteins) 
Anti-mouse- Anti-mouse IgG (whole molecule) FITC- Sigma AldrichIF-0257 
FITC conjugate developed in goat against purified 
mouse IgG 
Dilution 
1:50 
1:100 
1:100 
1:50 
1:100 
1:50 
1:50 
1:50 
1:500 
1:500 
1:500 
1:500 
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2.2.5 Polarized light microscopy 
Polarized light microscopy was performed as described elsewhere (Nongthomba and 
Ramachndra, 1999). Briefly, etherised flies were placed on their back on a microscope 
slide in a drop of 50 % ethanol and were submerged into liquid nitrogen. A razor blade 
was used to bisect the flies along the longitudinal axis. The samples were then 
dehydrated using an alcohol series (50 %, 70 %,80 %, 90 %, 100 % one hour each) and 
were left overnight in methyl salicylate. The head, legs and abdomen from each half fly 
were removed; thoraces were placed on a microscope slide, mounted in DPX mountant 
(Sigma-Aldrich) and a cover slip was placed over the sample that was left to set. 
Samples were examined on a Nikon inverted Eclipse T2000-U microscope fitted with a 
conventional Nikon 35 mm photographic camera. Photographic film was developed in a 
regular photo-shop to obtain digital images. A representative image from several 
pictures obtained for each genotype is shown. 
2.2.6 Brightfield and fluorescent microscopy of whole organisms 
Brightfield and fluorescent pictures of whole pupae and anesthetized adult flies that 
were positioned on a microscope slide, were taken using a Zeiss AxioCam MRcS digital 
camera fitted to a Zeiss Stereo Lumar V12 microscope. 
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2.3 Molecular Biology 
2.3.1 Media and bacterial strains 
E. coli cultures were either grown in autoc1aved Luria-Bertani (LB) broth (1 % Bacto-
tryptone, 0.5 % Bacto-yeast extract, 10 glL NaCI) or plated on autoclaved LB-agar. 
Antibiotic selection was perfonned by use of ampicillin (amp) (100 ~glml), and 
chloramphenicol (chI) (34 ~glml) where indicated (Melford). The bacterial strains used 
in this project are listed in Table 2.3. 
2.3.2 Preparation of chemically competent E. coli cells 
Competent cells were prepared from 35 ml E. coli cultures that had reached an OD600nm 
of ~0.3-0.6. Cells were harvested by centrifugation, washed in 20 ml of ice-cold 20 mM 
Tris-HCI, 50 mM CaCh, pH 8.0 and left on ice for 1 hour. Cells were harvested again 
by centrifugation and resuspended in 2 ml of ice-cold 20 mM Tris-HCI, 50 mM CaCh, 
20% w/v glycerol pH 8.0. Aliquots of 100 ~l were made and stored at -80°C. 
Table 2.3. Bacterial strains used in this project. 
Strain 
DH5a 
(F q>80laeZ~M 15 ~(laeZY A-
argF)Ul69 recAl endAl 
hsdRI7(rk", mk +) phoA supE44 
thi-l gyrA96 relAl ),:) 
BL21(DE3) pLysS 
(F-, om pT, hsdSa (ra-, mB-), 
dem, gal, A(DE3), pLysS, Cmr) 
XL 1 O-GOLD ultracompetent 
cells (Stratagene 200314): Tef 
J(mcr A) 183 J(mcrCB-
hsdSMR-mrr) 1 73 endAI 
supE44 thi-I reeAI gyrA96 
re lA 1 lac Hte [F' proAB 
lacflZJMI5 TnIO (Ten Amy 
Cam1a 
Uses 
Competent cells used for transformation of plasmids 
generated by ligation or whole plasmid mutagenesis 
« 1 0 kb). Cells were also used for the preparation of 
plasmid DNA for sequencing and transformation into the 
pET15b expression strain. 
Competent cells used for induced protein expression 
from recombinant plasmids under the regulation of a T7 
promoter. Protein expression was controlled by 
isopropyl-~-D-thiogalactopyranoside (lPTG) 
Ultracompetent cells used for transformation of > 12 kb 
plasmids made by whole plasmid mutagenesis or ligation. 
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2.3.3 Transformation of competent E. coli cells 
Approximately 50 ng plasmid DNA was added to 100 /!l DH5a or BL21 (DE3)pLysS 
competent cells and incubated on ice for 30 minutes. The cells were heat shocked at 
42°C for 90 seconds, followed by a 5 minute incubation on ice. Next 400 /!l of pre-
waimed LB were added and cells were left to incubate at 37°C for 1 hour. After this 
step cells were plated onto pre-warmed LB-agar plates (containing the correct 
antibiotic) and incubated overnight at 37°C. When XLIO-GOLD ultracompetent cells 
were used, 45 /!l of cells were incubated on ice for 10 minutes, heat-shocked at 42°C 
for 60 seconds, followed by a three minute incubation on ice and treated as described 
above for DH5aIBL21 (DE3)pLysS cells. 
2.3.4 Preparation of glycerol stocks 
200 /!l of overnight culture was added to 800 /!l of autoc1aved glycerol and the mixture 
was stored at -80°C in 2 ml screw cap polypropylene tubes. 
2.3.5 Plasmid DNA extraction 
Plasmids were isolated using the Qiagen Mini and Maxi prep kits as per manufacturer's 
instructions. 
2.3.6 Restriction digests 
lllg of DNA was digested with 5-10U of the appropriate restriction enzymes purchased 
from New England Biolabs (NEB). Using the appropriate buffer (and BSA if needed), 
reactions were performed at a 20 /!l scale at 37°C for 2 hours. Agarose gel 
electrophoresis (see section 2.3.14) was performed on the digested PCR products and 
linerarised vectors, which were extracted using the QIAquick Gel Extraction Kit 
(Qiagen) as per manufacturer's instructions. 
2.3.7 Ligation reactions 
Ligation reactions of double stranded DNA were performed using the T4 DNA ligase 
and the 10 x T4 ligase buffer (Promega). An excess of PCR product was mixed with 
linerarised vector and incubated for 3 hours at room temperature before transformation 
in competent DH5a cells as described above. 
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2.3.8 DNA Primers 
DNA primers were synthesised by Sigma Genosys (Sigma-Aldrich). A full list of the 
primers used for whole plasmid mutagenesis is listed in Table 1 of the Appendix. The 
rest are indicated in the relevant sections of Materials and Methods or relevant Results 
Chapters. 
2.3.9 Cloning of the IFM-specific TnI gene coding sequence 
2.3.9.1 RNA extraction from Drosophila IFM 
The IFM of wild-type 96 hour APF old pupae were dissected in 70 % ethanol and RNA 
was isolated using the QIAgen RNeasy mini kit as per manufacturer's instructions. 
2.3.9.2 Synthesis of the first strand cDNA 
The RNA was reversed transcribed into cDNA using the Stratagene Stratascript First-
Strand synthesis kit. Briefly 15 J..ll of the RNA was mixed with 1 J..lI of oligo dT primer 
(0.5 J..lg/J..lI), 0.8 J..lI of dNTP mix and 2 J..lI of 10 x AffinityScript RT buffer. The mixture 
was incubated at 65 °C for 5 minutes and the reaction was subsequently cooled to room 
temperature for 10 minutes to allow the primers to anneal to the RNA. 2 J..lI of the 10 x 
AffinityScript RT buffer, 0.8 J..lI of dNTP mix, 0.5 J..lI of RNase Block Ribonuclease 
Inhibitor (40U/J..lI) and 1 J..lI of AffinityScript Multiple Temperature RT were mixed and 
incubated at 55 °C in a thermal block for an hour before terminating the reaction by 
incubation at 70 °C for 15 minutes. 
2.3.9.3 Amplification of the coding sequence 
The primers used to amplify the TnI gene from the IFM cDNA created an EcoR I 
restriction site before the 5' end and a Kpn I restriction site on the 3' end (see Table 1 of 
the Appendix). The peR conditions are shown in Table 2.4. 
Table 2.4. The peR conditions used to isolate the TnI gene coding sequence from 
the cDNA. 
Number ofCycies Temperature 
16 
Time 
1 seconds 
30 seconds 
1 minute 
2 minutes 
5 minutes 
00 
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2.3.9.4 Subcloning of Tn] gene coding sequence and site-directed whole plasmid 
PCR mutagenesis 
The TnI gene coding sequence was then digested, gel-purified and ligated to the 
digested TA vector. Site-directed whole plasmid mutagenesis was performed to create 
four Tnl mutant plasmids each carrying a different single point mutation. The primers 
used to perform the site-directed peR mutagenesis reactions are shown in Table 1 of the 
Appendix and the peR conditions in Table 2.5. The wild type TnI gene coding sequence 
and those carrying the K245@, V256G, ~K257 and ~E258 mutations were excised 
from the TA vector and ligated into the pP[UAST] vector to create the pP[UAST-TnI], 
pP[UAST-Tn.f245@], pP [UAST_TnIV256G], pP[UAST-TnrK257] and pP[UAST_TnrE258] 
plasmids all of which were used to transform XLI0-GOLD ultracompetent cells. 
Table 2.5. The site-directed PCR mutagenesis conditions used for creating the TnI 
mutants. 
Number ofC~cles Temeerature Time 
1 95°C 1 seconds 
95 °C 50 seconds 
16 60°C 50 seconds 
68 °C 4.5 minutes 
68°C 7 minutes 
4°C 00 
2.3.10 Site-directed whole plasmid peR mutagenesis of TnT gene 
coding sequence and subcloning 
The IFM-specific TnT gene coding sequence carried in a TA cloning vector (Bangalore 
Genei) was a kind gift from Dr Upendra Nongthomba (Indian Institute of Science, 
Bangalore). Site-directed whole plasmid mutagenesis was then performed to create two 
TnT mutant plasmids each carrying a different single point mutation. The primers used 
to perform the site-directed peR mutagenesis reactions are shown in Table 1 of the 
Appendix and the peR conditions were the same as for the Tnl gene coding sequence. 
The wild-type TnT gene coding sequence as well as those carrying the K43H and 
E314@ mutations were excised from the TA vector and ligated into the pP[UAST] 
vector to create the pP[UAST-Tn1], pP [UAST-TnT<43H] and pP[UAST_TnT'314@] 
plasmids all of which were used to transform XLIO-GOLD ultracompetent cells. 
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2.3.11 Subcloning of the a-actinin actin binding domain (ABO) gene 
coding sequence of Gal/us gal/us 
The a-actin in ABD gene coding sequence (1-807 bp) of Gal/us gal/us in the pMW172 
expression vector (Way et al., 1992) was a kind gift from Dr Steve Winder (University 
of Sheffield). Whole plasmid PCR site directed mutagenesis was performed to create 
the a-actinin ABD SI 03C mutant (reaction conditions Table 2.6 and mutagenesis 
primers listed in Table 1 of the Appendix). Stratagene XLIO-GOLD uItracompetent 
cells were transformed with the mutagenized plasmid. 
Table 2.6. Whole plasmid PCR site directed mutagenesis conditions for creating 
the a-actinin ABD Sl03C mutant. 
Number ofC~c1es Temeerature Time 
1 95 DC 1 minute 
95 DC 50 seconds 
16 60 DC 50 seconds 
68 DC 7 minutes 
72 DC 7 minutes 
4 DC 00 
PCR was performed to introduce the Nde I and Xho I restriction sites, at the N and C 
terminus respectively, of the a-actinin ABD gene coding sequence in the S 103C mutant 
as well as for the wild type. In addition a Factor Xa cleavage site was introduced at the 
5' - end of the gene, which leaves a blunt end after cleavage (primers are listed in Table 
1 of the Appendix). The wild type and mutant a-actinin ABD gene coding sequences 
were subsequently digested and cloned to a pre-digested pETI5b His tag vector 
(Novagen, cat nbr. 69661-3). The PCR conditions for isolation of the gene coding 
sequence are shown in Table 2.7. 
Table 2.7. The peR conditions for isolation of the a-actinin ABD gene coding 
sequence from the pMW172 vector. 
Number ofC~c1es Temeerature Time 
1 95 DC 2 minute 
95 DC 30 seconds 
30 60 DC 30 seconds 
72 DC t minutes 
72 DC 10 minutes 
4°C 00 
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2.3.12 Construction of pW8Act88F plasmid and site-directed whole 
plasmid PCR mutagenesis 
The pP{W8, w +mW.hs Act88F} plasmid was a gift from Vikash Kumar, who constructed 
this plasmid by subc10ning a 4.0 kb Sal! fragment of the Act88F gene taken from the 
pUC9Act88Fplasmid (Drummond et al., 1990) into the pP{W8, W+mW.hs} plasmid, a 
Drosophila P-element vector for germline trangenesis (Klemenz et al., 1987), between 
twoXho I restriction sites. Whole plasmid site·directed mutagenesis was performed on 
this plasmid to create all the Act88F mutants during this project. The PCR conditions 
are shown in Table 2.8 and the primers in Table 1 of the Appendix. The mutagenized 
plasmids were used to transform XL10-GOLD ultracompetent cells and were 
subsequently sequenced. 
Table 2.8. The peR site directed mutagenesis conditions for creating all the 
Act88F mutants. 
Number of Cl:cles Teml!erature Time 
1 95°C 1 seconds 
95 °C 50 seconds 
16 55°C 50 seconds 
68°C 17 minutes 
68 °C 7 minutes 
4°C 00 
2.3.13 Site directed mutagenesis of whole plasmids 
Whole plasmid mutagenesis was performed to create point mutations and deletions of 
single residues. The QuikChange@ Site-Directed Mutagenesis kit (Stratagene) protocol 
was used. The protocol required the use of complementary mutagenic primers which 
had a melting temperature (T m) greater than 78°C. In certain cases this was not possible 
and therefore all primers were designed to have a T m greater than 70°C. The T m was 
calculated using the following formula; 
Tm = 81.5 + (0.41 x (%)GC) - (6751N) - (%)MM 
where (%) GC is the percent of G and C bases content in the primer, N is the number of 
bases in the primer and (%) MM is the mismatch percentage of the primer with 
complementary region of the template. Whole plasmid mutagenesis was performed 
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using a total reaction volume of 50 ~l. The PCR reaction mixture is listed in Table 2.9. 
A negative control was performed where no PfuUltra 11 Phusion was added. Following 
the PCR reaction, treatment with DpnI enzyme was performed in order to digest the 
methylated parental DNA strands at 37°C for 1 hour. The DpnI enzyme was 
deactivated at 80°C for 20 minutes. 
Table 2.9. A typical whole plasmid mutagenesis peR reaction mixture. 
Component 
Autoc1aved Milli-Q water 
lOx PfuUltra 11 Phusion Polymerase Reaction Buffer 
QuickSolution 
dNTPs (10 mM stock) 
Plasmid template dsDNA (50 ng/~l) 
Forward primer (125 ng/~l) 
Reverse primer (125 ng/~l) 
PfuUltra 11 Phusion Polymerase (2.5 U/~l) 
2.3.14 DNA agarose gel electrophoresis 
Volume 
37 ~l 
5 ~l 
3 ~l 
1 ~l 
1 ~l 
1 ~l 
1 ~l 
1 ~l 
1 % w/v agarose gels were prepared using 89 mM Tris-Borate pH 8.3 with 2 mM 
EDT A (TBE). 5 ~l of SYBR® Safe 10000x concentrate (Invitrogen) was added per 50 
ml of gel. Agarose gels were run in 1 x TBE at a constant voltage of 120 V using the 
Mini-Sub Cell GT system (BioRad) and imaged using Gene Genius bioimaging gel 
documentation system (Syngene). 
2.3.15 DNA quantification 
DNA concentration was measured at 260 nm using an ND-I000 spectrophotometer 
(NanoDrop ). 
2.3.16 Sequencing 
DNA sequencing reactions were out-sourced (Cogenics) and performed on an AB! 
3730xl Platform (Applied Biosciences). The universal primers T7F and T7R were used 
for sequencing pET based plasmids and self-designed primers for sequencing plasmids 
containing the Act88F, a-actinin ABD, TnI, and TnT genes. 
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2.4 Biochemical techniques 
2.4.1 1 D SDS gels 
To examine the protein contents of intact IFM, dissections were carried out in PBS 
(phosphate buffered saline), which was subsequently removed by a 1 minute 13000 rpm 
spin on a microcentrifuge. Then Ix sample buffer [312.5 mM Tris-HCI pH 6.8, 10 % 
SDS (Sodium dodecyl sulfate), 0.5% bromophenol blue, 50% glycerol] was added to 
the pellet and samples were boiled for 3 minutes at 90°C. When examining the protein 
contents of skinned myofibrils the IFM were dissected in rigor solution (section 2.2.2) 
and were kept at -20°C overnight. The following day glycerol was washed out three 
times using rigor buffer without glycerol, and three times with rigor buffer without 
glycerol and Triton X-lOO. Subsequently the muscles were homogenized in I x sample 
buffer and boiled for 3 minutes at 90°C. All samples were stored at -20°C until ready to 
load on the gels. Proteins were separated in 10 % SDS gels (37.5 acrylamide: 1 
bisacrylamide ratio) using the Mini-protean 3 electrophoresis system (BioRad) unless 
stated otherwise. The protein samples were run at a constant voltage (200 V) in Tris-
glycine running buffer containing 25 mM Tris base, 0.1 % SDS and 200 mM glycine 
until the dye front had reached the bottom of the gel. Gels were stained with Coomassie 
blue (10 % acetic acid, 0.1 % Coomassie brilliant blue-R, 40% methanol) for 20 
minutes. A 10 % acetic acid solution was used to destain the gels which were imaged 
using the Gene Genius bioimaging gel system (Syngene). 
2.4.2 Actin purification from Drosophila IFM 
The actin purification method has been described in Razzaq et al., 1999. Briefly, the 
IFM from 120 flies were dissected in rigor buffer and centrifuged. The IFM pellet was 
then homogenized on ice using a sealed glass pipette in high salt buffer [1 M KCI, 10 
mM NaPi, 20 mM KPi pH 7.0, 4 mM dithiothreitol (DTT), 1 mM EGTA, 4 mM MgCh, 
11500 v/v phenylmethylsulphonyl fluoride (PMSF)]. The pellet was washed twice with 
500 JlI of ddH20, followed by one wash with 50% acetone and one wash with 100 % 
acetone. The pellet was air-dried for 1 hour before actin was extracted from the muscles 
with three consecutive incubations of 45 JlI low salt actin extraction buffer (2 mM Tris 
pH 8.0, 0.2 mM CaCh, 0.2 mM ATP, 1 mM DTT) 1 hour long each and this was 
repeated 3 times. The samples were spun after each extraction and the supernatants were 
combined and transferred to a Beckman 7x20 polycarbonate centrifuge tube and 1110th 
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volume of 10x polymerization buffer (50 mM Tris pH 8.0, 500 mM KCI, 20 mM 
MgCh, 10 mM A TP) was added to the supernatant and actin was allowed to polymerize 
for 2 hours at room temperature. When actin was going to be subsequently used in 
fluorescent anisotropy measurements 30 pmol phalloidin was also added at this step. 
Then KCI was added to a final concentration of 850 mM and was left to incubate for 5 
minutes. The actin filaments were then spun at 100.000 rpm for 15 min, at 4 °C in a 
TL-I00 centrifuge using the TLA-I00 rotor. The supernatant was removed and the 
pellet was gently dissolved using previously filtered F-buffer. Protein concentration was 
measured using a Nanodrop. 
2.4.3 a-Actinin overexpression and purification 
pET15B a-actinin ABO plasmids were transformed into BL21(OE3) pLysS cells for 
expression. Single colonies were picked for overnight 60 ml starter cultures. AI: 1 000 
dilution of a 60 ml overnight culture was used to inoculate 6 x 0.8 L media, and cultures 
were grown on an Innova 2300 platform shaker (New Brunswick Scientific) at 37°C. 
When an 00600 of 0.5-0.6 was reached protein expression was induced with a final 
concentration of 1 mM IPTG (isopropyl-beta-O-thiogalactopyranoside) (Melford). Cells 
were grown for 4 hours on the orbital shaker at 37°C before harvesting in a Sorval 
centrifuge (SLC-6000 rotor for 12 minutes, 4000 rpm, 4°C). The pellets were combined 
and resuspended in approximately 35 ml binding buffer (20 mM Tris pH 7.5, 500 mM 
NaCl, 5 mM imidazole) containing 5 mM MgCh, 1.4 mg DNAse 1,60 mg lysozyme, 1 
mM PMSF and 4 complete protease inhibitor tablets were added. Cells were lysed by 
sonication on ice twice using a Sonicator 3000 with a 3/8 inch stud probe (Misonix) with 
50x3 seconds pulses at 70 Wand a 7 second spacing between pulses. Lysed cells were 
then left for 15 minutes at room temperature and were subsequently centrifuged (SS34 
rotor for 30 minutes at 17000 rpm, at 4°C) to remove the cell debris. The supernatant 
was filtered prior to purification using a 0.22 ~m filter (Millipore). 
All solutions, protein samples and ddH20 were filtered prior to all chromatography 
steps. The cell extract was loaded onto a 10 ml nickel column previously equilibrated 
with binding buffer at a flow rate of 2 mUmin. 5 column volumes (c.v.) of nickel 
sulphate was used to charge the resin (His Bind Resin, Novagen). Excess nickel 
sulphate was removed by passing 5 c.v. of binding buffer. Protein loading was 
monitored by UV absorbance at 280 nm on an Akta Prime purifier (GE Healthcare), 
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Binding buffer was passed through the column to elute the unbound proteins until the 
UV signal had returned to A280 nm - O. The a-actinin ABO was eluted from the 
column using an imidazole gradient over 90 ml (5 mM to 400 mM). The peaks were 
analyzed by 12% SOS gels and the a-actinin ABO containing fractions were pooled and 
dialysed overnight against 50 mM Tris pH 7.5, 200 mM NaCI, 5 mM EDTA buffer at 4 
°C using a 3500 molecular weight cut-off dialysis tube (Spectrum). 
The protein was further purified by size exclusion chromatography using a Hiload 26/60 
Superdex 75 pg column (GE Healthcare). The column was equilibrated with 50 mM 
Tris-HCI, 250 mM NaCI, pH 7.5 prior to injecting 10 ml of protein. The protein was 
eluted at 3 ml/min flow rate and was monitored by the absorbance at 280 nm. All 
elution peaks were analysed by a 12 % SDS gel. The a-actinin ABD containing 
fractions were pooled and dialysed overnight at 4 °C using a 3500 molecular weight cut-
off dialysis tube against 20 mM Tris pH 8.0, 100 mM NaCI, 2 mM CaCh buffer for 
cleavage of the His tag. 
2.4.4 Factor Xa His tag cleavage 
The His tag was cleaved using Factor Xa protease (Sigma Aldrich F9302) according to 
the manufacturer's instructions for 7 hours at room temperature and the reaction was 
stopped using 1 mM PMSF. Subsequently the protein was dialyzed overnight in binding 
buffer and was purified using a 1 ml Nickel column pre-equilibrated with binding 
buffer. Cleaved a-actinin ABD eluted in the flow through. A sample of the a-actinin 
ABD containing fraction was analyzed by a 12% SDS gel and the remainder was 
dialysed overnight against 50 mM Tris pH 7.5, 200 mM NaCI, 5 mM EDTA buffer at 
4 °C using a 3500 molecular weight cut-off dialysis tube. Cleaved protein mass was 
confirmed by a 20 % SDS gel and electrospray ionisation mass spectrometry (section 
2.4.12). 
2.4.5 Protein estimation 
A Biophotometer (Eppendorf) was used to measure protein concentrations by the 
absorbance at 280 nm. The following formula was used to calculate the theoretical 
molar absorbance coefficient (e280nm) for cleaved a-actinin ABO: 
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E280nm = (Ncys x E280nm ofcys) + (Ntyr x E280nm oftyr) + (Ntrp x E280nm oftrp) 
where N is the number of amino acids (cys, cysteine; tyr, tyrosine; trp, tryptophan) and 
E280nm is the molar absorption coefficient for the amino acids (125 M-! cm-!, 1490 M-! 
cm-! and 5500 M-I cm-! respectively). Based on the above equation the predicted molar 
extinction coefficient for a-actinin is 45045 M-! cm-I. The Beer-Lambeth law was used 
to calculate the protein concentration: 
C =A/d'( 
Where c is the protein concentration (mol L-J), A the A280 absorbance, d the length of 
wavelength path (cm) and E: the molar extinction coefficient (M-! cm-I). 
2.4.6 Protein labelling 
Cleaved a-actinin ABD was dialyzed overnight at 4 °C against 2 M sucrose, 
50 mM MOPS pH 7.0, 200 mM NaCl. The dialysed protein was reduced with 3-fold 
excess DTT for 1 hour at room temperature. A 20-fold excess of 5-carboxyfluorescein 
(FAM, C1359 Invitrogen) fluorophore was added; the tube was wrapped in foil and was 
kept at 37°C for 10 minutes. Excess fluorophore was quenched with 35 mM DTT. A 
small sample was taken for electrospray ionisation mass spectrometry (see section 
2.4.12) and the remnants of the protein was dialyzed overnight in F-buffer (50mM 
NaCI, 1 mM MgCh and 20mM Tris pH 7.0) at 4°C. Small aliquots oflabelled a-actinin 
ABD were snap-frozen in liquid nitrogen and stored at -80°C. 
2.4.7 Electrospray Ionisation Mass Spectrometry (ESI-MS) 
Protein samples were concentrated to 50 J.lM and ESI-MS analysis was performed on an 
ABI Qstar tandem mass spectrometer by Berni Strongitharm in the University of York 
Technology Facility. The observed molecular weight of wild type a-actinin with and 
without the His tag was shown to be 33616.3 Da and 30866 Da, respectively. 
2.4.8 Matrix-Assisted Laser Desorption Ionisation - Time Of Flight 
mass spectrometry (MALDI-TOF MS) 
10 J.lI of protein sample was loaded and run on a 10 % I-D SDS gel. The gel was stained 
with Coomassie blue solution (section 2.4.1) and the appropriate band was excised and 
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stored in ddH20. The samples were analysed by MALDI-TOF MS by the University of 
York Technology Facility in the Biology Department (Adam Dowle). 
2.4.9 Sedimentation assays 
The interaction of a-actinin with wild type and mutant actin was estimated by 
sedimenting a-actinin with F-actin. G-actin extracted from the IFM was mixed with a-
actinin in F-buffer (section 2.4.6) to give a constant actin concentration of 3 )lM 
whereas the a-actinin concentration was 7.2 )lM in 100 )ll reaction volume. After 
incubating for 1 hour at 25°C, samples were centrifuged at 40.000 rpm for 40 min, at 
4 °C in a TL-IOO centrifuge with a TLA-I00 rotor. Control samples of a-actinin were 
centrifuged without actin. After the centrifugation 30 )ll of 1 x sample buffer were added 
to the pellet and 200 )ll of2x sample buffer were added to the supematant. Supematants 
and pellets were denatured at 90°C for 3 minutes and analyzed on a 10 % 1-D SDS gel; 
all sample volumes were loaded using a Hamilton syringe for high accuracy. 
2.4.10 Fluorescence anisotropy 
Fluorescence anisotropy measurements were used to study the binding of fluorescently 
labelled a-actinin ABD to F -actin. 
Fluorescence anisotropy parameters: 
• Black 96 well plate (FluoroNunc) 
• Temperature = 24°C 
• Plate reader with polarisers (BMG Labtech POLARstar OPTIMA): 
Excitation = 490 nm 
Emission = 520 nm 
• FAM: Excitation = 492 nm 
Emission = 512-520 nm 
Labelled a-actinin ABD (prepared as described in section 2.4.10) was used at a constant 
concentration of 4 nM and was diluted to this concentration by F-buffer (section 2.4.6). 
F-actin (prepared as described in section 2.4.3) was titrated at concentrations between 
0.025 )lM to 4.6 IlM in the case of wild type actin and 6.2 IlM for the R372H actin. 
After each aliquot ofF-actin was added, the plate was shaken for 10 seconds, given two 
minutes to equilibrate and the anisotropy was measured 25 times and averaged. 
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Absorption and emission spectra of the labelled a-actinin ABD were measured pre- and 
post- titration to confirm no quenching of the fluorophore by F-actin was occurring. 
Data were fitted with equations derived in Appendix Ill. Graphs were plotted using 
SigmaPlot vII. 
2.5 Single myofibril mechanical experiments 
The single myofibril mechanical experiments were done in collaboration with Dr B. 
Iorga and ProfG. Pfitzer (University of Ko en). Single myofibrils and chemical solutions 
were prepared by myself. Dr. B. Iorga performed the single myofibril stretching 
experiments and analyzed the force transients. Video analysis was also carried out by 
Dr. Iorga because the file format (NAF) was only readable on a computer from their 
laboratory . 
2.5.1 Myofibrillar preparation 
Half thoraces from 10 newly emerged flies were dissected and skinned in rigor solution 
(Section 2.2.2). Half thoraces were left overnight at -20°C. The next day fly thoraces 
were washed three times using rigor buffer without glycerol, and three times with rigor 
buffer without glycerol or Triton X-lOO. The half thoraces were then washed in 
degassed relaxing solution [0.1 M NaCl, 20 mM NaPi pH 7.2, 90 mM KPr, 6 mM 
MgCh, 2 mM DTT, 5 mM ATP, 5 mM EGTA, 30 mM BDM (2,3-butane- dione 2-
monoxime), complete protease inhibitor cocktail-Roche]. The muscles were dissected in 
the relaxing solution and teased with needles to produce single myofibrils. 
2.5.2 Apparatus and experiments 
The setup for single myofibril force measurements was previously described (Stehle et 
al., 2002a, 2002b). Single myofibrils were attached in relaxing solution to a glue-coated 
length-driving tungsten stiff needle at one end and to the coated tip of an atomic force 
cantilever (AFC) at the other end (Figure 2.3). Both the length-driving tungsten stiff 
needle and the AFC were previously coated with a mixture of 50 % flowable silicon 
(Dow Coming 3140, Dow Coming Corp., Midland, MI) and pyroxylin in 2 % amyl 
acetate. The chamber was washed with 100 % EtOH so as to create an electrical charge 
which later helped with sedimentation of the myofibrils to the bottom of the chamber. A 
100 J.lI drop of freshly prepared single myofibrils was placed in the chamber and left for 
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one and a half hour to allow the myofibrils to sediment. Following this the chamber was 
filled with 10 ml of filtered degassed relaxing solution. After sedimentation, to remove 
debris (e.g. myofibril aggregates) the chamber was washed with degassed relaxing 
solution. Myofibrils between 100-150 I-lm long were only used for the measurements, 
which were performed at 15 QC. 
Piezodriver 
force cantilever 
90x 
phase contrast microscope 
CCO camera 
laser 
relaxed IFM myofibril 
~ -----
Figure 2.3. Schematic representation of the apparatus used for stretching single 
myofibrils. Inside the chamber a myofibril is attached on one end to the length-driving 
tungsten stiff needle attached to a piezodriver and to the AFC at the other end. A laser 
beam hits on a mirror positioned at the back of the AFC, and becomes redirected to a 
photo detector to measure movement of the AFC (calibrated to measure force). A phase 
contrast microscope charge-coupled device (CCO) camera positioned below the 
chamber is used to record brightfield microphotographs and videos. Diagram 
reproduced from an image provided by Dr. Stehle. 
Passive force responsiveness was recorded in successive stretch protocols applied to 
fully relaxed single myofibrils. Figure 2.4 highlights the stretching protocol. The 
mounted myofibrils was stretched over a 3 seconds ramp (1 st ramp) so that its length 
increased by 2 %, subsequently maintained at steady stretch for 4 seconds during which 
time the force (F 1) was measured. Next the myofibril was imposed to a higher stretch 
over a 3 seconds ramp (2nd ramp) so that its length increased to 4%, maintained at 
steady stretch for 4 seconds during which the force (F2) was measured. Finally the 
myofibril was released to zero passive force and was then ready for another round of 
stretching from 3 % - 6 %, followed by a third stretch of 4 % - 8 % of its slack 
sarcomere length. 
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1" ramp Steady stretch 2" ramp Steady stretch Fast re'ea.e 
F2 
F1 
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0.5 sec: 3 see 
Figure 2.4. Schematic description of the stretching protocol. 
2.5.3 Data acquisition and analysis 
During the stretching protocol, videos and micrographs of myofibrils were recorded 
with a CCD camera (Photonics, Hamamatsu City, Japan) in brightfield. The video 
frames corresponding to slack and stretched lengths of myofibrils were analyzed at the 
periods when force signal was steady. Acquisition and analysis of force data was 
performed with custom-written programs in LabView 5.0 (National Instruments, Austin, 
TX). Video images were quantitatively analyzed by selecting a rectangular region of 
interest and integrating pixel intensities to an intensity profile in Aqua Cosmos 1.3.0.1 
(Photonics, Hamamatsu City, Japan). Mean sarcomere length (SL) values were then 
determined from the profiles using the Lab View built-in files. 
2.5.4 Calculations 
Explanations and values of the symbols used in the equations are summarized in Table 
2.1 O. Total slack myofibril length 10 (J..lm) was measured before and after stretching the 
myofibrils, to compute the change in myofibril length £110 (J..lm). 
The equation used in order to calculate the voltage to be applied on a myofibril with 10 
length in order to achieve an x % stretch: 
69 
2. Materials and Methods 
To calculate the force per cross sectional area (CSA) the force was divided by the 
diameter of individual myofibrils: 
Cross sectional area = d2 • n/4 
The mean SL was calculated from length of the entire mounted myofibril divided by the 
number of sarcomeres using the equation: 
MF length(~m)· Pixel SL= 
Number of sarcomeres 
The incorporation of the pixels in the equation was necessary to calibrate the image 
before taking myofibril length measurements. Length position of the needle coupled 
with a DAQ-board interfaced piezodriver and the force signal detection and acquisition 
are described elsewhere (Stehle et al., 2002a, 2002b). Briefly, to calibrate the AFC a 
direct mechanical contact between the length-driving tungsten stiff needle and the AFC 
was imposed and a displacement of the AFC tip by ~lo = 300 nm was imposed and the 
detected ~ V at the photodetector due to this applied mechanical displacement was 
obtained. This process was repeated thrice and an average ~ V was computed. With the 
spring constant for cantilever (c) from the AFC data sheet and these values (LlI, Ll V) the 
calibration factor of the AFC was computed using the equation: 
c ( nN ). ~I (nm) 
Calibration factor = _ ...... l I_m ___ _ 
~Vcalib(V) 
Force (F) values in the experiments were calculated by: 
F = calibration factor . ~ V 
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Table 2.10. Explanation and values of symbols that were used in equations. 
Symbol Representation Value 
c Spring for cantilever 
CSA Cross sectional area 
d Myofibril diameter 
~lo Difference in myofibril length 
~V Average voltage 
F Force applied on myofibril 
10 Total slack myofibril length 
MF Myofibril 
SL Mean sarcomere length )lm 
2.6 Generation of transgenic lines 
The DNA constructs created to generate the transgenic flies for this project were 
microinjected by Dr. Teresa Jagla (MYORES Injection Platform, Clermont Ferrant, 
France). The wild-type UAS-TnI construct was microinjected at York using the 
protocols described below. 
2.6.1 Nucleic acid preparation 
A protocol for P-e1ement mediated transformation described by Rubin and Spradling 
(1982) was followed. Briefly, 5 )lg of the transposase-carrying p~2-3 plasmid were 
mixed with 20 Jlg of pP[UAS-TnI] plasmid DNA. The two-plasmid mixture was 
precipitated with 3M NaOAc-EtOH and then redissolved to a final concentration of 
1 Jlg/Jll using Spradling injection buffer (5 mM KCI, 0.1 mM NaH2P04 pH 6.8). The 
plasmid mixture was then spun on a benchtop centrifuge for 10 minutes and loaded into 
needles pulled from borosilicate capillaries. 
2.6.2 Egg preparation 
Flies from the w118 strain were left in a cage with an apple juice-agar plate (5 % sugar, 
2 % agar and apple juice) and fresh yeast paste at 21 QC. Eggs laid during 50 minutes 
were collected with a paintbrush, previously washed with distilled water, and spread on 
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double-sided sticky tape placed on a glass slide. A second glass slide equipped with 
non-toxic double-sided sticky tape on which copper wire was stuck lengthwise was used 
to sandwich the embryos and pulled apart causing the chorions of the eggs to split. The 
eggs were then lined up with their posterior ends just overhanging a small strip of 
double sticky tape on a coverslip. 
2.6.3 Embryo microinjections 
Lined-up embryos were covered in oxygen penneable halocarbon oil (kind gift from Dr. 
Sweene) to prevent them from drying out and were placed on a glass slide that was pre-
positioned on the stage of a light microscope. The DNA fitted to a glass needle was 
attached to a micromanipulator. The posterior end of the embryos was gently pierced 
with the needle and pressure was applied to the air-fitted syringe to inject the DNA. 
Between injection rounds the needle was kept dipped in the halocarbon oil to avoid 
drying of the DNA solution. Each embryo coverslip was treated within 10 minutes. 
2.6.4 Manipulation post-injection 
The embryo-containing coverslip was then placed on an agar-apple juice plate, with 
fresh yeast paste, and kept in a moist container at 25°C. Hatched larvae were 
transferred to a standard yeast-sugar vial and eclosed adults were individually crossed to 
W1l8 flies. The progeny of this cross was screened for successfully transfonned w + eyed 
flies and maintained by selection for w +. 
2.6.5 Determining the insertion chromosome 
Transfonned male flies (red eyed) were individually crossed with y w; +; TM6BITM3 
female flies. If all female flies in the progeny were w + (red eyed) then it meant that the 
insertion was in the first chromosome and the FM7c balancer was used to balance those 
lines (Figure 2.5.1 A). If male flies in the progeny were a mixture ofw (white eyed) and 
w + (red eyed) then it meant that the insertion was either in the second or third 
chromosome. Those flies were first crossed again to y w; +; TM6BITM3 and if in the 
progeny flies identified were w + (red eyed) and TM6BITM3 it meant that the insertion 
was in the second chromosome. Those lines were balanced with CyO, y + 
(Figure 2.6.1 B). If on the other hand the progeny were all w (white eyed) it meant that 
the insertions were in the third chromosome and those lines were balanced with either 
the TM6B or TM3 balancers (Figure 2.6 C). 
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Figure 2.5. Mating scheme to identify the P-element insertion site. Genetic crosses 
to obtain stable lines for inserts in the first (A), second (B) and third (C) chromosomes, 
[w+] for the insert, '+' for wild type alleles, 'CS' for male and '~' for female flies, 
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2.6.6 Inserting the Act88pmutationj transformants in the correct genetic 
background 
The wild type Act88F gene is on the third chromosome hence amongst the different 
Act88pmutation] lines that were obtained the ones selected for further analysis were in the 
first or second chromosome. Each Act88pmutation] line was studied as wild-type 
heterozygote or homozygote by eliminating one or two wild type Act88F copies 
respectively. In order to achieve this the third chromosome wild type Act88F gene was 
exchanged with the amorphic Act88rM88 allele. The mating schemes for obtaining 
stable Act88pmutation] lines are described in Figure 2.6. One red star indicates 
Act88pmutation]l+ heterozygotes and two red stars indicate Act88pmutation]IAct88pmutation] 
homozygotes. 
2.6.7 Inserting the UAS_Tnpmutation j and UAS_Tnpmutation j transformants 
in the correct genetic background 
The TnT (u/) and TnI (hdp3) null mutations, both w, are in the first chromosome. The 
VAS-TnT, VAS_Tnfmutationl, VAS-TnT and VAS_Tnr'muta,ion1 insertions (w +) are in the 
second or third chromosome. The VAS-TnI lines (w +) were crossed with the y w 
hdp31FM7c line so as to be studied in a TnI null background. Similarly all the VAS-TnT 
lines (w+) were crossed with the y w u/IFM7c line so as to be studied in a TnT null 
background (Figure 2.7 A). The mating scheme for lines carrying the insert on the 
second chromosome is shown in Figure 2.8 A. The mating scheme for the lines carrying 
the insert on the third chromosome was the same as that for the dmef2-GAL4 driver 
(Figure 2.8 B). The progeny that was crossed later to the GAL4 driver is pointed by a 
single red star. 
The dmef2-GAL4 driver (third chromosomal) was used to express the VAS-TnT, VAS-
Tnfmutationl, VAS-TnT and VAS_Tnr'mu,ation] constructs; and it had to be inserted in a 
TnI or TnT null background (Figure 2.7 B). The progeny that was crossed later to the 
VAS constructs is pointed by two red stars. Flies from A and B with one and two red 
stars, respectively were mated (Figure 2.7 B) and the progeny that was used for further 
analysis is pointed by the three red stars. 
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Figure 2.6. Mating scheme for obtaining stable heterozygous and homozygous 
Act88pmulationllines. The position . of the A C188F<M88 allele is in the third chromosome. 
Transformants for the A c t8 8pmutallon] insert in the first (A) and second (B) chromosome 
were inserted in a wild type heterozygote or in a homozygote background. Wild type 
fi th · A /88 rimutallon] A 88 rimula/ion] h heterozygotes or e msert C 1" or cl j< ' omozygotes are 
designated by one and two red stars respectively. '+' indicates wild type alleles, '0 ' 
male and ' ~ ' female flies. 
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Figure 2.7. Mating scheme for obtaining lines expressing VAS-Till or VAS-TilT and 
dmef2-GAL4 in wild type Till and TilT null backgrounds, respectively. Genetic 
crosses to obtain VAS-Tnl (w +), VAS-TnT (wl lines (single star) (A) and dmej2-GAL4 
(two stars) lines (B) in up' or hdp 3 backgrounds. (C) Progeny from A (single star) and B 
(two stars) were mated to obtain progeny with a single insertion for a VAS construct 
and the GAL4 driver (three stars). [w+] indicates the insert, '+' wild type alleles, 'CS 
male and ' ~ ' female flies. 
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Chapter 3: Characterization of transgenic lines of 
mutant Act88F carrying human nemaline phenotypes 
3.1 Aims 
The main aim of this chapter was to express and characterize six different Act88F 
mutants in the IFM that are homologous to six human skeletal muscle a-actin mutants, 
which result in different aspects of congenital actin myopathies. 
3.2 Introduction 
In the absence of a clear hypothesis about how mutations in actin can result in nemaline 
myopathy, P-element transformation was used to express transgenically six different 
actin mutants in the indirect flight muscles (lFM) of Drosophila and investigate their 
effects on the structure and function of the muscles. Transgenic flies were created that 
express one of six different site-directed Act88F mutations: GI5R, I136M, D154N, 
V163L, V163M or D292V in the IFM, together with one wild type copy of the Act88F 
gene to develop a model in Drosophila for this disease. In humans the ACTA1 mutations 
are largely dominant and hence the mutations studied here would be predicted to also be 
dominant in Drosophila. 
These mutations were chosen because in humans they result in different phenotypes 
(Table 3.1); G15R results in actinopathy, I136M results in nemaline myopathy (Ilkovski 
et al., 2001) and D292V results in congenital fibre type disproportion (CFTD) (Clarke 
et al., 2007). D154N, V163L and V163M all give rise to intranuclear rods, as well as 
actin filament aggregate myopathy (Schroder et al., 2004; Kaimaktchiev et al., 2006; 
Hutchinson et al., 2005). In addition D154N also gives rise to nemaline myopathy. The 
mutated residues are found at different sites in the actin structure (Figure 3.1) hence it is 
assumed that they will have different effects on actin structure and function. Here, in 
depth analysis was carried out to study the effects of the six different NM mutations on 
muscle structure and function by flight testing, electron microscopy, immunostaining 
and protein analysis of the isolated muscles. Moreover, apart from studying the 
mutations in a heterozygous state, Drosophila genetics enables one to easily study them 
in a homozygous state in wild type Act88F null background so as to understand how 
muscle structure is affected when composed solely of mutant actin. 
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Table 3.1 List of the nemaline myopathy actin mutants. Actin filament aggregate 
myopathy (AM), congenital fibre type disproportion (CFTD), intranuclear rods (IR), 
nemaline myopathy (NM) and sarcoplasmic rods (SR). 
Mutation Phenotype NM classification References 
G15R AM, NM Nemaline Goebel et dl . 1997a 
I136M mild NM Typical nemaline Il kovski et al., 2001 
D154N AM, IR NM Severe nemaline Schroder et al., 2004 
V163L AM, IR sparse SR Severe nemalin 
Weeks et al., 2003' 
Kaimaktch iev et al., 2006 
V163M AM, IR, sparse SR Typical nemaline Hutchinson et al. , 2005 
D292V CFTD Severe nemaline Clarke et al. , 2007 
Figure 3.1. Cartoon of the A TP-bound G-actin highlighting the position of the six 
Act88F mutations. The ATP is shown in green sticks the mutations G 15R, 1136M 
D1 54N, V163L/M and D292V are shown in red, yellow, blue, magenta and orange, 
respectively. The image was created using PYMOL and PDB file 1 A TN (the same pdb 
structure is used for all the G-actin images in Chapters 3,4 and 5). 
The IFM are an excellent model to study the effect of mutations on sarcomere structure. 
The wild type flies have very regular Z-discs and fixed sarcomere length of about 3.2 
f-lm (Reedy and Beall 1993) (Figures 3.2; 3.3) allowing to easily identify structural 
defects caused by mutations in sarcomeric proteins. Each Act88F mutation was 
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introduced in a heterozygous or homozygous actin null background using the 
Act88pKM88 actin null line (Hiromi and Hotta, 1985). Wild type heterozygous flies for 
the Act88pKM88 actin null produce > 85 % actin compared to wild type flies (prof. John 
Sparrow unpublished results). The Act88pKM881+ mutants are flightless and display 
myofibril fraying. The thin filaments appear detached or torn from the Z-discs (Figure 
3.3 top black arrowhead) and in some cases gaps in the filament lattice can be seen 
(Figure 3.3 bottom black arrow head) . The Z-discs appear bent at their ends and the M-
lines are not always apparent across the entire width of the sarcomere. Since there are 
no significant sarcomeric defects, the Act88p<M881+ heterozygous flies provide a 
suitable genetic background to study Act88F mutants and their dominant effects on 
muscle structure and function. In Chapters 3, 4 and 5, lines containing one transgenic 
insert in a heterozygous Act88pKM88f+ background are referred to as 'Act88pMutation}l+ 
heterozygotes' . These flies contain one wild type Act88F allele, one functional 
transgenic mutant allele (Act88p Mutation}) and one actin null allele (Act88pKM88). The 
Act88pMutation} IAct88pMutation} homozygous flies are homozygous for both the 
Act88pMutation} insert and the actin null Act88rM88 allele. Hence these fl ies express 
solely mutant actin in their IFM. 
Kettin Phalloidin Merge 
Figure 3.2. Whole muscle light microscopy of wild type flies. Fibres were stained 
with phalloidin and anti-kettin antibody. Scale bar: 5 ~m. 
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Wild type KM88/+ 
Figure 3.3. TEM of wild type and Act88~88/+ heterozygous flies. Arrowheads 
highlight areas with significant sarcomere damage as demonstrated by gaps in the 
filament lattice. Scale bars: 2 !lm. 
3.3 CFTD and nemaline rod producing mutants - G15R, 1136M, 
D292V 
The mild I136M ACTA] mutation causes typical nemaline myopathy with nemaline 
bodies (llovski et aI., 2001). It was chosen to see ifit also results in a rilllder phenotype 
in Drosophila IFM than the other mutants. A single line was obtained for the I136M 
mutation. The G1SR ACTA1 mutation causes congenital nemaline myopathy; residue 
G IS is located in the nucleotide-binding pocket and is likely to affect A TP-binding and 
turnover (Sparrow et al., 2003) as it takes part in a ,a-hairpin and directly contacts the 
,B-phosphate of the adenine nucleotide (Kabsch et aI., 1990). A total of three lines were 
obtained for the GlSR mutation all of which showed the same phenotype. The third 
ACTA] mutation D292V results in CFTD (Laing et aI., 2004). Three lines were 
obtained for the D292V mutation. Two of the lines showed sinUlar phenotypes, the third 
line was not analyzed. Whole muscle staining was performed to obtain an overview of 
the structural integrity for the whole muscle fibre. The muscles were studied at the 
ultrastructural level by electron microscopy. However not all the characteristics and 
abnormalities observed for each mutant could be captured in a single EM image. Hence 
some of them are being described in the text but not shown. 
Immunostaining of the indirect flight muscle for the Z-line protein kettin and staining 
for actin using fluorescent phalloidin showed a range of muscle fibre disruption for the 
different mutations (Figure 3.4, 3.S). In all cases, there was positive phalloidin staining 
for actin filaments even in homozygote mutants, suggesting that the actin is produced 
80 
3. Characterization oftransgenic lines of mutant Act88F carrying human nemaline 
phenotypes 
and able to polymerise (Figure 3.4, 3.5). However, both actin filament and Z-disc 
organisation varied from almost normal (I136M mutant heterozygote) to very 
disorganised (G15R heterozygote and homozygote mutants). In G15R the Z-lines 
appear to have an irregular staining and patteming. This effect is even more distinct in 
homo zygotes (Figure 3.5 arrow), and the regular actin staining is also more highly 
disrupted in homozygotes. 
The ultrastructure of the muscle, as shown by electron mlcroscopy, demonstrates 
sarcomeric disorder and Z-disc and M -line disruption in the heterozygous and 
homozygous G 15R mutants (Figure 3.6). Pieces of Z-discs stacked parallel to each other 
otherwise known as zebra bodies (Yamaguchi et al., 1982; Morris et al., 1990; Luther 
and Squire, 2002) were also found in both heterozygotes and homozygotes G 15R 
mutants (Figure 3.6 arrowhead). The zebra bodies caused by the G15R mutation were 
very frequent, long (laterally) and spanning the whole of the myofibre. There is 
myofibrillar branching, and areas of broken/disorganised thick and thin filaments (not 
captured in Figure 3.6). 
In the mildest mutation, I136M, the myofibrils appeared almost normal in heterozygotes 
but in homozygotes the myofibrils had a wavy appearance and others were found to be 
disordered. In agreement with the immunostaining for the heterozygote 1136M, by EM 
the myofibrils looked relatively normal, but some actin filaments are not well organised 
into muscle sarcomeres and appear to lie outside the myofibril and/or join up with 
adjacent myofibrils (Figure 3.6 arrow). This is reminiscent of actin filament aggregate 
myopathy in humans where actin filaments are found that are not organised into 
myofibrils at all next to areas of normal sarcomeres. Small and infrequent zebra bodies 
(Figure 3.6 arrowheads) as well as Z-disc and M-line disruption can also be seen in both 
heterozygote and homozygote I136M mutants. In the homozygous state the I136M 
mutation displays the same characteristics at the ultrastructural level but the muscle 
appears more disrupted and the myofibrils are not as tightly packed. 
In D292V whole muscle staining, disrupted myofibrils were present but many 
myofibrils look relatively normal in both heterozygote and homozygote mutants (Figure 
3.4, 3.5). By EM Z-disc and M-line abnormalities can be seen as well as zebra bodies 
(Figure 3.6 arrowhead). Aberrant structure of myofibrils and areas of 
broken/disorganised thick and thin filaments can also be observed. The myofibrils of the 
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Act88pD292V/+ heterozygotes seem to vary in size with some being half the size of 
others. The decrease in size can also be seen when comparing the myofibril shown for 
the Act88pD292V/+ heterozygote in Figure 3.6 to that of the wild type in Figure 3.3. 
This is least pronounced in the D292V homozygotes, which display Z-disc or M-line 
shifting (only shown for the M-line). 
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Figure 3.4. Whole muscle light microscopy of mild nemaline myopathy mutants. 
Act88p015R, Act88F'136M and Act88pD292V heterozygotes were stained with phalloidin 
and anti-kettin antibody. Arrows indicate disorganised thin filaments. Scale bar: 5 Ilm. 
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G15R1G15R 1136M/1136M D292V/D292V 
Figure 3.5. Whole muscle light microscopy of mild nemaline myopathy mutants. 
Act88pG15R, Act88pl36M and A ct88pD292 V homozygotes were stained with phalloidin and 
anti-kettin antibody. Disorganised thin filaments are indicated by arrows and aberrant z-
discs by arrowhead. Scale bar: 5 ~m. 
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Figure 3.6. TEM images of nemaline myopathy mutants. Longitudinal sections of 
Act88p15R. Act88pl36M and Act88p-D292V heterozygotes and homozygotes. White arrows 
show myofibril branching. White arrowheads show zebra bodies. Z: Z-line. M:M-line. 
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3.4 Actin filament aggregate myopathy 
producing mutants - D154N, V163L, V163M 
and intranuclear rod 
Human ACTAl mutations of residues D154 and V163 showed intranuclear rods, 
nemaline bodies and accumulations of actin filaments in patient biopsies (Schroder et 
al., 2004; Hutchinson et al., 2005; Kaimaktchiev et al., 2006). These mutations produce 
the more rare NM phenotypes and were chosen to determine if when expressed in the 
IFM they produced similar phenotypes. Two nuclear export signals are found in actin; 
NES1 (170-181) and NES2 (211-222) (Wada et ai., 1998). The D154 and V163 residues 
are located near the first nuclear actin export signal of actin (Figure 3.7). 
Figure 3.7. Cartoon of ATP-bound G-actin showing the proximity of residues D154 
and V163 to nuclear export signals 1 and 2. ATP shown in stick (green); NESl in 
cyan, NES2 in yellow, D154 and V163 residues are shown in blue and magenta, 
respectively. Image produced using PYMOL. 
Two transgenic lines were obtained for the D 154N mutation only one of which was 
analyzed as the second line contained the Act88pDI54N insert on the third chromosome. 
Three lines were obtained for the V163L mutation, two of which showed the same 
sarcomeric phenotypes and disarray, but one displayed the intranuclear actin rods at a 
higher frequency than the other. The third line was not analyzed as the Act88FVI63L 
insert was in the third chromosome. Also three lines were obtained for the V 163M 
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mutation, which showed the same phenotypes in two of the lines analyzed. The third 
line was not studied as the Act88FVl63M insert was too found in the third chromosome. 
Studying the Act88pmUlationj transgenes in a homozygous state requires that they are 
expressed in an Act88F null background. As both the Act88rM88 actin null and wild 
type Act88F genes are located on the third chromosome, studying lines carrying the 
Act88pmutationj inserts on the same chromosome would not have been possible. 
Immunostaining and phalloidin staining of whole muscle fibres showed that the D154N, 
V163L and V163M mutations resulted in greater myofibrillar disarray compared to the 
nemaline rod and CFTD causing mutants discussed in Section 3.3. In the muscle fibres 
of the D154N, Vl63L and Vl63M mutants sarcomeres are formed but areas devoid of 
sarcomeres can also be found. The latter are identified as areas stained solely by 
phalloidin and lacking the regular kettin staining normally found on the Z-discs (Figure 
3.8, 3.9). Moreover heterozygous transgenics carrying mutations in residues D154 and 
V163 display disruption of the regular Z-line staining pattern. The Z-lines are irregular, 
bent and differ in size. Another feature of these muscles are kettin and actin stained 
rods, which in some cases were ring-shaped and from this point forward will be called 
Z-rings (Figure 3.8 arrow head). 
As homozygotes the V163M and some in cases V163L mutants are not much different 
from their heterozygous counterparts. They display myofibrillar disorganization with Z-
disc defects and Z-rings (Figure 3.9, the result for the V163L mutant is not shown). 
However in the Dl54N and, in some cases, in the V163L homozygotes the regular 
myofibril pattern is completely lost and only disorganised actin filaments are present 
(Figure 3.9). In those muscles no Z-disc or sarcomeric pattern can be observed. The 
kettin staining for these mutants is grainy and no specific pattern can be identified 
(Figure 3.9). 
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Figure 3.8. Whole muscle light microscopy of intranuclear rod-linked mutants. 
r-D154N A 88Fv/63L d A 88FvI63M " !FM from Act88Jr ,ct an ct heterozygotes stamed Wlth 
phalloidin and anti-kettin antibody. Arrowheads show Z-rings. Scale bar: 5 Ilm. 
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Figure 3.9. Whole muscle light microscopy of intranuclear rod-linked mutants. 
!FM from A ct88pD 1 54N, Act88Fv/63L and Act88p V163M homozygotes stained with 
phalloidin and anti-kettin antibody. Arrowheads show Z-rings. Scale bar: 5 /lm. 
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By electron microscopy, the myofibrils are often narrower than in wild type and regions 
of ordered sarcomeres are found next to regions of disordered sarcomeres (Figure 3.10), 
similar to the biopsy samples from human patients. Other features include myofibrillar 
branching, aberrant structure of myofibrils and areas of broken/disorganised thick and 
thin filaments, although this was not observed in the latter case for D154N, or V163L 
homozygotes, as they did not form myofibrils (this was not always true for the V163L 
homozygotes which sometimes formed myofibrils). All three mutants (both 
heterozygotes and homozygotes) display Z-disc and M-line disruption as well as zebra 
bodies. The size and frequency of the zebra bodies varies. However the zebra bodies 
found in these mutants are not detected as often as in the G 15R mutant and are not as 
long (laterally) as the ones caused by the G15R mutation. 
The D154, V163L and V163M heterozygote mutants (also V163UM homozygotes), 
resulted in a novel ring-like Z-disc structures, which varied in diameter from 0.2 ~m to 
4 Jlm (as measured by EM). These structures seen in the EM are likely to be the same 
structures as the ring-shaped structures seen by confocal microscopy in these mutants. 
Furthermore, a feature found specifically in the V163L heterozygous mutants was very 
short sarcomeres with lattice gaps where filaments are missing (Figure 3.10 box). 
Consistent with the light microscopy, the D154N and V163L mutations showed the 
most extreme phenotypes as the homozygotes completely abolish myofibrillar structure 
leaving broken filaments and very long but narrow zebra bodies, which highlights the 
severity of these mutations (Figure 3.10). It is possible that the muscles in the D154N 
and of the severely affected V163L mutants were not properly formed during 
myogenesis. The V163M mutation appears to be less severe compared to D154N and 
Vl63L as it permitted the formation ofmyofibrils in the homozygous state. 
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Figure 3.10. TEM ima§,es of intranuclear rod-linked mutants. Longitudinal sections 
of Act88plJ154N, Act88F 163L and Act88pVI63M heterozygotes and homozygotes. White 
arrows show thin filaments running between/across adjacent myofibrils. White 
arrowheads point at zebra bodies. Black arrowheads point at disrupted Z-discs. Z: Z-
line, M: M-line. White box shows lattice gap. The black box shows a magnified zebra 
body. 
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To confirm that the ring-like structures seen by kettin immunostaining are the same as 
the ones seen by EM, immunostaining of Act88FY154N/+ heterozygotes with a-actinin, 
another Z-disc protein, was performed. This also showed the ring-like structures 
observed with the anti-kettin antibody (Figure 3.11 arrow heads). In the same figure 
spacing of the Z-discs in the mutant is shown to be irregular compared to that seen in 
the wild type. The Z-discs themselves are bent, broken and irregular, which was also 
seen with the anti -kettin antibody. The wild type muscle fibre is tightly packed with 
myofibrils composed of regularly spaced sarcomeres. In the mutant this does not seem 
to be the case as shown by the very few Z-lines. The Act88FY154N/+ heterozygote mutant 
shown here shows greater muscle disarray compared to the one in Figure 3.8. This could 
be due to the fact that the section of the fibre imaged in this case was different from the 
section imaged in Figure 3.8 or due to variations seen between flies. 
Figure 3.11 . Immunostaining with a-actinin antibody of whole fly muscles for wild 
type and Act88p.D154 /+ heterozygotes . In the mutant irregular Z-lines which vary in 
size, and circular structures can be seen. Arrowheads show Z-rings. Scale bar: 10 Ilm. 
In order to understand if the Z-rings are composed solely of Z-disc proteins, 
immunostaining with myosin was performed. This showed that myosin is also 
associated with these Z-rings (Figure 3.12 arrows). The expected staining pattern for 
phalloidin, myosin and kettin in wild type sarcomeres is shown in Figure 3.13. 
Phalloidin stains actin filaments extending from the Z-discs until close to the H-zone 
where the thin filaments terminate. Signal from the anti-myosin antibody is only visible 
at the M-line and at the Z-disc. The thick filaments terminate at the end of the A-band, 
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which in the !FM is very close to the Z-disc due to very narrow I-bands. As result, a Z-
disc staining pattern is observed. The reason for the absence of myosin staining across 
the thick filament is due to problems with antibody penetration, caused by the very 
regular thin/thick filament lattice of the !FM. This problem is not seen in other muscles 
where the lattice is much less regular and more widely spaced so that the anti-myosin 
antibodies can completely stain the A-band (Ackermann et al., 2009). 
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Figure 3.12. Light microscopy of single myofibrils from wild type and 
Act88pDJ54N/+ heterozygotes. Anti-kettin, anti-myosin antibodies and phalloidin. A: A-
band, M: M-line, Z: Z-line. 
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Figure 3.13. Diagram showing the expected position of the fluorescent signal for 
phalloidin, myosin and kettin in wild type Drosophila sarcomeres. 
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Since single micrographs do not show all the aberrant features observed for each 
mutation, a selection of micrographs for Act88FVJ63M/+ heterozygotes demonstrates that 
many different features can be observed for a single mutation (Figure 3.14). EM images 
show accumulations of actin thin filaments and a multiplicity of Z-disc material. Zebra 
bodies can be seen as defined by their distinct stripe pattern (Figure 3.14 A) as well as 
ring-like Z-discs (Figure 3.14 A and B). By EM the zebra bodies and the ring-like Z-
discs consist of many round electron dense pieces of Z-disc material (Figure 3.14 A 
arrow and 3.14 B inset), which from this point forward will be called Z-bodies. Except 
for Z-rings and zebra bodies, any large aberrant/unstructured accumulations consisting 
of Z-bodies will be referred to as Z-body aggregates. This term will also be used to 
describe any other electron dense accumulation in which Z-bodies cannot be 
distinguished. Large actin and Z-disc material aggregations identified by light 
microscopy will also be referred to as Z-body aggregates. 
Whole muscle confocal imaging shows the co-staining of Z-body aggregates for kettin 
and actin. The kettin staining seems to be at the periphery of the Z-body aggregate 
whereas fluorescent phalloidin seems to stain the greater part of this structure. It is not 
possible to determine if the Z-body aggregates observed by the whole muscle staining 
are the same as the ones seen by EM and this is mainly due to the fact that they differ in 
size. The ones seen by confocal microscopy are 5 Ilm long whereas the ones observed 
by EM vary between 500 nm and 1 Ilm in length. However the Z-ring structures shown 
by EM vary in diameter from 200 nm to 41lm (Figure 3.14 B). It is probable that the Z-
rings are the same aggregates as those seen by confocal microscopy (Figure 3.14 A). 
Cutting a section through them can result in rings of different sizes depending on how 
close to the centre or the periphery of the aggregate the section was cut. 
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Figure 3.14. Examples of the aberrant structures found in the IR-linked mutants 
by electron and light micro copy. (A) Act88FVI63M/+ heterozygote, arrowheads point 
at Z-body aggregates, white arrows point at Z-bodies. Anti-kettin antibody and 
phalloidin were used for light microscopy. (B) Act88FJI54N/+ heterozygote arrowheads 
point at Z-body aggregates. The inset shows magnification of the Z-body aggregate. 
95 
3. Characterization oftransgenic lines of mutant Act88F carrying human nemaline 
phenotypes 
The three mutations D154N, V163L and V163M result in actin-containing nuclear rods 
in human skeletal muscle and this is also observed in the nuclei of Drosophila IFM. 
The nuclei in these mutants are often enlarged (see Act88FV163L/+ heterozygote, Figure 
3.15) and contain rod-like structures that consist of filaments. Phalloidin staining 
confirms that these rods consist ofF-actin and span the nucleus (Figure 3.16). This was 
also confirmed by Z-stacks of whole muscle fibres stained with DAPI and phalloidin 
(Movie 3.1. Intranuclear rods.avi). In VI63L heterozygotes, rods were found in the 
nuclei of almost every fly examined, and most of the nuclei in the muscle contained 
rods. Nuclear rods were less common in V163M heterozygotes than in V163L, and 
infrequent in D 154N heterozygotes. The D 154N mutation results in the most severe 
muscle disorganisation but the whole cell may be affected. Most nuclei appear abnormal 
and may be displaying signs of apoptosis as seen in electron micrographs of I-day old 
flies (data not shown). Reduced cell survival could mean that different nuclear 
processes may be affected including those involved in actin import inside the nucleus, 
which would prevent the formation of IRs. This could explain the lower frequency of 
nuclear rods in this mutant. 
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Figure 3.15. Intranuclear rods. TEM images of Act88Fv/63L/+ and Act88Fv/63M/+ 
heterozy~otes showing aggregates inside the nuclei. In the higher magnification of 
Act88FV 63L/+ heterozygotes ·(bottom right panel) the intranuclear aggregates are clearly 
filamentous. 
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OAP. Phalloidin 
Figure 3.1 6. Intranuclear actin rods. Whole muscle light microscopy of wild tyPe, 
Act88pD154 , Act88F v/63L and Act88FVJ63M mutants with DAPI and phalloidin. 
Arrowheads point at phalloidin-stained nuclear actin rods. Scale bar: 5 )lm. 
3.5 Is there a correlation between nemaline myopathy and central Core 
disease? 
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ACTA} mutations (D3Y, E336K) have also been associated with another congenital 
myopathy called central core disease (Kaindl et al., 2004). This is a non-progressive 
myopathy typically caused by mutations in the ryanodine receptor-l gene (RYR}) 
(Robinson et al., 2006) and in the myosin heavy chain-7 gene (Fananapazir et al., 
1993). To identify the disease the patients' muscle biopsies are treated with a stain 
containing nitroblue tetrazolium (NBT). The principle behind this histochemical 
technique is that tetrazolium blue acts as an electron acceptor, which becomes reduced 
to a blue-grey product at the site of the enzyme activity. The intensity of the reaction 
product is a reflection of the mitochondria within the fibre and varies amongst the 
different muscle fibre types found in humans. The histopathological feature of the 
disease is the lack of staining in the centre of the muscle fibre when treated with NBT. 
A simultaneous appearance of nemaline rods and central core disease has been observed 
in a patient with an ACTA} mutation (M 134V) (Jungbluth et al., 2001). In this particular 
patient type 1 fibres displayed nemaline bodies whereas type 2 fibres displayed core-
like areas. This mixture of rods and cores is more often caused by mutations in RYR} 
(Monnier et al., 2000; Scacheri et al., 2000). Here stained preparations of whole muscle 
fibres for Act88pV163L/+ heterozygotes show that the top section of the fibre appears less 
damaged or not damaged (observed only by confocal imaging) compared to the more 
central section (Figure 3.17). This result is presented only for the Act88pV163L/+ 
heterozygous mutant although the other IR-linked mutants also displayed the same 
characteristic (not shown). The fact that the more central section of the fibre appears 
more damaged than peripheral regions raises the question as to whether this phenotype 
is similar to the central core disease phenotype seen in humans. In order to investigate 
that further transverse muscle sections from wild type and Act88pVJ63L/+ heterozygous 
flies were stained with NBT, the diagnostic method used to identify central core disease 
in patient biopsies. However the staining was too pale to see a difference between the 
wild type and the mutants fibres. 
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Top of fibre 
C) ) 
Middle of fibre 
E) ) 
Figure 3.17. Optical sectioning of stained whole muscle from the Act88FV163L/+ 
heterozygote mutant. Upper and lower panels show different optical sections of the 
same muscle fibre. The top panels are from a section at the top of the fibre, the bottom 
panels are from the middle section as shown in the cylindrical diagram with the 
horizontal line, indicating the fibre section that was captured in images. Scale bar: 5)lIn. 
In all the mutants studied here there was variation in the frequency of the different 
phenotypes amongst flies of the same genotype. The Act88FVI63M homozygotes are 
shown as an example. In the wild type thorax the six DLMs are clearly seen and 
numbered (Figure 3.18). Polarized light images of A ct88p v/63M /+ heterozygotes shows 
that the DLM are present however parts of the muscle are not as birefringent because 
they are damaged (Figure 3.18). In the case of the Act88pv/63M homozygotes some flies 
showed the hypercontraction phenotype and their IFM autodestruct (Figure 3.18 bottom 
left image). However other flies don't hypercontract and their IFM resemble those of 
the Act88pVI63M /+ heterozygotes by polarized light microscopy (Figure 3.18 bottom 
right image). 
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Wild type Act88FV163M/+ 
Act88P'63M/Act88FV163M A ct88FV163M/Act88FV163M 
Figure 3.18. Polarized light analysis of Act88FV163M mutants. In the wild type the six 
DLMs are numbered I-VI. Arrow points at the sole birefringent IFM of an Act88FV163M 
homozygote and the star at the jump muscle. The flies for all the samples were 1 day 
old. 
Finally, all the different actin mutations give rise to different aspects of the disease in 
humans and also resulted in novel phenotypes in Drosophila. Based on the phenotypic 
observations the mutants can be split into two groups: those resulting solely in zebra 
bodies (G15R, I136M, D292V) and those resulting in F-actinlZ-body aggregates, zebra 
bodies, Z-rings and intranuclear rod aggregates (D154N, V163LIM). Both groups result 
in general myofibril and sarcomeric disorganization. A summary of all the phenotypic 
observations made for each heterozygous and homozygous mutant is shown in 
Table 3.2. 
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Table 3.2. Summary of observations in heterozygous and homozygous mutants. 
Note: + indicates the presence of a characteristic and - indicates the absence of a 
characteristic, nd indicates that it was not possible to determine if a characteristic was 
present or not. 
Act88F Mutation Intranuclear Zebra Myofibrils Aggregates F-actin Flight Z-rings 
rods bodies abili~ 
G15RJ+ + + + 
1136M/+ + + + some 
D154N/+ + + + + + 
V163U+ + + + + + + 
V163M/+ + + + + + + 
D292V/+ + + nd + + 
G15RJG15R + + + 
1136MII136M + + nd + 
D154N/D154N nd + + 
V163UV163L + + +/- + + + 
V163M1V163M nd + + + + + 
D292V /D292V + + 
3.6 Detailed single myofibril analysis of the Act88F mutations shows 
aberrant staining patterns. 
Detailed single myofibril analysis of the Act88F mutations was carried out as part of a 
collaborative research project with Dr. Peckham (Institute of Molecular and Cellular 
Biology, Faculty of Biological Sciences, University of Leeds). Single myofibrils from 
each mutant were stained with a combination of different antibodies against muscle 
proteins in order to study which proteins are missing or not properly localized in the 
mutants. For this I-day-old flies of the correct genotypes were selected, bisected in 
YMG and stored at -20°C overnight (Chapter 2, section 2.2.2). The next day the half 
thoraces kept in YMG on ice were collected by Dr. Michelle Peckham, who proceeded 
with the single myofibril immunostaining protocol described in Chapter 2 Section 2.2.2. 
Images from the single myofibril immunostaining are shown in Figure 3.19, 20, 21, 
which were also prepared by Dr. Peckham. 
Mutations in actin might be expected to result in aberrant muscle structure for several 
reasons. First, the actin itself might not polymerize as well as wild type actin, although 
the staining of the intact flight muscles from homozygote mutants (Figures 3.5 and 
3.1 0) argues that all of the mutant actins are able to polymerize into F-actin filaments. 
Second proteins that bind to actin and regulate its length in the sarcomere such as 
capping protein in the Z-disc, tropomyosin and tropomodulin (the pointed end 'capping' 
protein) may bind less well to actin filaments, resulting in increased instability and/or 
variation in thin filament length. Although none of the mutated actin residues lie within 
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the known myosin binding sites on actin, a change in the binding affinity of actin to 
tropomyosin, might indirectly affect force generation. 
The pattern for tropomyosin immunostaining in wild type muscle shows a strong band 
at the Z-disc and weaker staining throughout the rest of the sarcomeres, with a fainter 
strip at the M-line (Figure 3.19). This is due to the fact that the tropomyosin antibody 
cannot penetrate and bind along the entire length of the actin filament, but does bind at 
the ends at the thin filaments at the M-line (doublet) and at the Z-line. In the mutant 
myofibrils G15R, V163M and V163L, this pattern is less regular, and staining near the 
Z-line is less obvious. This suggests that these mutations may affect tropomyosin 
binding to the thin filaments . The immunostaining pattern for tropomyosin in I136M, 
D292V and D 154N heterozygotes is similar to that found in wild type muscle. It is 
surprising that the staining for D154N is not disrupted much, as this mutation has an 
otherwise severe phenotype in both heterozygous and homozygous flies. 
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Figure 3.19. Deconvolu tion images of myofihrils from heterozygous mutants 
stained for actin and immunostained for tropomyosin. 
Thin filaments extend from the opposite Z-discs of a single sarcomere and terminate at 
the H-zone with their pointed end capped by tropomodulin. For tropomodulin (Figure 
3.20 A), a distinctive doublet is observed at the M-line in myofibrils from wild type 
muscle as expected (Fowler et al. , 1993). This doublet pattern is also observed in the 
myofibrils from the ACl88p l36M mutant, which displayed a mild phenotype. M-line 
staining is also observed for D292V and D154N, though not as a clear doublet, but there 
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is also evidence of tropomodulin staining throughout the muscle sarcomeres. M-line 
staining is weak (V163M) or absent for the V163L and G15R mutations, although there 
is weak staining throughout the sarcomere and even at the Z-line. These results suggest 
that the interaction of tropomodulin with the thin filaments may be affected in some of 
the mutants, in particular in G15R, V163L and V163M. Failure to cap thin filaments by 
tropomodulin could result in aberrant filament growth. lmrnunostaining for projectin, a 
myosin binding protein was similar to that found in wild type in all of the mutants with 
a doublet staining on either size of the Z-line (Figure 3.20 B). 
A 
WT 
1136M 
D292V 
G15R 
V163L 
V163M 
D154N 
8 
WT 
1136M 
D292V 
G15R 
V163M 
V163L 
D292V 
Tmod 
"11111' 
" 1/ ~ • n . ~ " 
. 
· .i ., . ... ". :' ",:"1 -; , . 
Projectin 
- • ., T · " .... , I . , ill . . .. ,. 
i~ll l ' J! ,-
.. ~ ID. l! 
1 . t I I \ . ' 
I " • • • , 
.. i 4 , , r 
. . 
.. .. ~ . ~ . , 
: ~ : ( l i,." 
Actin 
......... -==---
Actin 
a •• •••• ••••• 
-------
--u ... -
--------
------ ... 
Merge 
• . ' . .. . ). ,. : I ..r"'t ' ~ • ". 
-= __ .. c._ ... , 
SJ.lm 
Merge 
• I '. ' , r , 
t ,I -a.. J . I !.' 
"1 1 , I l. .1 
-. .) " . . . 
• • • I , . ,., . 
.. ... ~. r:. .. • 
- ... I ~ io~ 
Figure 3.20. Deconvolution images of myofihrils from heterozygous mutants 
stained for actin and immunostained for CA) Tropomodulin (Tmod) and (B) 
Projectin. 
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Like with the tropomyosin antibody that cannot penetrate to stain the thin filament, the 
myosin antibody does not appear to penetrate in wild type myofibrils and bind to the 
entire length of the thick filament. As shown before in Figure 3.12 the antibody stains 
the myosin enriched M-line where the myosin thick filaments originate, as well as the 
Z-disc. The staining at the Z-line is because the thick filaments terminate at the end of 
the A-band, which due to the narrow I-bands in the IFM is very close to the Z-disc. In 
order to visualize the doublet staining at the Z-discs or M-lines for the different 
antibodies used here, Dr Peckham slightly stretched the single myofibrils during 
microdissection prior to immunostaining them. Stretching of the myofibrils allowed 
seeing a doublet myosin staining at the Z-disc. This is because the antibody can bind to 
the A-band thick filament ends from two adjacent sarcomeres that surround the same Z-
disc. Hence the anti-myosin antibody binds mainly to the ends and the middle of the 
thick filament, resulting in a doublet staining either side of the Z-line and a single stripe 
at the M-line respectively as well as a weak staining in the sarcomere. Single myofibrils 
showing in Figure 3.l2 from wild type and Act88pDJ54N/+ heterozygous mutant 
prepared by myself, had not been stretched, which is why the myosin doublet at the Z-
disc cannot be visualized. The immunostaining pattern for projectin in the Act88pJ36M/+ 
and Act88pD292V/+ heterozygous mutants was similar to wild type (Figure 3.20). 
Nevertheless the staining was less regular in all the remaining mutants. This may have 
resulted from a general disruption of the organization of the thin filaments that allowed 
a greater degree of antibody penetration into the sarcomere. 
Finally, obscurin co-localized with myosin to a single stripe at the M-line in wild type 
myofibrils and in all the mutants (Figure 3.21). Interestingly, obscurin staining was 
relatively normal in the mutants and also displayed a faint localization at the Z-line. 
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Figure 3.21. Deconvolution images of myofibrils from heterozygous mutants 
stained for actin and immunostained for myosin and obscurin. 
A general observation was that the myofibrils from the mutants were narrower 
compared to the wild type ones, which is in agreement with the images from the 
electron micrographs (Figures 3.6 and 3.10). 
3.7 Protein analysis of nemaline myopathy mutants 
The aberrant muscle structure seen in the different mutants could be due to reduced 
actin and/or other sarcomeric protein levels. In order to determine if protein levels were 
altered in the IFM of mutant heterozygotes and homozygotes compared to the wild type 
flies, 10% I-D SDS PAGE analysis was performed on dissected intact IFM. Actin null 
Act88pKM88 homozygous flies that do not express actin in the IFM were also used as a 
control. Protein gels (Figure 3.22) show that the actin levels are similar to the wild type 
in mutant heterozygotes and homozygotes. Actin-myosin ratios measured from three 
gels showed that the actin levels are decreased in all homozygotes (Figure 3.23). The 
fact that the actin levels are not significantly reduced in the heterozygous mutants 
suggests that the muscle phenotypes observed in the IFM are not due to insufficient 
actin levels but because the mutant actin interferes with the wild type actin function. All 
the other thin filament proteins and the myosin heavy and light chains (MLC2) are 
indicated and they are unchanged compared to the wild type. Studies on humans have 
also shown that nemaline myopathy actin mutants are expressed at relatively normal 
levels, as are the majority of other sarcomeric proteins examined, with the exception of 
nebulin, which has more variable levels of expression (llkovski et ai. , 2004) . 
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Arthrin is a stable mono-ubiquitinated fonn of actin, with a molecular weight of 55 kDa, 
that fonns part of the thin filament in Drosophila IFM (Ball et a!., 1987; Burgess et al., 
2004; Schmitz et al., 2003). The presence of a band corresponding to the molecular 
weight of arthrin in homozygous Act88pKM88 flies has previously been demonstrated not 
to be arthrin (Clayton et al., 1998). 
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Figure 3.22. Coomassie blue stained I-D SDS PAGE analysis of sarcomeric 
proteins from intact IFM. 10% SDS gel of IFM from: (A) wild-type, Act88F null 
(KM88) homozygous and Act88F heterozygous mutants; (B) wild-type, homozygous 
Act88F null (KM88) and Act88F mutants. Image created by Dr. Peckham. 
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Figure 3.23. Actin-myosin ratios of Act88F mutants. The actin and myosin measured 
by three different I-D SDS gels for heterozygotes and homozygotes. 
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3.8 Can the nemaline phenotype be rescued? 
Patients with nemaline myopathy nonnally carry one wild type actin copy and one 
mutant actin copy. Only seven homozygotes for null mutations in the ACTA1 gene have 
been identified and show the nemaline phenotype (Nowak et al., 2007). Some of the 
individuals survived a few months and one even longer by continuing the expression of 
the cardiac, ACTC, actin isofonn. In Drosophila it is easy to test whether addition of a 
second wild type Act88F copy to the heterozygous mutants, which with the exception of 
Act88F'J36M are dominant flightless as soon as they emerge, could rescue the nemaline 
phenotypes seen in the IFM. All the heterozygous mutants presented in this study were 
bred to carry one copy of the transgene mutant Act88F, one wild type Act88F copy and 
one copy of the Act88plCM88 mutation. In order to 'rescue' the mutants the flies were 
bred so as to carry one copy of the transgene mutant Act88F and two wild-type Act88F 
copies. These flies were flight-tested at 1- and 7-days-old (Figure 3.24). All mutants 
with two wild type Act88F copies were flighted at day 1 implying that increasing wild-
type actin expression rescues the damaging effects caused by the mutant actin. When 
the flies were tested after 7 days most were still flighted. 
However in the case of the Act88FVJ63L and Act88pDJ54N 'rescued' mutants the 
percentage of flighted flies was not as high as for the others and some displayed the 
wings-up phenotype, which is sometimes associated with muscle hypercontraction. 
When the IFM are hypercontracted they appear tom from the cuticle and bunched in the 
middle or either side of the thorax by polarized light microscopy. The correlation 
between the wings-up and hypercontraction phenotypes is true for IFM mutants for the 
Act88F, TnI, TnT and Tm genes. However, a few Act88F mutants display the wings-up 
phenotype but their IFM are not hypercontracted (An and Mogami, 1996). In order to 
see if the !FM of the 'rescued' Act88FVJ63L and Act88pDJ54N mutants that display the 
wings-up phenotype are hypercontracted, polarized light microscopy was performed. 
This showed that the !FM are not birefringent and only the TDT (jumping) muscle can 
be seen (Figure 3.25). Lack of polarized light signal implies that there is absence of 
ordered structure in these muscles but does not imply a hypercontracted phenotype. This 
result is not surprising as these mutants showed the most severe phenotypes in electron 
microscopy images amongst the transgenics presented in this study. 
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Figure 3.24. Flight-testing of 'rescued' mutants. Flies homozygous for the P-element 
insert containing wild type Act88F in an Act88F null background (Wt rescue) were 
flight-tested at days 1 and 7. Transgenic flies containing two wild type and one 
transgene mutant Act88F copy were flight-tested at days 1 (blue bars) and 7 (red bars). 
Mutant heterozygotes containing a wild type and a mutant Act88F copy were flight-
tested at day 1 (green bars). 
Act88FD 154N Act88F'I 63. 
Figu re 3.25. Polarized light analysis of Act88pD154N and Act88FV163L mutants with 
two wild type Act88F copies. The IFM of these mutants are not birefiingent despite 
having two wild type actin copies, only the jump muscle can be seen. 
Representative TEM images of the flighted Act88FVI63L and Act88p-D154N (Figure 3.26) 
rescued mutants show normal sarcomeres. In the case of the Act88F>154N animals, 
which despite having two wild type Act88F copies were flightless and did not show the 
wings-up phenotype the sarcomeres also appear normal (Figure 3.26). The wild type 
rescue' line homozygous for the transgenic wild type Act88F copy (created by Vikash 
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Kumar) in a Act88pKM88 homozygous background acted as control. Those flies were 
shown to be flighted indicating that when flies are transformed with the wild type 
pP{W8, w +mW. hs Act88rj plasmid functional ACT88F can be adequately produced to 
ensure formation of wild-type sarcomeres. Therefore any sarcomeric defects observed 
in the lines carrying Act88F mutant variants of this plasmid are due to the effects of the 
respective mutations in the actin structure and function. The fact that patients 
homozygous for the ACTA1 null mutation still survive by upregulating the cardiac actin 
suggests that the cardiac actin can still function to some extent in post-natal skeletal 
muscle. Based on the fact that cardiac and skeletal actins are 99% homologous at the 
amino acid level a therapy has been proposed that involves maintaining the expression 
of the cardiac actin thereby diluting the mutant skeletal actin. The results presented here 
highlight the potential of using Drosophila IFM as a quick system to assess for which of 
the different human actin mutants increasing the wild type actin levels might be an 
effective therapy. 
Act88pl63L 
Act88plS4N flightless 
Figure 3.26. TEM images of the D154N and V163L transgenics containing two 
wild-type and one mutant Act88F copies. The sarcomeres of the rescued mutants 
appear like that of the wild type, though the D154N mutant was flightless despite 
having a second wild type actin copy and not displaying the wings-up phenotype. 
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3.9 Ranking of the nemaline myopathy mutants 
The Act88F mutants have been ranked according to severity and compared to the 
published clinical severity of the equivalent mutations in human patients (Table 3.3) 
(Sparrow et al., 2003; Laing et al., 2009). The criteria used to rank the Drosophila 
mutants are based on the extent of sarcomeric disruption in each mutant, the flight 
ability as heterozygotes, and how well the mutations were rescued by adding an extra 
wild type actin copy. 
The mutation I136M was the mildest, it was th~ only that produced some flighted 
heterozygotes and showed the less pronounced sarcomeric disruption as heterozygotes 
and homozygotes (except for D292V). The I136M is also classified as having a mild 
disease phenotype in patients (Ilkovski et al., 2001). The D292V mutation was more 
severe than I136M as there were areas showing myofibril disarray and normal 
myofibrils at whole muscle immunostaining of heterozygous and homozygous flies. In 
patients the D292V substitution causes CFTD (Clarke et al., 2007) in which the type I 
muscle fibres are uniformly smaller compared to type II fibres. Since fly IFM have a 
single fibre type the CFTD phenotype was not seen in the IFM. The G 15R mutants 
(both heterozygotes and homozygotes) showed worse sarcomeric disruption than the 
D292V mutation with very large zebra bodies throughout the muscle. Patients carrying 
the G 15R mutation displayed AM but this phenotype was not found in flies. These 
mutations were also ranked as more severe than the I136M mutation in human patients. 
The D154N, V163L and Vl63M IR-linked mutations were more severe as they resulted 
in the formation of sarcoplasmic aggregates, intranuclear rods, Z-rings and other Z-disc 
structures. Amongst them the D154N mutation showed the most severe muscle disarray 
and abolished myofibril formation in the homozygote state. In humans this mutation 
displays all three nemaline phenotypes (Shroeder et al., 2004). The V163L mutation 
was less severe than D 154N as some homozygous flies did form myofibrils. Both the 
D154N and V163L mutants were not completely rescued upon addition of a second 
wild type actin copy. The V163M mutation was less severe; it did not abolish myofibril 
formation in homozygotes and completely rescued upon addition of a second wild type 
actin copy, which was not the case with the D154N and V163L mutants. Also based on 
clinical data in human patients, the V163L mutation is classified as severe congenital 
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(Goebel et al., 1997a) whereas V163M is described as typical congenital (Sparrow et 
ai., 2003). 
Table 3.3. Comparison of the muscle phenotypes caused by the actin mutations in 
human patients and in the Drosophila IFM. 
Human biopsy Drosophila IFM 
Mutation Classification Phenotypes 
01 54. S ' \" r ' 1\.\1. IR. 
~t I)' l' ael 111 
V163L ·l'wreA:'\t. IR 
VI 63 M AM.IR 
(j I- R A L . \-t 
0_')_ \" CFT D 
11 361\1 ;\1i ld 1\M 
3.10 Discussion 
Z 'bra b dil'~. Z' Tl n ·S. In lrwluckar rod~. mu ch: ~Iruc lufl: I. m m: di rupled 
Ih,m V 16 I, In 'ompll:ll' r ·~cue . addtl ion ot' . n exlia c p} of \\ i Iu I) pc 
d ' 1111 uoes nol Cl mplel '1)' n:~ ' u ' Ihl' ph'n Iyp ' 
L 'bra b dlc~. Z'rm:~ . mtranu 'leaf rod . . Z.body aggrl'gJK' . 
Larg ' :t:l'br..l -bodi . ' Ihroughlllll 1l1 11 ~de 
. m ' Lcbr,s lh c~ and di~or~amL'd mu;-;dc slruc ll r ' in hClCTOLygoll'S. 
H mozygoll's haH' r ' Iall\ d~ n Olml m I ~d c slruc lure. 
Minor et1l:Cls on mlls 'I ' slnlClll r ' in I 'I 'roz~ gOI '~ . L'b a UI .~ only round 
III hOInOL)'J; ll·S .. mall " ,. 01' III .~ I.'an Il} 
3.10.1 Drosophila IFM nemaline myopathy mutants 
Three main characteristic features are seen in the muscles of patients with NM; actin 
filament aggregate myopathy (AM), nemaline myopathy (NM), and intranuclear rods, 
in which actin filaments form aggregates in the nucleus. Introducing NM-related actin 
mutations into the Drosophila !FM Act88F gene has resulted in a range of phenotypes 
in the muscles that show some important similarities to those seen in human patients. 
The types of structures observed and degree of severity for each mutation depends to the 
mutant actin expressed. 
The main observation is that the actin mutations affect the ability of the !FM to form 
normal myofibrils, which in turn results in flightlessness. The only exception are the 
Act88FI 36M/+ heterozygotes that retain some flight ability. Homozygous actin mutants 
still contain actin filaments suggesting that none of the mutations prevent actin 
polymerization. Reduced myofibril diameter in the D154N and D292V mutants as well 
as shorter sarcomeres in the V163L mutant suggest that less F-actin is being 
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incorporated into the myofibrils. The concomitant reduction in myofibrillar volume 
would result in reduced power output and inability to support flight. However, since all 
the mutants also have mild to severe disruption of sarcomere organization (similar to 
patients), the ability of the mutant muscles to power flight would be severely impaired. 
Other features of the disease identified in Drosophila IFM mutants were Z-disc 
streaming, myofibrillar disruption, branching of the myofibrils to form separate 
myofibrils that are only connected at the site of branching and 'whirling' of actin 
filaments. An interesting feature of the IR-linked mutants was the Z-ring phenotype, 
which has never been previously reported in humans or in other model systems. 
The pathological characteristic of nemaline myopathy is the presence of electron-dense 
rods of different size and shape at the EM level. The rods, which consist of Z-disc 
material are usually found under the sarcolemma although they can be also seen within 
the nucleus or within the sarcomere. Here some of the Drosophila mutants produced 
sarcoplasmic Z-body aggregates, which were smaller than the ones seen in humans. The 
continuous turnover of skeletal muscle proteins in human muscle supports the formation 
of large protein aggregates. In the IFM of adult flies there is no evidence for repair of 
damaged muscle or continuous expression of muscle proteins. Hence large protein 
aggregates may be more difficult to form in the IFM. Furthermore the rods found in 
patients do not accumulate uniformly within the muscle, some myofibrils contain more 
rods than others. In Drosophila the Z-body aggregates emerge occasionally from the Z-
discs or they accumulate in areas lacking any other material. In the patient with the 
V163M ACTA] mutation the cytoplasmic rods were much smaller than the intranuclear 
rods (Hutchinson et a!., 2006). It was observed that the Z-body aggregates of the 
Drosophila V163M mutant were half the length of the IRs (Figures 3.14; 3.16). 
Actin filament aggregate myopathy is usually associated with severe NM clinical cases. 
In patient muscle biopsies actin filament aggregate myopathy is shown as filamentous 
accumulations within a large region of amorphous material or as large aggregations of 
actin filaments in the muscle fibre. Here a phenotype resembling actin filament 
aggregate myopathy was observed in the V163M mutant. EM analysis showed a 1.2 Jlm 
long accumulation of filamentous material next to sarcomeres. This accumulation is 
very small in comparison to the actin filament aggregate myopathy areas that some 
times occupy a large part of the patient's fibre. The lack of continuous turnover of 
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muscle proteins in the IFM of adult flies could be why only small protein aggregates 
can form. The V163M was one of the very severe IFM mutants and represents the only 
occasion when the actin filament aggregate myopathy -like phenotype was observed. 
The D154N and V163L mutations also result in actin filament aggregate myopathy in 
humans but the phenotype was not observed by EM analysis in Drosophila !FM. Actin 
filament aggregate myopathy is a very rare phenotype and is often missed in the human 
biopsies. This could also be the case here and perhaps if more flies were examined actin 
filament aggregate myopathy-like phenotypes would be identified in transgenics 
carrying the D154N and V163L mutations. 
The third phenotype associated with the disorder, intranuclear rod myopathy, is also 
rarely found in human patients. Expressing the three different IR-linked human 
mutations (D154N, V163L, V163M) in Drosophila resulted in the formation of 
filamentous actin accumulations in the !FM nuclei of all three mutants. The human IRs 
have been shown to form loosely arranged filamentous actin accumulations like the 
ones formed in the Drosophila IR-linked mutants. However the ones seen in humans 
can be rod-like which was never the case in any of the three Drosophila IR-linked 
mutants. The IRs in the patient carrying the V163M ACTA] mutation varied between 2-
8 ~m in length (Hutchinson et al., 2006). The Drosophila IRs as measured from 
confocal images of whole muscle stained with DAP! and phalloidin seem to vary 
between 5-12 ~m. By phalloidin staining the Drosophila IRs are similar to the ones 
observed in cell culture studies (Ilkovski et al., 2004). A similarity between the human, 
the cell culture and the Drosophila IRs is that all three seem to distort the nuclei. 
Interestingly the filamentous actin accumulations found in Drosophila nuclei resemble 
the actin filament aggregate myopathy-like accumulations found in the sarcoplasm of 
the V163M mutants. In Drosophila IFM intranuclear rods were only observed in the 
most severe mutants D154N, V163L and V163M. They were mostly seen in the V163L 
mutants, then in the V163M and rarely seen in the D154N. Among nemaline myopathy 
patients there is also variability in the percentage ofmyofibres with intranuclear rods. 
For the first time in an intact model genetic organism two of the rare phenotypes of the 
disease were recapitulated. The Drosophila intranuclear rods are very similar to the 
human ones and are frequently found in the !FM nuclei suggesting that this is a good 
model system with which to study their appearance. The actin filament aggregate 
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myopathy-like phenotype was difficult to reproduce, hence Drosophila IFM may not be 
an ideal system to understand the aetiology of this phenotype. 
3.10.2 The effects of the Act88F mutations vary between muscle fibres of a fly 
population 
A variation in severity of the phenotypes was observed amongst flies carrying the same 
mutation. This was observed both by EM or whole muscle staining for each mutant. 
This is not only a feature of Drosophila IFM, but also of human patients. Similar 
phenotypes can be observed in more than one patient such as with the H42Y mutation 
where 3 out of 4 patients show IR (Sparrow et al., 2003). In contrast the G270C 
mutation showed high variation in phenotypes across 8 patients from mild to severe 
nemaline myopathy (Sparrow et al., 2003). The variations in severity between unrelated 
patients with the same mutation as well as the intra-familial variation suggests that other 
factors could be affecting the phenotype caused by actin mutations and this may also be 
the case in Drosophila. 
Furthermore, a phenotype can be observed more frequently in some patients than in 
others. For example muscle biopsies of patients suffering from intranuclear rod 
myopathy show that with some mutants the number of affected nuclei is many (80 % 
and 75%, Barohn et al., 1994 and Goebel et al., 1997b, respectively) whereas in others 
the intranuclear rods are infrequent (2 %) (Fukunaga et al., 1980). This could also be the 
case for the Drosophila Act88pDI54N/+ heterozygous mutants, which do not show IRs as 
often as the Act88FVI63L/+ and the Act88FVJ63M/+ heterozygotes. 
In addition, the muscle disorganization of the Act88F mutants also varied within the 
same fibre. An example of that was shown in Figure 3.18, for the Act88FVI63L/+ 
heterozygous mutant, where sections at the top of the fibre were less disorganized than 
sections in the centre of the same fibre. Wild type and mutant IFM fibres were treated 
with NBT, the diagnostic stain used to identify central core disease in patient biopsies, 
but the fibres turned pale blue, which was not enough to see a difference between the 
two genotypes. Different fibre types in humans exhibit variations in the intensity with 
the stain being most effective in type 1 fibres, weakest in type 2A fibres and 
intermediate in 2B type fibres. Hence it is likely that the Drosophila IFM are a type of 
fibre that can only be poorly stained. The stain used for the Drosophila IFM is identical 
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to the one used for human biopsies. It therefore may be possible to stain the fibres by 
using a range of different pHs. 
3.10.3 The Drosophila Act88F mutants vary in severity 
In the Drosophila IFM mutants there is a correlation between severity and muscle 
disarray. The I136M mutation was the mildest as it was the only heterozygous mutant 
that produced some flighted flies and showed the least sarcomeric disruption. This 
mutant was also classified as mild disease phenotype in patients. The D292V mutation 
was more severe as it produced areas showing myofibril disarray but also normal 
myofibrils. In turn the G 15R mutation showed worse sarcomeric disruption than the 
D292V mutation with very large zebra bodies throughout the muscle. The most severe 
effect both in a heterozygous and homozygous condition have had the D154N, V163L 
and V163M mutations. The D154N mutation was more severe as it abolished myofibril 
formation in the homozygous state whereas flies homozygous for the V163L mutation 
in some cases formed myofibrils thus making this a less severe mutation. The V163M 
homozygotes are less severe as they always produced myofibrils. Also based on clinical 
data in human patients, V163L is classified as severe congenital and V163M as typical 
congenital. Interestingly residues D 154 and V 163 are in neighbouring ~-strands in one 
of the ~-sheets in subdomain 3 of G-actin and produce similar defects (Figure 3.27). 
Overall the severity ranking of the Drosophila Act88F mutations matches the ranking of 
the human mutations. 
Figure 3.27. G-actin cartoon sho~ing the D154 and V163 residues in the G-actin 
atomic structure. Image created usmg Pymol. 
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The correlation between severity and muscle disarray seen in the Drosophila IFM 
mutants is not surprising. In nemaline myopathy patients the proportion of individual 
myofibres occupied with nemaline rods, the size of the rod clusters and the degree of 
myofibrillar disruption appear to correlate with clinical severity. In the muscle fibres of 
individuals that exhibit the mild nemaline phenotype there is very little sarcomeric 
disruption by rods and the muscle fibres appear normal at the ultra-structural level. In 
contrast two individuals affected with the lethal severe congenital form of the disease 
showed both sarcomeric actin disorganization and regions of the myofibres devoid of 
sarcomeres (Ilovski et al., 2001). 
3.10.4 Molecular effects on actin structure 
The DI54 and VI63 residues reside near a hydrophobic pocket at one end of the 
hydrophobic cleft in actin subdomain I. This region of actin is a binding 'hot spot' for a 
large array of proteins to both G- and F-actin (reviewed in Dominguez, 2004). It 
mediates important interactions in five G-actin complexes (Bubb et al., 2002; Burtnick 
et al., 2004; Hertzog et al., 2004; Klenchin et al., 2003; McLaughlin et al., 1993). 
Hence, mutations that disrupt the molecular surface of this region are highly likely to 
cause severe phenotypes. 
An explanation why the VI63L substitution could cause more severe defects than the 
V163M one came by examining the location of the V163 residue in the G-actin atomic 
structure. There the V 163 residue is depicted as a partially buried amino acid 
(Figure 3.28 A). A cross section through the structure shows that there are two cavities 
near the VI63 residue pointed by the arrows (Figure 3.28 B). Although methionine has 
a longer side chain compared to valine it would be possible to fit it into one of the two 
cavities. However, leucine is a branched hydrophobic amino acid; it would probably not 
fit as easily and would cause local rearrangement of the surface. Together these 
observations suggest why the VI63L mutation causes a more severe phenotype than 
VI63M in Drosophila IFM. Moreover, the V163 residue is located near actin-actin 
contacts and near the nucleotide-binding cleft. Disruption of that region by the mutation 
might result in loss of nucleotide binding. However, V163L was previously shown to 
polymerize similarly to the wild type (Costa et al., 2004). 
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Figure 3.28. G-actin surface sections showing the V163 residue. (A ) The V163 
residue colored blue is shown to be partially buried. (B) Cross section through G-actin 
showing that V163 occupies a cavity that could accommodate a large amino acid. 
Images were created using Pymol. 
3.10.5 Pointed end capping is affected in NM mutants 
The main defect observed is that the actin mutations all affect the ability of the IFM to 
form normally structured myofibrils, which in turn results in flightlessness . The 
reduced diameter of the mutant myofibrils suggests that less actin is being incorporated 
into the myofibrils. The concomitant reduction in myofibrillar volume along with the 
aberrant sarcomere structure would result in inability to support flight. However, all of 
the actin mutants formed filaments in the homozygotes, so all the mutant actins 
maintain their ability to polymerize to form F-actin. 
Immunostaining for tropomodulin in the G15R, V163L and V163M mutants showed 
that its localisation was less regular than in wild type and in other actin mutants . Effects 
on capping at the pointed end would result ill increased rates of 
polymerisationldepolymerisation and irregular thin filament length. In human skeletal 
muscle, nebulin, a large protein found in the thin filament bound to actin has been 
suggested to regulate thin filament length (Labeit et al., 1991). Mutations in nebulin 
result in congenital myopathies (pelin et aI., 1999) with the patient's actin filament 
lengths being less well regulated (Ottenheijm et al., 2009). Drosophila IFMs do not 
contain nebulin (Bullard et al. , 2006), hence regulation of the thin filament length is 
likely to depend mainly on capping protein and interactions of the thin filament with 
other proteins at the Z-disc (Schafer et aI. , 1993) together with capping of the pointed 
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end by the tropomodulinltropomyosin complex (Littlefield and Fowler, 1998; Littlefield 
et al., 2001). 
Whole muscle protein analysis showed that levels of a variety of sarcomeric proteins 
were normal including that of actin, which suggests that the effects of the mutations are 
not due to insufficient actin levels but because the mutant actin interferes with the wild 
type actin function. The most likely explanation for the various structures such as zebra 
bodies, aberrant Z-discs or nemaline rods is that the mutant actin, unable to incorporate 
normally into thin filaments is still able to bind to actin binding proteins such as 
a-actinin and in doing so, forms these aberrant structures. 
3.10.6 Summary 
The six human congenital actin myopathy mutations that were introduced into 
Drosophila produced similarities to the human phenotypes, including the rare 
phenotypes associated with the disease and their severity varied according to their 
human counterparts. Hence Drosophila provides a genetically tractable system which 
can be used to understand the aetiology behind this disease. The next chapter focuses on 
different genetic approaches that were used to study some of these mutations further. 
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Chapter 4: Use of genetic approaches to understand 
the NM phenotypes 
4.1 Aims 
Having produced a Drosophila model for NM, specific aspects of the Act88F mutants 
were investigated to understand the aetiology of certain phenotypes associated with the 
disease. 
4.2 Introduction 
To date no intact animal system has been reported where the NM-linked actin mutations 
have been introduced and that recapitulates all the disease phenotypes. Without an intact 
animal model system it is difficult to follow the appearance of the different phenotypes 
associated with congenital actin myopathies and understand their aetiology. The 
majority of 22 different ACTA1-linked actin mutants have been expressed in vitro, or 
examined in vivo in cultured fibroblasts, myoblasts or myotubes. These show a variety 
of defects, including the inability of the protein to fold (two mutants), or the formation 
of aggregates (Costa et al., 2004; Domazetovska et al., 2007a;b; Ilkovski et al., 2004). 
However many questions remain unanswered such as why, how and when do the 
phenotypes associated with congenital actin myopathies appear in the patients? Which 
actin, wild type, mutant or a combination of both is present in the intranuclear rods? 
The Drosophila Act88F mutants presented in Chapter 3 show some of the phenotypes 
associated with the disease such as intranuclear rods, sarcoplasmic rods and actin 
filament aggregate myopathy, although these are not recapitulated in exactly the same 
way as in the patients. For example the Drosophila intranuclear rods are not as electron 
dense, rod-like (by EM) and compact as the ones seen in patients. Only one case of actin 
filament aggregate myopathy was observed by EM (V163M). However, phalloidin-
stained actin filaments, which were not assembled into sarcomeres did appear in several 
mutants. It is not possible to determine if these are similar to the human actin filament 
aggregate myopathy phenotype as they may had also consisted of myosin thick 
filaments. The Drosophila mutants also displayed sarcoplasmic actin and Z-body 
aggregates which are the closest representation of the human sarcoplasmic rods, 
although they are much smaller. The zebra body phenotype, which is uncommon in 
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humans, is observed frequently for most mutants studied here. Despite the lack of 
absolute similarity in the appearance of the phenotypes, the Drosophila IFM still 
present an intact animal system with which it can be possible to study these muscle 
abnormalities. 
4.3 Developmental analysis of the intranuclear rod-containing actin 
mutants 
Human patients with intranuclear actin rod myopathy present the rods at birth. This 
poses a difficulty in investigating how the rods appear in humans and suggests that IR 
form during development in the womb. Drosophila mutants for the IR-linked mutations 
display the IR phenotype and can therefore be used to understand when during muscle 
development the IRs first appear. Drosophila IFM development occurs during the pupal 
stage, which lasts approximately four days (96 hours after puparium formation, APF) at 
25°C. In order to see at what point during muscle development the intranuclear actin 
rods first appear in Drosophila, whole muscle imaging was carried in the IFM of pupae. 
IFM myofibrillogenesis starts at around 48 hours APF (Reedy and Beall, 1993), which 
coincides with peak Act88F expression (Fyrberg et al., 1983). Since expression of the 
Act88F gene starts at early pupal stages (Fyrberg et al., 1983) it is likely that the IR 
phenotype will be observed only at later pupal stages. 
When adult Act88[IJ154N/+, Act88FV163L/+ and Act88FV163M/+ heterozygous mutants 
were analyzed by immunofluorescence and EM not all the flies in each genotype 
showed intranuclear actin rods. Amongst the three mutants the Act88FVJ63L/+ 
heterozygous flies in all the cases displayed the phenotype. Therefore in order to 
increase the chances of observing the phenotype at the pupal stages, only the 
Act88FV163L/+ heterozygous pupae were studied. In 60 hour old APF Act88FVJ63L/+ 
heterozygous pupae intranuclear rods were not found. The intranuclear rods were first 
observed in the IFM of 70 hour old Act88FV163L/+ heterozygous pupae (Figure 4.1 
arrows). Muscle disarray is obvious at that stage, the Z-discs vary in size and appear 
misshaped and Z-rings can be seen (Figure 4.1 arrow heads). This demonstrates that the 
IRs appear before the muscle development process is finished and muscle contraction 
has begun. 
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Figure 4.1. Intranuclear actin rods are present at 70 hours APF. Whole muscle lioht 
. d 88FVJ63t, . . b 
microscopy of wlld type an Act 1+ heterozygous mutant. Arrows mdIcate IRs 
and arrowheads Z-rings. Scale bar 5 f!m. 
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4.4 Are the intranuclear rods caused by inability to export the mutant 
actin from the nucleus? 
G-actin is exported out of the nucleus via the nuclear export receptor specific for the 
profilin-actin complex, exportin 6 (Exp6) (Stiiven et al., 2003). It contacts primarily 
actin but the interaction is greatly enhanced in the presence of profilin. Knockdown of 
Exp6 in Drosophila Schneider cells by RNAi results in the formation of actin 
aggregates inside the nucleus (Stiiven et aI. , 2003). The existence of the Exp6 pathway 
for the actin-profilin complex suggests that trafficking of the complex out of the nucleus 
must occur. The actin D154 and V163 residues are located near the proposed profilin 
binding sites on actin (Figure 4.2) (Schutt et al., 1993). Hence mutations in these 
residues may affect the interaction between profilin and actin resulting in detainment of 
the mutant actin in the nucleus. 
Low levels of G-actin as well as short F-actin filaments (that cannot be phalloidin-
stained) can be found inside the nucleus. The presence of F-actin filaments inside the 
nucleus suggests that in the nuclear environment mechanisms exist to support actin 
polymerization. Therefore abnormally increased actin levels inside the nucleus and the 
inability to export the mutant actins could result in the formation of intranuclear rods 
observed in the nuclei of Drosophila IFM and human patients. 
Figure 4.2. The prop?~ed resid~es involved in profilin binding on actin. G-actin 
monomer with the pOSItIon of resldues D154 and V163 are shown in red and yellow 
respectively. The proposed profilin residues that bind actin are shown in green. Imag~ 
created in pymol. 
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In order to see if Exp6 is also expressed in the Drosophila IFM, PCR was performed to 
amplify the gene from cDNA made from isolated Drosophila IFM rnRNA using the 
primers listed in Table 1 of Appendix I. Two PCR products were obtained for Exp6 
when cDNA was used. A 615 bp product corresponding to the expected product when 
IFM cDNA is used confirmed that the gene is expressed there (Figure 4.3). The second 
1147 bp band corresponds to the product from genomic DNA probably due to genomic 
DNA contamination of the rnRNA. The Exp6 PCR product using genomic DNA is 
1147 bp, which is the same size as the one of the cDNA (Figure 4.3). 
Affymetrix micro array data of isolated IFM from Drosophila pupae by Dr Ari Franco 
show that profilin is also expressed in IFM (personal communication). As Exportin 6, 
actin and profilin are expressed in the Drosophila IFM it was assumed that ACT88F 
will be exported from the nucleus by the same mechanism described by Stiiven et al., 
2003. 
70: b p 
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Figure 4.3. Exportin 6 is present in Drosophila IFM. PCR for Exportin 6 and the 
ribosomal protein 49 (rp49) control was performed on cDNA made from RNA isolated 
from Drosophila IFM. Two products corresponding to Exportin 6 are seen, one is the 
expected 1146 bp band for genomic and one for 614 bp for the cDNA. The expected 
band for rp49 runs at around 609 bp for genomic DNA and 444 bp for the cDNA. The 
two genes were also amplified using genomic DNA. 
The chickadee gene of Drosophila encodes profilin (Cooley et al., 1992) with the null 
chickadee mutant resulting in late embryonic lethality (Verheyen and Cooley, 1994). 
The GAL4-UAS system offers the advantage of targeting downregulation of gene 
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expression by RNAi in both a spatial and temporal manner. In order to examine if a 
reduced ability of actin to bind to profilin results into intranuclear actin rods, an attempt 
was made to knockdown the profilin mRNA in Drosophila IFM. An RNAi line for 
chickadee (stock ID 9553R-3) was purchased from the National Institute of Genetics in 
Japan, NIG that targets all four reported chickadee variants. NIG has used the Act5C-
GAL4 driver at 28°C which contains the Actin5C isoform promoter resulting in 
Ubiquitous silencing of chickadee. As reported by the NIG website, the UAS-
dsRNAi[ chic] line has an additional 26 off targets. The later include the transcription 
factor Alhambra (CGI070), the RNA helicase Vasa (CG3506), the histone deacetylase 
HDAC6 (CG6170) as well as uncharacterized proteins. Though no muscle genes are 
reported. 
The IFM-specific driver UH3-GAL4 (kind gift of Dr. Upendra Nongthomba) was used 
to downregulate the expression of chickadee exclusively in the IFM at 25°C. This 
driver was recovered from an enhancer trap screen. The UH3-GAL4 insert is localised 
upstream of the gene for CG1445, a zinc ion binding uncharacterized transcription 
factor (personal communication, Dr. Upendra Nongthomba). Preliminary results 
indicate that it is expressed in wing disc in larval stages and starts expressing in the 
IFM after 30 APF. To demonstrate the specificity of the driver, homozygous flies for 
the UAS-GFP and UH3-GAL4 inserts were crossed and GFP expression was followed 
in the progeny. Figure 4.4 shows that the GFP is expressed in the head, abdomen and 
thorax of 24-hour-old pupae but it then becomes exclusively expressed in the 
developing IFM at 48 hours APF (Figure 4.4 arrows) and remains exclusively expressed 
in the IFM of I-day-old flies. Thus UH3-GAL4 is a suitable driver line for knocking 
down the chickadee mRNA levels solely in the IFM. 
Both the UH3-GAL4 driver and the UAS-dsRNAi[chic] lines alone are flighted as 
heterozygotes (F,igure 4.5) suggesting that the inserts do not have an affect on IFM 
structure or function. The UAS-dsRNAi[chic] line was driven using the UH3-GAL4 
driver but the flies never emerged and died as pupae. The dmef2-GAL4 panmuscle 
driver (Ranganayakulu et al., 1996) was also used to knockdown profilin mRNA. The 
GAL4 activity in Drosophila is temperature dependent so that at 16°C it is minimal and 
at 29 °C maximal (Jarrett, 2000). Since null chickadee mutants result in late embryonic 
lethality (Verheyen and Cooley, 1994), to avoid activation of the dmef2-GAL4 
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panmusc1e driver at the embryonic and larval stages, the progeny from the dmej2-GAL4 
cross were first grown at 18°C (the lowest temperature controlled available room for 
fly maintenance). Those individuals that had reached the pre-pupal stage were 
transferred to 25°C to allow activation of the dmej2-GAL4 driver. However, the 
progeny from this cross, died as pupae as did those driven with the UH3-GAL4 driver. 
The lethality observed with both GAL4 drivers could be due to the off-targets reported 
for this RNAi line. 
24 hours 48 hours 
100 hours 
Figure 4.4. Pattern of expression of the UB3 driver. Peeled pupae and I-day-old fly 
are shown under normal light and by GFP imaging of the same specimens. 
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Figure 4.5. Flight ability of UH3 and dsRNAi[chic] flies. The number of flies (n) 
tested was n = 54 for the wild type, n = 39 for the UH3-GAL41+ and n = 37 for the 
dsRNAi[chic] /+ . 
4.5 Are the intranuclear rods composed of wild type or mutant actin? 
In the Drosophila IFM the presence of the Exp6 pathway could mediate the transport of 
profilin-actin complexes out of the nucleus. This raises the question as to whether 
inability of the Act88F intranuclear rod variants to bind to profilin would lead to 
detainment of the mutant actins inside the nucleus and result in intranuclear actin rods. 
It is still unknown whether the intranuclear actin rods seen in nemaline myopathy 
patients consist of wild type, mutant actin or both species. This was investigated in 
Drosophila by fusing GFP to either the mutant or wild type ACT88F actin, so as to 
reveal which one localizes in the intranuclear rods. Transgenic flies expressing a UAS-
GFP-Act88r insert, where the GFP is attached to the 5'- end of the Act88F gene 
through a short linker sequence were previously reported not to cause obvious IFM 
sarcomeric structural defects, although the flies cannot fly when driven with the 
panmuscle dmef2-GAL4 driver (Roper et al., 2005). The UAS-GFP-Act88r transgenic 
line was obtained from the Bloomington Stock Centre and was found to be flighted in 
the absence of a GAL4 driver (Figure 4.6). This suggests that the insert does not affect 
muscle function and structure when it is not expressed, which was also supported by 
whole muscle staining (Figure 4.8 A). When the UAS-GFP-Act88r /+ flies were driven 
using the UH3-GAL4 driver the muscle structure appears normal as expected (Figure 
4.8 B) however the flies are flightless (Figure 4.6). Intranuclear rods are not observed 
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as shown by the lack of phalloidin staining inside the nucleus and the absence of GFP 
signal in the nucleus (Figure 4.8 B). 
In order to determine if the mutant actin is present inside the intranuclear rods the UAS-
GFP-Act88P plasmid (kind gift of Dr Roper) was used to introduce the Act88FVJ63L 
and Act88FVJ63M mutations by whole plasmid peR-mutagenesis. The mutagenized 
plasmid was injected into fly embryos and stable lines were obtained. Two independent 
transgenic lines were obtained for the UAS-GFP_Act88FVJ63L construct, but no 
transgenics were obtained for· the UAS_GFP_Act88FVJ63M construct. No UAS-GFP-
Act88rJ54N flies were created as the D154N mutation did not show the intranuclear rod 
phenotype as often when compared to the V163 mutation. Both the UAS-GFP-Act88r 
and UAS_GFP_Act88FVJ63L/+ transgenic lines were flighted in the absence of a GAL4 
driver (Figure 4.6) suggesting that these inserts do not affect muscle function and 
structure when they are not expressed. This was also supported by whole muscle 
staining (Figure 4.8 A and Figure 4.9 A). When the UAS-GFP-Act88r 1+ flies were 
driven using the UH3-GAL4 driver the muscle structure appears normal as expected 
(Figure 4.8 B). However the flies are flightless (Figure 4.6). Intranuclear rods are not 
observed as shown by the lack of phalloidin staining inside the nuclei and the absence 
ofGFP signal in the nuclei (Figure 4.8 B). 
In order to determine if the wild type actin is present in the intranuclear actin rods 
transgenic flies were created that were heterozygous for the Act88FVJ63L and for the wild 
type UAS-GFP-Act88P inserts. In order to achieve this, flies homozygous for the 
Act88FVJ63L insert in the first chromosome and for the UAS-GFP-Act88P insert in the 
third chromosome were created. These were then crossed to the IFM-specific UH3-
GAL4 driver which was previously put in homozygous Act88rM88 actin null 
background. So in the progeny flies containing one copy of UH3-GAL4, one of the 
Act88FVJ63L insert, one of the UAS-GFP-Act88P insert and two of the Act88rM88 
insert were generated (Figure 4.7, 4.8 e). Fluorescence microscopy for these flies shows 
that the GFP signal does not colocalize with the intranuclear actin rods stained with 
phalloidin (Figure 4.8 e). This suggests that the intranuclear rods are not composed of 
wild type actin but instead they are composed solely of mutant actin. However. this 
result could also be due to the fact that the GFP fused to the actin does not allow the 
protein to enter inside the nucleus. Another interesting result in the same flies was that 
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the wild type actin fused to GFP did not colocalize with the sarcoplasmic rods (Figure 
4.8 C bottom panel) . Instead the latter were stained only with phalloidin, which implies 
that these actin aggregates consist solely of mutant actin. For the bottom panel in Figure 
4.8 C DAPI staining is not shown as there were not any nuclei in that section. 
The UH3-GAL4; UAS-GFP-Act88Fv/63L/+; Act88pKM88/+ flies were also flightless 
(Figure 4.6). Whole muscle staining with DAPI showed that the GFP-Act88Fv/63L actin 
localizes inside the nucleus (Figure 4.9 B arrowheads). This shows that the mutant actin 
is present in the nuclear actin rods and that the GFP does not prevent actin from entering 
the nucleus. However the GFP-signal appears "grainy" and that ~as also the case when 
anti-GFP antibody was used (Figure 4.9 C). These transgenics also displayed 
sarcoplasmic rods (Figure 4.9 C left phalloidin image arrows) and abnormally large Z-
discs (Figure 4.9 C anti-GFP merge arrows and right phalloidin image curly bracket) . 
Given the facts that only mutant actin is present in the intranuclear rods, that the IR-
linked residues are near the profilin binding site, and that the exportin 6 pathway is 
present in Drosophila IFM, these observations suggest that inability to export the 
mutant actin from the nucleus is likely to be one of the underlying causes for the 
intranuclear rods. 
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Figure 4.6. Flight-analysis of GFP-Act88F flies. Flight ability of wild type (n = 31), 
UH3-GAL4/+ (n = 33), UAS-GPP-Act88P/+ (n = 31), UH3-GAL4/+; UAS-GPP-
Act88P/+ (n = 40), UAS-GFP-Act88pv/63L/+ (n = 26) and UH3-GAL4/+ ; UAS-GPP-
Act88pv/63L/+ ; Act88FKM881+ (n = 36) (where n is the number ofilies tested) . 
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A. UAS·GFPAct88F/+ 
OAP I Phalloidin 
B. UH3·GAL4I+; UAS·GFPAct88F/+; Act88p·"/+ 
OAPI Antl-GFP 
Merge 
Phalloidin 
C. UHJ.GAL4IAct88P"J4 ; UAS·GFPAct88F/+; Act88P''''/Act88P-
OAPI Antl-GFP Phalloidin 
Figure 4.8. Wild type GFP-ACT88F does not localize to intranuclear rods. Whole 
muscle light microscopy of (A) UAS-GFP-Act88PI+; Act88pKM88/+ flies with DAPI 
and phalloidin, (B) UH3-GAL4/+ ; UAS-GFP-Act88PI+; Act88pKM88/+ and (C) UH3-
GAL4IAct88Fv/63L ; UAS-GFP-Act88PI+; Act88pKM88/Act88pKM88 flies with DAPI, 
phalloidin and anti-GFP. Arrowheads indicate intranuclear rods and arrows indicate 
sarcoplasmic aggregates. Scale bars: 5 /-Lm. 
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A. UAS·GFPAct88P"J4./+ 
OAPI Phalloidin 
B. UHJ.GAL4I+ ; UAS-GFPAcr88P" !4/+; Act88F'tlu/+ 
OAPI GFP 
C. UH3-GAL4I+ ; UAS·GFPActB8P" JC./+; Act88ptlA,+ 
OAPI AntJ -GFP 
Phalloidin 
Merge 
Figure 4.9. The intranuclear rods consist of GFP_Act88FVJ63L actin. Whole muscle 
light microscopy of (A) UAS-GFP-Act88Fv/63L/+ flies with DAPI and phalloidin, UH3-
GAL4/+; UAS_GFP_Act88Fv/63L/+ ; Act88pKM88/+ flies with: (B) and (C) DAPI, anti-
GFP and phalloidin. Intranuclear rods are indicated by arrowheads, sarcoplasmic 
aggregates by arrows and large Z-discs are encompassed by the curly bracket. Scale 
bars: 5 pm. 
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4.6 Does the Z-ring phenotype arise from impaired actin-capping 
protein interactions? 
The Z-ring phenotype and the appearance of sarcoplasmic aggregates containing Z-disc 
proteins was a common feature of the Drosophila intranuclear rod-linked mutants. 
Images of the Act88FVI63L/+ heterozygous adults show parts of the Z-discs are enlarged 
and filled with material, which is less electron dense than the Z-disc (Figure 4.10 A, B). 
Also lateral 'splitting' of Z-discs can be observed (Figure 4.10 C). 
Figure 4.10. Z-disc defects in Act88FV163L/+ heterozygotes. TEM of I-day-old 
Act88pV163L/+ heterozygote adults. (A, B) Arrowheads point at the parts of the Z-discs 
that are enlarged, (C) Arrowhead indicates a splitting' Z-disc. 
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Following the analysis of the IFM from 70 hour old pupae, which displayed Z-disc 
defects, 60 hour old pupae were also examined for both intranuclear rods and Z-disc 
abnormalities. IFM microdissections of 60 hour old APF pupae are more challenging 
preparations than those performed at later stages as it is difficult to detect by eye the 
small and translucent IFM. Also at that stage the developing IFM are not strongly 
attached to the tendon cells and are often lost during the preparation. In addition, it was 
thought too soon to notice muscle defects in pupae younger than 60 hours APF as 
myofibril formation starts at around 40-42 hours APF (Reedy and Beal1~ 1993b). Based 
on these facts pupae younger than 60 hours APF were not examined. 
For the Act88FV163L mutation 38 heterozygote pupae were examined, 8 Act88f'J154N/+ 
and 5 Act88FV163M/+ were examined at 60 hour APF. At this age Z-rings can already be 
seen and are bigger compared to the Z-discs (Figure 4.11 arrowhead). The Z-discs are 
found not to be properly aligned and are misshaped or smaller compared to the wild 
type ones. The Z-ring phenotype must not be caused by mechanical damage during use 
(at least at that age), as the muscles are not in use at 60 hours APF. These observations 
suggest that the mutant actins are affecting Z-disc assembly during very early muscle 
development. Moreover no intranuclear actin rods were observed for any of the mutants 
at this age. 
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Figure 4.11 . Z-rings are present at 60 hours APF. Whole muscle light microscopy of 
rDT54N/ A 88Fv163L/ d A 88Fv163M/ . wild type, Act881' · +, ct + an ct + heterozygous mutants. AntI-
kettin antibody was used to stain the Z-discs. Arrowheads indicate Z-rings. Scale bar 
5 ).!m. 
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Since actin has numerous binding partners it is difficult to pinpoint which interaction is 
likely to be impaired in the intranuclear rod-linked mutants. In many actin cytoskeletal 
structures thin filaments elongate principally from their barbed ends (Pollard et al., 
2000). In contrast, during IFM myofibrillogenesis the thin filaments elongate from their 
pointed ends (Mardahl-Dumesnil and Fowler, 2001). This process is regulated by 
sanpodo, the Drosophila homologue for the gene encoding for tropomoduIin. Because 
the IR-linked mutants presented several Z-disc abnormalities it was suggested that there 
might be defective thin filament capping at the barbed end. If the barbed ends of the thin 
filaments are not capped actin could accumulate and present as electron dense material 
between the split Z-discs (Figure 4.10 A). 
Actin is capped at the barbed end by capping protein (CP), also known as CapZ in 
skeletal muscle. CP is thought to nucleate thin filament assembly during 
myofibrillogenesis (Schafer et al., 1995) and to stabilize actin filaments by preventing 
depolymerization and polymerization from the barbed end (Cooper et al., 1999, Huang 
et al., 2003). CP is a heterodimeric protein consisting of a and (3 subunits, which cap the 
first two actin protomers on the F-actin helix through their flexible C-terminal helical 
extensions (Wear et al., 2003). In particular, the (3 tentacle of the CP(3 subunit binds to 
the hydrophobic cleft between subdomain 1 and 3 of the end protomer in the filament 
(Yamashita et al., 2003). According to the latest model by Narita et al., 2006 for barbed 
end capping by CP, residue 167 on actin is implicated in the interaction with the (3-
tentacle of CP(3. Residues D154 and V163 on actin are therefore in close proximity to 
the proposed area where the (3 tentacle of the CP(3 sub unit binds. Furthermore, deletion 
of 12 amino acids from the C-terminus of the (31 subunit of CP(3 in chicken myotubes 
has been shown to remove the ability of CP(3 to bind to actin but otherwise does not 
affect the formation of the c43 heterodimer (Hug et al., 1992). The mutation abolishes 
the formation of the (3-tentacle of CP(3, which results in actin aggregates and phalloidin-
stained bright foci (Schafer et al., 1985) resembling the Z-ring phenotype seen by 
immunofluorescence in the IR-linked actin mutants Act88p-D154N, Act88FV163L and 
Act88FV163M. Altogether these observations raised the hypothesis as to whether actin-
CP(3 interactions are impaired in the IR-linked mutants. 
Homologues of the mammalian CP a and (3 subunits exist in Drosophila which are 
called capping protein a and b (CPa and CPb) and each has only one reported gene 
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isofo11l1 and transcript in Drosophila (Hopmann et al. 1996). In order to investigate if 
the phenotype created by the actin mutants is due to inability to cap actin at the barbed 
end I looked for existing mutants or CP nulls. However, lines carrying null mutations 
for the genes are early larval lethal (Hopmann et al., 1996), which highlights the 
importance of this protein in regulating actin polymerization at the barbed end. Partial 
loss of function alleles exist that are viable and affect only bristle morphology 
(Hopmann et al., 1996). For those flies it was reported that flight ability is not affected, 
which would suggest that the IFM sarcomere structure is n011l1al and devoid of Z-disc 
defects (Hopmann et al., 1996). Another way to study CPb is to knock down gene 
expression using RNAi. An RNAi line targeted against the Drosophila CPb 
(transfo11l1ant ID: 45668) exists and was purchased from the Vienna Drosophila RNAi 
Centre. According to the Vienna Drosophila RNAi Center website there is only one 
reported OFF target coding for the protein, 1-acylglycerol-3-phosphate 0-
acyltransferase activity (CG3812). As this is not a muscle protein, its targeting by RNAi 
is unlikely to be causing the Z-disc phenotypes observed here. 
When the dsRNAi[cpb] flies were driven with either the UH3-GAL4 and dmef2-GAL4 
drivers the majority were found to be flighted and only 17 % of those driven with 
UH3-GAL4 and 22% ofthose driven with dmef2-GAL4 were flightless (note that 8 % of 
the wild type flies fly down or are flightless) (Figure 4.12 A). Furthe11l1ore, when using 
either drivers, the cross resulted in lethality of late pupae. The lethality was quantified 
by measuring the number of dead and live late pupae and was found to be 23 % and 
(n = 39) and 55.8 % (n = 34) from crosses using the UH3-GAIA and dmef2-GAL4 
drivers, respectively. These observations show that the RNAi is not effective in every 
fly thus resulting in pupallethality when it has been the most effective, flightless adults 
when it has partially knocked down cpb mRNA and flighted adults when the RNAi has 
not been effective at all. Capping protein is not visible in an SDS-page gel due to its 
small quantities in muscle and it is not possible to compare the CPb protein levels in the 
wild type flies and the flies where the cpb message was downregulated. Anti-CPb 
antibody was used to confi11l1 knockdown of cpb (kind gift of Dr. Miller) by Western 
blotting but its signal was very weak in wild type flies and thus it was not possible to 
use it. 
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Therefore, semi-quantitative peR was performed to verify that the cpb mRNA had been 
knocked down. The primers for amplifying cpb were designed to span an intron and are 
listed in Table 1 of Appendix I. peR was performed under identical conditions with 
varying cycles (30, 35 and 40) (Figure 4.12 B). The peR shows that the mRNA for the 
cpb knocked-down flies is reduced only about 37 % at 30 cycles, 40 % at 35 cycles and 
remained the same at 40 cycles. This is not a surprise as the flight-testing results showed 
that the majority of the cpb knocked-down flies were flighted. When preparing cDNA 
from Drosophila IFM newly eclosed flies were used, which contain high mRNA levels. 
The mRNA in the IFM is still present in 24 hour Drosophila adults but in lower levels 
when compared to pupae (Fyrberg et al., 1983). It is not possible to choose flightless 
individuals as newly eclosed flies are not yet mature enough to be flighted. Therefore 
the mRNA levels were not expected to be found completely knocked down in the peR 
performed here. 
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Figure 4.12. Analysis of cpb knockdown mutants. (A) Flight ability of wild type (n = 
52), UH3-GAL41+ (n = 52), dmej2-GAL4/+ (n = 34), dsRNAi[cpb] /+ (n = 45), UH3-
GAL4/+; dsRNAi[cpb] (n = 40) and dmej2-GAL4/dsRNAi[cpb] (n = 41) flies (where n 
is the number of flies tested). The UAS and GAL4 inserts are present as single copies. 
(B) Semi-quantitative PCR of wild type and dmej2-GAL4/dsRNAi[cpb] flies with 30, 
35 and 40 cycles for cpb and rp49 control. (C) cpb mRNA levels measured from semi-
quantitative PCR. Rp49 was used to nonnalize the cpb band intensities between 
samples/lanes. 
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Staining of whole IFM with phalloidin and anti-kettin antibody shows that knocking 
down cpb mRNA in the IFM results in the formation of Z-disc aggregates composed of 
actin and kettin (Figure 4.13 second set of panels from the bottom). Smaller Z-disc 
aggregates were observed in the nemaline myopathy intranuclear rod-linked mutants 
Act88p-lJJ54N, Act88FVJ63L and Act88FVJ73M. Therefore defective capping of the mutant 
actins at the barbed end may be a possible reason for the Z-ring phenotype. In addition 
actin aggregates were observed that, unlike the Z-disc aggregates, did not contain the Z-
disc protein kettin (Figure 4.13 last set of panels). 
The dmefl-GAL4 pan-muscle driver was also used to knockdown the cpb mRNA in 
order to see if there are any differences between the two drivers. Mutations in the 
Drosophila cpb gene cause lethality during early larval stages, therefore the cross was 
performed at 18 °C and the progeny that had reached the late larval stage were moved at 
25 °C allowing activation of the GAL4 driver. The dmef2-GAL4 driver reductions of cpb 
mRNA also resulted in the appearance of Z-disc aggregates containing actin and the z-
disc protein kettin (Figure 4.14). In addition large actin aggregates could be seen almost 
devoid of Z-disc material stained only for F-actin (Figure 4.14 last panel from the 
bottom) that were also observed with the UH3-GAL4 driver. Together these results 
suggest that downregulation of cpb in the IFM perturbs capping of the thin filaments at 
the Z-disc resulting in large actin aggregates as well as to changes in the Z-disc 
structure which result in the 'Z-ring' phenotype. However, flies where CPb was reduced 
do not show as a dramatic phenotype as the actin mutants described earlier. The effects 
of the GAL4 drivers are stronger at 29 °C. However, performing the cross at that 
temperature did not produce a more severe phenotype. 
The a and b tentacles of CP are capable of binding the actin independent from the 
formation of the heterodimer, hence the effect observed here with knockdown of cpb is 
not due to an inability to cap because the heterodimer cannot form, but because only one 
subunit caps the barbed end, CPa, which on its own is not sufficient. 
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Figure 4.13. Whole muscle light microscopy of UH3-GAL41+;UAS-dsRNAi[cpb]/+ 
flies. Anti-kettin and phalloidin staining of of wild type, UH3-GAL41+ heterozygote, 
UAS-dsRNAi[cpb] /+ heterozygote and UH3-GAL41+;UAS-dsRNAi[cpb]/+ flies. 
Arrowheads indicate Z-disc aggregates. Scale bar: 5 Ilm. 
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Figure 4.14. Whole muscle light nllcroscopy of dmej2-GAL4IUAS-dsRNAi[cpb) 
flies. Anti-kettin and phalloidin staining of wild type, dmej2-GAL41+ heterozygous and 
dmej2-GAL4IUAS-dsRNAi[ cpb] flies. Arrowheads indicate Z-disc aggregates. Scale 
bar: 5 /lm. 
Electron microscopy of flightless cpb knockdown flies revealed normal muscle 
structure; abnormal sarcomeres were rarely seen. Three distinct phenotypes can be 
identified. The first phenotype is splitting of the Z-discs; in some cases the Z-discs split 
at one end, but remain attached on the other end (Figure 4.15 A EM image). 
Immunofluorescence reveals Z-ring like structures like the ones seen in the IR-linked 
mutants. A second phenotype observed in the cpb knockdown flies is characterized by 
Z-discs that appear to have expanded laterally (Figure 4.15 B). EM and whole muscle 
immunofluorescence with anti-kettin showed that the Z-discs can be wider than normal 
or to also surround the sarcomeres. Z-disc-like parallel lines can be seen within these 
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wider Z-discs, which are separated by 0.22 J.Lm (Figure 4.15 B EM black arrowheads). 
In other cases Z-discs appear disorganized and wider though only at one end (Figure 
4.15 B EM). Interestingly where the Z-discs have laterally expanded and become wider, 
there is also associated sarcomere damage as shown by the missing thin filaments 
(Figure 4.15 B EM red asterisk). These enlarged Z-discs bear the closest similarity to 
the nemaline rods compared to the other sarcoplasmic aggregations seen in this project. 
The third phenotype observed in the cpb knocked down mutants is large sarcoplasmic 
aggregates that are also reminiscent of the human nemaline rods in size (Figure 4.15 C 
EM). 
Overall the majority of the myofibrils are normal as shown in Figures 4.13 and 4.14. 
The aberrant Z-discs and sarcoplasmic aggregates are rare and would not be easy to 
quantify by EM. Hence phalloidin-stained whole muscle images of UAS-RNAi[cpb] 
driven with the dmef2-GAL4 driver were used to quantify them. This showed that large 
Z-discs and sarcoplasmic aggregates represent only 3 % of the total Z-disc popUlation. 
However, immunofluorescence is not as sensitive as EM and splitting of Z-discs cannot 
be identified with this method; hence the percentage of abnormal Z-discs could be 
higher. A Z-stack from whole muscle immunofluorescence with anti-kettin shows that 
the sarcoplasmic aggregates and enlarged Z-discs are indeed filled throughout with Z-
disc material (Movie 4.1. cpb _ dmef2.avi). 
Impaired actin-capping at the barbed end could be an explanation for how the nemaline 
rods seen in humans are formed. Unlike the continual turnover of actin that takes place 
in vertebrates, in Drosophila IFM protein synthesis post-eclosion is not observed, which 
is probably why large nemaline rods are not seen. 
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A. Splitting Z-discs 
-~---
Kettin 
B. Wider Z -discs 
Figure 4.15. Z-disc abnormalities in cpb knockdown flies. TEM images and anti-
kettin immunostaining of whole muscle from UAS-dsRNAi[cpb]/+; dmej2-GAL41+ flies 
showing (A) splitting Z-discs, (B) Wider Z-discs, (C) sarcoplasmic aggregates. White 
arrow-heads indicate splitting Z-discs. Black arrowheads indicate parallel Z-lines in the 
Z-disc aggregate and red asterisks indicate missing sarcomere filaments . Scale bar for 
immunofluorescence images: 3 /lm and for EM images: 2 /lm. 
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The myofibrils of the IFM have an extended modified terminal Z-disc (Figure 4.16). In 
wild type early pupal muscles, which detach easily from the cuticle these are seen with 
anti-kettin antibody as bright ends (Zacharias Orfanos, personal communication). In the 
wild type adult muscle fibres the terminal Z-discs cannot b seen by 
immunofluorescence following microdissection of the fibre from the thorax. This is due 
to the terminal Z-discs remaining strongly attached to the cuticle. Hence any attempt to 
detach the muscle fibres from the cuticl results in breaking of the fibre leaving the 
terminal Z-discs still attached to it. However in flies with reduced level of cpb it 
appears that during microdissection the muscle fibre can be easily separated from the 
cuticle and the terminal Z-discs remain bound to the myofibril (Figure 4.17 arrow). This 
shows that reduction in cpb affects attachment of the terminal Z-d iscs to the cuticle. The 
modified terminal Z-discs of myofibrils are connected to the myotendinous junction 
(Figure 4.16) (Danowski et al. , 1992' Pardo et al. 1983; Hudson et al. 2008). In the 
cpb knockdown flies the interaction between the modified terminal Z-disc and proteins 
of myotendinous junction may be affected resulting in weaker attachment of the 
terminal Z-discs to the cuticle. 
Figure 4.16. Image of the terminal Z-di cs of myofibrils attached to the cuticle. 
picture reproduced from Prof. parrow' s original. 
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Figure 4.17. Image of the terminal Z-discs of single myofibrils from a whole fibre. 
Anti-kettin immunostaining of whole muscle from UH3-GAL41+; UAS-dsRNAi[cpb]/+ 
flies. The terminal Z-discs are the green circles and the green lines are the sarcomere Z-
discs. Scale bar: 10 )..tm. 
TEM analysis of the UAS-GFP-Act88FVI63L flies driven with UH3-GAL4 showed 
similar Z-disc defects as those observed in the cpb knockdown flies. These include 
splitting Z-discs and wider Z-discs that show the zebra body pattern (Figure 4.18 A, B 
white asterisk) with some surrounding the rnyofibrils (Figure 4.18 B top left image). 
Large zebra body structures often as long as a sarcomere were found in the sarcoplasm 
(Figure 4.18 C, right). Electron dense structures resembling the sarcoplasmic aggregates 
of the cpb knockdown flies were also seen (Figure 4.18 C, left). A stripy pattern is 
observed in areas of the aggregates, suggesting that these may possibly be zebra body 
structures. The Z-disc defects observed in the UAS-GFP-Act88FVI63L flies coincide with 
splitting of the myofibrils (Figure 4.18 A, B red asterisk) as seen in the cpb knockdown 
flies. 
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B.Wider Z-discs 
500 nm 
C. Zebra bodies 
. l·t·· TT AS GF VJ63L Figure 4.18. Z-dISC ab~orma I le~ ID v~ - 'P-Act88F flies. TEM images 
showing (A) splitting Z-dlSCS, (B) wIder Z-dISCS, (C) zebra bodies. White arrow-heads 
indicate splitting Z-discs. White asterisk indicates parallel Z-lines in the Z-disc 
aggregates and red asterisks indicate splitting of myofibrils. Scale bars are indicated. 
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4.7 Hypercontraction in the IFM 
Hypercontraction (HC) is a condition in which the muscles initially form normally but 
then show excessive contraction (Nongthomba et al., 2003). This causes the muscles to 
rip themselves apart and for material to gather at the centre or at either attachment site 
on the thorax. Some mutations in the Drosophila muscle genes for actin (An and 
Mogami, 1996), flightin (Reedy et al., 2000), myosin (Kronert et al., 1995), troponin I 
(Nongthomba et al., 2003) and troponin T (Beall and Fyrberg, 1991) are known to result 
in a phenotype characterized by wings in an elevated position and HC of the IFM. 
The recessive troponin missense mutations of the TnI and TnT genes are called heldup2 
(hdp2) and upheliOJ (upJOJ), respectively (Fyrberg et al., 1990; BeaU and Fyrberg, 1991; 
Prado et al., 1995; Nongthomba et al., 2003). The IFM of these mutants develop 
normally but then when they begin to twitch at 78 hours APF signs of degeneration are 
observed. The IFM of the adult flies show HC followed by muscle destruction. These 
observations have suggested that it is the activation ofthe muscle that leads to HC. 
When the muscle is in the resting state, tropomyosin lies across the thin filament and 
blocks the myosin binding sites on actin (OFF state) thereby inhibiting actin-myosin 
interactions. An increase in Ca2+ intracellular levels induces a conformational change in 
the tropomyosinltroponin complex relative to the thin filament (OFF state) thereby 
exposing the myosin binding sites and initiating force generation. EM reconstructions 
have shown that hdp2 acts to hold tropomyosin away from the blocked state, which is 
independent of calcium (Cammarato et al., 2004). Based on these observations it has 
been speculated that the hdp2 and upJOJ mutations act to hold tropomyosin in the 
activated state and thus the muscle stays permanently activated. Mutations in residues of 
the Act88F gene exist that suppress the HC phenotype and that are located where 
tropomyosin would lie on the F-actin surface when the muscle is activated. Three of 
. 8·....E57K A 88·....E93K d A 88,rJ?254H) these mutations (Act8 r , et r an et r suppress the HC phenotype 
of both the hdp2 and upJOJ mutants. The Act88p334Q mutant was found to suppress only 
the phenotype of the hdp2 mutant (Sarah Haigh PhD thesis, 2003, University of York, 
unpublished data). Amongst these mutants, Act88~57K is able to restore also flight. The 
CFTD-causing actin residue D292 is also located in the tropomyosin binding area of 
actin. Hence the Act88~292V could potentially act as a suppressor of the hdp2 and upJOJ 
mutants. 
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4.7.1 A ct88pD191 V is a suppressor of the hdp1 and UplOl phenotype 
In vitro motility studies using 50% wild type and 50% D292V mutant actin extracted 
from patient biopsies provide strong evidence that the D292V mutation causes a 
functional abnonnality of the actin-myosin contractile unit by altering tropomyosin 
dynamics (Clarke et al., 2007). The authors found that addition of tropomyosin 
abolished motility in the presence of the troponin complex and high Ca2+ 
concentrations. Residue D292 is located on the surface of the F-actin structure (Figure 
4.19 A arrow). In the presence of high Ca2+ concentrations (,ON state') the predicted 
location of tropomyosin is to the left of residue D292 (Figure 4.19 B, C). In low Ca2+ 
concentrations ('OFF' state) tropomyosin is predicted to be in contact with residue 
D292 (Figure 4.19 C). The authors proposed that the D292V mutation obstructs 
actomyosin interactions by stabilizing tropomyosin in the 'OFF' state, which would 
result in a hypocontractile phenotype. 
In the Act88pJJ292V/+ heterozygote flies different combinations of wild type and mutant 
actin on the thin filament would cause tropomyosin shifting to be more difficult or not 
take place where mutant actin predominates, thereby blocking muscle contraction. This 
could result in some areas of the thin filament being able to contract and others not 
resulting in muscle damage. 
To test whether the D292V mutation results in a hypocontractile phenotype, Act88pDZ9ZV 
homozygous flies were crossed to the troponin I hdpz as well as troponin T upJOJ flies to 
see if the Act88pJJZ9ZV mutant actin suppresses the hypercontractile phenotype of those 
mutants. In the progeny male flies that were hemizygous for either one of the troponin 
mutations and heterozygous for the actin mutation were flight-tested and were found to 
be flighted (Figure 4.20). Therefore the Act88pDZ9ZV actin mutant, which is predicted to 
inactivate muscle contraction, can act as a suppressor of the troponin mutations that lead 
to constant muscle activation. The fact that the D292V mutation leads to inactivation of 
muscle contraction also explains why the IFM of Act88pJJ29ZV homozygotes do not show 
any structural defects. In these flies the IFM are composed solely of ACT88FD292v actin, 
which means that contraction cannot take place at any part of the myofibril. This is in 
contrast to the heterozygote mutants, which consist of a mixture of wild type and mutant 
actin leading to muscle contraction in some parts of the myofibril and not in others. 
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Figure 4.19. Location of D292V mutation in the F-actin structure and its relation 
to tropomyosin. CA) D292V is shown in white, each actin monomer is colored 
differently. The position of tropomyosin (white double helix) is shown in the high Ca2+ 
state (B) and in the low Ca2+ state (C). Picture adapted from Clarke et al. , 2007. 
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Figure 4.20. Suppressing of the /tdp2 and u/OJ mutations. Flight-testing for wi ld-type 
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KM88/+ (n = 31) flies. Where On' is the number of flies tested. 
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4.8 Discussion 
4.8.1 When do the intranuclear rods appear? 
Developmental analysis of intranuclear rod-linked heterozygous actin mutants showed 
that the intranuclear rods fonn by 70 hours APF. There can be many explanations as to 
why the intranuclear rods do not appear earlier, by 60 hours APF. One reason is that the 
actin levels inside the nucleus are not high enough at earlier stages to induce actin 
polymerization and rod fonnation. Fyrberg et ai, 1983 have reported that expression of 
ACT88F begins at early pupal stages but becomes more strongly expressed at mid and 
late pupal stages (Fyrberg et al., 1983). IFM myofibrillogenesis starts at around 40-42 
hours APF (Reedy and Beall, 1993b), which is also when the ACT88F expression levels 
peak (Fyrberg et al., 1983). Hence 60 hours APF is perhaps too early to observe the 
intranuclear rods as the myofibrillogenesis has proceeded for only 12 hours. 
Furthermore if in the 60 hour old Act88FVJ63L/+ heterozygous pupae the Z-disc 
formation is disrupted, actin polymerization at the barbed end and sarcomere growth 
could be affected which could result in accumulation of actin in the cytoplasm. Z-discs 
may act as scaffolds for sarcomere development. Mutations in actin causing improper 
Z-disc assembly may contribute to the increase in levels of G-actin in the fibres. 
Inability of free mutant actin to incorporate in the sarcomere could force the cell to 
initiate the transport and confinement of actin inside the nucleus. 
4.8.2 How do the intranuclear rods appear? 
Actin itself is exported out of the nucleus through the CRMl exporter (Wada et al., 
1998) and through Exp6, as a profilin-actin complex (Stiiven et al., 2003). Drosophila 
mutants for Exp6 exist, though they are recessive lethal and as homozygotes die before 
the pupal stage due to accumulation of the profilin-actin complex in the nucleus 
(Perrimon et al., 1989). 
Indeed actin cycling in the nucleus may even help to regulate actin levels (Miralles et 
al., 2003). The presence of actin rods in the nucleus suggests that the D154N, V163LIM 
mutations interfere with its export from the nucleus, and this effect should be strongest 
for V163L where the intranuclear rods were most common. The position of these 
substitutions is in the region of the monomer towards the barbed end, where profilin is 
known to bind. Therefore it is possible that fonnation of the profilin-actin complex in 
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the nucleus is affected, and hence exportin is unable to transport actin out of the 
nucleus. In yeast cells deficient for profilin or carrying a single point profilin mutation, 
thick actin bars are detected which may have formed as a result of improper regulation 
of actin assembly (Haarer et al., 1990; 1996). 
In the actin structure the nucleotide (ATP or ADP) is bound between subdomains 3 and 
4 (Kabsch et al., 1990). In the 'tight-state' of the actin-profilin crystals (Schutt et al., 
1993), the nucleotide ~-phosphate forms H-bonds to the amide nitrogens of S14, G15 
and MI6 in one of the actin loops and to D157 in the other actin loop. The 'Y-phosphate 
of the nucleotide is bound to S14, D157, G158 and V159. As the G-actin interdomain 
contact is established via the nucleotide-binding site (Fried en et al., 1980; Frieden et al., 
1985; Crosbie et al., 1994; Muhlrad et al., 1994; Strzelecka-Golaszewska et al., 1995) 
mutations in the nucleotide-binding cleft could influence binding to profilin. Based on 
these observations it could be speculated that mutations in the actin residue D154 may 
affect binding to profilin and inability to export actin from the nucleus. In yeast the 
double actin mutation D154A1D157A is lethal (Wertman et al., 1992). 
Actin contains two nuclear export signals (NESs) that are recognized by the export 
factor CRMlIexportinl (Kudo et al., 1998). The IR-linked actin residues are near one of 
the two NESs on actin, hence the mutations may be affecting processes involving the 
NESs resulting in actin detainment inside the nucleus. In addition the inability to export 
actin from the nucleus might also be coupled with abnormally increased levels of F-
actin entering the nucleus. If the mutant actins are less stable in filaments, free G-actin 
may have a higher probability of entering the nucleus. Hence, if levels of G-actin 
become high in the nucleus, then it could polymerize and form the observed actin rods. 
In support of this hypothesis developmental analysis of the IR-linked mutants showed 
that the mutant actin is affecting Z-disc and sarcomere assembly before the IRs start to 
appear. Lastly and importantly the fact that the intranuclear rods appear before the 
muscle is fully formed suggests that they may also appear in human patients before the 
end of gestation. 
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4.8.3 Are both wild-type and mutant actins present inside the intranuclear rods? 
It is not yet known whether the human intranuclear rods contain solely mutant actin or a 
combination of wild type and mutant actin. Previous studies in a mouse myoblast 
culture system have demonstrated that the V163LIM ACTAl mutants are capable of 
forming actin aggregates inside the nucleus (Domazetovska et al., 2007a;b). Drosophila 
IFM mutants heterozygous for the Act88FVI63L mutation show the intranuclear rod 
phenotype thus offering the advantage of having an intact animal system, which 
expresses both wild type and mutant actins. Here it was possible to examine which one 
of the two actin species is located inside the intranuclear actin rods by fusing GFP to 
each one of them. Analysis of flies expressing one wild type GFP-Act88F and one 
Act88FV63L copy did not show co-localisation of the GFP with the intranuclear rods 
suggesting that these structures do not contain any wild type actin. However the GFP-
Act88Fv63L/+ heterozygous mutant showed co-localisation of the GFP within the 
intranuclear rods suggesting that the intranuclear actin rods consist of mutant actin. 
Furthermore an unexpected result was that the sarcoplasmic rods also contained solely 
mutant actin as the wild type GFP-fused actin was excluded from these aggregates. This 
further highlights the advantage of studying the disease in an intact animal system as it 
has allowed the identification of the actin species found in IRs. 
4.8.4 Barbed end actin capping is affected in the intranuclear rod-linked mutants 
Capping protein prevents polymerization or depolymerisation ofthe thin filaments from 
the barbed end. The protein is a heterodimer of subunits a and p each of which is 
composed of a base and a flexible tentacle, which binds directly the actin mono mer 
(Narita et al., 2006). The CPa and CPb subunits bind to distinct regions of the terminal 
actin protomers at the barbed end (Narita et al., 2006). The actin D154 and V163 
residues reside near the proposed binding site for the p-tentacle of CP. Thus mutations 
in these residues could affect binding of the p-tentacle of CP at the fast growing end of 
the thin filaments resulting in aberrant Z-disc structures and actin aggregates. 
To test this hypothesis cpb was knocked down using the dsRNAi[ cpb] line and two 
different GAL4 drivers, an IFM-specific (UH3-GAL4) and a pan muscle (dmefl-GAL4) 
driver. Using both drivers the result was actin aggregates, enlarged Z-discs and Z-ring 
structures stained with anti-kettin and phalloidin like the ones seen in whole muscle 
immunostaining of the intranuclear rod-linked mutants. This suggests that a failure or 
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reduced ability to cap the actin barbed ends resulting in continuous addition of actin 
monomers at the Z-disc, alters the Z-disc structure and results in actin aggregates. 
Failure to cap the thin filament barbed ends could be a major underlying cause of 
nemaline bodies observed in human patients. 
4.8.5 Act88~292V can act as a suppressor for the HC phenotype 
Suppressor mutations can also help to understand the aetiology of some nemaline 
phenotypes. In the 'OFF' state tropomyosin lies across the actin filament on the 
proposed myosin binding site and inhibits actomyosin interactions. The residue D292 
forms part of the tropomyosin binding site and it has been suggested that the D292V 
mutation might obstruct actomyosin interactions by stabilizing tropomyosin in the 
'OFF' state (Clarke et al., 2007). Here the hypercontractile phenotypes of the TnI and 
TnT mutants were suppressed by introducing the Act88FJ292V mutant actin, supporting 
the idea that the D292V mutation obstructs actomyosin interactions and prevents muscle 
contraction. This highlights the advantage of adopting an intact animal system where 
genetic approaches can be applied to understand how a mutation can disrupt muscle 
function. 
Finally, eight ACTAl mutations (E4K, G46D, E205D, L221P, E241K, D292V, P307S 
and P332S) are known to result in CFTD in humans (Laing et al., 2009). The eight 
residues mutated in CFTD patients are all located close to tropomyosin-binding sites on 
actin in both the high (ON) and low-Ca2+ states (OFF) (Figure 4.21). Therefore it can be 
speculated that the CFTD mutations share a common disease mechanism whereby the 
tropomyosin sliding is disrupted, resulting in inability to regulate actomyosin 
interactions. Although the eight CFTD mutations may obstruct actomyosin interactions 
there are other ACTAl mutations that are also predicted to perturb actin/tropomyosin 
interactions and do not cause CFTD (Sparrow et al., 2003). Therefore disruption of 
actin/tropomyosin interactions cannot be the sole aetiology for CFTD and other factors 
must be involved. 
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Figure 4.21. Position of the eight CFTD-Iinked ACTA! mutation . Cartoon of 
G-actin complexed with A TP (red), the residues which are mutated in CFTD are shown 
in green. The green box indicates where tropomyosin lies on actin when in the ' 0 ' 
state and the red box the position of tropomyosin on actin when in the ' OFF' state. 
Image created using Pymol. 
4.8.6 Summary 
Different genetic approaches were used to further understand the aetiology of the severe 
Drosophila mutations D154N and V163LIM. It was fOlmd that the intranuclear and 
sarcoplasmic rods appear during muscle development. Fusing GFP to both wild type 
and mutant actin, showed that the mutant actin is present in both intranucl ar and 
sarcoplasmic rods, whereas wild type actin was excluded from these structures. Knock 
down of the cpb mRNA produced the same Z-disc abnormalities a seen in the 
intranuclear rod-linked mutants, suggesting insufficient capping of actin by cpb may be 
the cause of sarcoplasmic rods. The D292V mutation was believed to cause 
hypercontraction. This was confirmed by suppressing two known hypercontractile 
mutants of the Tn] and TnT genes. In the next chapter the nemaline myopathy mutation, 
R372H, was used to study the development of the nemaline phenotype. 
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Chapter 5: The Act88y372H mutation: a progressive 
nemaline myopathy model. 
5.1 Aims 
Use of the Act88r372H mutant to investigate the progression of the Drosophila 
equivalent of the nemaline phenotype by examining the sarcomere ultrastructure and 
determine the effect of the ACT88FR372H mutant actin. 
5.2 Introduction 
Initial studies (Sarah Haigh, PhD thesis, 2003, University of York) showed that 
genomic mutations in the IFM-specific Act88F gene at specific residues associated in 
humans with NM (Figure 5.1) cause phenotypes comparable to those seen in human 
skeletal muscle myopathy such as formation of structures resembling nemaline rods, 
variable sarcomere lengths as well as aberrant thin filament assembly. In particular four 
ACT88F Drosophila (A138V, R256C, G268D, R372H) mutations corresponding to six 
ACTA1 nemaline mutations (A138P, R256H1L, G268RJC, R372H) (Figure 5.1) result in 
similar phenotypes to those seen in human biopsies. As homozygotes, three of these 
Act88F mutants (A138V, R256C, G268D) do not form sarcomeres during early 
myogenesis and show the zebra body phenotype (Figure 5.2 B, C). The flies also exhibit 
muscle disarray (Figure 5.3 C, D, E, F) and as heterozygotes they were flightless. The 
Act88r372H mutant displayed normal myogenesis and the pupae show normal 
myofibrils (Figure 5.2 D). However, as heterozygotes the flies that emerged could fly at 
first but became flightless as time progressed and developed the nemaline phenotype 
(Figure 5.3 G, H). 
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Figure 5.1. The position of the four Drosophila Act88F mutations in actin. Cartoon 
of the ATP-bound G-actin showing in space-fill the position of the four Drosophila 
Act88F mutations which correspond to the six human nemaline mutations (in 
parenthesis). The positions of A138V, R256C, G268D and R372H are shown in blue, 
purple, yellow and red, respectively. The ATP is shown as sticks. Image produced using 
pymol. 
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Wild-type 
R256C R372H 
Figure 5.2. TEM images of (A) wild-type, (B) Act88pG268D, (C) Act88p-R256C and (D) 
Act88r372H 44 hours old pupae. White arrows point at zebra bodies. M: M-line, Z: Z-
line. Scale bar: 250 nm. Taken from Sarah Haigh, PhD thesis, 2003. 
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Figure 5.3. TEM images of (A), ~) wild-type; (C), (D) Act88pG268D; (E), (F) 
Act88r256C and (G), (H) Act88r372 adult flies. The panels on the left are transverse 
sections and on the right longitudinal sections. White arrows point at zebra bodies, 
white arroW heads point at disorganised filaments. M: M-line, Z: Z-line, Myo: 
myofibril, Mt: mitochondrion. Scale bar: 1 j.lm. Taken from Sarah Haigh PhD thesis, 
Z003. 
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5.3 The Act88pR372H/+ heterozygotes lose their flight ability 
The transgenic line with the genomic Act88[1l372H mutation used for EM analysis shown 
in Figures 5.2 and 5.3 was lost. However we were in possession of a line carrying a P-
element insert for Act88[1l372H, which was located in the third chromosome. When 
studying Act88F mutants it is important that the P-element insert carrying the mutant 
Act88F gene is not in the third chromosome but instead is located on the first or second 
chromosome. The reason for this is that the wild type actin gene as well as the ACT88F 
null mutation (Act88rM88) also reside in the third chromosome. In order to study the 
Act88F mutants in a homozygous state or be able to extract mutant actin for 
biochemical experiments the wild type actin gene must not be present. Since the P-
element insert containing Act88[1l372H is located in the third chromosome it was not 
possible (except by recombination) to eliminate the wild type Act88F copy. It was 
therefore easier to create a transgenic line that would allow to control the number of the 
Act88[1l372H mutant and wild type Act88F gene copies. The objective was to 'hop' the 
Act88[1l372H transgene to the first or second chromosome. This was achieved by 
crossing the Act88[1l372H mutant line to an active transposase coding line (Ll2-3) 
(Chapter 2, section 2.1.4). 
This generated 33 lines carrying a single copy of the Act88£,?372H mutation in the first or 
'second chromosome. Amongst those lines, the ones where the inserts generated good 
expression of the Act88y372H gene were selected for further study. The Act88[1l372H/+ 
heterozygous flies from different lines were flight-tested at 1- and 7- days post eclosion 
and were compared to the wild type (Figure 5.4). At day 1 the flight ability varied for 
different lines and at day 7 most lines were flightless. However, there were some lines 
that were still flighted at day 7 (data not shown), which suggested that the muscle 
structure was not severely affected by the mutation. Therefore these lines were not 
studied further. As the aim of this chapter was to use the R372H mutant to follow the 
disease progress, a line with an initial normal muscle structure (identified by being 
flighted at day 1), which deteriorates (tested by being flightless at a later time point) was 
needed. Line 16 gave the best flight ability at day 1 and the flies were flightless after 7 
days and therefore it was selected for further analysis. 
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Figure 5.4. Flight index for wild type and lines of Act88r372H/+ heterozygous flies. 
1- and 7 -days old wild type and Act88V372H/+ heterozygous flies were flight-tested. . 
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5.4 Electron micrographs show progressive deterioration of sarcomere 
structure 
The IFM of wild type (Figure 5.5), heterozygous and homozygous Act88F372H flies at 
different stages were examined using electron microscopy to closely follow a change in 
sarcomere structure. Transverse and longitudinal sections of the heterozygous mutants 
were obtained at days 1, 3, 5 and 7 after eclosion. In longitudinal sections of the I-day 
old mutant (Figure 5.6 A, B) the sarcomeres appear normal with clear M-lines and Z-
discs. Transverse sections show normal packing of thin and thick filaments within the 
myofibrillar lattice (Figure 5.6 C). At day 3 longitudinal sections show loss of the M-
lines and splitting of the myofibrils is observed (Figure 5.6 A, B). In the transverse 
sections at day 3 myofibre diameter begins to vary and gaps begin to appear 
(Figure 5.6 C arrow). At day 5 the Z-lines are damaged greatly and the M-lines are no 
longer visible. The sarcomere is disorganised and some zebra bodies have developed 
(Figure 5.7 B arrow-head). Myofibril branching is also observed (result not shown). 
Transverse sections at day 5 (Figure 5.7 C) show that the myofibrils are not as tightly 
packed as those of 1-day-old flies, and display gaps. The sarcomeres of 7 -day-old flies 
appear more disorganized with large zebra bodies forming between them that are found 
more frequently in the muscles than in 5-day old flies (Figure 5.7 A arrow-head). In 
addition to the lack of visible M-lines already observed at 5-day old flies, the Z-discs 
are also difficult to discern. These observations show that there is progressive 
sarcomeric damage explaining why on day 1 the mutants can fly but become flightless 
by day 7. 
1~ 1~ 
Figure 5.5. TEM images of longitudinal and transverse sections from wild type 
flies. 
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Day 1 Day 3 
B 
c 
..,.R37'H Figure 5.6. TEM of 1- and 3-day old Act88r - 1+ heterozygotes. (A) LS 
magnification at 8.200, (B) LS magnification at 4.200, (C) TS magnification at 11.500. 
Arrows indicate myofibril fraying in B and gaps in C. M : M-line. 
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Figure 5.7. TEM of 5- and 7-day old Act88r37ZH/+ heterozygotes. (A) LS 
magnification at 8.200, (B) Ls magnification at 4.200, (C) TS magnification at 11 .S00. 
Arrowheads point at zebra bodies. 
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Moreover measurement of sarcomere length in wild type and mutants from electron 
micrographs revealed very large variations in mutant sarcomere length with age. The 
sarcomere length of l-day-old Act88f"'l372H/+ heterozygous flies is similar to that of the 
wild type flies. However as the mutants become older the standard deviation of their 
sarcomere length increases with time and is greater than that of the wild type flies 
(Figure 5.8). 
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Figure 5.8. Sarcomere length of wild type and Act88pR372H/+ heterozygotes. The 
sarcomere lengths from 3 day old wild type flies and 1-, 3-, 5- and 7-day-old mutants 
were measured from EM images, the standard deviation is shown as error bars. 
When Act88f"'l372H homozygous mutants were examined already on day 1 there is 
muscle disarray with zebra bodies extending from the Z-discs (Figure 5.9 A arrow-
head). Overall the sarcomeres appear damaged, no discernible M-lines, the Z-discs 
appear damaged and broken (Figure 5.9 B arrows) and there are filaments gaps 
(Figure 5.9 B). In transverse sections large empty patches are seen inside the 
myofibrils (Figure 5.9 C arrow). By day 3 large electron dense bodies start to appear 
(Figure 5.9 A arrow-head). No sarcomeric structure is present and the fibre is filled 
with broken filaments . Many more large empty gaps are seen inside the myofibrils in 
transverse sections (Figure 5.9 C arrows) . Hence in the absence of a wild type actin 
copy the Act88f"'l372H homozygotes already show muscle disarray from day 1 with 
progressive muscle damage to the point of no obvious sarcomeric structure being 
present by day 3. 
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Figure 5.9. TEM of 1- and 3-day old Act88pR372H homozygotes. (A) LS 
magnification at 8.200, (B) Ls magnification at 4.200, (C) TS magnification at 11.500. 
Arrowheads point at zebra bodies and electron dense bodies. Arrows indicate damaged 
Z-discs in B and gaps in C. Arrowheads indicate zebra and electron dense bodies. 
M: M-line 
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5.5 Is muscle degradation in the Act88pR371H mutant use-dependant? 
The Act88V372H mutants initially form normal sarcomeres but as the flies grow older 
their muscle structure progressively deteriorates. This observation raised the notion as to 
whether the sarcomeric disarray is not only due to the mutation but also because the 
muscles are being used. This hypothesis can be explored if the flies are prevented from 
contracting their flight muscles. In order to achieve this the wings of newly emerged 
flies were clipped and flies were confined in a Petri dish filled with normal fly food 
leaving enough space for the flies to walk but not to jump or fly (Figure 5.10 C). This 
was performed for heterozygous and homozygous mutants as well as wild type control 
flies. The flies were aged under these conditions and collected at different time points to 
be analysed by confocal microscopy. Heterozygous mutants without clipped wings were 
also aged in a standard culture vial as a control. Figure 5.10 demonstrates that 
suppression of the muscle degradation in Act88V372H/+ heterozygous flies occurs only 
when the wings are clipped. Their myofibrils are similar to the wild type control and 
remain like this even after 10 days. Actin is arranged in thin filaments as suggested by 
the phalloidin staining and the Z-lines are properly aligned as shown by the staining 
with an antibody against the Z-disc protein zetalin. In comparison the myofibrils of 
Act88V372H/+ heterozygous mutants kept in the vial without clipped wings that were 
allowed to use their flight muscles show no thin filament staining and aberrant Z-lines 
as they get older. This result suggests that the progressive muscle damage observed in 
the Act88V372H/+ heterozygous mutants is due to the fact that the muscles are being 
used. The R372H mutation weakens the sarcomeres which upon contraction are unable 
to sustain their structure and become damaged. 
When Act88V372H homozygotes confined in the Petri dish were collected at later stages 
their muscles broke during dissections and no myofibril separation was possible. There 
is no phalloidin staining suggesting the integrity of the thin filaments has been 
compromised (Figure 5.10). Therefore in the case of the homozygotes where muscle 
damage has already begun at I-day old flies as shown by EM (Figure 3.8), clipping their 
wings cannot prevent further muscle degradation. 
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Figure 5.10. Light microscopy of myofihrils stained for actin and immunostained 
for zetalin. Myofibrils isolated from (A) wild type fly kept in standard vial, 
Act88r372HI+ heterozygote fly with clipped wings confined in petri plate (at different 
time points), and at the right end Act88F'd 72HI+ heterozygote fly without clipped wings 
grown in a standard vial. (B) Single myofi~rils £r:om wild tYP~ flies with clipped wings 
at different time e0ints. (C) Cartoon shOWIng flies confined In a fly food-filled Petri-
plate. (D) Act88r372H homozygotes: at the top is a. myo?bril.from ne~ly emerged flies 
and at the bottom whole muscle from 5-day-old flies WIth clIpped wmgs confined in a 
petri plate. Anti-zetalin antibody and TRITC-phalloidin were used. Scale bars are 
indicated. 
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5.6 Act88pR372H homozygotes display a bypercontraction phenotype 
Polarized light images show flight muscles of Act88V372H/+ heterozygous mutants 
appear like wild type, but the flight muscles of homozygote mutants seem to be 
detached from one end of the semi-thorax (Figure 5.11). This is reminiscent of the 
hypercontraction phenotype seen in myosin (Kronert et al., 1995), troponin I and 
troponin T mutants where the muscles are detached from one or both ends of the thorax 
or break in the middle (Beall and Fyrberg, 1991; Prado et aI., 1995; Nongthomba et al., 
2003). In electron microscopy images of other hypercontraction mutants the myofibrils 
are completely destroyed and show fields of disordered thick and thin filaments 
(Nongthomba et aI., 2003). Hypercontraction appears in muscles that have developed 
normally suggesting that it occurs due to the forces produced from actomyosin 
interactions in response to aberrant regulation of contraction or when the sarcomere 
structure is weak. Under these conditions the force exerted by the myosin head is too 
strong leading to detachment of the muscles from the cuticle. Therefore the Act88F3 72H 
homozygotes initially must form normal sarcomeres but because their structure is 
compromised they cannot wi.thstand muscle contraction, eventually leading to 
degradation of the myofibrillar lattice and sarcomeric structure. 
ActlJlJP"IJt/+ 
Figure 5.11. Polarized light microscopy of Drosophila semi-thoraces. The IFM of 
the Act88rJ 72H/+ heterozygotes appear normal, however in the Act88F372H 
homozygote the muscles have detached from one end of the cuticle (arrow) . 
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5.7 Mechanical properties of the Act88pR372H1+ sarcomere. 
The Act88y372H/+ heterozygote mutants can fly initially but become flightless over 
time and display progressive myofibril disarray as shown by TEM images. When the 
wings of newly emerged Act88y 372H/+ mutants were clipped and the flies were 
confined in petri plates so as to prevent them from using their flight muscles, the 
myofibrils did not display any structural damage over time. This would suggest that the 
muscles become damaged only when they are being used. An explanation why this 
could happen is that the muscles are mechanically compromised and gradually become 
damaged upon contraction and lose their structure. In order to pursue this hypothesis 
single myofibril mechanics were performed in order to measure the passive force 
produced from wild type and Act88r372H/+ heterozygote myofibrils. Single myofibrils 
are the smallest structures of muscle cells that maintain the complete contractile 
machinery. These features make them the optimal specimen for muscle mechanics. 
The number of thick filaments from wild type and newly emerged Act88y372H/+ 
heterozygote myofibrils was measured from transverse TEM images before performing 
the myofibril mechanics. This was done to ensure that the force signal produced from 
each genotype was generated from a similar group of thick and thin filaments per 
myofibril. From 6-8 myofibrils, it was found that the number of thick filaments varied 
between 900 and 1200 among flies for each genotype (Table 5.1). Although the mean 
and variance within the myofibrils of the same fly do not vary significantly, there is a 
large variation between flies. This is an unexplained developmental phenomenon 
always observed in Drosophila IFM (Prof. Sparrow, personal communication). 
As there was no significant difference between the number of thick filaments in the wild 
type and mutant myofibrils, single myofibril force measurements were performed at the 
University of Cologne, in Germany, in collaboration with Prof. Pfitzer's laboratory. The 
apparatus used for the experiments involves attaching single myofibrils to a length-
driving tungsten stiff needle at one end and to the coated tip of an atomic force 
cantilever (AFC) at the other end (Figure 5.12); upon stretching of the myofibril with 
the length-driving needle the force can be recorded. Throughout these experiments 
Dr. Bogdan Iorga operated the apparatus and analyzed the force transients obtained and 
produced Figures 5.13, 5.14 and 5.15, which are presented in this chapter. 
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Table 5.1. Number of thick filaments present in the myofibrils of newly emerged 
wild type and Act88r37lH/+ heterozygous flies. The number of thick filaments from 
6-8 myofibrils was measured for each fly. 
Genotype Fly Number of thick fllaments 
1 1103 ± 14 
2 900 ± 33 
Wild type 3 1239 ± 25 
4 945 ± 19 
5 977 ± 17 
1060 ± 44 
2 1021 ± 11 
Act88r372H/+ 3 925 ± 22 
4 904 ± 13 
5 920 ± 38 
Figure 5.12. Brightfield image of a single mounted myofibril. Single IFM myofibril 
attached to length-driving tungsten stiff needle on the left and to the tip of an AFC on 
the right. 
The passive force was recorded in successive stretch protocols applied to fully relaxed 
single myofibrils (Chapter 2 section 2.5.2). Briefly, single myofibrils were extended 
step-wise to 2% - 4%, 3% - 6% and 4% - 8% of their slack sarcomere length (SL) 
(Figure 5.13 A), and at each stage the force was measured. Stretching protocols higher 
than 8% were not carried out, as they would cause the myofibrils to break. 
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For a single applied sequential stretching protocol (2% - 4%), the passive force 
responsiveness of mutant myofibrils was significantly reduced (p < 0.01) when 
compared with that of wild-type myofibrils at a given applied stretch 
(mean ± SEM, n = 3): at 2 % applied stretch, Fp = 17.7 ± 0.4 kPa for Act88~372H and 
Fp = 31.6 ± 2.9 kPa for wild-type myofibrils; at 4% applied stretch, Fp = 31.7 ± 2.7 kPa 
for Act88~372H and Fp = 51.3 ± 2.5 kPa for wild-type myofibrils (Figure 5.13 B, C). 
Moreover during the applied stretch ramp to the 6 % level, the mutant myofibril has 
broken (Figure 5.13 B, grey trace of the force transient). The same event happened with 
the wild-type myofibril but upon a greater applied stretch, i.e., during the ramp to the 8 
% level (Figure 5.13 C, light grey trace of the force transient) and the passive force 
responsiveness upon the corresponding stretch was reduced (Figures 5.13 B and C). 
Corresponding video files are shown in Table 5.2. The fact that less force is required to 
stretch the mutant myofibrils compared to the wild type ones and that the mutant 
myofibril brakes during the 8% stretch ramp, suggested that their structure is much 
weaker. 
Video analysis of the myofibrils discussed in Figure 5.13 B and C showed that the 
observed sarcomeric stretch upon identical applied stretch is larger for mutant 
myofibrils than for wild-type ones and, for both myofibril types, is smaller than the 
applied mechanical perturbation (Figure 5.15 B). At 2 % (p < 0.05) applied stretch the 
observed stretch is 1.158 ± 0.093 % for the wild type and 1.767 ± 0.107 % for the 
mutant myofibril, and at 4 % (p < 0.001) applied stretch the observed stretch is 1.970 ± 
0.036 % for the wild type and 3.175 ± 0.065 % for the mutant myofibril (Figure 5.15 B). 
This disagreement between applied and observed stretch of Drosophila IFM myofibrils 
has been observed by others (Hao et al., 2004). This is due to the glue used to attach the 
myofibril to the length-driving needle and the tip of the AFC is more compliant than the 
myofibril itself, resulting in the glue also being stretched along with the myofibril. The 
consequence of this is that the myofibril becomes less stretched than expected. 
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Figure 5.13. Myofibril force measurements. The force transient for a mutant (B) and 
wild-type (C) myofibril upon applied stretch (A) expressed as percentage of the slack 
length of the entire mounted myofibril. Force is normalized to CSA (kPa). The black 
transient corresponds to the protocol of the successive 2% and 4% applied stretch; the 
dark grey transient corresponds to the protocol of the successive 3% and 6% applied 
stretch; the light grey transient (only for the wild-type myofibril, C) corresponds to the 
protocol of the successive 4% and 8% applied stretch. The duration of each steady 
applied stretch is 4 seconds followed by a ramp of 3 seconds. The mutant myofibril has 
the diameter = 1.4 )..tm (CSA = 1.54 )..tm2) and the initial slack length = 121.0 )..tm (N = 
33 sarcomeres). The wild-type myofibril has the diameter = 1.85)..tm (CS A = 2.69 )..tm2) 
and the initial slack length = 133.2 )..tm (N = 37 sarcomeres). (D) Microphotographs of 
mutant (top) and wild-type (bottom) myofibrils at different moments during the steady 
slack, just before the next ramp or rapid release. The imposed (left) and measured 
(right) stretched lengths are indicated. 
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Table 5.2. Movie files of wild type and Act88pR372H/+ stretched single myofibrils. 
The playing speed of the movies can be accelerated during viewing. The video files are 
named WT for wild type or MUT for mutant, followed by #1 or #2 indicating the 
myofibril number and 0-2-4, 0-3-6 or 0-4-8 which corresponds to the stretch protocol 
applied. In the CD the movies are numbered Movie 1,2,3,4,5,6. in the order they are 
presented in the table 
File name Myofibril Integrity 
WT# 1_ 0-2-4.avi Survived 
WT#I_0-3-6.avi Survived 
WT#I_0-4-8.avi Broken during ramp to 8% 
MUT#1_0-2-4.avi Survived 
MUT# 1_ 0-3-6.avi Broken during ramp to 6% 
MUT#2 _ 0-3-6.avi Broken during ramp to 6% 
Comments 
Applied stretch protocol to 2 % - 4 %, 3 % - 6 % 
and 4 % - 8 % of myofibril slack length (1 pixel = 
160 nm) 
Applied stretch protocol to 2 % - 4 % and 3 % - 6 
% of myofibril slack length (1 pixel = 106.9 nm) 
Applied stretch protocol to 3 % - 6 % of myofibril 
slack length (1 pixel =160 nm) 
In addition, before the same mutant myofibril was subjected to the second stretching 
protocol (3% - 6%), its slack SL was measured as larger than its initial slack (S1.o) by 
1.49 % (indicated by arrow in Figure 5.14), suggesting a remnant structural plastic 
deformation. This was not the case for the wild-type myofibril, which did not show a 
significant plastic deformation before commencing the third stretching protocol (4% -
8%), i.e. only by 0.1 5% and 0.23 % after the first and second applied stretching 
protocol, respectively. Therefore the fact that the mutant myofibril exhibits substantial 
plastic deformation upon stretching supports the idea that it is prone to become 
damaged upon use. Furthermore its estimated stiffness seems to be at least 2.5 - 3 times 
smaller than that of wild-type control for all the applied stretches (Figure 5.14). 
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o WT protocol: 0-2-4% 
C WT protocol: 0-3-6% 
<> WT protocol: 0-4-8% 
• MUT protocol: 0-2-4% 
• MUT protocol: 0-3-6% 
Protocol 
0-2-4 (kPa) 
0-3-6 (kPa) 
0-4-8 (kPa) 
3550 3600 3650 3700 3750 3800 3850 
SL (nm) 
Stiffness for wild type Stiffness for mutant 
0.8014 ± 0.02227 0.2700 ± 0.009593 
0.6342 ± 0.02984 0.2370 
0.4230 Broken during ramp 
Figure 5.14. The passive force responsiveness upon stretch of mutant and wild-type 
myofibrils. Force is nonnalized to CSA (kPa). SL (run) is the observed sarcomere 
length of wild-type (open symbols) and mutant (closed symbols) myofibrils stretched to 
the applied values indicated in percents (%). Circles correspond to the first applied 
protocol (2% - 4%), squares to the second one (3% - 6%) and diamonds to the last 
protocol (4% - 8%) applied to the myofibrils. The arrow indicates the plastic 
deformation observed for the mutant myofibril by 1.49% of its initial slack sarcomere 
length (Sl<». Dashed lines indicate that upon the protocol "4% - 8%" for wild type and 
"3% - 6%" for mutant, myofibrils brake-down during the application of the final ramp. 
Slopes of the best-fit linear regression estimate the stiffness (kPa/run). 
177 
5. The Act88r372H mutation: a progressive nemaline myopathy model. 
Less passive force is required to achieve a higher observed stretch for the mutant 
myofibril compared to the wild type (Figure 5.15 A, B). The estimated stiffness 
acquired for the mutant is similar (Figure 5.15 C), which denotes the linearity of the 
passive force-sarcomere length relationship shown in Figure 5.14. The linearity implies 
that the elastic component predominates in the mutant myofibrils. However, a small 
viscous component cannot be completely neglected, at least for the wild-type myofibril, 
since a peak in the force responsiveness was observed at the end of each ramp of 
stretching before reaching a the steady state. Mutant myofibrils did not display a clear 
peak of passive force even when the ramp of the stretching was faster (transients not 
shown). Overall these results suggest that myofibrils isolated from the IFM of 
Act88rJ71H/+ heterozygotes are mechanically less stiff and more fragile than wild-type 
controls supporting the hypothesis that this mutation has structural consequences on 
myofibrillar filaments. 
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Figure 5.15. Passive force, observed stretch responsiveness and stiffness of wild-
type and mutant . myo~brils. .(A) Passive force and (B) observed stretch 
responsiveness upon Identical apphed stretch (2% and 4% of the slack myofibrillar 
length) for wild-type (white ?ars) and mutant (grey bars) myofibrils are shown. For each 
myofibril, force was normallZed to CSA (kPa). The observed stretch was normalized to 
its slack length, expressed in % and then averaged. (C) Mean ± SEM values for stiffness 
expressed as the passive force induced by 1 % observed stretch of slack myofibrils are 
shown. Significance level between values of n = 3 mutant and wild-type myofibrils: • (p 
< 0.05), •• (p < 0.01), ••• (p < 0.001). 
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5.8 Is the reduced myofibrillar stiffness in the Act88pR372H/+ 
heterozygote mutants a result of weakened F -actin/ a-actinin 
interactions? 
The R372 residue is not known to be in direct contact with other major sarcomeric 
proteins such as tropomyosin, myosin or the troponin complex and it is therefore less 
likely that the R372H mutation will directly affect the actin binding to any of those 
proteins. The reduced stiffuess seen in the myofibrils of Act88pJ?372H/+ heterozygous 
mutants compared to the wild type ones could be due to a weakened interaction of actin 
with a binding partner situated in the Z-disc. a-Actinin is a Z-disc protein involved in 
cross-linking the actin thin filaments within the Z-disc (Saide et al., 1989; Lakey et al., 
1990). The binding constant of actin for a-actinin has been measured to be 2.1JlM (van 
Straaten et al .• 1999). a-Actinin exists as an anti-parallel homodimer with the actin 
binding domains at opposite ends of the homodimer (Djinovic-Carugo et al., 1999, 
Tang et al., 2001). Actin thin filaments of adjacent sarcomeres overlap and terminate 
within the Z-disc where they are linked by transversely oriented a-actinin molecules 
that form ladder-like structures within the thin filaments (Figure 5.16 B) (Meyer and 
Aebi., 1990; Vigoreaux, 1994). Cryo-EM reconstructions of a-actinin decorated F-actin 
(McGough et al., 1994) and biochemical data (Mimura and Asano, 1987; Lebart et al., 
1993) place the a-actinin binding site on residues 83-117 and 350-372 of the actin 
monomer. The R372 residue is on the outer surface of the thin filament (Figure 5.16 A) 
and is located in one of the two proposed a-actinin binding sites on actin (Lebart et al., 
1993). 
The Act88F mutation, E93K, is in the other a-actinin binding site (Sparrow et al., 1995) 
on actin and results in a hypercontraction phenotype similar to that seen in the polarized 
light images of the Act88pJ?372H homozygous mutant (Figure 5.11). A weakened 
interaction between a-actinin and the actin thin filaments caused by a mutation could 
lead to detachment of the thin filaments from the Z-discs upon muscle contraction. 
Detachment of the thin filaments from the Z-discs of Act88pJ?372H homozygotes were 
also observed in EM images (Figure 5.17). This would explain why the R372H actin 
mutation affects the attachment of the thin filaments at the Z-disc and why a reduced 
stiffness of the mutant myofibrils was observed. 
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Figure 5.16. The R372 residue is in the proposed a-actinin binding site on actin. 
(A) In the F-actin helix the R372 residue in each actin monomer is shown in red and the 
two black circles surround the proposed a-actinin binding sites on actin . (B) In the 
Z-discs a-actinin (aA) homodimers form cross-bridges with actin filaments (other 
proteins that are not shown here are also involved in the attachment of thin filaments on 
the Z-disc). Picture adapted from Djinovic-Carugo et al., 2001. 
Figure 5.17. TEM of ~-day-old Act88~372~ homozygotes showing thin filaments 
detaching from the Z-dlsc. Scale bars are mdlcated. 
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5.9 Purification of the Gallus gallus a-actinin ABDSt03C mutant 
Given the fact that the R372 residue is within one of the two proposed a-actinin ABD 
on actin the interaction between the two proteins may be affected by mutation R372H. 
One way to pursue this hypothesis is to measure the interaction between the a-actinin 
ABD and the wild type and R372H actins using fluorescence anisotropy. For this 
experiment, the chicken smooth muscle a-actinin ABD (a kind gift from Dr Winder) 
had to be fluorescently labelled. Currently three a-actinin ABD atomic structures have 
been solved: human a -actinin 1 (Borrego-Diaz et al., 2006), human a -actinin 3 
(Franzot et al., 2005) and human a -actinin 4 mutant K255E (Lee and Dominguez, 
2008). Chicken smooth muscle a-actinin shares 98% sequence identity to the human a -
actinin 1 (Figure 5.18). This structure was used to identify possible residues which 
could be mutated to a cysteine for fluorescent labelling. 
Chicken 
60 
Human 
59 
Chicken 
120 
Human 
119 
Chicken 
180 
Human 
179 
Chicken 
240 
Human 
239 
Chicken 
Human 
MDHHYDPQQTNDYMQPEEDWDRDLLLDPAWEKQQRKTFTAWCNSHLRKAGTQIENIEEDF 
MD-HYDSQQTNDYMQPEEDWDRDLLLDPAWEKQQRKTFTAWCNSHLRKAGTQIENIEEDF 
** *** ***************************************************** 
RDGLKLMLLLEVISGERLAKPERGKMRVHKISNVNKALDFIASKGVKLVSIGAEEIVDGN 
RDGLKLMLLLEVISGERLAKPERGKMRVHKISNVNKALDFIASKGVKLVSIGAEEIVDGN 
************************************************************ 
VKMTLGMIWTIILRFAIQDISVEETSAKEGLLLWYQRKTAPYKNVNIQNFHISWKDGLGF 
VKMTLGMIWTIILRFAIQDISVEETSAKEGLLLWCQRKTAPYKNVNIQNFHISWKDGLGF 
********************************** ************************* 
CALIHRHRPELIDYGKLRKDDPLTNLNTAFDVAEKYLDIPKMLDAEDIVGTARPDEKAIM 
CALIHRHRPELIDYGKLRKDDPLTNLNTAFDVAEKYLDIPKMLDAEDIVGTARPDEKAIM 
************************************************************ 
TYVSSFYHAFSGAQKAETAANRICKVLAV 269 
TYVSSFYHAFSGAQKAETAANRICKVLAV 268 
****** ********** ************* 
Figure 5.18. Prot~in seque~c~ alignment of the chick~n and human a-actinin 
ABDs. Identical resldues are mdlcated by a star. The acceSSIOn number for the chicken 
a-actinin 1 ABD is NM_204127 and for the human a-actinin 1 (ACTNl) ABD from 
transcript variant 3 is NM 001130005. Sequence alignment was performed using 
Clustal W2. 
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The a-actinin ABD consists of 269 residues. The structure solved by Borrego-Diaz et 
al., 2006 only resolves residues 30-253. a-Actinin ABD naturally contains three 
cysteines, two of which are buried beneath the surface (C42 and C181). The last 
cysteine (C264) was not solved in the structure. Serine 103 was mutated to a cysteine 
for two reasons; (1) it is not close to the proposed actin-binding site (Figures 5.19 A, B) 
and (2) it is solvent exposed (Figure 5.l9 C, D). The NH2-terminal His-tagged a-actinin 
ABD S 103C variant was overproduced and purified as described in Chapter 2 Section 
2.4.3., the purification steps and purity at each stage are shown in Figures 5.20 A, B, C, 
D,E. 
D 
Figure 5.19. Crystal structure of human smooth muscle a-actinin ABD isoform 1 
(residues 30-25.3) with the ~hree proposed a.ctin-binding sites (ABS). (A and B) 
ABS 1 is shown m :ed, ABS2 I? bl~e and ~S3 m purple. (C) The surface SI 03 residue 
that was mutated mto a cysteme IS shown m yellow. (0) The free S103 is shown as 
stick. Pdb file (2EYI) taken from Borrego-Diaz et al., 2006, pictures were made using 
pymol. 
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F igure 5.20. Purification of reco~bin~nt tagged a.~actinin ABD 103 • (A) 10% SDS 
gel of cell extract after IPTG mduction. (B) This was treated to nickel-affinity 
chromatography monitored by UV absorbance at 280 nm (blue line). Flow through (1,2) 
was collected and bound proteins (3,4) were eluted with an imidazole gradient (red 
line). (C) 10% SDS gel of the flow t~ough (1,2) and. fractions confirmed that a-actinin 
ABDS103C is in peak 4. (D) Gel filtration profile momtored by absorbance at 280 nm on 
a Superdex S75 26/60 column of flow through. (E) 10% SDS gel of fractions from the 
h . . ABD I03C · three elution peaks shows t at a -actmm IS present in the fractions D4 to D14. 
a-Actinin ABDSI03C bands in 10% SDS PAGE gels are indicated by an arrow. 
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Post purification and labelling of a-actinin ABD SI 03C, electrospray ionisation mass 
spectrometry (ESI-MS) was used to confirm the expected molecular weight. Although 
the molecular weight of purified a-actinin ABD SI 03C was correct (33616.4 Da), after 
fluorescent labelling the protein was found to be labelled with 5-carboxyfluorescein 
(FAM) more than once. To identify which cysteines were being labelled MALDI-TOF 
MS analysis of the protein was performed. Briefly, the labelled protein band was 
excised from an SDS gel, digested with trypsin and the masses of the peptides generated 
were measured. If all cysteines were unlabelled then the following peaks would be 
expected (Table 5.3). A typical MALDI-TOF MS of the unlabelled protein is shown in 
Figure 5.21. 
Table 5.3. Spectra results for unlabelled a-actinin ABD. 
Residue Protein Sequence Fragment Size 
Cys42 TFTAWCNSHLR 1392.6 Da 
Cys 181 DGLGFCALIHR 1258.6 Da 
Cys 103 ALDFIACK 937.4 Da 
Cys 264 ICK 420.2 Da 
All cysteine-containing peptides were observed except for the ICK peptide, which is not 
seen as its mass is in the MlZ range dominated by matrix generated noise caused by the 
matrix. If all cysteines were labelled with FAM (labelling with a two-fold excess) the 
expected masses of the cysteine-containing peptides are listed in Table 5.4. A typical 
MALDI-TOF MS of the labelled protein is shown in Figure 5.22 
Table 5.4. Spectra results for labelled a-actinin ABD. 
Residue Protein Sequence Fragment Size 
Cys42 TFTA WC*NSHLR 1780.7 Da 
Cys 181 DGLGFC* ALIHR 1646.7 Da 
Cys 103 ALDFIAC*K 1325.5 Da 
Cys 264 IC*K 808.1 Da 
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The MALDI-TOF MS of the labelled a-actinin ABD SI 03C clearly shows that all four 
cysteines became labelled. The buried cysteines (C42 and C181) must become exposed 
during the labelling procedure. Whether this is due to protein 'breathing', a less 
compact structure or due to the SI 03C mutation is not known. C264, which was not 
seen in the crystal structure, is also labelled. The termini of proteins are usually not 
observed in X-ray crystallography due to the high flexibility. The labelling of C264 
demonstrates that this region of the protein is solvent exposed. The genetically 
engineered cysteine (S 103 C) is also labelled. However, as it stands it is not possible to 
use this variant of a-actinin ABD due to labelling of all cysteines. Even if conditions 
were sought to suppress labelling of the buried cysteines (C42 and C181) the solvent 
exposed cysteine (C264) would still be labelled. Therefore wild type a-actinin ABD was 
used instead to label the intrinsic cysteine, C264. 
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Figure 5.21. Spectra of unlabelled a-actin in ABD I03C. Arrows are pointing at the 
cysteine containing fragments. The smallest cysteine-containing fragment is not visible. 
Analysis and representation of spectra carried out by Adam Dowle at the Technology 
Facility of the Biology Department. 
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Figure 5.22. Spectra of labelled (X-actinin ABD t03C labelled with two fold molar 
excess of fluorophore. The spectra show that all four cysteines are labelled in the 
sample, as well as some peaks of unlabelled fragments. Analysis and representation of 
spectra carried out by Adam Dowle at the Technology Facility of the Biology 
Department. 
187 
5. The Act88~372H mutation: a progressive nemaline myopathy model. 
5.10 Purification of the Gallus gallus wild type a-actinin ABD 
The wild type His-tagged a-actinin ABD was purified as described in Chapter 2 Section 
2.4.3. The purification steps along with the purity of the a-actinin ABD at each step are 
shown in Figure 5.24 A, B, C, D, E. The elution profile of the size exclusion 
chromatography step shows two peaks, which according to SOS-PAGE both are a-
actinin ABO. The earlier peak (3) may be a dimer and the later peak (4) the monomer. 
To test this the samples were run on an SOS-PAGE gel in sample buffer with and 
without mercaptoethanol. In the absence of mercaptoethanol disulfide bonds are not 
reduced thus allowing dimers to be visualized (Figure 5.23 F). In lane 1 (no 
mercaptoethanol) two bands can be seen, one corresponding to the dimer (66 kDa) and 
one corresponding to the monomer (33 kDa). This demonstrates that the wild type a-
actinin ABO exists as both dimer and monomer in solution. In lane 2 (mercaptoethanol) 
only a single band (33 kDa) can be seen. Therefore peak 3 of the elution profile 
represents the a-actinin ABO dimer and peak 4 the a-actinin ABD monomer. Based 
upon the absorption of the elution profile wild type a-actinin ABO exists primarily as a 
dimer in solution. As the overexpressed a-actinin ABD lacks the dimerization domain, 
mercaptoethanol has demonstrated that dimerization occurs probably due to an exposed 
cysteine. The tendency of a-actinin ABD to dimerize caused problems with labelling. 
Figure 5.24 shows that labelling of a-actinin ABO results in the labelling of the dimer, 
despite DTT being present in the labelling reaction. In addition to this mUltiple labelling 
was still occurring, suggesting the internal cysteines (C42 and C181) are still exposed. 
To overcome this problem, the role of kosmotropes was explored. Kosmotropes added 
to protein solutions lead to dehydration of the protein surface and increase the strength 
of the hydrophobic interaction causing stabilization of the structure. Sucrose, a known 
kosmotrope, was used in the labelling buffer (2 M). ESI-MS of the labelled protein 
resulted in no dimerization of a-actinin ABO although it still shows labelling of the 
buried cysteines (Figure 5.25 A). Although ESI-MS is not quantitative, the relative 
intensities of the peaks with and without sucrose suggest that less multiple labelling is 
occurring in the presence of sucrose (Figure 5.25 A, B). 
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Figure 5.23. Purification of recombinant tagged a-actinin ABD. (A) 10% SDS 
PAGE gel of cell extract after IPTG induction. a-Actinin ABD is indicated with an 
arrow. (B) This was treated to weak-anion exchange chromatography (DE52) monitored 
by UV absorbance at 280 nm (blue line). Flow through (1) was collected and bound 
proteins (2) were eluted with an imidazole gradient (bottom line). (C) 10% SDS PAGE 
gel of the flow through (lane 1) .and fractions c.onfmned that a-actinin ABD is in 
fractions C3 to C12. (D) Gel filtratIOn profile morutored by absorbance at 280 nm on a 
Superdex S75 26/60 colwnn of flow through. (E) 10% SDS PAGE gel of fractions from 
tbe two elution peaks sbo~s a -actinin ABD i~ present in both. (F) 10% SDS PAGE gel 
of fraction A9 prepared ill sample buffer WIthout mercaptoethanol (lane 1) shows it 
contains an a-actinin ABD dimer at 66 kDa and a mODomer at around 33 kDa. Fraction 
A9 prepared in standard sample buffer (lane 2) shows monomeric a -actinin ABD. All 
a-actinin ABD are indicated by arrow. 
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Figure 5.24. Fluorescently labelled tagless a-adinin ADD. (A) 10% SOS gel of 
labelled a-actinin ABO quenched with excess DTT after addition of the fluorescent dye. 
In lane 1 standard sample buffer was added to the protein and a single band can be seen 
at around 30 kDa, which is the size of the monomeric a-actinin ABD. In lane 2 the 
labelled protein was not quenched with DTT after addition of the fluorescent dye and 
sample buffer without mercaptoethanol was used this time. The monomer can be seen 
around 30 kDa and a band matching the size of the dimer around 60 kDa. (8) Image of 
the same gel taken in the transilluminator prior to staining it. In lane 1 a single 
fluorescent band can be seen which is the monomer. However in lane 2 two fluorescent 
bands can be seen, the top represents the dimer and the bottom one the monomer. 
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Figure 5.25. The effect of a kosmotrope on FAM-Iabelling of a-actinin ABD 
monitored by ESI-MS. The reconstructed masses of the raw ESI-MS data for a-actinin 
ABD showing unlabelled, single-, double-, triple- and quadruple labelling of exposed 
cysteines in the presence (A) and absence (B) of sucrose. 
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A co sedimentation assay of labelled a-actinin ABD and F-actin was performed to 
ensure that labelled a-actinin ABD is still able bind to F-actin after addition of the 
fluorophore (Figure 5.26). In the absence of F-actin labelled a -actinin ABD is mostly 
present in the supernatant although some is present in the pellet. Upon addition of F-
actin, more labelled a-actinin ABD bas been retained in the pellet suggesting that the 
two proteins are able to bind. 
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Figure 5.26. Fluorescently labelled tagless a-actinin ABD and F-actin 
cosedimentation. (A) 10% SDS gel of labelled a-actinin ABD and F-actin. CB) Image 
of the same gel taken in the transilluminator prior to staining it. SN and P denote 
supematant and pellet, respectively. 
5.11 Fluorescence anisotropy measurements of a-actinin ABD and F-
actin 
Fluorescence anisotropy is concerned with changes of the plane of polarised light upon 
protein complexation. For instance, when a protein is excited with vertical polarised 
light, the light is emitted in the same polarised plane, if the protein is not tumbling 
during the excited state (~ ns timescale). However, if the protein tumbles out of this 
plane, the light is remitted in a different plane. During the course of the experiment, the 
intensity of both the vertical and horizontal planes is measured. The changes from the 
vertical to the horizontal plane (depolarisation) are therefore dependent on changes in 
the speed of protein tumbling. The largest fluorescence change measured is when a 
small protein (fast tumbler) binds to a large protein (slow tumbler) . Hence, protein 
interactions can be detected when the smaller of two interacting partners is fused to a 
fluorophore and binds to a larger partner (this maximizes the difference in signal 
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between bound and unbound states). The amount of polarization observed is 
proportional to the amount of protein complex formed, which is proportional to the 
concentration of the binding partners in solution. Hence by titrating one of the two 
proteins a binding curve can be generated. 
Here fluorescence anisotropy was performed to compare the binding of fluorescently 
labelled wild type a-actinin ABD to wild type and ACT88FR372H mutant F-actin. 
ACT88FR372H actin was extracted from homozygous Act88f'?372H flies to ensure no wild 
type actin was present. The concentration of the fluorescently labelled a-actinin was 
kept constant and actin was titrated. Two steps can be observed in the binding curve for 
wild type actin and a-actinin ABD shown in Figure 5.27 as closed and open circles. 
This is probably due to the fact that the single- and the double-fluorescently labelled a-
actinin ABD species shown by ESI-MS (Figure 5.25 A) bind to actin. Although ESI-MS 
is not quantitative, it was assumed from the relative intensities of the peaks that the 
amount of double-labelled a-actinin ABD will be less than that of the single-labelled a-
actinin ABD. Hence, given the fact that the change in anisotropy is concentration 
dependent, it was assumed here that the smaller step in the binding corresponds to the 
double-labelled a-actinin ABD which must be present in smaller amounts (Figure 5.27 
closed circles). The second step in the binding must correspond to the single-labelled a-
actinin ABD (Figure 5.27 open circles). A binding curve was generated from the single-
labelled a-actinin ABD readings using SigmaPlot and the dissociation constant (~) of 
the wild type actin for the a-actinin ABD was shown to be 0.39 ~M (R2 = 0.9006). 
In the mutant the two step binding is not as obvious. Closed and open triangles were 
used to plot the readings assuming there are two different steps in the binding due to the 
single and double-labelled a-actinin ABD binding to R372H actin. A binding curve was 
generated using the open triangle readings and the Kd of the R372H actin was shown to 
be 5.21 ~M (R2 = 0.9278), approximately 13.35-fold weaker than that of the wild type 
actin. Hence reduced affinity of the mutant actin for a-actinin could explain the 
detachment of the thin filaments from the Z-discs seen in the images of Act88f'?372H 
homozygous flies. 
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Figure S.27. Binding CUn'es for a-actin in ADD interacting with, wild type and 
R372H-mutant F-actin. The curves are produced by plotting the average anisotropy 
difference versus F -actin concentration corrected for dilution effects. Open and closed 
circles correspond to the wild type actin. Closed and open triangles correspond to the 
R372H actin. Vertical error bars show errors in anisotropy values. Although the first 
and second open circle readings in the wild type were considered when drawing the 
binding curve, SigmaPlot did not permit the line to intercept them. 
S.12 Discussion 
S.12.1 Two pathways leading to NM 
Four Act88F mutations in Drosophila IFM (A138V, R256C, G268D, R372H), which 
correspond to six ACTA] nemaline mutations (A138P, R256H1L, G268R1C, R372H) 
seen in humans show the Drosophila equivalent of the human nemaline phenotype. 
Three of the mutants (A138P, R256H1L, G268R1C) do not form any sarcomeres during 
sarcomerogenesis and the flies never fly. However one mutant, Act88~372H, forms 
nonnal sarcomeres during muscle development as seen by 1 day old flies which can fly, 
lose their flight ability within 7 days. TEM images from 1- to 7-day-old Act88~372H/+ 
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heterozygous flies show that there is progressive sarcomeric damage explaining why 
they become flightless. When newly eclosed flies were prevented from using their flight 
muscles, no sarcomere deterioration was observed and the muscles appeared normal 
even when the flies were 10 days old. This suggested that the mutant myofibrils become 
damaged upon use. Interestingly, wild type confined flies whose wings had not been 
clipped were flight-tested after 1 and 3 days and did not make any attempts to fly, jump 
or beat their wings when released. It was found after four hours that 85% of them could 
fly (n = 22). This implies that wild type flies were not using their flight muscles when 
confined. Therefore the Petri-dish confinement method is a useful technique for 
preventing IFM usage. This observation suggests that there are at least two pathways 
leading to a nemaline myopathy phenotype. The first pathway is characterized by an 
inability to form normal sarcomeres. The second pathway, which is seen in the 
Act88[1?372H mutant, results from the inability to maintain thin filament organization that 
causes loss of sarcomere structure. 
5.12.2 The R372H mutation weakens myofibril mechanical stiffness 
The IFM of the Aet88V372H/+ heterozygous mutants are normal when the flies emerge 
but progressively deteriorate due to usage. In addition the thin filaments of Aet88[1?372H 
homozygous flies appeared tom from the Z-discs. These observations led to the 
proposal that the mutation may weaken the thin filament attachment to the Z-disc. 
Hence when the sarcomere contracts the thin filaments become more likely detached 
from the Z-disc. This was investigated by single myofibril mechanical experiments. 
However this technique using myofibrils from Drosophila IFM has a number of 
problems associated with it. 
First due to their very small size, myofibrils pose some difficulties such as insecure 
attachment to the force transducers (Hao et al., 2004). Though measurements of the 
passive force produced from Drosophila IFM single myofibrils have been obtained by 
wrapping them around the force transducers and reinforcing the attachment with glue 
(Dickinson et al., 1997; Kulke et al., 2001; Hao et al., 2004). However it was not 
possible to use these experimental setups during this study. Instead the myofibrils were 
touched to glue-coated length-driving tungsten stiff needle at one end and an AFC at the 
other end. As the myofibrils behaved as rigid rods, due to their well known high 
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stiffness compared to vertebrate myofibrils, the first challenge was securely attaching 
them to the needle and the AFC. However, merely touching them with either the needle 
or the tip of the AFC would cause the myofibrils to 'bounce' off. If on the other hand 
the pressure applied was too great the myofibrils would break at the point of contact. 
These facts made their manipulation and the mounting procedure very difficult and 
laborious. Furthermore, following an overall inspection of the myofibrillar suspension 
with the microscope (40x-90x magnification, phase-contrast) it was evident that the 
mutant myofibrils manifest a tendency to aggregate more than wild-type ones, 
suggesting a different surface electrical charge. They also had a reduced ability to 
sediment within the same time compared to the wild-type ones (90 minutes). These 
difficulties acted as a 'filter' in selecting the mutant myofibrils to be subjected to 
mechanical analysis. 
Wild type IFM myofibrils are known to be very stiff and do not contract more than 
- 3 % (Peckham et al., 1990). As previously shown it is very difficult to obtain 
sufficient stretch to produce a sarcomere length change (Hao et al., 2004). This was also 
the case here as too great a stretch would break the myofibril. In the laboratory where 
these experiments were performed, single myofibril mechanical experiments with 
cardiac smooth muscle are routinely performed. Cardiac muscle is far less stiff than the 
Drosophila IFM and mounting or stretching cardiac myofibrils is a lot easier and a large 
set of samples can quickly be processed. The high passive stiffness of Drosophila IFM 
posed a great challenge and as a result not many IFM myofibrils could be processed. 
For a larger and representative myofibrillar population of IFM from the mutant, the 
differences in mechanical parameters (stiffness, plastic deformation) could be even 
larger. 
The high passive stiffness of the IFM myofibrils posed a third obstacle. The wild type 
myofibrils were stiffer than the glue, which resulted in deformation of the glue upon 
stretching. Different combinations of glue and nitrocellulose were tried out but this 
problem could not be overcome. Therefore there is an associated error with the 
measurement of the wild type sarcomere length change. The Act88p-R372H/+ 
heterozygotes myofibrils were more fragile than wild type as was observed during 
handling and isometrically mounting them between the needle and the tip of the AFC. 
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They were found to be mechanically less stiff, displayed plastic deformation and would 
break during the third stretching protocol. The observed mechanical weakness of the 
mutant myofibrils demonstrates that glue deformation due to stretching is insignificant, 
because the mutant myofibrils are more compliant than the glue. Although there is an 
error in the stiffness in the wild type, the mutant sarcomere must be mechanically 
compromised and explains why myofibrillar damage is use-dependent. 
5.12.3 Weakening of the F-actin R372H1a-actinin interaction causes NM 
R372 is on the exposed surface of the F-actin helix, within one of the two proposed a-
actinin ABD sites. These observations suggest that the R372H mutation has reduced the 
F-actinla-actinin binding, weakening the attachment of the thin filaments on the Z-disc 
as seen in the EM images of Act88y 372H homozygotes. The reduced myofibrillar 
mechanical stiffness observed for the mutant supports this hypothesis. The ACT88FE93K 
mutation resides on a residue located in the other a-actinin ABD site and displays the 
hypercontraction phenotype as does the ACT88FR372H mutation. This suggests that weak 
binding to a-actinin ABD may be the molecular basis of pathogenesis for both 
mutations. Indeed ACT88FR372H actin extracted from Drosophila IFM displayed a 
13.35 -fold weaker interaction with the a-actinin ABD. A lO-fold weakening in the F-
actinla-actinin binding has also been reported for the human ACTA1 K336E mutation, 
which is associated with nemaline myopathy and cardiomyopathy (D' Amico et al., 
2006). The fact that the binding constant between R372H F-actin and a-actinin is only 
13.35-fold weaker from that of the wild type F-actin to a-actinin is not ·surprising. As 
heterozygotes, the R372H mutants are able to fly at day 1 thus the effect of the mutation 
must be subtle. However, the damaging effect of the mutation in Drosophila IFM is 
progressive which is in contrast to the situation in humans, as nemaline myopathy is 
normally a non-progressive disorder. The reason behind this difference could be due to 
repair and regenerative mechanisms present in human muscle, which are apparently 
absent from Drosophila IFM. 
The interaction of chicken smooth a-actinin ABD with Drosophila Act88F F-actin has 
not been previously measured. However, in other systems the affinity between chicken 
smooth muscle a-actinin and a-actinin ABD with rabbit F-actin has been reported. The 
temperatures, buffer conditions and biochemical approaches used vary from the 
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conditions used here. The ~ for a-actinin ABD with rabbit F -actin has been shown by 
stop-flow measurements to be 0.82 J..lM at 15°C and 2.38 J..lM at 25°C (Kuhlman et al., 
1992), whereas co sedimentation measurements have shown the Kd to be 0.23 J..lM and to 
be unaffected by temperature (Bennette et al. 1984). However, they find that the 
interaction is weakened 5-fold in the presence of Ca2+. The wide discrepancy between 
reported values of the Kd for the F-actinla-actinin binding could be due to Ca2+ ions 
present in the distilled water, as certain groups used EGTA in their buffers. 
In Drosophila there is a single a-actinin gene whose differential splicing results in two 
a-actinin muscle isoforms (104 kDa and 107 kDa). Their protein sequences are identical 
except for the amino acids that join the actin-binding domain to the first spectrin repeat 
(Roulier et al., 1992). This part of the sequence contains a 22 amino acid insertion 
resulting in the larger isoform. The 104 kDa isoform is expressed in the IFM and leg 
muscles whereas the 107 kDa isoform is predominantly expressed in the larval 
supercontractile muscles and visceral tissues of the adults (Roulier et al., 1992; 
Vigoreaux et al., 1991). Substitution of the 104 kDa isoform for the 107 kDa isoform 
results in flightless flies with reduced a-actinin levels (Roulier et al. 1992). The 
myofibrils of newly emerged flies look normal but the Z-bands degenerate as the flies 
become older. These results suggested that normal a-actinin levels are not required for 
sarcomere assembly in the IFM but are for maintaining sarcomere structure. It is 
therefore not surprising that the R372H mutant, in which F-actinla-actinin binding is 
weakened, can develop normal sarcomeres. That the Act88y 372H myofibrils degenerate 
as the flies become older in similar ways to where the a-actinin 104 kDa isoform levels 
is substituted for the 107 kDa isoform supports the idea that weakened actinla-actinin 
interactions are the mode of pathogenesis in the R372H mutant. 
Finally it should be pointed out that in yeast, the residue 372 of actin is a histidine 
(H372). Mutation of this residue to an arginine (the reverse of what has been done here) 
causes a mitochondrial-vacuole phenotype and the actin cytoskeleton appears 
depolarised (McKane et al., 2005). The authors also find that in vitro the H372R actin 
showS slightly faster polymerisation that the wild type actin. 
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5.12.4 Summary 
Congenital actin myopathy mutations that were studied in Chapter 3 and 4 resulted in 
sarcomeric defects being present during muscle development. Unlike previous 
Drosophila actin mutants for congenital actin myopathies, the IFM of the R372H mutant 
form normally but then the nemaline myopathy phenotype is generated over time. A 
variety of biophysical approaches was used to understand this progressive muscle 
disarray. It was observed that the myofibrils were less stiff by single force 
measurements. This was because the attachment of the thin filaments by a-actinin to the 
Z-discs was weakened. 
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Chapter 6: Drosophila IFM as a model system for studying 
arthrogryposes 
6.1 Aims 
To express the IFM-specific TnI and TnT isoforms using the GAL41UAS expression 
system in the IFM to rescue the hdp 3 and u/ nulls, respectively. To express and study 
IFM mutations of the genes encoding for TnI and TnT responsible for arthrogryposis. 
To express a truncated TnT to investigate the role of its COOH-terminus. 
6.2 Arthrogryposis 
Distal arthrogryposes are a group of disorders characterized by permanent contractures 
of two or more body areas that affects limb function (Bamshad et al.. 1996a; b). The 
disorder has multiple unknown origins but in some cases is caused by mutations in ~ast 
skeletal muscle TnI and TnT genes. There are four mutations in the gene encoding for 
fast TnI (Sung et al., 2003; Kimber et al., 2006; Jiang et al., 2006; Robinson et al .• 
2007) and one mutation in the gene encoding fast TnT (Sung et al., 2003) that cause 
arthrogryposis in humans (Table 6.1). In Drosophila IFM-specific TnI and TnT 
isoforms exist that could be used to introduce the human arthrogryposis mutations. 
Nulls also exist for these genes so that mutations can be studied in the absence of the 
wild type protein. 
Table 6.1. Human mutations in TnI and TnT genes responsible for arthrogryposis 
and their Drosophila counterparts. 
Disease Humans D. melanogaster References 
Arthrogryposis Fast TnT R63H TnTK43H Sung et al.,2003 
Arthrogryposis Fast Tn! R156@ TnI K245@ Robinson et al., 2007 
Arthrogryposis Fast TnI R174G TnI V256G Sung et al., 2003 
Arthrogryposis Fast Tn! ~K175 Tn! ~K257 Jiang et al., 2006 
Arthrogryposis and myopathy Fast TnI ~K176 Tn! ~E258 Kimber et al., 2006 
(changes in type 11 fibres) 
TnT E314@ 
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Figure 6.1. Diagram of the tertiary structure of the troponin complex in the thin 
fIlament and localization of troponin mutations. TnI, TnT and TnC are coloured in 
green, blue and red respectively with alpha helices represented as cylinders and coils 
represented as lines. Movement of the TnI NH2-terrninus is upon Ca2+ activation is 
indicated. Diagram and labeling of protein domains are based on the X-ray crystal 
structure of the partial troponin complex solved by Takeda et al., 2003. The localization 
of mutations causing arthrogryposis (green and black for humans and Drosophila, 
respectively) are approximately represented in each troponin subunit. The tropomyosin 
dim er is shown in grey. ' Original in colour' 
Expression of mutations in the Tnl and TnT encoding genes had to be high and 
restricted to the IFM. The Act88F mutations in the previous chapters were expressed 
using the native Act88F promoter, which drives high levels of expression specifically in 
the !FM. Overexpression of the IFM-specific TnT isoform gene under the control of the 
very strong ACl88F gene promoter was shown to cause reduction of the endogenous 
TnT, TnI, actin and tropomyosin levels and muscle abnormalities (Marco-Ferreres et 
al. , 2005). Hence the Act88F gene promoter could not be used for the expression of the 
mutations in the TnI and TnT genes. The spatial and temporal transcriptional regulation 
of both the TnT and TnI genes is very complicated and requires two regulatory elements 
upstream and downstream of the transcription initiation site (Mas et al., 2004; Marin et 
al., 2004). Trying to reconstruct this arrangement to successfully express the TnI gene 
would not be trivial. We were in possession of the adult wild type IFM-specific TnT 
clone as part of a collaborative project with Dr Nongthomba, in which mutations could 
be readily introduced. Dr. Ferrlis of the Cajal Institute, Spain, provided other UAS-TnI 
transgenic construct lines to be expressed as part of a collaborative project within the 
MYORES network. Therefore the aim was to use the GAL41UAS system to drive the 
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expression of TnI and TnT genes carrying these mutations specifically in the IFM null 
mutants using the UH3-GAL4 driver. Two Drosophila lines exist that are each IFM-
nuUs for the TnI (hdp3) and TnT (up!) isoforms and are both located within the first 
Drosophila chromosome (Nongthomba et al., 2003; Nongthomba et al., 2007). 
In order to use Drosophila IFM to study the effect of the TnT mutations in muscle 
structure, two requirements had to be met: the UAS_Tnyimutalionj inserts had to be studied 
in a TnT null background and they had to be expressed sufficiently. The Drosophila 
upheld gene is organized into 11 exons and encodes all TnT isoforms, which are 
produced by alternative splicing (Fyrberg et al. 1990, Benoist et al., 1998). Expression 
ofthe different isoforms is regulated by a single promoter (Benoist et al., 1998). A TnT 
mutant exists, upheli (up\ in which defective splicing of exon lOa results in lack of 
TnT message and protein in the IFM (Nongthomba et al., 2007). Hemizygous male up! 
mutants and up! 1+ heterozygote female are flightless (Deak et aI., 1982). The IFM of 
the u/ hemizygous mutants lack normal sarcomeres though short sarcomere-like 
structures have been reported and zebra bodies (Nongthomba et al., 2007). The up! 1+ 
heterozygote females show myofibrillar branching, Z-disc and M-line streaming but 
display more myofibrillar organization than u/ hemizygotes (Nongthomba et al., 
2007). Therefore, the u/ hemizygous mutant was used for studying the UAS-
Tnyfmutationj transgenics in TnT null background. The mating scheme for obtaining lines 
expressing UAS-TnT in TnT null background is shown in Chapter 2, section 2.6.7, 
Figure 2.7 A. 
Like with the UAS_Tnyimutation] inserts, in order to use Drosophila IFM to study the 
effect of the TnI mutations in muscle structure the UAS_Tnfmu,ationj inserts had to be 
studied in a TnI null background and they had to be adequately expressed. A TnI mutant 
exists, heldup3 (hdp3), in which alternative splicing of the IFMlTDT -specific ex on 6b 1 
is affected (Barbas et al., 1993). As a result the IFMlTDT TnI RNA isoforms are not 
expressed resulting in an IFMlTDT TnI null. The hdp3 hemizygotes and hdp31+ 
heterozygote adults are dominant flightless and display aberrant muscle structure 
(Barbas et al., 1991; Deak et al., 1982; Prado et al., 1999). The muscles initially form 
normally but autodestruct when hypercontraction starts at 70-75 hours APF 
(Nongthomba et al., 2003). Hence, the hdp3 mutant was used to study the UAS-
Tn/mutatiOn] transgenics in wild type TnI null backgrounds. The mating scheme for 
202 
6. Drosophila IFM as a model system for studying distal arthrogryposes 
obtaining lines expressing UAS-TnI in wild type TnI null background is shown in 
Chapter 2, section 2.6.7, Figure 2.7 A. 
When this project started it was originally thought that the UH3-GAL4 insert was in the 
second Drosophila chromosome and could therefore be used to create lines that 
contained this insert and either the TnI or TnT nuBs, which are located in the first 
chromosome. Therefore hdp3 and u/ lines were created that also carried the UH3-GAL4 
driver in the second chromosome. However, it was discovered late on in the research 
that there are two GAL4 (pGawB enhancer trap) drivers in the stock - one on the first 
chromosome expressing in the IFM and another on the second chromosome expressing 
in the midgut. This meant that in the hdp3; UH3-GAL4 and Upl; UH3-GAL4 lines that 
were created, because the UH3-GAL4 insert was selected to be in the second 
chromosome, expression of the UAS-TnI and UAS-TnT constructs could not be achieved 
in the IFM. A way to circumvent this problem is to recombine the UH3-GAL4 driver 
into the same chromosome as the upl and hdp3 genes. However, as creating/studying the 
arthrogryposis mutants was the last piece of research that was carried out there was not 
sufficient time left to perform the recombinations. Therefore the dmej2-GAL4 
panmuscle driver, which is in the third chromosome (Ranganayakulu et al., 1996), was 
used instead to express the arthrogryposis constructs. The mating scheme for obtaining 
lines expressing dmej2-GAL4 in wild type TnI or TnT null background is shown in 
Chapter 2, section 2.6.7, Figure 2.7 B. 
Transgenics carrying the wild type UAS-TnT and UAS-TnT constructs were created in 
order to rescue the IFM TnI (hdp3) and TnT (Upl) gene nuBs. Also transgenics for the 
UAS_Tnfmutationl and UAS_Tnyfmutation1 inserts carrying the arthrogryposis mutations were 
created and studied. All crosses described in this chapter, involving dmej2-GAL4 flies, 
the vials were kept at 18°C where the GAL4 driver shows weak expression. Those 
individuals that had reached the pre-pupal stage were then transferred to 25 °C or 29°C 
to allow increased expression of the dmej2-GAL4 driver. 
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6.3 Troponin T mutants 
A single mutation in the human fast skeletal isoform TnT, R63H, has been discovered 
that causes arthrogryposis. It is found within the region of TnT that binds the NH2-
terminus of TnC (Sung et aI. , 2003). Protein sequence alignment of the Drosophila 
IFM-specific TnT and the human fast skeletal muscle TnT isoform (Figure 6.2) shows 
that the human protein is poorly conserved compared to that of Drosophila one (25% 
sequence homology). Based on the sequence alignment residue K43 of Drosophila TnT 
was mutated into H43 to recapitulate the human residue R63 of TnT responsible for 
arthrogryposis. 
Human TNNT1 
Human=TNNT3 
Drosophila 
Human TNNT1 
Human=TNNT3 
Drosophila 
Human TNNT1 
Human-TNNT3 
Drosophila 
Human TNNT1 
Human- TNNT3 
Drosophila 
Human TNNT1 
Human=TNNT3 
Drosophila 
Human TNNT1 
Human-TNNT3 
Drosophila 
Human TNNT1 
Human- TNNT3 
Drosophila 
MSDTEEQEYEEEQPEEEAADEEEEAPEEPEPVAEPEEERPKPSRPVVPPLIPPKIPEGER 60 
MSDEEVEQVEEQYEEEEEAQEEEEVQEDT-AEEDAEEEKPRPK------LTAPKIPEGEK 53 
MSDDEEYTGEGDPEFIKRQDQKRSDLDDQLKEYITEWRK- - - ------- - --------- - 39 
*** * * * 
VDFDDIHRKRMEKDLLELQTLIDVHFEQRKKEEEELVALKERIERRRSERAEQQRFRTEK 120 
VDFDDIQKKRQNKDLMELQALIDSHFEARKKEEEELVALKERIEKRRAERAEQQRlRAEK 113 
-------RS EEDELKKLKEKQAKRKVTRAEEEQKMAQRKKEEEERRVREAEEKKQREIE 92 
* * * ** * * ** ** * 
ERERQAKLAEEKMRKEEEEAKKRAEDDAKKKKVLSNMGAHFGGYLVKAEQKRGKRQTGRE 180 
ERERQNRLAEEKARREEEDAKRRAEDDLKKKKALSSMGANYSSYLAKADQKRGKKQTARE 173 
EK- -RMRLEEAEKKRQAMLQAMKDKDKKGPNFTIAKKDAGVLGLSSAAMERNKTKEQLEE 150 
* ** * * * * 
MKVRILSERKKPLDIDYMGEEQLRARSAWLPPSQPSCPAREKAQELSDWIHQLESEKFDL 240 
MKKKlLAERRKPLNIDHLGEDKLR----- ----- - - -- - -DKAKELWETLHQLEIDKFEF 217 
EKKISLSFRIKPLAIEGFGEAKLR----------------EKAQELWELIVKLETEKYDL 194 
* * * *** * ** ** ** ** ** * 
MAKLKQQKYEINVLYNRISHAQKFRKGAG---KGRVGGRWK----- - ---- - -------- 278 
GEKLKRQKYDITTLRSRIDQAQKHSKKAGTPAKGKVGGRWK----------- - - -- - --- 258 
EERQKRQDYDLKELKERQKQQLRHKALKKGLDPEALTGKYPPKIQVASKYERRVDTRSYD 254 
* * * * * * 
DKKKLFEGGYNTVYAETLEKTWQERQERFTQRTKSKLPKWFGERPGKKAGEPETPEGE D 314 
--- - ---- ---- - - - ---- -- - ------- - --------- - - ------------- - -- --
AKADEDIVEDDEEVEEEVVEEEDEEAEEDEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE 373 
Figure 6.2. Sequence alignment of Homo sapiens troponin T type 1 (skeletal, slow) 
(TNNTl), troponin T type 3 (skeletal, fast) (TNNT3) and Drosophila melanogaster 
IFM-specific troponin T isoform. The human TnT residue R63 is highlighted in 
yellow and Drosophila homologue K43 in cyan. Drosophila residue E314 is also 
highlighted in cyan. Sequence alignment was performed using Clustal W2 software. 
The accession number for human TNNTl is P13805 , human TNNT3 is NP 006748 and 
for Drosophila TnT is AAR24586.1. The asterisk denotes conserved residu~s . 
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In contrast to vertebrates, the Drosophila TnT IFM isoform has a negatively charged 
Glu-rich, COOH-terminal extension. The human and Drosophila TnT proteins are 
poorly conserved, it is hitherto unknown what the functional importance of the 
Drosophila TnT poly-E tail. Therefore, a stop codon at residue E314 was introduced 
(Figure 6.2) leading to a loss of 70 amino acids in the COOH-terminus. It was also of 
interest to investigate if Drosophila TnTE314@ will integrate into the myofibrils since 
previous studies have shown that a human truncated TnT mutant (E180@) does not 
integrate into muscle fibres (Jin et al., 2003). 
First, the wild type UAS-TnT construct was expressed in an upl background. If 
expression of wild type TnT in the IFM restored the flight ability or suppressed the 
muscle abnormalities of the upl male mutant it would suggest that the UAS_Tnyfmu,a'ionj 
inserts can also be adequately expressed thus allowing this system to be used to study 
the UAS_Tnyfmu,a'ionj constructs. The mating scheme to obtain lines expressing the VAS-
TnT and dmefl-GAL4 inserts in wild type TnT null backgrounds is shown in Chapter 2, 
section 2.6.7, Figure 2.6.3. 
Transgenic flies carrying the VAS-TnT insert in the Upl background were created and 
driven with the dmefl-GAL4 driver. Control flies carrying a single copy of the dmefl-
GAL4 or the UAS-TnT inserts are flighted (Figure 6.4, Table 6.2) suggesting that the 
presence of the inserts does not cause any muscle defects. Control Upl; VAS- TnTI+; + 
and upl; + ; dmefl-GAL4 flies were flightless showing that the VAS-TnT and dmefl-
GAL4 inserts alone cannot rescue the u/ phenotype. Males expressing wild type TnT 
in the u/ background (Upl; VAS-TnT/+; dmefl-GAL41+) from crosses kept at 25°C 
were flightless (Figure 6.4. Table 6.2) and showed the wings-up phenotype 
characteristic of muscle hypercontraction (Figure 6.5). This suggested that the IFM TnT 
null cannot be rescued by expression of the VAS-TnT. Male progeny expressing wild 
type TnT in the presence of the native TnT gene (+; UAS-TnTI+; dmefl-GAL41+) were 
also flightless (Figure 6.4). 
In the case of the mutants, flies bearing single copies of the UAS-TnT'43H or VAS-
TnyC314@ inserts were flighted, suggesting that the inserts do not cause any muscle 
defects (Figure 6.4, Table 6.2). Control u/; + ; UAS_TnT'43HI+ and Upl; +; VAS-
Tnr314@/ + flies were flightless showing that the VAS_TnTmUlalionj inserts alone cannot 
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rescue the up] phenotype. Expression of the UAS_TnyK43H and UAS-TnyE314@ mutants in 
u/ background with dmej2-GAL4 (upl; + ; UAS-TnyK43Hldmej2-GAL4 and upl; + ; 
UAS-TnyE314@/dmej2-GAL4) resulted in flightless flies at 25 QC (Figure 6.4, Table 6.2), 
which showed the wings-up phenotype (Figure 6.5). Expression of the UAS_TnyK43H 
and UAS-TnyE314@ mutants in the presence of a wild type TnT copy also resulted in 
flightless flies (+; + ; UAS-TnyK43Hldmej2-GAL4 and +; + ; UAS-TnyE314@/dmej2-
GAL4) (Figure 6.4) with the wings up phenotype. 
Table 6.2 Number of male flies tested for the TnT mutation and deletion of the 
polyE tail. 
Genotype 
wt 
+/Y; +; dmej2-GAL41+ 
upllY; +; + 
upllY; + ;dmej2-GAL41+ 
+/Y; UAS-TnTI+; 1+ 
u/IY; UAS-TnTI+;+ 
upllY; UAS-TnTI+; dmej2-GAL41+ 
+/Y; UAS-TnTI+; dmej2-GAL41+ 
+/Y; + ; UAS_TnyK43HI+ 
+/Y' +. UAS-TnyE314@,I+ 
, , rrK43H 
u/IY; +; UAS-Tnl 1+ 
u/ /Y; + ; UAS_TnyE314@,I+ 
upllY; +; UAS_TnyK43H/dmej2-GAL4 
upllY; +; UAS-TnyE314@,ldmej2-GAL4 
+/Y; +; UAS_TnyK43H/dmej2-GAL4 
+/Y; + ; UAS-TnyE314@,ldmej2-GAL4 
Number of flies 
27 
45 
35 
28 
21 
18 
31 
22 
30 
37 
30 
29 
32 
26 
34 
32 
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Figure 6.4. Flight testing of male wild type UAS-Tnr flies and mutant variants grown at 25 °C. The inserts: VAS-TnT, VAS-
TnyK43H, UAS-Tn yE314@ and dmej2-GAL4 are present as single copies, 
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WT 
up '/Y ; UAS-TnT/+ ; dmef2-GAL4/+ up'/y ; + ; UAS-Tn r
4 3f1/dmef2-GAL4 
up '/Y ; + ; UAS-Tny3' 4S /dmef2-GAL4 
Figure 6.5. Polarized light microscopy of male wild type VAS-TnT" flies and 
mutant variants. Arrowheads show hypercontracted muscles, 
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The UAS-TnT+-, dmej2-GAL4 and UAS_Tnyfmutationj inserts were also expressed in up! 1+ 
heterozygote females which on their own are completely flightless (Figure 6.6). Control 
upll+ ; VAS-TnTI+ ; + flies were flightless showing that the VAS-TnT insert alone 
cannot restore flight ability. When the VAS-TnT insert was expressed, 30% of the 
upll+; VAS-TnT/+; dmej2-GAL41+ progeny were flighted (Figure 6.5, Table 6.3). This 
shows that some rescue can be achieved in the up! 1+ heterozygote females. Perhaps the 
presence of the hdp + allele in these flies allows for some rescuing. However, it should 
be noted that the GAL4 activation is not the same in every fly. Less active GAL4 in 
some of the progeny may account for incomplete rescue. Such was the situation for the 
cpb knockdown flies in Chapter 4. 
For the mutants, control female flies bearing single copies of the VAS_Tny-K43H or UAS-
Tnr314@ inserts were flighted (+; + ; UAS_Tnr43HI+ and +; + ; UAS-Tny£314@/ +), 
suggesting that the inserts do not cause any muscle defects (Figure 6.6). Control up! 1+; 
+ ; UAS_Tny-K43HI+ and upll+; + ; UAS_Tny£314@/ + flies were flightless showing that 
the UAS_TnTmutationj inserts alone cannot restore flightness in upll+ heterozygote 
females. Expression of the UAS_Tnr43H insert in wild type heterozygote background 
(u/I+; + ; UAS_Tnr43Hldmej2-GAL4) resulted in flightless flies (Figure 6.6, Table 
6.3). However, expression of the UAS-Tny£314@ insert in wild type heterozygote 
background (upll+; + ; UAS-Tny£314@/dmej2-GAL4) resulted in 70% flight ability 
(Figure 6.6, Table 6.3). The presence of the wild type up+ gene may be responsible for 
the flight rescuing in this case. Polarized light microscopy should be performed for both 
the K43H and E314@ flightless progeny, so as to see if the muscle defects are less 
pronounced compared to the u/I+ flies. 
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Table 6.3 Number of female flies tested for the TnT mutation and deletion of the 
polyE tail. 
Genotype 
wt 
+ . + . dme"-GAL41+ 
" './ .. 
u/I+; +; + 
upll+ ; + ; dmefl-GAL41+ 
upll+; UAS-TnTI+; dmefl-GAL41+ 
+; +; UAS_Tnr43HI+ 
+ . + . UAS-TnyE3J4(g)I+ 
, , rrK.43H 
upll+; +; UAS-Tm 1+ 
upll+ ; +; UAS_TnyE3J4(g)I+ 
+ ; + ; UAS_Tnr43Hldmefl-GAL4 
+ ; + ; UAS-TnyE3J4(g)ldmefl-GAL4 
u/I+; +; UAS-Tnr43H/dmefl-GAL4 
upll+ ; + ; UAS-TnyE3l4(g)ldmefl-GAL4 
Number of flies 
20 
25 
12 
24 
28 
37 
45 
35 
31 
47 
28 
21 
18 
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UA S_Tn yE314@ and dmej2-GAL4 are present as single copies, 
0'1 
~ 
~ 
.g 
~ 
~ 
....... 
'"r:1 
~ 
e; 
Pl 
a 
o 
0.. g.. 
Cl> 
~ 
Cl> 
et 
a 
()"l 
"'"1 
Cl> 
e-
o.. 
~ 
6' 
(JQ 
&. 
Vl 
2-
~ g-
o 
(JQ 
"'"1 
~ 
o 
Vl 
(1) 
Vl 
6. Drosophila IFM as a model system for studying distal arthrogryposes 
6.4 Troponin I arthrogryposis mutants 
A single TnI gene in Drosophila encodes 13 exons and produces all Tnl isoforms. The 
adult IFM-specific TnI isoform is encoded by the constitutive exons and the alternative 
spliced exons 3, 6bl and 9 (Herranz et al., 2005). The mRNA of this isoform was 
isolated from the IFM of late pupae and cDNA was created. The gene was inserted in 
the pUAST vector to create flies carrying the UAS-TnT insert. The Drosophila 
IFM-specific TnI protein sequence is 87 amino acids longer than the human fast skeletal 
muscle Tnl. The two proteins show only 25% homology (Figure 6.7). The 
UAS_Tnr245@, UAS_Tnt'256G, UAS _TnpK257 and UAS_Tnp E258 mutant constructs were 
created using whole plasmid mutagenesis to model arthrogryposis in Drosophila. 
Drosophila 
Human 
Drosophila 
Human 
Drosophila 
Human 
DrOsophila 
Human 
Drosophila 
Human 
MADDEKKAAAPAAAPAAAAKPAAPAAAPAANGKAAPAANGKAAPAAAAAPAGPPKDPNDP 60 
KVKAEEAKKAKQAEIERKRAEVRKRMEEASKAKKAKKGFMTPERKKKLRLLLRKKAAEEL 120 
----------------------------MSQCKKRNR- - AITARRQHLKSVMLQlAATEL 30 
* ** * * ** ** 
KKEQERKAAERRRIIEERCGSPRNLSDASEGELQEICEEYYERMYICEGQKWDLEYEVRK 180 
EKEESRREAEKQNYLAEHCPPLHIPGSMS--EVQELCKQLHAKIDAAEEEKYDMEVRVQK BB 
** * ** * * * * ** * * * * * * * 
KDWEINDLNAQVNDLRGKFVKPALKKVSKYENKFAKLQK---KAAEFNFRNQLKVVKKKE 237 
TSKELEDMNQKLFDLRGKFKRPPLRRVRMSADAMLKALLGSKHKVCMDLRANLKQVKKED 148 
* * * ****** * * * * * ** *** 
FTLEEEE EKKPDWSK---GKPGD EVEAEA 269 
TEKERDLRDVG- DWRKNIEEKSGMEGRKKMFESES 1B2 
* ** * * * * * * 
Figure 6.7. Sequence alignment of Homo sapiens troponin I type 1 (skeletal, fast) 
(TNNI2) and Drosophila melanogaster IFM specific troponin I isoform. The human 
TnI residues R156@, R174G, t.K175 i1K176 are highlighted in yellow and the 
Drosophila homologues K245@, V256G, t.K257 and Llli258 are highlighted in cyan. 
Sequence alignment was performed using Clustal W2 software. Accession number for 
the Drosophila TnI is NM_167608.l and for the human TNNI2 is NP _001139313.l. 
The asterisk denotes conserved residues. 
The wild type UAS-Tnr construct was expressed in a hdp3 background. If expression of 
wild type TnI in the IFM restored the flight ability or the muscle abnormalities of the 
hdp3 mutant it would suggest that the UAS _TnpmutGtiOnJ inserts can also be adequately 
expressed. Hence, this system could be used to express and study the UA _TnpmlllationJ 
constructs. The mating scheme to obtain lines expressing the UAS-TnI and dmej2-GAL4 
inserts in hd/ backgrounds is shown in Figure 2.6.3 of Chapter 2. Due to time 
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constraints, the pupae from these crosses were grown at 29°C where the GAL4 activity 
is higher instead of25 QC, which was the case for the UAS-TnTconstructs. 
Control flies carrying a single copy of the dmef2-GAL4 or the UAS-Tnt inserts are 
flighted (Figure 6.4) showing that the inserts does not cause any muscle defects. Control 
hdp3; UAS-TnTI+ ; + and hdp3; +; dmef2-GAL4 male flies were flightless showing that 
the UAS-TnT or the dmef2-GAL4 inserts alone cannot rescue the hdp 3 phenotype. Male 
progeny expressing wild type TnI in hdp3 background (hdp 3; UAS-Tnt /+; dmef2-
GAL41+) from crosses kept at 29°C (Figure 6.8, Table 6.4) were 100 % flighted 
indicating that the dmef2-GAL4 driver can achieve expression of the UAS-TnI inserts at 
high enough levels to rescue the flight ability of hdp3 (Figure 6.8, Table 6.4). However, 
overexpression of Tn! in males already bearing the wild type TnI copy (+; UAS-Tnt /+; 
dmef2-GA L 41+ ) resulted in flight reduction. 
Control TnI male flies bearing only the UAS_Tn/mutationj inserts were flighted suggesting 
that the integration of the inserts is not affecting muscle function. Control male hdp 3; + 
; UAS_Tnl<245@, hdl; + ; UAS_TnIV256G, hdl; + ; UAS_TnpK257 and hdp3; + ; UAS-
TnpA258 flies were flightless showing that the UAS-Tnpmutationj inserts alone cannot 
rescue the hdl phenotype. In the presence of the dmef2-GAL4 driver the Tnr245@ 
mutation resulted 14 % flighted progeny (hdp3; +; UAS_Tnr245@ ; dmef2-GAL4), 
TnIV256G mutation resulted 3.57 % flighted progeny (hdp3; + ; UAS_Tnl256G ; dmef2-
GAL4), the TnpK257 mutation resulted in 44 % flighted progeny (hdp 3; + ; UAS_Tnr K257 
; dmej2-GAL4), whereas the UAS_TnpE258 mutation resulted in 40 % flighted progeny 
(hdp3; + ; UAS_TnpE258 ; dmej2-GAL4) (Figure 6.8, Table 6.4). These results suggest 
that the mutations affect muscle function. However, in contrast to the male TnI null 
(hdp\ the K245@ and ~K257 arthrogryposis mutants and to a lesser extent the V256G 
and ~E258 ones, form birefringent dorso ventral and dorsal longitudinal muscles 
(Figure 6.9). Hence, they suppress to different degrees the muscle degeneration 
phenotype of the TnI null. As this work was the last part of the project there was not 
enough time to study these mutants further and to express the UAS-Tnt constructs in 
hdp31+ heterozygote females. 
In the presence of a single wild type TnI copy expressing the four mutant inserts using 
the dmej2-GAL4 driver resulted in reduced flight ability compared to the wild type 
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which was mostly pronounced in the Tnr245@ (75 % flight ability) TnIV256G (64 % flight 
ability), and TnlK257 (62 % flight ability) and TnlE258 (75 % flight ability) mutants 
(Figure 6.8, Table 6.4). The presence of excess Tnl protein when the VAS-TnT was 
expressed in wild type (hdp +) background also resulted in reduced flight ability. 
Table 6.4 Number of male flies tested for the Tnl arthrogryposis mutations. 
Genotype 
wt 
+ ; + ; dmej2-GAL4/+ 
hdp3/y; +; dmej2-GAL41+ 
hdp31Y; +; + 
+IY ; VAS-Tnt; + 
hdp3/y; VAS-Tnt; + 
+/Y; +; VAS-TnT/dmej2-GAL4 
hdp31Y; VAS-TnT;dmej2-GAL4 
+/Y ; + ; VAS-Tnr245@1+ 
+/Y ; + ; VAS- TnIV256G /+ 
+IY . + . VAS_TnPK257/+ , , 
+/Y; +; VAS_TnpE2581+ 
hdp3/y; +; VAS_Tnr245@/+ 
hdp3/y; + ; VAS_TnIV256G/+ 
hdp3/y; + ; VAS_TnpK257/+ 
hdl/Y; +; VAS_TnpE2581+ 
hdp31Y; +; VAS-Tnr245@ldmej2-GAL4 
hdp3lY; +; VAS_Tnl256Gldmej2-GAL4 
hdp31Y; +; VAS_TnIK257Idmej2-GAL4 
hdp31Y; +; VAS-TnIE258/dmej2-GAL4 
+/Y; +; VAS-Tnr245@ldmej2-GAL4 
+IY; +; VAS_TnIV256Gldmej2-GAL4 
+IY; +; VAS_TnIK257Idmej2-GAL4 
+IY ; + ; VAS_TnIE258Idmej2-GAL4 
Number of flies 
26 
41 
30 
31 
28 
19 
35 
52 
50 
82 
63 
24 
25 
31 
28 
24 
35 
32 
36 
30 
45 
50 
32 
29 
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Figure 6.8. Flight testing of male wild type VAS-TnT flies and mutant variants at 29°C. The inserts: UAS-TnT, UAS_Tnl(245@, 
UAS_TnIV256G, UAS_TnIK257, UAS_TnIE258 and dmej2-GAL4 are present as single copies. 
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6. Drosophila IFM as a model system for studying distal arthrogryposes 
WT 
hdp3/y ; + ; UAS-Tn (245@/dmef2-GAL4 hdp3/y ; + ; UAS- TnIV256G/dmef2_GAL4 
3 ,J1K257 hdp /Y; + ; UAS-Tm /dmef2-GAL4 hdp3/y; + ; UAS-TnfE258/dmef2-GAL4 
Figure 6.9. Polarized light microscopy of male UAS-TnI mutant variants. 
Arrowheads show hypercontracted muscles detached from the cuticle. 
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6.5 Discussion 
TnI and TnT arthrogryposis mutations were expressed using the GAL41UAS system. The 
mutations were expressed in IFM TnI (hdp3) and TnT (up!) null backgrounds. The null 
mutations result in lack of Tnl and TnT mRNA in the IFM (Nongthomba et al., 2003; 
Nongthomba et al., 2007). Male flies are flightless; their muscles are hypercontracted 
and display the wings up phenotype. To establish if the mutant genes can be expressed 
sufficiently using this strategy the nulls had to be rescued by expressing the wild type 
genes. Rescuing the flight ability or the muscle phenotype would show that this system 
can be used to express the mutant constructs. 
However, the IFM Upl null could not be rescued using the dmej2-GAL4 driver and the 
flies were flightless and still displayed the wings up phenotype. The UH3-GAL4 driver 
has been used more recently to express the UAS-TnT" construct at 25 ·C by Prof. 
Sparrow (personal communication) and this did not rescue the phenotype of the up! 
mutation either. The IFM-specific isoform is encoded by an mRNA made by 
constitutive exons and by the mutually exclusive lOa and lOb exons (Fyrberg et al., 
1990; Benoist et al., 1998; Herranz et aI., 2005; Nongthomba et al., 2007). The ex on 
lOb isoform is present during all stages of muscle development and later becomes 
replaced by the ex on lOa isoform, which is present in late pupae and adult flies 
(Nongthomba et al., 2007). The u/ mutation causes defective splicing of the alternative 
TnT exon lOa but does not affect expression of the exon lOb isoform. The UAS-TnT 
encoding the exon lOa isoform was expressed in an u/ background from the early 
pupal stage. This is concomitant with the expression of the native ex on lOb isoform. 
Expression of exon lOa isoform during early development may interfere with the 
function of exon lOb isoform. This could result in defective muscle development 
instead of rescuing the up! mutation. In fact, others have shown that the overexpression 
of TnT in the IFM using the very strong Act88F gene promoter causes flightless flies 
characterized by a decrease in the levels of thin filament proteins (Marco-Ferreres et al., 
2005). The authors report the increase in TnT during early stages of adult muscle 
formation followed by a decrease in the TnT, tropomyosin, Tnl and actin levels. The 
decrease in thin filament protein levels was not only due to degradation but also their 
mRNA levels were also diminished. Hence, early expression of the ex on lOa isoform 
up! pupae may lead to muscle abnormalities. Functional differences between the lOa 
and lOb TnT isoforms have been hypothesized to occur due to differences in 
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phosphorylation sites (Nongthomba et al., 2007). Since the IFM Upl null could not be 
rescued here, Drosophila cannot be used yet as a model system to study UAS-TnT 
mutants. 
If the concomitant expression of the IFM adult TnT lOa isoform with the lOb is indeed 
causing defects in early pupal stages, one could use a driver that permits the expression 
of the UAS-TnT constructs at late stages of pupal development. Also, using the existing 
drivers one could perform shifts in temperature so that the flies are grown at 18 ·C 
where the GAL4 activity is weak and then transferred to 25 ·C or 29 ·C degrees where 
the GAL4 activity is stronger. The GAL80ts driver, which is the native repressor of 
GAL4 in yeast (Lohr et al., 1995) could also be used. The GAL4 transcription activation 
domain is blocked at temperatures below 30 ·C degrees when the GAL80ts driver 
becomes active. Introduction of the GAL80ts driver into the system could be a possible 
way to circumvent parallel expression of the lOb and lOa isoforms during early pupal 
stages. 
Rescuing of the TnI hemizygote null was successful. Expression of the Tnl 
arthrogryposis mutations resulted in either flighted or flightless flies with some 
mutations affecting flight ability more than others. From actin-myosin ATPase studies 
using the human proteins, the mutations have been hypothesized to result in 
hypercontractile phenotypes (Robinson et al., 2006). In Drosophila, homologous 
transgenic mutations resulted in hypercontracted muscles. One way to study which Tnl 
function is affected is to search for suppressor mutations in other proteins or in Tnl. The 
mutations in TnI are located at one of the interaction sites with tropomyosin (Ferrus, 
2005). Hence, suppressor mutations in the tropomyosin gene could be tested. There was 
not enough time during this project to test the TnI gene mutations in hdl/+ 
heterozygote females, which is an important experiment to perform. 
There was not enough time to further analyze the TnI and TnTtransgenic lines presented 
in this chapter. An important experiment would be to compare the level of expression of 
the TnT and TnI genes between the wild type and transgenic flies for the different 
constructs using RT-PCR. 
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6.6 Summary 
The inability to rescue the flight ability or muscle abnormalities of the Upl mutant shows 
that Drosophila cannot be used yet for the study of UAS-TnT mutants. Expression of 
wild type TnI in the IFM rescued flight ability. Some TnI mutants were flighted whereas 
others displayed the hypercontracted muscle phenotype. The biochemical study of these 
mutants was not completed. 
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Chapter 7: General Discussion 
7.1. Drosophila IFM as a possible model for studying human nemaline 
myopathy 
Of the currently known 3714 human disease genes, 657 are estimated to have 
sufficiently well conserved homologues to be analyzed in Drosophila. Amongst the 
various muscle components there is a variation in gene redundancy, sequence identity, 
inserts and isoform splicing. The conserved homologues of the sarcomeric components 
some show high protein sequence similarity e.g. Act88F and a-actinin, but others show 
poor sequence similarity e.g. the TnI and TnT. The work presented here dealt with both 
highly and poorly conserved homologues, the Act88F actin and the troponin complex, 
with respect to modelling two human muscle diseases. 
The high sequence similarity between ACTA1 and Act88F has allowed the study of 7 
different NM-causing point mutations in the IFM. These actin mutations were chosen 
because they result in different disease symptoms in humans; actin filament aggregate 
myopathy, nemaline myopathy, intranuclear rods and congenital fibre type 
disproportion. All the mutants resulted in Z-disc and M-line disruption, zebra bodies, 
myofibre splitting/branching, 'whirling' of actin filaments and areas of 
broken/disorganised thick and thin filaments; which are seen in human patients. 
Concerning the major disease phenotypes, large nemaline bodies were not observed, 
however the IRs were recapitulated by the mutants that expressed only the human IR-
linked mutations. Actin filament aggregate myopathy was not observed, though an actin 
filament aggregate myopathy-like phenotype was found in one case but it was not as 
pronounced as in humans. 
Each of the Act88F mutants displayed an array of different characteristics, though they 
all produced a general muscle weakness (flightlessness) caused by the inability of the 
IFM to form normal myofibrils. However, at day 1 the Il36M mutation resulted in some 
flight ability and the R3 72H mutation in completely flighted flies. The myofibrils of 
Act88F136M/+ and Act88V372H/+ heterozygotes appeared relatively and completely 
nonnal at day 1, respectively. The Il36M mutation resulted in characteristic features of 
NM such as occasional and small zebra bodies. It was observed with the R372H 
mutation that the muscle progressively deteriorates and is accompanied by the 
fonnation of zebra bodies due to use over time. This suggested that there can be at least 
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two pathways leading to nemaline myopathy. The first pathway is characterized by an 
inability to form normal sarcomeres and the second pathway seen in the case of the 
Act88r372H mutant by an inability to maintain thin filament and subsequently 
sarcomere structure, followed by the appearance of aberrant Z-disc structures. 
Another mutation, G 15R, resulted in greater muscle disorganisation than the I 136M and 
R372H mutations, with very large zebra bodies seen throughout the muscle and within 
the myofibrils themselves. The V163M mutation resulted in IRs, a novel ring like Z-
disc structure and an actin filament aggregate myopathy-like phenotype. Actin filament 
aggregate myopathy is usually associated with severe clinical phenotypes in humans. In 
Drosophila based on the characteristics of each mutation V163M is a severe mutation. 
A different amino acid substitution of the same residue, V163L, resulted in all the above 
features with the exception of the actin filament aggregate myopathy-like phenotype 
and occasionally abolished myofibril formation in the homozygous state. These features 
were also caused by the D 154N mutation, which always abolished myofibril formation 
in the homozygous state. The actin filament aggregate myopathy-like phenotype was 
not observed here either. Actin filament aggregate myopathy and intranuclear rod 
myopathy are often missed in the human biopsies due to their rarity. This could also be 
the case here and if more flies were examined it might be possible to identify actin 
filament agg~egate myopathy in flies with the D154N and V163L mutations. However, 
the AM phenotype in flies is only identifiable by EM, which is an expensive and time-
consuming method. In addition the AM-like aggregation seen in the V163M mutant is 
very small and difficult to find by eye. Hence, further processing of flies to identify AM 
with this method was not pursued. 
The D292V mutation was studied because it causes congenital fibre type disproportion 
(CFTD), a disease that many patients with nemaline myopathy exhibit (lannaccone et 
al., 1987; Miike et al., 1986; Ryan et al., 2003). In those patients, the type I muscle 
fibres are uniformly smaller compared to type 11 fibres. Although loss of sarcomeres is 
an important cause of weakness in A eTA 1 nemaline myopathies, it is not the case for 
ACTA1 CFTD as a disease because sarcomeric structure is intact (Laing et al., 2004; 
Clarke et al., 2007). Hence, there might be a distinct characteristic underlying CFTD. 
The distribution of mutant ACTA 1 is unlikely to be a cause as it is produced in all 
skeletal muscle fibres. An explanation could be that the presence of different protein 
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isoforms between type I and 11 fibres result in the mutant actin disrupting a type 1-
specific interaction with tropomyosin or with another actin-binding protein. In 
Drosophila, IFM abnormal fibre type I or 11 differentiation cannot be studied as the IFM 
consist of only one fibre type. Nevertheless, Drosophila Act88jiJ292v mutants displayed 
relatively normal and disrupted myofibrils, with some being half the size of the normal 
ones. This mutation resulted in sarcomeric defects in Drosophila IFM and in 
cytoplasmic aggregates in culture cell studies (Clarke et al., 2007). In humans this 
mutation does not disrupt sarcomere structure nor does it cause sarcoplasmic rods 
(Laing et al., 2004). The reason behind this difference is probably the fact that 
Drosophila IFM lack the continuous protein turnover and muscle repair mechanisms 
present in the patients' musculature. 
In nemaline myopathy patients the proportion of individual myofibres occupied with 
nemaline rods, the size of the rod clusters and the degree of myofibrillar disruption 
appear to correlate with clinical severity. In the muscle fibres of individuals that exhibit 
the mild nemaline phenotype there is very little sarcomeric disruption by rods and the 
muscle fibres appear normal at the ultra-structural level. In contrast, two individuals 
affected with the lethal severe congenital form of the disease showed both sarcomeric 
actin disorganization and regions of the myofibres devoid of sarcomeres (Ilovski et al., 
2001). An important question is if the degree of sarcomeric disruption in ACTAl 
nemaline myopathies is an important factor that influences whether nemaline bodies 
form in vivo (Clarke et al., 2007). Studying nemaline myopathy mutations in 
Drosophila IFM showed that the degree of myofibrillar abnormalities correlates with 
the formation of sarcoplasmic and nuclear aggregates. The D154N, V163L and V163M 
mutations showed the most pronounced sarcomeric disruption and resulted in 
sarcoplasmic and intranuclear rods. Whereas the GI5R, I136M and D292V that showed 
less sarcomeric disruption did not result in any type of rods. 
For the same mutation it was noted that the severity amongst flies of the same line 
varied. This is not only a feature of Drosophila IF M, but also of human patients 
(SparrOW et al., 2003). In some cases similar phenotypes are observed in more than one 
patient such as the H42T mutation where 3 out of 4 patients show IR (Nowak et al., 
1999; Sparrow et al., 2003); Q43R leading to typical nemaline myopathy in 2 patients 
(Wallgren-Pettersson and Laing, 2001; Sparrow et al., 2003); H75LIR leading to severe 
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nemaline myopathy in 2 patients (Laing et al., 2009); Nl17T leading to mild nemaline 
myopathy in 2 patients (Sparrow et al., 2003) and M134V resulting in mild nemaline 
myopathy in 2 patients (Nowak et al., 1999; Jungbluth et al., 2001; Sparrow et al., 
2003). In contrast, the G270C mutation showed high variation in phenotypes across 8 
patients from mild to severe nemaline myopathy (Ilovski et al., 2001; Sparrow et al., 
2003). Furthermore, apart from the variations in severity between unrelated patients 
with the same mutation there is also intra-familial variation. This was also true here for 
the Drosophila V163L mutation, which in the homozygous state would some times 
abolish myofibril formation and other times not. Also all three IR-linked mutations 
sometimes displayed the. wings-up phenotype when a single copy of the mutant actin 
and two of the wild type were present. These observations suggest that other factors 
could be affecting the IRs caused by actin mutations in both flies and humans. 
7.2 Actin rods 
The pathological hallmark of nemaline myopathy is the presence of dark staining bodies 
called nemaline rods. In the EM these rods appear as electron-dense bodies of different 
size and shape and usually found in the sarcoplasm or within the sarcomere. 
Occasionally they emerge from the Z-discs or they accumulate in an area lacking 
sarcomeric material. The rods do not accumulate uniformly within the muscle, as some 
myofibrils seem to contain more rods than others. The rods consist of actin and other Z-
disc proteins, however it is unknown whether it is the mutant or the wild type actin or 
both (Laing et al., 2009). 
In Drosophila large nemaline bodies were rarely observed (by whole muscle staining). 
However, small Z-body aggregates were frequently observed in the muscles of the very 
severe intranuclear rod-linked Act88F mutants. Differences in the size of the rods and 
sarcomeric disruption between patients and Drosophila are probably due to the very 
much reduced levels of muscle protein expression and repair mechanisms in adult flies 
(Smith et al., 1970). In humans muscle repair mechanisms may prevent muscle 
disorganisation and continuous protein turnover will support the formation of protein 
aggregates. For example the intranuclear rod-linked 60 hour APF pupae already show 
severe muscle disarray and Z-body aggregates formation. As there are reduced levels of 
protein turnover in the adult fly, the Z-body aggregates cannot accumulate more protein 
to match the size of the human ones. 
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Interestingly in flies carrying both the mutant Act88FVl63L and wild type GFPAct88r 
alleles, the GFP signal was excluded from the phalloidin-stained sarcoplasmic actin 
rods. This suggested that only the mutant ACT88FvI63L actin is present in the 
sarcoplasmic rods. Indeed, expressing GFPAct88FVl63L in the IFM resulted in very large 
sarcoplasmic GFP-aggregates. Never before has it been shown that in muscles the 
mutant actin alone accumulates in the sarcoplasmic rods, which may also be the case in 
humans. An explanation for the large GFPACT88FvI63L aggregates is that they may be 
due to higher levels of expression driven by GAL4, as opposed to the native Act88F 
promoter used to express Act88FV163L. This supports the hypothesis that the absence of 
large nemaline bodies in the IFM is due to the lack of protein turnover in the adult flies. 
The ACTAl mutations causing sarcoplasmic and intranuclear rods in patients also form 
identical structures in cell cultures studies fibroblasts, myotubes (Costa et al., 2004; 
Ilovski et al., 2004; Domazetovska et al., 2007a, b). However, the tissue culture studies 
are not always ideal as the R183G and the D292V CFTD-causing mutation caused 
intranuclear rods cytoplasmic rods, respectively to form in culture despite the fact that 
these phenotypes were not found in the patients (Ilovski et al., 2004; Clarke et al., 
2007). There could be two reasons for that disagreement: 1) the artificial situations in 
tissue cultures may result in different effects compared to those seen in patients (Feng 
and Marston, 2009) or 2) because some nemaline myopathy characteristics are 
overlooked in the biopsies (Ryan et al., 2003). In Drosophila IFM the intranuclear rod 
phenotypes were only observed in transgenics expressing human intranuclear rod-linked 
ACT A 1 mutations further highlighting the suitability of this model for studying 
congenital actin myopathies. 
7.2.1 Sarcoplasmic rods are caused by inability to cap actin 
studying congenital actin myopathies in Drosophila IFM not only allowed the 
identification of the actin species present in the sarcoplasmic rods but also helped to 
understand how the rods may be forming. A mutant CP in chicken myoblasts lacking 
the C-terminal ~-tentacle region results in abnormal phalloidin-stained actin aggregates 
resembling those seen by whole muscle immunostaining in the Drosophila IFM D 154N 
and V163LIM Act88F mutants (Schafer et al., 1985). The actin D154 and V163 
residues reside near the proposed binding site for the ~-tentacle of CP. Thus mutations 
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in these residues could affect CPb binding at the fast growing end of the thin filaments 
resulting in aberrant Z-disc structures and actin aggregates. When Drosophila cpb was 
knocked down by RNAi using the IF M-specific (UH3) and pan muscle (dmej2) GAL4 
drivers, Z-ring structures were observed with both drivers resembling those seen in the 
intranuclear rod-linked mutants. These results suggested that a failure or reduced ability 
to cap the actin barbed ends resulting in continuous addition of actin monomers at the 
Z-disc alters the Z-disc structure and results in actin aggregates and aberrant Z-disc 
structures. Failure to cap the thin filament barbed ends could be one of the underlying 
cause of nemaline bodies observed in human patients. 
In support of these observations when a Cpp 1 mutant that poorly binds actin was 
expressed in mice, it resulted in myofibril disruption with sarcomeric and Z-disc defects 
(Hart and Cooper, 1999). Moreover, mutations in Drosophila genes encoding the 
capping protein a and ~ subunits result in abnormal accumulation of actin in eye-
imaginal discs and retinal degeneration (Delalle et al., 2005) or dramatically increase F-
actin levels in Drosophila bristles (Hopmann and Miller, 2003). Together these 
observations support the hypothesis that reduced capping of the barbed end of the thin 
filaments could result in the formation of sarcoplasmic actin rods. 
Interestingly, chicken cultured myotubes transfected with a-actinin mutants that lack 
any part of the region from the beginning of the fourth spectrin repeat to the start of the 
EF hands present a-actinin doublets, Z-line hypertrophy (up to 20-fold of the typical 
width) and nemaline-like body formation (Zhang et al., 2009). All these phenotypes 
were also seen in the cpb knockdown flies studied here. The reported a-actinin doublets 
are reminiscent of the splitting Z-discs shown in the cpb knockdown flies. 
7.3 Actin in the nucleus 
Actin has no nuclear localisation signal (NLS) but cofilin, a G-actin and F-actin binding 
protein, has an NLS and can translocate actin in the nucleus (Ohta 1989; Pendleton et 
al., 2003). The concentration of nuclear actin is 100-1000 times greater than the 
concentration required for actin to spontaneously polymerize in vitro (Pollard et al., 
2000). The pool of polymerized actin in the nucleus was found to be 20% of the total 
nuclear actin (McDonald et al., 2006). 
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Several actin binding proteins have been detected in the nucleus such as, profilin (binds 
to G-actin and promotes nucleotide exchange) (Skare et al., 2003), the point end 
binding proteins CapG (Onoda et al., 1993), tropomodulin (Kong and Kedes, 2004), the 
barbed end binding protein CapZ (Ankenbauer et al., 1989), cofilin (Nishida et al., 
1987) and zyxin (promotes actin-polymerization) (Nix et al., 1997; Fradelizi et al., 
2001). This indicates that although actin may not necessarily be in a polymerized state, 
it must still be in a functional form. In fact nuclear actin has been associated with 
diverse nuclear activities (reviewed in 10ckusch et al., 2006) such as chromatin 
remodelling, nuclear structure and stability, mRNA export and RNA polymerase I, 11, 
III activity. 
Normally cytoplasmic F-actin is identifiable by its binding to the toxin phalloidin. 
However, cell culture studies have shown that the filamentous nuclear actin structures 
are not stained by phalloidin. This suggested that the form of nuclear F -actin differs 
from the conventional form of F -actin in the cytoplasm (Pederson and Aebi, 2002, 
2005; 10ckusch et al., 2006). A monoclonal actin antibody generated against the skeletal 
muscle actin-profilin complex recognizes a specific conformation of the actin molecule 
that is not prevalent in the cytoplasm but is present in the nuclei of certain cell types 
(Gonsior et al., 1999). The antibody recognises three regions of actin that are buried 
upon polymerisation. 
In Drosophila IFM the intranuclear actin rods 'are stained with phalloidin. This is most 
likely due to the fact that they polymerize in such large structures. The same was 
observed for cell myoblast studies (Domazetovska et al., 2007 a; b). 
7.4 Actin rods in the nucleus 
A nuclear exporter was recently discovered that is specific for the profilin-actin 
complex named exportin 6 (Exp6). Exp6 is a conserved protein found in a wide variety 
of organisms from amoeba to vertebrates (Stiiven et al., 2003). Knockdown of 
Exportin 6 in Drosophila Schneider cells by RNAi results in the formation of actin 
aggregates inside the nucleus (Stilven et al., 2003). Nuclear actin aggregates have also 
been visualized in cells that were subjected to stress such as heat shock (Welch and 
Suhan, 1985; Ono et al., 1996) or ATP depletion (Sanger et al., 1983). Treatment with 
toxins such as dimethylsulfoxide was also shown to result in paracrystaline actin arrays 
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in the nucleus of the slime mould Dictyostelium amoebae (Fukui, 1978; Fukui and 
Katsumaru, 1979; Ono et al., 1993). However, nuclear actin aggregates can also appear 
naturally during spore formation by Dictyostelium discoideum (Fukui and Katsumaru, 
1979; Sameshima et al., 1994). Overexpression of leiomodin, an actin nucleator, has 
also been reported to result in the formation of intranuclear actin rods (Chereau et al., 
2008). Hence a variety of causes, from cell stress to disruption of actin binding proteins 
and proteins involved in the export of actin from the nucleus, can result in the formation 
of intranuclear rods. Several actin-binding proteins exist in the nucleus to support 
formation of actin aggregates. 
Actin is exported out of the nucleus through the CRMl exporter (Wada et al., 1998) and 
through exportin 6, as a profilin-actin complex (Stuven et al., 2003). Indeed actin 
cycling in the nucleus may even help to regulate actin levels (Miralles et al., 2003). The 
presence of actin rods in the nucleus suggests that the D154N, V163L1M mutations 
interfere with its export from the nucleus. This effect is strongest for V163L where the 
intranuclear rods were most common. Several reasons could account for the intranuclear 
actin rod phenotype seen in the Drosophila IFM and in human patients. The IR-linked 
residues are near the profilin binding site on actin. Therefore one explanation could be 
that mutations in these residues disrupt the profilin-actin interaction and the formation 
of the complex in the nucleus. Hence, exportin is unable to transport actin resulting in 
the mutant actin being retained in the nucleus and aggregating once certain levels of 
actin have accumulated. 
Actin has two putative nuclear export signals (170-181 and 211-222) that are highly 
conserved and have been shown to be functional by mutational analysis and cell 
transfection (Wada et al., 1998). The ACTAl mutations that lead to intranuclear rods in 
patients are not located within these sequences but some e.g. V163LIM are found close 
by (Figure 3.7) (Hutchinson et al., 2006) and they may affect nuclear export of actin. 
This lack of export via CRMl (G-actin) and Exp6 (profilin-actin complex) and coupled 
with increased levels of actin entering the nucleus would result in IRs. If the mutant 
actins are less stable in filaments, free mutant G-actin may have a higher probability of 
entering the nucleus. Interestingly, if levels of free tropomodulin increase in cell 
cultures, tropomodulin begins to be observed in the nucleus (Kong and Kedes, 2004). 
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Mouse myoblasts and fibroblasts transfected with GFP-tagged ACTA1 intranuclear rod-
mutants showed that the mutant actins can accumulate in the nucleus and form rod 
structures (Domazetovska et al., 2007 a; b). Live-cell imaging has demonstrated that the 
nuclear aggregates form within the nucleus rather than forming in the cytoplasm and 
then translocated to the nucleus (Domazetovska et al., 2007a). Hence, the nuclear 
environment supports the formation of intranuclear rods. However, it is not yet known if 
the wild type or mutant actin species is present in the human IRs. Here, it was possible 
to coexpress the wild type GFPAct88F and the Act88FVJ63L actin genes. This showed 
that the GFP signal is excluded from the IRs, suggesting that wild type actin is not 
present in the IRs. When the wild type Act88F and the GFPAct88FVJ63L actin genes 
were coexpressed, the mutant GFP-tagged actin was incorporated into the IRs, 
suggesting that the mutant actin is only present in the IRs. However, coexpression of 
wild type GFP-tagged actin and V163M untagged actin in mouse myoblasts showed 
that the wild type GFP-tagged actin also localised in the intranuclear rods 
(Domazetovska et al., 2007b). These observations were in mononucleated cells and not 
in the mature multinucleated muscle fibres of a whole organism, which is the case in 
this thesis. Artificial cell culture environments may not produce different effects 
compared to a study in the context of a whole organism. 
The intranuclear rods seen in Drosophila IFM, like those reported in the tissue culture 
studies distort the shape of the nuclei. In fact those in cell culture studies were shown to 
be motile (Domazetovska et al., 2007b). In cells the Z-disc proteins a-actinin, y-filamin 
and myotilin have been reported to be components of intranuclear actin rods 
(Domazetovska et al., 2007a). Here, the Z-disc protein kettin was not found to 
colocalize with the intranuclear rods by immunostaining. 
Interestingly, amongst the different thin filament proteins causing congenital 
myopathies, only mutations in actin result in intranuclear rods. 
7.5 Understanding the effect of a single mutation in muscle structure 
To date there are more than, 196 known ACTA1 mutations responsible for the nemaline 
phenotype (Laing et al., 2009). The mutations are spread throughout the actin gene 
hence actin interactions with many different proteins can be affected. Actin is a protein 
involved in many cell functions with numerous binding partners. Some mutations in 
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actin are likely to disrupt more than one protein-protein interactions leading to loss of 
functions and making it difficult to pinpoint which interaction is affected. Drosophila 
IFM is a tractable system for studying the effects of mutations in muscle structure. An 
unanswered question is whether the muscle weakness in NM patients is solely due to 
the skeletal muscle atrophy. It is unknown whether certain mutations could induce 
specific alterations in the contractile function, which would contribute to the muscle 
weakness. This question was answered by studies in the Act88?J292v and Act88p-R372H 
mutants. 
7.5.1 Characterisation of the R372H mutation using genetic, mechanical and 
biochemical approaches 
The R372H mutant allowed a study of how the progression of the Drosophila 
equivalent of NM using different approaches. First, confining the flies to prevent the 
muscles from contracting showed that the muscle damage is use-dependant in this 
mutant. Single myofibril mechanical experiments showed that the mutant myofibrils 
were less stiff compared to wild type ones, and displayed plastic deformation. This 
suggested that the myofibrils were mechanically compromised consistent with the 
observation that the thin filaments appeared torn from the Z-discs of this mutant. The 
R372 residue is located in one of the a-actinin binding sites on actin identified by other 
(Lebart et al., 1993). This raised the hypothesis that the R372H mutation could affect 
the F-actinla-actinin interactions within the Z-discs, weakening the attachment of the 
thin filaments to the Z-disc. Fluorescence anisotropy measurements showed that the 
binding constant of the R372H mutant actin for a-actinin was indeed 13-fold weaker 
than with wild type actin. A 10-fold weakening in the F-actinla-actinin binding has also 
been reported in an ACTAl K336E mutation associated with nemaline myopathy and 
cardiomyopathy (D' Amico et al., 2006). The Act88p-R372H mutant has allowed to use 
several methods in order to understand how a single mutation affects muscle structure. 
Mutations of the a-actmm gene are known, which result in nemaline bodies. For 
example deletion of the COOH-terminal residues 730-897 of chicken a-actinin results in 
hypertrophy of the Z-disc in 7-8 day myotubes, which resembles nemaline bodies 
(Schultheiss et al., 1992; Lin et al., 1998). Another a-actinin mutant lacking the region 
from the beginning of the fourth spectrin repeat to the start of the EF hands also results 
in Z-disc hypertrophy, formation of nemaline-like bodies and splitting of the Z-discs as 
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seen by a-actinin doublets In immunofluorescence staining of cultured chicken 
myotubes (Zhang et al., 2009). 
Similar to the Act88j!?372H mut~t, other Drosophila models of a human skeletal muscle 
disease are reported that have been studied both genetically and biochemically 
(Shcherbata et al., 2007). Fluorescence anisotropy was used to measure the human and 
Drosophila versions of dystroglycan (Dg) interacting with both human and Drosophila 
dystrophins (Dys). It was found that Drosophila Dg binds both human and Drosophila 
Dys with similar KI (- 20 JlM). Human Dg also binds Dys from both species with 
similar KI (- 5 IlM). These data showed that the Dys-Dg interaction is conserved 
between humans and Drosophila (Shcherbata et al., 2007), which further supports 
Drosophila is a suitable system for studying human muscle diseases. 
7.5.2 Genetic interactions revealed that D292V causes a hypocontractile phenotype 
The residue D292 forms part of the Tm binding site on actin and in vitro motility 
studies predicted that the CFTD D292V mutation obstructs actomyosin interactions by 
stabilizing tropomyosin in the 'OFF' state (Clarke et al., 2007). Indeed the 
ACT88FD292v mutation suppresses the hypercontractile phenotypes of the hdp2 and upJO/ 
mutants. This suggested that the presence of sarcomere defects caused by the 
ACT88FD292v is a consequence of functional abnormalities. This highlights the 
advantage of using a genetic organism whereby suppressor mutations counteract the 
effect of another mutation. This allows the interpretation of the underlying malfunction 
due to a mutation. The D292V adds to another four Act88F mutations that form part of 
the tropomyosin binding site on actin, and were previously shown to suppress the hdp2 
and up/OJ mutations (Sarah Haigh PhD thesis, 2003, University of York). 
The hypercontractile phenotype displayed by the troponin mutants can be suppressed by 
mutations in other proteins of the contractile machinery. For example the hdp2 
phenotype can be suppressed by mutations in genes encoding tropomyosin (also 
suppressor of up/OJ) (Naimi et al., 2001), TnI (Prado et al., 1995) and the myosin heavy 
chain (Kronert et al., 1995; Nongthomba et al., 2003). The mutation in the tropomyosin 
h hd 2 d /0/ h . gene suppresses both t e rp an up p enotypes and IS thought to do so by 
disrupting the interactions ofTm with TnT and/or actin (Naimi et al., 2001). One of the 
TnI mutations is thought to affect its interaction with TnT and affects a region close to 
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the interaction site with TnC (Prado et al., 1995). Hence, it was proposed that 
hypercontraction results from misregulation of muscle contraction. The myosin heavy 
chain mutations map to two functionally important regions of the myosin head: the A TP 
binding and entry sites, which could perturb the myosin ATPase cycle and the actin-
binding domain that could stericalIy hinder the actomyosin interaction (Rayment et al., 
1993). In fact disrupting the effectiveness of the myosin head and thus the transduction 
of force to the thin filament can prevent hypercontraction in hdp2 flies crossed with 
myosin null mutants (BeaU and Fyrberg, 1991; Nongthomba et al., 2003). Based on 
these observations, it has been speculated that the force exerted by the myosin head can 
also drive hypercontraction. 
7.6 The effects of muscle protein mutations on Z-disc assembly 
Analysis of Act88F mutants has shown that the Z-disc structure can be affected in 
different ways and produce three phenotypes: Z-rings, zebra bodies and Z-body 
aggregates. The most likely explanation for these structures is that the mutant actin, 
unable to polymerise and incorporate normally into thin filaments, is still able to bind to 
actin binding proteins e.g. a-actinin and in doing so, forms these aberrant structures. 
In Drosophila actin and Troponin H (a tropomyosin isoform) have been demonstrated 
to localise to the zebra bodies by immuno-gold labelling (Dr Bullard, personal 
communication). In particular, the anti-actin antibody co-localises with the electron 
dense bodies and filaments between them. The anti-TnH antibody recognises the thin 
filaments that project from them. These findings suggest that the zebra bodies might be 
aberrant Z-discs. The spacing of the Z-discs in Drosophila zebra bodies is always 
-200 nm. An explanation for this regular spacing could be due to kettin, the high 
molecular weight modular protein present in Drosophila that spans from the Z-disc 
through the I-band and the edge of the A-band by binding to F-actin (Figure 7.1) 
(Bullard et al., 2005). Its NH2-terminaI domain is at the centre of the Z-disc (van 
Straaten et al., 1999) and spans 93 nm of the thin filaments protruding from the Z-disc 
with a further 30 nm located within the Z-disc (Figure 7.1) (van Straaten, et al., 1999). 
Two kettin molecules extending from the opposing Z-discs of a single sarcomere would 
result in regular - 200 nm spacings like the ones seen in the zebra bodies. Kettin 
consists of 35 Ig domains separated by short linker sequences and binds to actin with a 
stoichiometry of one Ig linker molecule to one actin subunit (van Straaten, et al., 1999), 
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suggesting that the function of kettin is to stabilize the thin fi lament (Burkart et al. 
2007). Hence this could be an explanation as to why thin fi laments are een protrud ing 
from the Z-discs of the zebra bodies. 
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F igure 7.1. R egular spacing of zebra bodies may be caused by kettin. Th Z-disc 
(Z) are shown as vertical dashed lines, 60 run in width, the actin th in fi lament h li e 
extend from the Z-disc, kettin is shown in blue with its N- and -termini indicated a N 
and C respectively and the length of a kettin polypeptide is indicated to b 123 run . 
Image produced by Or. Bullard. 
The zebra bodies may be formed due to abnormal sarcomere dev lopment or aft r 
splitting of the Z-disc due to mechanical damage (Figure 7.2). A break in th Z-disc 
followed by regeneration can lead to the zebra body phenotype. The nemaline-like 
bodies caused by cpb knockdown are very closely compacted zebra bodies. Th se are 
probably caused due to unregulated growth at the barbed end of the fil ament resulting in 
continuous addition of actin subunits. Insufficient capping of the thin fi lament at the 
barbed end could be resulting in Z-ring structures (e.g. intranuclear rod-li nked mutant 
and cpb knock down) . Mechanical damage of the Z-rings could further re ul t in z bra 
body formation. The Z-body aggregates do not show a zebra body pattern. In t ad th y 
appear as degraded Z-discs that maintain their parallel arrangement. Each d grading Z-
disc appears to consist of small Z-bodies. Sometimes the parallel arrangement i not 
fully maintained and an aggregation of Z-bodies forms. Other electron den e tructures 
without a distinguishable pattern may also be Z-body aggregations. 
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/ Zebra bodies 
Z-disc / Nemaline-like body 
Z-rings 
" I Z-bodyaggregates Z-body 
Figure 7.2. Different Z-disc phenotypes observed in the Act88F mutant. 
Abnonnalities in Z-disc structure result in nemaline-like bodie Z-rings z bra b die 
and Z-aggregates consisting of Z-bodies (indicated by red circle). 
7.7 Rescuing of the nemaline phenotype 
The ACTAl mutations affect many actin functions hence therapi focu d at individual 
functions are unlikely to be effective and the therapy of choice would b on that i 
independent of actin function. In humans upregulating the skeletal mu cle A TA 1 gene 
would not rescue the congenital actin myopathy phenotypes as it wou ld I ad to 
overexpression of both wild type and mutant variants. Another candidat that could b 
used is cardiac a -actin (ACTC). The skeletal and cardiac muscle A TA 1 and A T 
actins share 99 % sequence homology (Kurnar et al. , 1997). ACT 1 i th maj r 
striated actin in fetal heart and skeletal muscle and is replaced by A TA 1 during th 
later stages pre-parturition (Ordahl, 1986). Recently fetal A r, wa u ed to 
successfully rescue the skeletal muscle a -actin-null mice (Nowak et al. 2009) which 
otherwise die 9 days after birth (Crawford et al. , 2002). The rescu d mice survive to old 
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age, and their skeletal muscles show no gross pathological features. These findings 
raised the possibility that keeping fetal ACTC expressed continuously might provide a 
therapy for ACTAl diseases. Here, increasing the wild type Act88F levels restores 
normal muscle function in flightless Drosophila mutants heterozygous for a congenital 
actin myopathy mutation. However, some mutants were rescued better than others and 
this may also well be the case if wild type actin levels were increased in human 
congenital actin myopathy patients. In fact, apart from the D154N and V163L mutations 
that did not rescue as well as the rest of the mutants, genomic Act88F mutants are 
known that are not rescued at all (A138V, R256C, G268D, Sarah Haigh, 2003, PhD 
thesis, University of York). Taking this into consideration, if upregulating cardiac actin 
was to be used as a therapeutic treatment, Drosophila IFM could be used. as a quick 
system to assess which mutations could be rescued by increasing wild type actin levels. 
Administrated doses of L-tyrosine (250-3000 mg/day) have been successful in 
alleviating some of the nemaline myopathy symptoms (Ryan et aI., 2008). Five patients 
showed marked improvements concerning energy levels and exercise tolerance upon L-
tyrosine treatment without side effects. The mechanism of this result is not known but 
may be effective through effects of catecholamines on muscle (Dr. K. North personal 
communication). The ease of growing flies cheaply and fast in large numbers allows 
their use to screen for therapeutic drugs. However, both in nematodes and flies there are 
limitations in drug discovery. Given the fact that metabolic pathways in humans and 
invertebrates differ, administrating drugs to alleviate/cure disease symptoms in 
nematodes and flies may have an adverse effect in humans due to toxic metabolites, 
side-effects or they may no be effective at all. Nevertheless, C.elegans has been 
successfully used to discover the molecules serotonin and prednisone for the treatment 
of Duchenne Muscular Dystrophy symptoms (Bessou et al., 1998; Gaud et al., 2004; 
Carre-Pierrat et al., 2006). This example shows that it is possible to discover therapeutic 
drugs invertebrate models to treat human myopathies. 
Other proposed therapeutic approaches include allele-specific knock down by RNAi 
(Nowak et al., 2008). However this approach must be made effective in vivo (Xia et al., 
2006). Although 75% of the mutations are found in individual families, the Wobble 
hypothesis leads to a variation of the third base in each codon. Targeting these 
variations by RNAi would require sequencing of each family member and given the fact 
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that new mutations appear almost as frequently as known mutations, RNAi therapy 
would need to be tailored to each individual. Third, not all mutations are amenable to 
RNAi. With 40 % of the body mass consisting of muscle (Netter, 2006), targeting of 
effective treatments for the mutated protein is a daunting task. 
7.8 Is Drosophila IFM a good model for studying human thin filament 
myopathies? 
Drosophila is not a perfect model and limitations in using flies to study human muscle 
disease have been stated throughout this chapter. Briefly, the human phenotypes cannot 
always be reproduced (in this thesis actin filament aggregate myopathy) and if so it is 
not always identical (in this thesis IRs were loosely packed instead of rod-like). Key 
human sarcomeric proteins, e.g. nebulin and titin, are missing in flies and other 
sarcomeric proteins are present only in Drosophila e.g. sallimus isoforms, flightin. A 
pathogenic protein interacts with other cellular proteins; hence since some of the 
proteins in Drosophila are different from the putatively interacting proteins in man one 
could potentially obtain false positive or negative results of interaction if the human 
disease protein cannot interact with a genuine target protein in Drosophila. Sufficient 
amounts of protein, for example myosin and actin, can be extracted from the IFM for 
studying protein-protein interactions (Anson et al., 1995; Silva et al., 2003). However, 
some muscle proteins are not as abundant as myosin and actin, hence the choice of 
biophysical techniques can be limited for such proteins. Screening for potential drugs to 
alleviate NM mayor may not be possible in Drosophila given the differences in 
metabolic pathways to humans. 
Studying a muscle disorder in a system where there is no innate immune response or 
muscle regeneration can be a disadvantage, as the model does not fully mimic the 
disease. However, the absence of muscle regeneration (satellite cells have not been 
found) in adult Drosophila can act as an advantage over other animal systems where 
muscle repair mechanisms are in place. The mdx mice, with only a mild dystrophy, have 
been used for studying Duchenne Muscular Dystrophy (Sicinski et al., 1989). With the 
exception of the diaphragm, which is the most affected muscle, the other muscles show 
signs of the disease during the first six weeks of life, but subsequently show little signs 
of weakness and the mice have a near-normal lifespan (Collins et al., 2003). The 
dystrophy remains subtle and non-lethal in these mice as expansion of satellite cells 
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allows them to adapt to degeneration and show muscle recovery (reviewed in Durbeej 
and Campell, 2002). Unlike mouse models of muscle disease that often show modest 
phenotypes, introducing mutations in Drosophila equivalent genes can impair muscle 
structure and often recapitulate the clinical phenotypes of human patients (as discussed 
in Chapter 1, section 1.4). 
While Drosophila has only been used as a model for studying human muscle disease for 
the last decade, it is well equipped with all the necessary tools for studying skeletal 
myopathies. With a complete genome sequence and a plethora of genetic tools, genes 
can be identified, mapped, cloned rapidly and their expression can be spatially and 
temporally controlled. The organism is easily amenable and muscle defects can be 
readily identified and studied. Furthermore, if a mutation is too severe it may result to 
death thus preventing studying of the muscle defects in mice. The IFM, which are an 
isolated group of muscles, is dispensable for the viability of the fly and permits one to 
study even the most severe mutations. 
Drosophila IFM meet most of the requirements to act as a genetic model system for 
NM. Using the Act88F mutants it was possible to reproduce to some extent the different 
congenital actin myopathy phenotypes in the IFM such as intranuclear rods, sarcomeric 
and myofibrillar abnormalities. The actin-aggregate filament myopathy phenotype was 
not reproduced. Large nemaline bodies were only observed when GFPAct88FVJ63L was 
expressed using a GAL4 driver. This might be due to overexpression of the 
ACT88Fv163L or less likely the GFP moiety. Hence Drosophila IFM is a suitable model 
with which to study how the IR, sarcoplasmic rods and myofibrillar disarray are caused. 
Furthermore, genetic approaches have helped to understand how the large nemaline 
bodies form. It was shown that only mutant actin is present in the intranuclear and 
sarcoplasmic rods. For such a small organism, flies still permit a variety of biochemical 
and mechanical approaches to understand the mechanism of disease as demonstrated 
with the studies of the R3 72H ACT88F mutation in this thesis. Moreover each Act88F 
mutation resulted in different phenotypes and matched in severity those of the human 
patients. This further shows that Drosophila IFM is a suitable model for studying NM. 
However, the work on troponins and their role in arthrogryposis has raised issues 
concerning the use of Drosophila in studying this disease. First the Drosophila TnI and 
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TnT genes share little homology to the human counterparts due to large 
insertions/deletions. As a result, the Drosophila equivalent of the human mutant 
residues causing arthrogryposis could not be identified with certainty. In order to study 
the arthrogryposis TnI and TnT mutations the UAS-TnI and UAS-TnT constructs had to 
be sufficiently expressed. The way to establish if that was feasible involved rescuing the 
wild type IFM nulls. The TnI null was rescued but the TnT null could not be. The UAS-
TnT" was expressed in an up} background. The up} mutation causes defective splicing 
of the alternative TnT exon lOa. This exon is used to generate an IFM-specific isoform, 
which in IFM development replaces the earlier expressed exon lOb isoform 
(Nongthomba et al., 2007). Here expression of the exon lOa isoform was initiated from 
the early pupal stage when the exon lOb isoform is still expressed. The presence of exon 
lOa isoform during early development may interfere with the function of exon lOb 
isoform. This would not allow rescuing of the upl mutation. Therefore Drosophila IFM 
are not yet a suitable system for modelling TnT arthrogryposis mutations. 
7.9 Future work 
Future directions should include isolating the IR-linked Act88F actins from the IFM to 
biochemically study their interactions to cpb and profilin. Weakened interaction of the 
actin mutants to profilin would strengthen the hypothesis that the mutant actinlprofilin 
complex is retained in the nucleus thus resulting in actin IRs. If the binding of those 
actins to cpb is weakened, it would suggest that aberrant Z-disc assembly is due to the 
inability to cap the barbed ends of the filaments in the mutants. 
The levels of expression of the GFP tagged-wild type ACT88F+ and ACT88FvI63L 
actins, using the UH3-GAL4 driver are unknown. Western blot analysis with anti-GFP 
and anti-actin antibodies for the UH3-GAL4/+; UAS-GFPAct88FVl63L/+ and UH3-
GAL 4/+; UAS-GFPAct88V /+ flies would reveal the expression levels of GFP-tagged 
wild type and GFP-tagged mutant actins. This would allow comparison to the native 
ACT88F protein levels. 
Other future work should include developmental analysis of the G 15R and D292V 
mutants by light microscopy of whole IFM. It is thought that the D292V mutant actin 
disrupts tropomyosin interactions. Biochemical analysis could be carried out to 
understand if the interaction of ACT88FD292V and tropomyosin is weakened. 
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Furthermore, it is unknown what proteins other than actin accumulate in the Drosophila 
IRs. Whole muscle immunostaining showed that kettin did not localise in the IRs. 
Whole muscle immunostaining for different proteins such as the actin nucleator formin 
(Evangelista et al., 2003) and a-actinin (present in human rods) can be carried out. 
Tropomodulin overexpression in cell cultures results in intranuclear rods (Kong and 
Kedes, 2004). Although sanpodo, the Drosophila homologue of tropomodulin, has 
previously been overexpressed, an intranuclear rod phenotype was not reported in those 
flies (Kong and Kedes, 2004). The phenotype may have been overlooked or if the 
muscles were not properly treated the intranuclear rods could have been lost. In this 
thesis fixing the IFM prior to permeabilisation was crucial in order not to lose the 
intranuclear rods. An interesting experiment would be to perform whole muscle staining 
with anti-sanpodo antibody in flies overexpressing sanpodo and see if they also show 
the intranuclear rod phenotype. 
For the rescue of the TnT up} null, to prevent parallel expression of the TnT lOa 
isoform with that of the TnT lOb isoform, a different driver could be used where 
expression occurs at a later stage during pupal development. Introduction of the 
GAL80ts driver into the system may also be a way to circumvent this problem. Shifts in 
temperature so that the flies are grown at 18 ·C where the GAL4 activity is weak and 
then transferred to 25 ·C or 29 ·C degrees at late pupal stages is another possible 
experiment. For the TnI mutants expression of the UAS-TnI constructs in hdp3/+ 
heterozygote females should be followed. Studying the UAS-TnI mutant constructs also 
requires further investigation. 
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Table 1. List of primers. Mutagenized residues are underscored and shown in bold. The '.' 
indicates that the primer was used for gene amplification. 
Gene Mutation 1- Forward (!rimer 5'- 3' Reverse (!rimer 3'- 5' 
a-actin in SlO3C GGATTTCATTGCCT~CAAAGGAGT TGACTCCTTTG£AGGCAATGAAATCC 
Actin CA 
Binding 
Domain GCGCGCCATATGATCGAAGGTCGT GCGCGCCTCGAGTTAGACTGCAGAA 
ATGGATCATCACTACGACCCGC CCTTGCAAATACG 
Actin88F I136M CGTGGCCAT~CAGGCCGTGCTCTC CAGGGAGAGCACGGCCTG£ATGGCC 
CCTG ACG 
Dl54N ACCGGTATTGTGCTG~ACTCCGGC CGCCGGAGTICAGCACAATACCGGT 
G 
V163L TGTCTCCCACACC£TGCCCATCTA CCCTCATAGATGGGCAQGGTGTGGG 
TGAGGG AGACA 
V163M TGTCTCCCACACC~TGCCCATCTAT CCCTCATAGATGGGCAIGGTGTGGG 
GAGGG AGACA 
D292V CATCCGCAAGGITCTGTATGCCAA ACGGAGTTGGCATACAGA~CCTTGC 
CTCCGT GGATG 
Troponin K245@ CGCTGGAGGAGGAGGAGIAGGAG TCTTTTATCTTI1TCTCCT~CTCCTCC 
I AAAAAGATAAAAGA TCCTCCAGCG 
V256G AAAGATGCCGCTGTGCTAQQTAAG TTACTIllTGGCCTTA££TAGCACAG 
GCCAAAAAGT AA CGGCATCTT 
AK257 GATGCCGCTGTGCTAAATGCCAAA GGTACCTTACTTIlTGGCATTTAGCA 
AAGTAAGGTACC CAGCGGCATC 
AE258 GCCGCTGTGCTAAATAAGAAAAAG TGCGGTACCTTACTIllTCTTATTTAG 
TAAGGTACCGCA CACAGCGGC 
CTATGCGAATTCATGGCTGATGAT GCATGAGGTACCTTCTIllTGGCCTT 
GAGAAAAAG ATTTAG 
Troponin K43H GCAAACAGAGATCC£A£GAGGAG CTCA TCCTCCTCQ1QGGA TCTCTGTT 
T GATGAG TGC 
E314@ AGACACCCGAGGGCGAGIAGGAC ATCGGCCTTGGCGTCCT~CTCGCCCT 
GCCAAGGCCGAT CGGGTGTCT 
Exportin GACACCACGGAGAATCAGT GCTCATGGGCTGGTCG 
6 
Capping ACGCAGCCCCTAACATAAACAGTG TCAGTTCGA TTCGGGCTTGACAITGC 
(!rotein ~ T 
rp49 TCCTACCACCTTCAAGATGAC GTGTATTCCGACCACClTACA 
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Legend: 
• intron 
• GENE FLANKING REGION 
• MESS ENGER R A 
• TRA L TIO I ITIATIO CODO 
• FORWARD and REVERSE PRIMER 
Actin88F (CGS178) 
GTCAACAGGAATCGAACGTGCGACTCTATCCAATTTTTCTCCTTTCGTTGACCTAAAAGGt 
gtgtgagtgcgacctcaatgtcgaaggatccaaggattattacagaaaaagccaagaggac 
taaggatattaaaactctttttaataagttcggattgtttgatggatttttctacaagtca 
ctaatcggtcttcgaaagttcaatatctaaatataaagtgaagagtaattgcaacgaaacg 
tattttcaattaatttgatacgtttaaattaagttctatgaactattcttttccgatattt 
atagagcactgatt t agtttcaagtgaataaccatattagcatgagtcaaaaggaaatgga 
atataccaattttggcaatttttcatggttttatttac tga a atgtgctcaaatggacaat 
agagtttcacttcacttcttcaatatcttaaaaagttaaatattttcttgagacacaaatt 
agttttctatgttgtcattaaag tagtagaatttaaagaattgagatgt aggtgggagcta 
taaaactttacatatataatcgacagatcgagctaaccgagtgcacttccatctcccttcc 
agATAAACAACTGCCAAGATGTGTGACGATGATGCGGGTGCATTAGTTATCGACAACGGAT 
CGGGCATGTGCAAAGCCGGCTTCGCCGGTGATGACGCTCCCCGTGCTGTCTTCCCCTCAAT 
TGTGGGTCGTCCCCGACACCAGGGTGTGATGGTGGGTATGGGTCAGAAGGACTCGTACGTG 
GGCGACGAGGCGCAAAGCAAGCGCGGTATCCTGACGCTGAAGTACCCCATCGAGCACGGCA 
TCATCACGAACTGGGACGACATGGAGAAGATCTGGCATCACACCTTCTACAACGAGCTGCG 
CGTGGCCCCCGAGGAGCATCCAGTATTATTGACCGAGGCTCCACTGAACCCCAAGGCCAAT 
CGCGAGAAGATGACCCAGATCATGTTCGAGACCTTCAACTCGCCGGCCATGTACGTGGCCA 
TCCAGGCCGTGCTCTCCCTGTACGCCTCCGGTCGTACCACCGGTATTGTGCTGGACTCCGG 
CGATGGTGTCTCCCACACCGTGCCCATCTATGAGGGCTTCGCCCTGCCCCACGCCATTCTG 
CGTCTGGATCTGGCTGGTCGCGATCTGACCGATTACCTGATGAAGATCCTGACGGAGCGCG 
GCTACAGCTTCACCACCACCGCCGAGCGTGAGATCGTGCGCGACATCAAGGAGAAGCTGTG 
CTACGTGGCTCTGGACTTCGAGCAGGAGATGGCCACCGCTGCCGCCTCCACCTCGCTGGAG 
AAGTCGTACGAGTTGCCTGACGGCCAGGTGATCACCATTGGCAACGAGCGCTTCCGCTGCC 
CCGAGGCTCTGTTCCAGCCCTCGTTCCTGGGCATGGAGTCGTGCGGCATCCACGAGACCGT 
CTACAACTCGATCATGAAGTGCGACGTGGACATCCGCAAGGATCTGTATGCCAACTCTGTG 
CTGTCCGGCGGTACCACCATGTACCCTGgtaagacaaatcattcgcttcagcagttgcact 
tgtgcttaatcctt t ggtgcactttcagGTATTGCCGATCGTATGCAGAAGGAGATCACTG 
CCCTGGCCCCATCGACCATCAAGATCAAGATCATTGCGCCACCCGAGAGGAAGTACTCCGT 
CTGGATCGGTGGCTCCATCCTGGCCTCGCTGTCCACCTTCCAGCAGATGTGGATCTCGAAG 
CAGGAGTACGACGAGTCCGGCCCCGGAATCGTTCACCGCAAATGCTTTTAAGTCTTTCGCC 
CGCCGCGAAAGCTCTTCAAAGGCAGCAACCAGCAGCGACCAACAAGCACCCATCGAGCTAC 
CCAACAACCTCGGCTCGGACAGTGATAGACAAAAGCAGCGAACCCATCGCACAACAATTAT 
CATCCAACTCAGATTCACAGCAGATAATCAGAGGCAACCTCCGGTTGTCGGTGCTCATCCT 
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TCATGGCCATTTCATCGGCAGCGGTATAGCGGATTTTTACTTTGAAGAACTAATCGTAAGA 
GTCGTGGCTGTGCTCCATGTCGAGTAGCAATCAAATGTATATGAGGAGCTTTTAACCCTAG 
TCAGTGAATTGAAAGCCAAATATATCTTCCATTAAAACTATTAAATATTTT 
a-actin in ABD (A28450) (1-807 bp coding sequence) 
ATGGATCATCACTACGACCCGCAGCAGACCAACGATTACATGCAGCCGGAGGAGGACTGGG 
ACCGGGACCTGCTCCTCGACCCGGCTTGGGAGAAGCAGCAGCGGAAGACATTTACAGCATG 
GTGTAATTCTCACCTCCGCAAGGCTGGGACACAGATTGAGAACATAGAGGAAGATTTCAGG 
GATGGTCTTAAACTCATGTTACTTCTGGAAGTCATTTCAGGTGAACGTTTGGCTAAGCCCG 
AAAGAGGCAAAATGCGAGTGCACAAAATATCCAACGTGAACAAGGCCTTGGATTTCATTGC 
CAGCAAAGGAGTCAAACTAGTATCAATTGGAGCAGAAGAAATTGTGGATGGCAACGTTAAA 
ATGACTCTTGGAATGATCTGGACCATCATCCTTCGTTTTGCCATTCAGGATATCTCAGTTG 
AAGAGACATCTGCTAAAGAAGGACTTTTGTTATGGTATCAGAGGAAGACAGCTCCCTACAA 
AAATGTAAACATCCAGAACTTCCATATCAGTTGGAAAGATGGCCTTGGTTTCTGCGCTTTA 
ATTCACAGACATCGTCCAGAGCTCATTGATTACGGGAAGCTACGAAAGGATGATCCTCTCA 
CTAATCTAAACACAGCCTTTGATGTAGCTGAAAAATATCTGGATATCCCCAAGATGCTGGA 
TGCAGAAGACATTGTTGGAACTGCCCGTCCTGACGAGAAAGCCATCATGACCTATGTTTCT 
AGCTTCTACCACGCCTTCTCAGGAGCCCAGAAGGCGGAGACAGCAGCAAATCGTATTTGCA 
AGGTTCTGGCAGTC 
Capping protein b (CG 17158) 
AATAATCGGGCTGTGTTCCAGCTCTAGCACACCATAGCAAAAATAAAAAATCCTAATAATA 
AGGAAAAAGAGTCAATTTAGTGCAATCACTTGCAATATAAGCCCGAAATCCTAGCTAGAGT 
TTAAGATCGGCCCTGCTCAGCGAACGCAGGCCCCTAACATAAACAGTGTAAAACTATCGAA 
ACAAGGGAAAGCAGAAAGTACCAAAATGgtgagtaatactacaatagtaacaagaaaaaaa 
agcaggccaacaaacggtgtttttggtcggaaccgcccattctgcaagccaaatattcttg 
gcaatcacctaatccaccgagaaaacctccagaggggcggcggcctgtggcctcaaataat 
gcccatatatggtaatccctggtttgccgggtggcagtggaaagcggagggattttttggg 
ctc t cttatcggcggtggtgcagtgactcaaattcaatttcactggtgtctcttctcctct 
cttctcagTCGGAAATGCAGATGGACTGTGCTTTGGATCTGATGCGGAGGCTGCCGCCCCA 
GCAGATCGAGAAGAACCTTATTGATCTGATAGACTTGGCACCGGATCTCTGCGAGGACTTG 
CTCTCCTCCGTGGACCAGCCGCTGAAGATCGCCAAGGACAAGGAGCACGGCAAGGACTATC 
TGCTGTGCGACTATAACCGGGATGGGGACTCCTACAGATCGCCCTGGTCGAACTCCTACTA 
TCCGCCGCTGGAGGATGGCCAAATGCCCTCGGAACGACTGCGCAAACTGGAAATCGAGGCG 
AACTATGCCTTCGATCAGTACAGGGAGATGTACTACGAGGGAGGCGTCTCCTCCGTCTACC 
TATGGGATCTGGATCACGGGTTTGCCGCCGTTATACTGATCAAAAAGGCGGGAGATGGCAG 
CAAGATGATCCGCGGCTGCTGGGACTCCATCCATGTGGTCGAGGTACAGGAGAAGACCACC 
GGCAGGACGGCCCACTACAAGCTCACCTCCACGGCAATGCTCTGGCTGCAGACCAACAAAC 
AGGGTTCGGGAACCATGAATCTGGGCGGATCCCTCACCCGGCAGCAGGAGCAGGACGCCAA 
CGTCAGCGAGTCGTCGCCGCACATCGCCAACATTGGCAAGATGGTCGAGGAGATGGAGAAC 
AAGATCAGGAACACCCTGAACGAGATCTACTTTGGCAAGACCAAGGACATCGTGAACGGAC 
TAAGGAGCACACAATCACTGGCCGATCAGCGCCAGCAGGCGGCCATGAAGCAGGACCTCGC 
AGCGGCAATCCTGCGACGCAATGTCAAGCCCGAATCGAACTGGTACTGAGCGGCTGAAGGC 
TGAATTTCCACATAAACCAATCCAGTCCAGGGGCGTCCCACAAGCTGGCTGCTCCCAAGAA 
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GAGCGCAGCAATATTCGAATTGCAAGGCACTGTTGTCACCACTAAATATTGTCATAAATAT 
AAATAATTTTCATAATATTTCGGCTGCACCCACCCAATTCGCTGTTACTCGCCCAATTGTG 
TTGAGCAGCTCCGTGGAGGACTCCGCTTGGACTGGACTAAAGAGCTGACTAAAAAATATTA 
AATACGCATTTCTAGGCAGTAAATTTGTTACATGAGAAAATTGTTACACCACGAGAAGCAC 
ATTAATGTAAATTTTGCCCGCCCGTTTCAACTGTCCTCCCACATTGTTGCCGTTTGGAGTC 
GCGCTTCATCCAGAGTTCAGCCGAAAATGCCAACTTCGCCGCCCTCAAGACAGTATCCATA 
AGTATTTGTATCTTATTTGTAATAATGCATATTTGCACCGAAGTCGAGGCACTTGCGTTTC 
GTTCTTAATCCTTCCGCGAATAAATATTGTGTTTATTAATTGTAACTTTGTGTTTGTGTGT 
AATCTAACAGTAAGGCGCTCGAAGCAAAATATTAACTGAAATCGCTTTGTGATTGTATTAT 
CTGAGGAAATGCACATTACCTTTCTTCTTTACTTAATATTTTTTAACTGAAATTTGGAAGG 
CAAGAGAAATTTTATACAAAGAAACTAATAAATATTGAATTACAA 
Exportin 6 (CG3923) 
(Only part of the gene sequence is shown so as to indicate the amplified regions) 
GCCAGCCGTGCGGAATTTGTTCACTTTCCCGGAGTAGATTTTGGCCACCTTTTGTGTAAAG 
ACACAAAGAAAACCATGCAATTAATGGACGCCGACTGCTGATGCGATCGGAATTAGAACCG 
CGAGCAAGCGGAGCTCACAGTGACCGTAACATCCAGATCACAGATACTCGGAAGGATCGTA 
AAGGACACGGAAAATGgtgaggcggggggctccgggccaaacgcactattttgccagtgat 
tcagagtgattccacctaaccgggaattggtttccacccacccactgtctgtgcagCACGC 
CGCATCTTTGACGACGGTGGAGGGACTGCTGCAGGAGTTTTATCAGCCCAGCACCTCCAAT 
GCCCGGAAACGAGAGATCGAGACAAACCTCTTGGCCTTCAAGTCCCAGCCAGAGGCGTGGC 
AACTTT GCCTCCGTGTGGCCACCTCTTCCGACACCACGGAGAATCAGTTCCTCTGGTTCTT 
CAGCACCTCAACCTTGGAGCACACAATCACGCGGAGATGGACACAGTTGACGTCCACGGAC 
AAGACTTTGCTGCGGGAGACCCTTTGGAACTCGTATGCCCAACTGGTAGCCACTCCAAATG 
TGGCCAAACGGCACAGGGACACACTGGCCCAGTTGATAGCCCTACTCGGAAAGAGGGAGTT 
CCCTGAACAGGACCCCAATTACATGCAACACTGCATGGAACTGACAAAAACACGGTTTCAA 
CTTGGCATCAACCTGCTTAAGATCACCTCCGAGGAGGTGGTAAGCAACAGGGGCGACCTGA 
CCACCGAATGGAAGCAGTACTTCTACTCCTGgtgggtaaatagagcgaagaggctaaaatc 
gtatgttttttaaaaaaggttttgtagtcccatacttttaatgtctgtttaagactacttg 
gatttttaactgagtacggcgtatcagatggtcgatgttttcgagcatagcgtatttttat 
tattaactttggtgttatttgtttaaatacacgattgcgtcgcacaacatagaataacaca 
atcccagaccttgtcagtccgttcttgtttttggtttattaataagtgttatattgagatt 
gagtatgtatatggcataacaactaaagtcagctgacctcttaaaactcaactaattgaac 
cgttaacccagttatcatattatattgctttgttgagagaaagcactataattactggtca 
gttgccacagcactgttcctaacccattttgtgctcccttttgccgtgtgtttctgtagCA 
TCTCCATGTGTGTACCCGATGTTCTGGACCTGGTAACCAAGTATCTGCTAATCGCTGTATG 
CCACATCAATGGCAAAGACATCCAAACAACCATACCAAACACCCTCATGGACTTTAGTCTA 
ACCTCAGCGCTGCCAAATGACAATCAATTAAGgtgggtcatcataacattcaaaagagcat 
atgttcattacaacattttgttataacatctctctatatactccgcaGTTCCTCAATTTTG 
GACCTGCTAGGATGTGTGCAGCACTTGGTCTCCTGGATACGCACTGAACTGATCTCGGAGT 
ACTTCCTTATGAGCATACTTGACCTTTCCCAGTGGCGACCAGCCCATGAGC CCATCTCCTT 
GGCGGCTCTCTCTGTGTTGAATGAGCTCCTCTACCTCCAGAAGCCACTGCCCTTCCCAGGA 
CCCTTGATGGGCGGCGTTACCAGCCTCCTGGAGCAGCACAATAACAATCGGCGGCAGAGCG 
AGATGTACAGCGACAAGTTTCGGGAGCTGCTGCGCCTCTACACCACCAAGTATGCCGCCAA 
GCTGATGCAGGAGCCAGACCTGCTGGAGACCTTTCTCAATCTGCTATACAGCTGCACCACT 
GAAT g t gagtcgcgtgataaaaa tattgccttt t gagatgctaac t tattttttattttga 
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gatgatctttttgctgtgtagtcataaaacactcgcaatattaaatgggttatgtgcatct 
cgtgatcgagatttcgaaatgtcgttgacaaagatatataaca a a agttattaattttgta 
t tccccaaacag 
Troponin I (CG7178) 
(Only the IFM specific gene coding sequence is shown) 
ATGGCTGATGATGAGAAAAAGGCAGCAGCTCCGGCCGCAGCTCCAGCGGCGGCGGCCAAAC 
CGGCGGCTCCGGCAGCAGCCCCGGCGGCCAATGGCAAGGCTGCTCCGGCGGCCAATGGAAA 
GGCTGCTCCGGCAGCTGCCGCCGCTCCCGCCGGTCCGCCCAAGGATCCCAACGACCCCAAA 
GTGAAGGCCGAGGAGGCTAAGAAGGCTAAACAGGCTGAGATCGAGCGCAAGCGTGCTGAGG 
TGCGCAAGCGCATGGAGGAAGCCTCCAAGGCCAAGAAGGCCAAGAAGGGTTTCATGACCCC 
AGAGAGGAAGAAGAAACTCAGGTTGCTGCTGCGTAAGAAAGCCGCTGAGGAGCTGAAGAAA 
GAACAGGAACGCAAAGCGGCTGAACGTAGACGCATCATCGAAGAACGTTGCGGCAGTCCCA 
GGAATCTCAGCGATGCCAGCGAAGGCGAATTGCAAGAGATTTGCGAAGAGTATTACGAGCG 
TATGTATATTTGTGAAGGCCAGAAATGGGATCTGGAATACGAAGTCAGGAAAAAAGACTGG 
GAGATCAACGATCTCAATGCCCAAGTTAACGATCTTCGCGGCAAGTTCGTCAAGCCAGCCC 
TGAAGAAGGTCTCCAAATACGAAAACAAATTCGCCAAGCTGCAGAAGAAGGCCGCTGAGTT 
CAACTTCCGCAACCAGCTCAAGGTGGTGAAGAAGAAGGAGTTCACGCTGGAGGAGGAGGAG 
AAGGAGAAAAAGATAAAAGATGCCGCTGTGCTAAATAAGGCCAAAAAGTAA 
Troponin T (CG7107) 
(Only the IFM specific gene coding sequence is shown) 
ATGTCCGACGATGAAGAGTACACAGGAGAGGGCGATCCAGAGTTCATCAAGCGTCAGGACC 
AGAAGCGCTCCGACCTCGATGATCAGCTGAAAGAATACATCACCGAGTGGCGCAAACAGAG 
ATCCAAGGAGGAGGATGAGCTGAAGAAGCTGAAGGAGAAGCAGGCCAAGCGCAAGGTCACC 
CGCGCCGAGGAGGAGCAAAAGATGGCCCAGCGCAAGAAGGAGGAGGAGGAGCGCCGTGTCC 
GTGAGGCTGAGGAGAAGAAGCAGCGCGAGATCGAGGAGAAGCGCATGCGTCTCGAGGAGGC 
CGAGAAGAAGCGCCAGGCTATGCTGCAGGCCATGAAGGACAAGGACAAGAAGGGCCCCAAC 
TTCACCATTGCCAAGAAGGATGCAGGCGTGTTGGGACTCTCGTCCGCCGCCATGGAACGCA 
ACAAGACTAAGGAACAGTTGGAGGAGGAGAAGAAGATCTCGCTGTCGTTCCGCATCAAGCC 
CTTGGCCATCGAAGGATTCGGCGAGGCTAAGCTGCGCGAGAAGGCCCAGGAGCTGTGGGAG 
CTCATTGTCAAATTGGAAACTGAGAAGTATGACTTGGAAGAAAGGCAGAAACGTCAGGACT 
ACGATTTGAAAGAGTTGAAGGAAAGACAGAAGCAACAGCTCAGGCACAAAGCCTTGAAGAA 
GGGTCTCGACCCGGAAGCTTTGACTGGCAAATACCCGCCCAAGATCCAAGTCGCCTCCAAG 
TATGAGCGACGTGTGGACACCCGCTCTTATGACGACAAGAAGAAGCTCTTCGAGGGTGGCT 
ATAATACGGTCTATGCGGAAACCTTAGAAAAGACCTGGCAAGAAAGACAGGAAAGATTCAC 
TCAGCGCACAAAATCCAAACTGCCAAAGTGGTTCGGCGAGCGACCAGGCAAGAAGGCCGGT 
GAGCCCGAGACACCCGAGGGCGAGGAGGACGCCAAGGCCGATGAGGACATCGTCGAGGATG 
ATGAGGAGGTCGAGGAGGAGGTCGTCGAGGAGGAAGATGAGGAGGCCGAGGAGGATGAGGA 
GGAGGAGGAGGAGGAAGAGGAGGAAGAAGAGGAAGAGGAGGAGGAAGAGGAGGAGGAGGAA 
GAAGAGGAAGAGGAGGAGGAGGAATAG 
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Appendix III 
A typical fluorescent anisotropy setup is shown in figure. 
r 
I [SJ + 
I.L 
Detector 
Figure 1. Schematic layout of the fluorescent anisotropy setup. 
Fluorescence anisotropy (r) is: 
r 
where I II is the fluorescence intensity of vertically polarized emission and h is the intensity 
of horizontally polarized emission with both symbols referring to emissions when the 
sample is excited by vertically polarized light. 
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A Angstrom 
A Adenosine 
A A280 absorbance 
aA a-Actinin 
ABD Actin binding domain 
ABP Actin binding protein 
ADP Adenosine diphosphate 
Act88F Actin88F 
AM Actin filament aggregate myopathy 
Amp Ampicillin 
ATP Adenosine-5'-triphosphate 
BDM 2,3-butanedione monoxime 
bp Base pairs 
c Protein concentration 
C Cytosine 
CAL Calponin homology domain 
CaM Calmodulin 
CAM Congenital actin myopathies 
Cc Critical concentration 
CCD Charge-coupled device 
C. elegans Caenorhabditis elegans 
CFTD Congenital fibre type disproportion 
CH Calponin homology 
Cm Chloramphenicol 
CP Capping protein 
cpa Capping protein a 
cpb Capping protein b 
cps Counts per second 
CSA Cross sectional area 
C.v. Column volume 
Cy5 Cyanine Dye 5 
t>sg B-sarcoglycan 
DA Distal arthrogryposes 
Da Dalton 
DAPI 4',6-diamidino-2-phenylindole 
Dg Dystroglycan 
DLM Dorsal longitudinal muscles 
DNA Deoxyribonucleic acid 
dSMN d Spinal muscular atrophy 
dNTPs Deoxyribonucleotide triphosphate 
dsRNA Double stranded ribonucleic acid 
DTT Dithiothreitol 
DVM Dorso ventral muscles 
Dys Dystrophin 
e molar extinction coefficient 
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EDTA 
EGTA 
EM 
EMS 
ENU 
ERC 
ESI-MS 
Fab 
FAM 
FITC 
G 
GFP 
hdp 
HC 
HMM 
IFM 
Ig 
IgG 
IPTG 
IR 
kb 
kDa 
K! 
kPa 
10 
L 
LB 
LMM 
LOM 
M 
Jlg 
JlI 
JlM 
Jlm 
MALDI-TOF 
MS 
MF 
mg 
MHC 
min 
ml 
Mol 
mRNA 
N 
nbr 
NEB 
NES 
NM 
Ethylenediaminetetraacetic acid 
Ethylene glycol tetraacetic acid 
Electron microscopy 
Ethyl-methane sulphonate 
ethyl-N-nitrosourea 
Essential light chain 
Electrospray ionisation mass spectrometry 
Fragment antigen binding 
5-carboxyfluorescein 
Fluorescein isothiocyanate 
Guanine 
Green fluorescent protein 
Held-up 
Hypercontraction 
Heavy meromyosin chain 
Indirect flight muscles 
Immunoglobulin-like 
Immunoglobulin G 
Isopropyl-beta-D-thiogalactopyranoside 
Intranuclear rods 
Kilo base 
Kilo dalton 
Equilibrium dissociation constant 
Kilopascal 
Myofibril length 
Litre 
Luria-Bertani broth 
Light meromyosin chain 
Larval oblique muscles 
Molar 
Microgram 
M icro litre 
Micromolar 
Micrometre 
Matrix-Assisted Laser Desorption Ionisation - Time Of Flight 
mass spectrometry . 
Myofibril 
Milligram 
Myosin heavy chain 
Minute 
Millilitre 
Moles 
Messenger ribonucleic acid 
Number of 
Number 
Nebulin 
Nuclear export signal 
Nemaline myopathy 
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nm 
P 
PAGE 
PBS 
PCR 
pdb 
PMSF 
R2 
RLC 
RE 
RNA 
RT 
SDS 
Sls 
SMA 
SMN 
siRNA 
SL 
SN 
T 
TILLING 
TC 
TCM 
TDT 
TEM 
TEMED 
Tm 
Tm 
Tmod 
TnC 
TnI 
TnT 
TRITC 
UAS 
up 
Nanometre 
Pellet 
Polyacrylamide gel electrophoresis 
Phosphate buffered saline 
Polymerase chain reaction 
Protein databank 
Phenylmethylsulphonyl fluoride 
Square of the correlation coefficient 
Regulatory light chain 
Regulatory element 
Ribonucleic acid 
Reverse transcriptase 
Sodium dodecyl sulfate 
Sallimus 
Spinal muscular atrophy 
Survival motor neurons 1 
Small interfering RNA 
Sarcomere length 
Supematant 
Thymine 
Targeting-induced local lesions in genomes 
Tendon cells 
Tendon cells and muscle 
Tergal depressor of the trochanter 
Templates 
N, N, N', N' - tetramethyl ethylenediamide 
Tropomyosin 
Melting temperature 
Tropomodulin 
Troponin C 
Troponin I 
Troponin T 
Tetramethylrhodamine isothiocyanate 
Upstream Activating Sequence 
Upheld 
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